data_2lx7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lx7 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.512 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.98 127.26 32.38 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 122.969 0.507 . . . . 0.0 110.451 -177.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.639 ' HG3' ' HB2' ' A' ' 60' ' ' LEU . 35.2 ptt180 -86.68 157.38 19.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.87 0.868 . . . . 0.0 110.149 175.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 28.5 p -152.18 146.84 25.78 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.218 1.007 . . . . 0.0 108.921 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -106.07 125.57 51.16 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.506 HG21 HG11 ' A' ' 57' ' ' VAL . 49.6 p -72.27 140.01 48.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.49 0.716 . . . . 0.0 109.337 177.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mp -85.16 -74.46 0.4 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -144.89 100.39 4.61 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -69.8 101.34 0.9 Allowed 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 123.322 2.681 . . . . 0.0 112.103 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -92.88 161.65 14.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.314 0.646 . . . . 0.0 110.017 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.0 p -152.1 176.96 11.0 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.552 0.741 . . . . 0.0 110.555 -173.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -171.51 -50.94 0.04 OUTLIER Glycine 0 C--N 1.34 0.774 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -85.67 86.23 7.37 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 173.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -100.56 100.09 10.76 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -142.91 123.36 13.94 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.8 -145.95 33.23 Favored Glycine 0 C--N 1.345 1.06 0 O-C-N 123.571 0.545 . . . . 0.0 112.022 -174.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -94.77 60.57 2.51 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.745 0.818 . . . . 0.0 111.297 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.53 136.65 44.7 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-O 119.393 -0.671 . . . . 0.0 111.589 174.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.437 ' HB3' ' HE2' ' A' ' 52' ' ' PHE . 47.4 tp -85.98 114.03 22.55 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 117.363 0.581 . . . . 0.0 109.769 -169.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -99.83 116.73 32.58 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.341 0.657 . . . . 0.0 109.841 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -86.43 157.15 19.89 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.274 0.63 . . . . 0.0 109.387 172.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.75 154.48 19.88 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 169.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.26 133.9 46.43 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.02 0.528 . . . . 0.0 110.538 173.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.92 5.82 88.76 Favored Glycine 0 N--CA 1.475 1.27 0 O-C-N 123.305 0.378 . . . . 0.0 113.474 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -77.13 140.73 40.31 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.028 0.931 . . . . 0.0 111.268 -173.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.1 mt -91.06 104.48 17.06 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.514 0.725 . . . . 0.0 109.2 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.5 mm -117.82 130.62 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.006 1.323 . . . . 0.0 109.666 -176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 87.7 m -90.45 138.52 31.49 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 171.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 pp -75.77 151.27 37.6 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.606 0.362 . . . . 0.0 110.692 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 93.6 mt -109.15 -2.41 18.06 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.016 0.926 . . . . 0.0 110.939 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.419 ' HG2' ' HD3' ' A' ' 35' ' ' PRO . 15.2 tt0 -143.48 152.54 41.61 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.51 56.15 21.29 Favored Pre-proline 0 CA--C 1.57 1.724 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.451 ' HD2' ' CD1' ' A' ' 40' ' ' TRP . 91.0 Cg_endo -77.16 126.29 8.46 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 121.727 1.618 . . . . 0.0 110.085 170.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -62.91 102.69 0.38 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.477 0.711 . . . . 0.0 109.699 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.9 54.22 7.37 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.237 -175.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -142.97 -172.55 14.07 Favored Glycine 0 C--N 1.343 0.951 0 C-N-CA 122.807 0.241 . . . . 0.0 112.68 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 25.0 m95 -81.38 140.74 34.55 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.451 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 12.5 m0 -117.64 136.63 53.19 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 2.2 mp0 -87.36 123.96 32.88 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 175.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.48 143.05 19.88 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -102.89 143.72 32.13 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 173.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -129.49 152.42 49.04 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.336 0.654 . . . . 0.0 110.296 173.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -67.26 -21.9 65.7 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.821 0.849 . . . . 0.0 109.997 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -51.35 -37.74 49.49 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.192 1.397 . . . . 0.0 111.15 169.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.02 -5.09 32.02 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-O 119.295 -0.725 . . . . 0.0 113.828 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 65.6 mt -92.23 172.6 8.31 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.076 0.938 . . . . 0.0 111.604 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -145.13 148.0 33.13 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.439 1.495 . . . . 0.0 109.05 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.403 ' N ' HD23 ' A' ' 21' ' ' LEU . . . -174.72 152.23 13.7 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 175.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.432 ' HB3' ' HG3' ' A' ' 41' ' ' GLU . 39.9 p-90 -97.23 129.98 44.5 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.862 0.865 . . . . 0.0 109.869 -174.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.437 ' HE2' ' HB3' ' A' ' 21' ' ' LEU . 78.8 m-85 -138.19 153.71 73.38 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 124.949 1.3 . . . . 0.0 109.041 -178.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -74.13 168.24 25.27 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.584 2.189 . . . . 0.0 112.457 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.47 -15.19 63.53 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.277 1.031 . . . . 0.0 111.787 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.8 m -55.64 -34.85 65.31 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.691 1.196 . . . . 0.0 112.658 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -97.03 -10.94 25.15 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.506 HG11 HG21 ' A' ' 8' ' ' THR . 34.5 m -122.53 161.1 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.44 0.696 . . . . 0.0 110.854 -177.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -131.18 115.58 16.56 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.346 1.058 . . . . 0.0 108.723 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.3 mt -58.49 132.42 53.69 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.335 0.654 . . . . 0.0 111.074 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.639 ' HB2' ' HG3' ' A' ' 5' ' ' ARG . 90.2 mt . . . . . 0 C--O 1.251 1.135 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.673 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.44 134.79 54.44 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.936 0.894 . . . . 0.0 109.833 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -154.68 177.18 11.52 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.105 0.962 . . . . 0.0 109.572 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.7 m -123.94 -176.45 3.48 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -142.83 128.51 19.22 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.1 p -66.99 147.54 53.1 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.73 0.812 . . . . 0.0 112.344 -176.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.7 mt -84.2 -52.62 6.11 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.271 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -139.11 166.69 22.95 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 124.151 0.98 . . . . 0.0 109.149 -176.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.69 95.58 0.34 Allowed 'Trans proline' 0 C--N 1.388 2.629 0 C-N-CA 121.801 1.667 . . . . 0.0 110.515 175.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -96.85 154.99 16.97 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.32 0.648 . . . . 0.0 111.285 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.7 m -122.47 -10.69 8.39 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.286 1.034 . . . . 0.0 111.059 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.76 -46.62 1.91 Allowed Glycine 0 C--N 1.349 1.269 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -172.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 63.64 16.84 10.0 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.897 1.279 . . . . 0.0 112.254 178.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -121.62 154.61 36.55 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 124.424 1.089 . . . . 0.0 108.663 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -70.43 154.23 42.12 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.216 0.607 . . . . 0.0 110.889 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.43 -116.34 4.88 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -92.29 76.63 5.24 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-O 121.695 0.759 . . . . 0.0 109.151 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.94 93.08 1.82 Allowed Glycine 0 C--N 1.338 0.65 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.7 174.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.542 HD22 ' HB2' ' A' ' 44' ' ' LYS . 36.4 tp -98.66 130.3 45.17 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.231 0.612 . . . . 0.0 109.508 177.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.92 158.32 30.78 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 168.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -158.41 150.5 21.65 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 174.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.01 142.75 38.05 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.815 0.846 . . . . 0.0 110.72 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.54 145.4 50.84 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.464 0.705 . . . . 0.0 111.35 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.46 19.79 79.74 Favored Glycine 0 C--N 1.345 1.053 0 O-C-N 123.808 0.693 . . . . 0.0 113.196 173.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -109.16 156.28 20.03 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.35 0.66 . . . . 0.0 110.776 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.7 mt -79.89 124.38 28.61 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.929 -171.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.554 HG13 HG12 ' A' ' 57' ' ' VAL . 47.6 mm -88.66 106.58 16.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 172.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.9 p -73.5 108.3 6.28 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.5 mt -66.76 93.35 0.25 Allowed 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.163 0.914 . . . . 0.0 109.148 -175.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.588 HD13 HH11 ' A' ' 49' ' ' ARG . 83.3 mt -75.16 -51.89 12.31 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.965 0.906 . . . . 0.0 109.638 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -101.9 136.07 42.37 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.16 86.56 41.7 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.287 1.035 . . . . 0.0 109.216 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.57 -174.41 2.26 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.868 2.378 . . . . 0.0 112.082 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -73.46 -23.27 60.06 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.281 0.632 . . . . 0.0 110.343 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 179.19 174.85 45.68 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 109.74 -101.57 1.47 Allowed Glycine 0 C--N 1.341 0.819 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 14.5 p-90 -137.83 165.1 27.29 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.59 0.756 . . . . 0.0 109.755 -177.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -122.32 149.27 43.98 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.587 0.755 . . . . 0.0 109.183 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.442 ' HG2' HD11 ' A' ' 32' ' ' LEU . 43.2 tt0 -91.15 138.43 31.6 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.89 158.61 16.59 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.572 ' HB2' HD12 ' A' ' 32' ' ' LEU . 28.8 tt0 -110.1 119.36 39.05 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.063 0.545 . . . . 0.0 110.032 -176.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.542 ' HB2' HD22 ' A' ' 21' ' ' LEU . 56.5 tttm -78.76 155.12 29.47 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.439 0.696 . . . . 0.0 109.262 171.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -66.75 -7.02 18.2 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -173.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -78.24 -8.53 58.46 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.517 0.727 . . . . 0.0 111.236 172.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.96 -5.36 84.6 Favored Glycine 0 C--N 1.347 1.193 0 C-N-CA 123.298 0.475 . . . . 0.0 112.403 -171.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.1 mt -78.78 140.59 38.22 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 123.861 0.864 . . . . 0.0 110.584 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.588 HH11 HD13 ' A' ' 32' ' ' LEU . 58.8 mtt-85 -107.07 149.88 27.13 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.562 1.145 . . . . 0.0 108.139 177.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -156.25 -176.3 28.2 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 121.282 -0.485 . . . . 0.0 113.753 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -73.38 126.64 30.63 Favored 'General case' 0 C--N 1.346 0.438 0 C-N-CA 123.235 0.614 . . . . 0.0 110.418 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -139.27 85.26 15.66 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 123.661 0.784 . . . . 0.0 110.149 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.3 151.42 82.51 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.032 2.488 . . . . 0.0 112.023 170.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.24 -15.76 60.7 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.965 0.906 . . . . 0.0 110.79 171.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.3 m -67.75 -38.12 83.05 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 124.32 1.048 . . . . 0.0 111.117 173.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -80.94 -13.0 59.29 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.361 1.064 . . . . 0.0 112.205 -173.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.554 HG12 HG13 ' A' ' 29' ' ' ILE . 29.8 m -132.78 146.2 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.462 0.705 . . . . 0.0 111.091 -171.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.2 127.56 41.34 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 169.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.0 mt -69.06 123.6 21.51 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.928 0.891 . . . . 0.0 110.291 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 72.0 mt . . . . . 0 C--O 1.248 1.008 0 C-N-CA 122.727 0.411 . . . . 0.0 109.95 178.857 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.894 0 CA-C-O 119.79 -0.45 . . . . 0.0 113.79 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.27 103.84 0.21 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.507 0.723 . . . . 0.0 111.494 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.459 ' HG2' ' HA ' ' A' ' 30' ' ' THR . 61.2 mtt180 -143.02 170.4 15.77 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.847 0.859 . . . . 0.0 111.004 -177.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.605 ' SG ' HD22 ' A' ' 59' ' ' LEU . 81.9 m -133.93 172.13 13.23 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 113.882 -1.508 . . . . 0.0 108.352 172.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.553 ' HB2' HD23 ' A' ' 60' ' ' LEU . 36.1 ttm180 -124.61 140.36 53.01 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 172.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.8 p -82.0 136.19 35.28 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.501 0.72 . . . . 0.0 110.262 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 75.3 mt -74.89 -67.1 0.67 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.497 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -141.73 157.66 64.4 Favored Pre-proline 0 N--CA 1.48 1.026 0 C-N-CA 124.718 1.207 . . . . 0.0 108.366 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.518 ' HD3' ' HB1' ' A' ' 25' ' ' ALA . 56.5 Cg_endo -66.38 88.53 0.26 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.263 1.976 . . . . 0.0 111.533 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -91.83 146.87 23.41 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.449 0.7 . . . . 0.0 110.498 -177.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.0 p -153.51 161.26 42.41 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.578 1.151 . . . . 0.0 108.276 173.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.5 -84.23 0.13 Allowed Glycine 0 C--N 1.348 1.236 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -144.5 160.35 41.25 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.829 1.252 . . . . 0.0 108.811 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -74.93 82.55 2.19 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 122.74 0.416 . . . . 0.0 110.736 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.6 t60 171.82 -50.17 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.265 1.826 . . . . 0.0 107.17 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.24 149.74 51.26 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 114.915 -1.039 . . . . 0.0 113.776 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -81.31 163.64 22.76 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.905 0.882 . . . . 0.0 112.106 -175.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.08 160.89 11.69 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.261 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.9 tp -89.53 115.99 27.35 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.563 ' HD2' ' H ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -85.74 154.8 21.37 Favored 'General case' 0 C--O 1.247 0.944 0 C-N-CA 123.648 0.779 . . . . 0.0 111.063 -176.474 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.463 ' HZ ' ' HE1' ' A' ' 56' ' ' TYR . 21.4 p90 -156.42 149.57 24.24 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.192 -171.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.87 148.58 22.01 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.936 0.895 . . . . 0.0 109.657 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.518 ' HB1' ' HD3' ' A' ' 11' ' ' PRO . . . -61.35 114.55 3.25 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.414 0.686 . . . . 0.0 111.606 -178.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.09 -13.16 24.1 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-O 119.248 -0.751 . . . . 0.0 114.209 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -70.91 163.0 28.33 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 118.056 0.928 . . . . 0.0 111.03 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 mp -99.03 126.15 44.68 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.53 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.3 mm -92.89 108.66 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 169.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.459 ' HA ' ' HG2' ' A' ' 5' ' ' ARG . 54.5 m -77.8 107.93 10.66 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.458 HD22 ' SG ' ' A' ' 6' ' ' CYS . 42.6 mt -69.3 115.07 8.15 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.53 ' HB2' ' HG3' ' A' ' 41' ' ' GLU . 46.7 mt -74.72 -50.55 17.05 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.412 0.685 . . . . 0.0 110.091 -173.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.461 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 52.3 tt0 -147.22 166.38 27.18 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.074 0.949 . . . . 0.0 108.624 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.5 m -101.96 84.4 0.57 Allowed Pre-proline 0 CA--C 1.566 1.588 0 C-N-CA 124.347 1.059 . . . . 0.0 109.713 173.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 33' ' ' GLN . 4.8 Cg_exo -74.42 -36.88 2.76 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 122.888 2.392 . . . . 0.0 111.663 -174.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -109.15 -67.61 0.97 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.241 1.016 . . . . 0.0 109.15 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.36 -35.47 1.88 Allowed Glycine 0 C--N 1.35 1.324 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -100.83 -42.52 2.44 Favored Glycine 0 C--N 1.345 1.078 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 171.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -86.8 137.47 32.39 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 168.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -128.02 177.5 6.84 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.727 0.811 . . . . 0.0 109.747 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.53 ' HG3' ' HB2' ' A' ' 32' ' ' LEU . 15.8 pt-20 -118.66 149.64 41.06 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.166 0.986 . . . . 0.0 108.384 174.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.41 125.68 1.87 Allowed Glycine 0 C--N 1.335 0.491 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.408 ' HB2' HD13 ' A' ' 32' ' ' LEU . 35.5 tt0 -101.16 123.55 45.48 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -77.04 167.24 22.15 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.915 0.886 . . . . 0.0 110.072 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -52.21 -35.4 49.18 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.407 1.483 . . . . 0.0 113.505 -175.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -78.26 -16.38 57.85 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.145 0.578 . . . . 0.0 111.662 -175.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.56 -7.55 30.1 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-O 119.702 -0.499 . . . . 0.0 113.446 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.01 125.1 25.6 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 117.619 0.709 . . . . 0.0 110.295 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.2 mtp85 -105.26 128.67 53.55 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -135.38 155.3 22.08 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 29.3 p-90 -80.88 138.98 36.17 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.149 0.579 . . . . 0.0 109.695 174.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -140.58 104.96 6.41 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 123.925 0.89 . . . . 0.0 108.881 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.448 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 94.5 Cg_endo -80.31 165.04 21.38 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.975 2.45 . . . . 0.0 112.219 172.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.01 -30.0 71.1 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.772 0.829 . . . . 0.0 111.013 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.0 p -75.39 7.48 3.53 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.136 0.974 . . . . 0.0 112.541 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.463 ' HE1' ' HZ ' ' A' ' 23' ' ' PHE . 2.6 t80 -124.9 -45.14 1.9 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.6 m -130.51 141.1 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.223 1.009 . . . . 0.0 109.643 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -89.39 132.97 34.73 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 122.952 0.501 . . . . 0.0 111.326 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.605 HD22 ' SG ' ' A' ' 6' ' ' CYS . 93.2 mt -62.32 145.3 54.17 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.225 1.01 . . . . 0.0 111.9 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.553 HD23 ' HB2' ' A' ' 7' ' ' ARG . 95.0 mt . . . . . 0 C--O 1.245 0.84 0 C-N-CA 123.617 0.767 . . . . 0.0 109.832 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.459 0.209 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 31' ' ' LEU . . . -134.88 149.64 50.33 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.755 0.822 . . . . 0.0 109.375 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -128.04 155.0 45.03 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.89 0.876 . . . . 0.0 110.717 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.451 ' SG ' HD12 ' A' ' 31' ' ' LEU . 72.4 m -143.62 173.13 11.93 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.229 1.412 . . . . 0.0 108.795 175.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.9 ttt180 -142.84 131.09 22.05 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.608 HG21 ' HB3' ' A' ' 23' ' ' PHE . 35.2 p -68.12 125.91 27.84 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 124.018 0.927 . . . . 0.0 111.24 -176.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.518 HD22 ' HB2' ' A' ' 58' ' ' GLN . 93.1 mt -67.21 -59.99 2.98 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 123.708 0.63 . . . . 0.0 109.505 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -139.83 153.84 70.22 Favored Pre-proline 0 N--CA 1.476 0.853 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.14 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.423 ' HD3' ' HB3' ' A' ' 25' ' ' ALA . 48.2 Cg_endo -83.63 29.8 0.54 Allowed 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.621 2.214 . . . . 0.0 113.73 -172.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -90.88 101.0 13.76 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.524 ' HB2' ' HA ' ' A' ' 22' ' ' ARG . 25.2 m -148.04 134.39 19.56 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -178.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.21 53.08 4.01 Favored Glycine 0 C--N 1.341 0.824 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -171.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -59.88 104.16 0.27 Allowed 'General case' 0 C--O 1.245 0.841 0 C-N-CA 124.26 1.024 . . . . 0.0 111.414 -177.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 61.8 18.03 9.34 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.651 1.18 . . . . 0.0 112.34 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -156.28 117.9 3.91 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.874 0.869 . . . . 0.0 108.825 -171.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.02 -162.99 16.84 Favored Glycine 0 CA--C 1.533 1.167 0 O-C-N 123.21 0.319 . . . . 0.0 112.539 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 71.53 -2.92 2.28 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.009 1.323 . . . . 0.0 113.304 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.4 178.61 35.62 Favored Glycine 0 C--N 1.348 1.201 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' A' ' 44' ' ' LYS . 43.7 tp -90.36 112.93 24.7 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.524 ' HA ' ' HB2' ' A' ' 13' ' ' SER . 64.7 mtt180 -82.42 139.05 34.23 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.852 0.72 . . . . 0.0 109.374 174.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.608 ' HB3' HG21 ' A' ' 8' ' ' THR . 97.1 m-85 -113.11 135.4 53.85 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.371 0.668 . . . . 0.0 109.604 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.12 138.42 33.04 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 171.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.423 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -64.29 135.59 56.36 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.546 0.738 . . . . 0.0 111.657 -176.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.4 -13.09 67.41 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-O 119.552 -0.582 . . . . 0.0 114.021 177.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -64.96 129.92 41.49 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.183 0.593 . . . . 0.0 111.919 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.9 mt -80.44 100.35 8.45 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.9 mm -95.62 115.2 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.468 0.707 . . . . 0.0 109.502 -175.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.0 m -74.65 125.24 28.25 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 122.943 0.497 . . . . 0.0 109.755 175.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 4' ' ' ALA . 82.4 mt -76.88 126.09 30.4 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 170.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.52 -51.31 15.09 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.529 0.68 . . . . 0.0 110.342 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -153.27 162.42 41.32 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.469 -173.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.9 m -100.82 89.13 1.16 Allowed Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 124.032 0.933 . . . . 0.0 109.569 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -79.76 -4.22 13.31 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.288 2.659 . . . . 0.0 113.518 -171.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -162.6 -69.86 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.808 0.843 . . . . 0.0 109.645 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.24 -52.85 0.55 Allowed Glycine 0 C--N 1.341 0.831 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -174.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -72.31 -46.44 33.98 Favored Glycine 0 C--N 1.344 0.984 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 173.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -93.71 135.46 34.98 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.882 0.873 . . . . 0.0 109.21 174.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 14.5 m0 -133.17 150.39 52.01 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.071 0.949 . . . . 0.0 110.388 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 42.2 mt-10 -91.54 145.85 24.27 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.875 0.87 . . . . 0.0 110.689 -173.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -147.57 170.31 28.34 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.241 0.925 . . . . 0.0 110.99 177.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.407 ' HG2' ' HG2' ' A' ' 49' ' ' ARG . 45.4 mt-10 -126.05 167.23 15.63 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.528 0.731 . . . . 0.0 112.423 -177.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.626 ' HB2' HD12 ' A' ' 21' ' ' LEU . 3.3 tmtp? -126.4 146.64 49.99 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 164.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.435 ' H ' ' HD3' ' A' ' 44' ' ' LYS . 1.7 mp0 -66.45 -9.71 36.87 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.081 0.952 . . . . 0.0 111.647 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -77.76 -8.65 58.29 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 124.858 1.263 . . . . 0.0 111.537 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.87 -13.42 57.67 Favored Glycine 0 C--N 1.355 1.61 0 C-N-CA 123.159 0.409 . . . . 0.0 112.916 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.16 133.66 34.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.311 0.644 . . . . 0.0 109.841 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.407 ' HG2' ' HG2' ' A' ' 43' ' ' GLU . 39.0 mtm180 -111.62 173.81 6.17 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.134 0.974 . . . . 0.0 109.689 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -167.88 153.49 22.8 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.56 174.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -121.61 125.75 47.46 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -144.02 156.14 58.56 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 124.217 1.007 . . . . 0.0 109.718 -168.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -68.57 153.85 72.76 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 122.725 2.284 . . . . 0.0 112.719 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.66 -14.51 63.0 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.6 1.16 . . . . 0.0 112.288 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.7 t -55.94 -23.58 32.88 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.508 1.123 . . . . 0.0 112.969 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -106.72 -7.07 17.43 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.2 0.6 . . . . 0.0 112.392 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 6' ' ' CYS . 12.9 m -135.9 124.76 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.688 0.795 . . . . 0.0 110.206 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.518 ' HB2' HD22 ' A' ' 9' ' ' LEU . 63.2 tt0 -80.81 127.09 32.12 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 37.9 mt -73.59 133.89 43.61 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.761 0.824 . . . . 0.0 110.871 -173.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.0 mt . . . . . 0 C--O 1.251 1.151 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.864 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.777 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.55 140.69 55.62 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 81.9 mtm-85 -126.55 138.61 53.49 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.082 0.553 . . . . 0.0 110.137 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.665 ' SG ' HD22 ' A' ' 59' ' ' LEU . 77.3 m -128.49 170.47 13.13 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.475 1.11 . . . . 0.0 109.709 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -140.71 138.18 34.03 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.607 0.763 . . . . 0.0 109.153 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.635 HG22 HD12 ' A' ' 29' ' ' ILE . 1.6 p -66.91 128.81 37.73 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.579 0.751 . . . . 0.0 110.839 176.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.5 mp -74.38 -38.17 63.24 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -129.78 152.63 80.16 Favored Pre-proline 0 C--O 1.245 0.867 0 C-N-CA 125.405 1.482 . . . . 0.0 108.03 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.48 145.29 76.39 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.065 1.843 . . . . 0.0 111.843 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -89.92 106.64 18.61 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 173.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.8 m -59.34 138.69 57.54 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 124.323 1.014 . . . . 0.0 111.164 -176.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.78 72.04 1.83 Allowed Glycine 0 C--N 1.349 1.257 0 O-C-N 123.92 0.763 . . . . 0.0 111.439 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -70.56 96.99 1.25 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.287 1.035 . . . . 0.0 109.856 -176.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -77.45 75.78 4.0 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.92 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -169.1 95.85 0.34 Allowed 'General case' 0 C--O 1.241 0.641 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.78 -131.19 10.6 Favored Glycine 0 N--CA 1.469 0.844 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -174.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -155.0 142.22 19.42 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.217 0.607 . . . . 0.0 109.994 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.23 157.55 29.69 Favored Glycine 0 C--N 1.344 1.001 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.8 tp -90.15 126.0 35.65 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -88.96 134.22 34.05 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.1 0.96 . . . . 0.0 111.615 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -145.07 111.53 5.71 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 163.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.71 157.74 28.48 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.54 0.736 . . . . 0.0 109.939 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.98 119.52 7.39 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.309 0.643 . . . . 0.0 111.326 -174.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.93 -22.03 12.96 Favored Glycine 0 C--N 1.347 1.184 0 O-C-N 123.654 0.596 . . . . 0.0 113.148 -176.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -72.2 143.11 48.98 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.179 0.514 . . . . 0.0 111.427 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.29 117.3 30.05 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.317 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.635 HD12 HG22 ' A' ' 8' ' ' THR . 3.3 mp -85.4 108.27 17.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.4 m -85.06 102.35 13.16 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.539 HD12 ' SG ' ' A' ' 6' ' ' CYS . 90.2 mt -76.23 104.52 6.79 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.243 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.494 HD13 ' HB2' ' A' ' 43' ' ' GLU . 58.9 mt -77.95 -42.91 31.41 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.537 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.447 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 32.6 mm-40 -121.33 136.99 54.89 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.384 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.7 m -137.38 72.06 52.09 Favored Pre-proline 0 CA--C 1.557 1.217 0 C-N-CA 124.301 1.04 . . . . 0.0 109.643 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.42 169.54 20.59 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.52 2.147 . . . . 0.0 112.269 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.46 92.17 0.43 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.618 0.767 . . . . 0.0 110.196 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 166.68 -164.84 38.02 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.563 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.08 -29.52 9.62 Favored Glycine 0 N--CA 1.473 1.115 0 N-CA-C 113.403 0.121 . . . . 0.0 113.403 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -94.19 100.21 12.33 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.526 0.73 . . . . 0.0 110.159 -168.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -111.19 150.98 28.75 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.304 1.042 . . . . 0.0 109.248 -175.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 33' ' ' GLN . 35.5 tt0 -89.39 125.91 35.33 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -176.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -123.17 140.6 13.17 Favored Glycine 0 C--N 1.34 0.752 0 O-C-N 124.689 1.243 . . . . 0.0 110.1 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.494 ' HB2' HD13 ' A' ' 32' ' ' LEU . 37.8 tt0 -106.37 140.67 38.93 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.123 0.487 . . . . 0.0 110.717 -177.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -97.05 151.85 19.33 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.013 1.325 . . . . 0.0 108.085 172.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -68.2 -14.2 62.81 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.934 0.493 . . . . 0.0 111.93 -173.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -69.12 -20.71 64.05 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.52 0.728 . . . . 0.0 111.644 174.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.07 -9.4 36.59 Favored Glycine 0 C--N 1.344 1.008 0 C-N-CA 123.413 0.53 . . . . 0.0 112.406 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.1 mp -75.72 121.33 22.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.576 0.75 . . . . 0.0 109.795 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -104.59 158.37 16.54 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.858 0.863 . . . . 0.0 108.978 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -172.13 163.1 35.33 Favored Glycine 0 CA--C 1.507 -0.461 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.879 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 3.6 p-90 -86.06 138.35 32.01 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.591 0.757 . . . . 0.0 109.062 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -132.26 140.13 37.03 Favored Pre-proline 0 C--O 1.242 0.677 0 C-N-CA 124.105 0.962 . . . . 0.0 108.429 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.482 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 39.7 Cg_endo -69.45 134.5 28.81 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 121.843 1.695 . . . . 0.0 109.98 173.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.62 -24.9 65.87 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.371 1.068 . . . . 0.0 111.29 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.0 m -64.82 -35.82 82.33 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.263 1.025 . . . . 0.0 111.32 176.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.482 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 35.5 t80 -81.69 -19.69 41.05 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.377 0.671 . . . . 0.0 111.581 -173.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.467 ' HB ' ' HB3' ' A' ' 6' ' ' CYS . 35.4 m -115.41 149.71 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.237 0.615 . . . . 0.0 110.691 -176.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -110.64 117.58 33.87 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.79 0.836 . . . . 0.0 110.168 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.665 HD22 ' SG ' ' A' ' 6' ' ' CYS . 64.2 mt -66.46 123.23 19.44 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 171.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.2 mp . . . . . 0 C--O 1.248 1.021 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.162 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.774 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.521 ' HB2' ' HB2' ' A' ' 31' ' ' LEU . . . -73.51 164.68 26.33 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.889 0.476 . . . . 0.0 109.95 173.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.466 ' HG3' ' HB2' ' A' ' 60' ' ' LEU . 15.6 ptt180 -141.89 149.55 40.36 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.445 0.698 . . . . 0.0 109.908 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.645 ' SG ' ' HA ' ' A' ' 59' ' ' LEU . 57.0 m -145.11 145.31 31.36 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.571 0.749 . . . . 0.0 109.503 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.53 ' HB2' HD11 ' A' ' 60' ' ' LEU . 6.7 tmm_? -106.77 136.56 46.38 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.44 ' HA ' HG12 ' A' ' 57' ' ' VAL . 52.5 p -75.59 127.46 33.12 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.779 1.232 . . . . 0.0 111.891 -174.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.401 ' HA ' ' NH1' ' A' ' 7' ' ' ARG . 96.1 mt -67.87 -56.47 8.98 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.443 0.697 . . . . 0.0 110.38 177.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -129.22 154.46 80.56 Favored Pre-proline 0 N--CA 1.478 0.949 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.249 -175.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.27 138.52 51.51 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.899 2.4 . . . . 0.0 111.983 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.425 ' HD2' ' HA ' ' A' ' 22' ' ' ARG . 50.4 t80 -111.38 101.24 9.71 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 172.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.0 m -138.27 70.16 1.39 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 169.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -106.27 -46.37 1.16 Allowed Glycine 0 C--N 1.34 0.786 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.977 176.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 56.74 31.81 20.06 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.337 1.055 . . . . 0.0 111.667 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -63.28 -36.41 83.58 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.73 0.812 . . . . 0.0 110.581 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -123.62 152.92 41.42 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.631 1.172 . . . . 0.0 109.36 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.62 -39.7 93.89 Favored Glycine 0 C--N 1.343 0.965 0 O-C-N 123.964 0.79 . . . . 0.0 112.234 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -82.15 89.3 6.47 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.37 136.24 2.89 Favored Glycine 0 C--N 1.345 1.082 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.0 tp -91.01 119.58 31.3 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.549 0.74 . . . . 0.0 109.685 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.425 ' HA ' ' HD2' ' A' ' 12' ' ' PHE . 15.3 ptm180 -92.23 146.68 23.52 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -158.96 174.59 14.72 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.073 0.949 . . . . 0.0 110.765 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.03 168.09 9.28 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.183 0.993 . . . . 0.0 108.855 170.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.79 146.65 49.62 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 172.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.86 -9.82 76.68 Favored Glycine 0 N--CA 1.468 0.799 0 CA-C-N 116.07 -0.514 . . . . 0.0 113.888 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -76.44 135.12 39.4 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.24 0.616 . . . . 0.0 111.019 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.411 HD22 ' HD2' ' A' ' 5' ' ' ARG . 6.9 mp -98.44 114.73 27.21 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.598 HG13 ' HD3' ' A' ' 44' ' ' LYS . 2.6 mp -102.24 125.34 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 174.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 87.0 m -76.3 126.88 31.79 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.77 0.828 . . . . 0.0 110.507 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.598 HD11 ' SG ' ' A' ' 6' ' ' CYS . 5.6 mp -76.2 140.56 41.73 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.907 174.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.3 mt -82.77 -47.24 12.15 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.593 177.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -146.83 156.67 43.3 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.126 0.97 . . . . 0.0 109.358 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.4 m -114.01 87.5 12.96 Favored Pre-proline 0 CA--C 1.561 1.377 0 C-N-CA 123.73 0.812 . . . . 0.0 109.968 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.57 82.89 1.6 Allowed 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.515 2.143 . . . . 0.0 111.584 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 59.03 -86.88 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.146 1.379 . . . . 0.0 111.553 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.55 -168.91 29.44 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-N 116.388 -0.369 . . . . 0.0 112.628 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.46 -71.86 2.61 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -124.0 136.91 54.6 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.076 0.95 . . . . 0.0 108.724 172.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -124.22 160.46 27.88 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 173.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -110.92 148.58 32.17 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.069 0.461 . . . . 0.0 110.635 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.82 175.31 31.41 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.531 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -139.4 144.73 38.26 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.598 ' HD3' HG13 ' A' ' 29' ' ' ILE . 27.6 tptp -101.99 156.36 17.58 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.724 -178.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -52.88 -25.76 12.68 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 125.535 1.534 . . . . 0.0 113.01 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.81 -16.07 63.46 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.36 1.064 . . . . 0.0 112.551 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.47 -0.96 75.3 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 -171.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.6 mt -85.5 124.21 31.82 Favored 'General case' 0 C--N 1.346 0.433 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 45.0 ttp85 -104.74 138.72 40.61 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 149.71 154.5 6.43 Favored Glycine 0 C--O 1.243 0.695 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.467 ' HZ2' ' HB2' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -154.73 172.47 17.88 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.518 0.675 . . . . 0.0 111.192 -174.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -138.87 153.09 71.61 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 124.591 1.157 . . . . 0.0 109.616 -168.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.99 172.98 3.41 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.564 2.176 . . . . 0.0 113.268 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.38 -15.4 10.47 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.728 1.211 . . . . 0.0 113.24 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.8 t -61.16 -34.06 74.42 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.688 0.795 . . . . 0.0 112.083 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -92.2 -33.06 14.85 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.277 0.631 . . . . 0.0 111.432 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 8' ' ' THR . 11.4 m -138.46 138.76 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.358 0.663 . . . . 0.0 111.069 -166.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -97.4 128.9 44.59 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.205 0.602 . . . . 0.0 110.466 174.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.645 ' HA ' ' SG ' ' A' ' 6' ' ' CYS . 5.0 mp -79.58 118.75 21.71 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.367 -173.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.53 HD11 ' HB2' ' A' ' 7' ' ' ARG . 85.9 mt . . . . . 0 C--O 1.249 1.079 0 C-N-CA 123.909 0.883 . . . . 0.0 109.863 -177.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.805 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.64 106.67 3.13 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.15 0.58 . . . . 0.0 110.2 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -136.52 139.4 42.23 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.576 ' SG ' HD23 ' A' ' 59' ' ' LEU . 54.4 m -129.71 154.44 47.17 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.959 0.904 . . . . 0.0 109.058 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.433 HH21 ' HA ' ' A' ' 9' ' ' LEU . 6.4 ttp180 -105.87 128.61 53.87 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 40.3 p -69.45 140.79 54.09 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.701 0.8 . . . . 0.0 110.976 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.51 HD21 ' HB2' ' A' ' 58' ' ' GLN . 91.0 mt -73.9 -68.03 0.55 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.024 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -144.7 157.76 54.56 Favored Pre-proline 0 N--CA 1.482 1.152 0 C-N-CA 124.131 0.972 . . . . 0.0 109.169 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 25' ' ' ALA . 10.9 Cg_exo -70.99 162.02 44.13 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 122.643 2.229 . . . . 0.0 110.919 173.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -91.93 155.44 18.15 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.979 0.511 . . . . 0.0 110.377 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.7 m -60.43 -31.11 70.09 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.201 0.601 . . . . 0.0 111.976 -175.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.2 -37.48 3.32 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-O 119.92 -0.378 . . . . 0.0 112.406 175.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -65.78 96.2 0.28 Allowed 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.111 0.565 . . . . 0.0 110.445 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.2 tpt180 -161.07 117.45 2.24 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.575 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -74.23 86.58 1.93 Allowed 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 121.894 0.854 . . . . 0.0 110.0 175.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.21 156.4 9.44 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.187 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.78 130.75 35.59 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -145.82 172.85 26.38 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 112.259 -0.336 . . . . 0.0 112.259 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.5 tp -90.91 136.56 32.99 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.445 0.698 . . . . 0.0 109.829 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -88.31 136.39 33.01 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 123.903 0.752 . . . . 0.0 110.272 174.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -160.18 176.11 12.14 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.174 0.989 . . . . 0.0 110.31 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.411 ' HA ' ' HG3' ' A' ' 11' ' ' PRO . . . -123.96 167.37 14.24 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.329 1.052 . . . . 0.0 109.874 176.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.582 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . . . -67.19 128.44 36.4 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.375 0.67 . . . . 0.0 110.686 175.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.22 1.46 59.41 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-O 119.738 -0.479 . . . . 0.0 113.671 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -78.93 116.69 19.41 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.967 0.507 . . . . 0.0 110.971 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 mp -76.63 100.61 5.41 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 172.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.5 mm -94.05 121.31 44.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 123.975 0.91 . . . . 0.0 109.274 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 31.6 m -74.95 125.38 28.76 Favored 'General case' 0 C--O 1.241 0.658 0 C-N-CA 123.158 0.583 . . . . 0.0 109.88 175.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.1 mt -73.48 128.68 36.16 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.568 HD12 HH11 ' A' ' 49' ' ' ARG . 74.2 mt -73.57 -52.2 14.31 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.871 0.868 . . . . 0.0 110.037 -174.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -139.0 144.57 38.96 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 173.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.5 m -110.01 108.89 59.19 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.661 0.784 . . . . 0.0 110.095 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -72.34 171.67 16.5 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.964 2.442 . . . . 0.0 111.549 171.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -81.47 -6.49 59.0 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.041 177.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.25 -176.81 39.05 Favored Glycine 0 C--N 1.351 1.397 0 O-C-N 123.18 0.3 . . . . 0.0 112.743 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -100.47 36.42 4.16 Favored Glycine 0 C--N 1.348 1.22 0 C-N-CA 123.395 0.522 . . . . 0.0 112.547 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -126.9 108.03 10.62 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 175.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 25.0 m0 -111.74 145.68 38.9 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.764 0.426 . . . . 0.0 110.459 -172.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.694 ' HG2' ' HB3' ' A' ' 51' ' ' TRP . 38.8 mt-10 -106.13 123.86 48.68 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.925 0.89 . . . . 0.0 109.602 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -118.6 -179.72 16.95 Favored Glycine 0 C--N 1.34 0.75 0 O-C-N 123.766 0.667 . . . . 0.0 112.468 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -145.86 159.61 42.96 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.069 0.947 . . . . 0.0 109.903 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.462 ' HE3' ' HG2' ' A' ' 45' ' ' GLU . 20.8 mmmt -121.02 170.4 9.55 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.908 0.883 . . . . 0.0 111.284 175.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.462 ' HG2' ' HE3' ' A' ' 44' ' ' LYS . 10.4 pt-20 -54.49 -28.67 46.41 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.614 1.566 . . . . 0.0 112.65 174.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -63.09 -34.17 77.03 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.844 1.257 . . . . 0.0 111.318 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.17 -22.61 24.8 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -173.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 51.7 tp -63.17 140.76 58.91 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 123.117 0.567 . . . . 0.0 109.877 175.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.568 HH11 HD12 ' A' ' 32' ' ' LEU . 49.9 mtt-85 -116.71 173.29 6.71 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.436 1.095 . . . . 0.0 108.491 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.65 175.66 45.9 Favored Glycine 0 CA--C 1.505 -0.537 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.694 ' HB3' ' HG2' ' A' ' 41' ' ' GLU . 33.0 p-90 -141.85 136.0 30.13 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.48 0.712 . . . . 0.0 109.765 -176.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -139.77 161.0 58.71 Favored Pre-proline 0 C--O 1.247 0.925 0 C-N-CA 124.603 1.161 . . . . 0.0 108.748 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.06 144.94 35.46 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.017 2.478 . . . . 0.0 113.095 171.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.22 -27.05 68.79 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.094 0.958 . . . . 0.0 111.404 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.1 m -68.62 -25.35 64.81 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.79 0.836 . . . . 0.0 111.468 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -77.37 -19.81 55.69 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.147 0.579 . . . . 0.0 111.276 -174.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.8 m -117.24 168.23 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.85 0.86 . . . . 0.0 109.837 175.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.51 ' HB2' HD21 ' A' ' 9' ' ' LEU . 24.6 tt0 -119.71 135.06 54.99 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.828 0.851 . . . . 0.0 108.796 177.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.576 HD23 ' SG ' ' A' ' 6' ' ' CYS . 96.6 mt -65.72 145.31 56.17 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.773 0.429 . . . . 0.0 110.206 172.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--O 1.251 1.18 0 C-N-CA 122.908 0.483 . . . . 0.0 109.992 177.941 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.374 0 N-CA-C 112.55 -0.22 . . . . 0.0 112.55 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.63 ' HB3' HD22 ' A' ' 31' ' ' LEU . . . -83.37 136.92 34.17 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.701 ' HB2' ' HB2' ' A' ' 60' ' ' LEU . 46.7 mtt-85 -120.97 169.52 10.4 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.682 0.753 . . . . 0.0 110.036 -167.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.1 m -135.32 148.29 49.42 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 169.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -123.53 128.92 50.44 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 175.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.2 p -79.73 125.88 30.23 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.528 -176.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.6 mt -72.47 -52.17 16.99 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.228 -174.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.426 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 71.3 m-85 -139.79 159.81 63.45 Favored Pre-proline 0 N--CA 1.483 1.207 0 C-N-CA 123.828 0.851 . . . . 0.0 109.656 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.414 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . 1.8 Cg_endo -79.17 99.95 1.3 Allowed 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 122.197 1.931 . . . . 0.0 109.886 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -99.72 140.49 33.84 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.314 0.646 . . . . 0.0 109.837 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.2 m -144.35 95.33 2.7 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.934 0.894 . . . . 0.0 108.819 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.34 -170.09 44.58 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.535 173.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -129.42 132.08 46.92 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.952 0.406 . . . . 0.0 110.65 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.8 mtt-85 -145.19 141.69 28.92 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.049 1.34 . . . . 0.0 108.895 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -68.95 99.56 1.08 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 171.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.8 -120.3 1.45 Allowed Glycine 0 C--N 1.341 0.849 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -176.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.412 HE21 ' HA ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -162.12 123.09 2.62 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.308 0.643 . . . . 0.0 110.054 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.27 163.69 21.09 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 169.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.6 tp -92.98 126.27 37.98 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 117.484 0.642 . . . . 0.0 109.499 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -77.76 150.19 34.4 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.218 1.007 . . . . 0.0 111.596 -171.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -152.35 148.46 27.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.584 0.753 . . . . 0.0 110.162 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.414 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . . . -110.06 167.09 10.43 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.648 1.179 . . . . 0.0 108.513 173.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.426 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . . . -75.98 142.74 41.85 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.636 0.375 . . . . 0.0 111.447 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.44 -21.49 45.27 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.753 170.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.77 162.4 22.93 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 121.267 0.556 . . . . 0.0 110.29 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 mp -108.16 119.81 40.55 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.427 -174.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.2 mm -85.84 114.86 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 174.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.5 m -89.42 131.07 35.65 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.391 0.676 . . . . 0.0 109.449 177.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.63 HD22 ' HB3' ' A' ' 4' ' ' ALA . 2.7 pp -76.15 148.85 37.51 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.29 0.567 . . . . 0.0 111.422 177.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.559 HD13 ' HB2' ' A' ' 43' ' ' GLU . 48.5 mt -99.66 -19.21 16.92 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.198 0.999 . . . . 0.0 109.664 176.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -153.53 150.54 28.81 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.642 0.777 . . . . 0.0 109.89 -173.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.8 m -119.62 86.57 35.08 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.088 0.955 . . . . 0.0 109.273 170.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -85.39 -168.35 0.49 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.693 2.262 . . . . 0.0 110.679 171.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -84.72 140.75 31.06 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 172.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.17 161.3 37.33 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 123.764 0.665 . . . . 0.0 111.788 -175.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.53 58.21 4.68 Favored Glycine 0 C--N 1.348 1.197 0 C-N-CA 123.134 0.397 . . . . 0.0 112.557 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -130.91 99.38 4.89 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 36.5 m0 -113.13 145.5 40.82 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.427 0.691 . . . . 0.0 109.432 -177.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.75 117.41 28.59 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -176.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.9 168.87 26.44 Favored Glycine 0 C--O 1.239 0.46 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 170.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.559 ' HB2' HD13 ' A' ' 32' ' ' LEU . 41.6 tt0 -149.79 146.71 27.32 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.889 0.476 . . . . 0.0 110.207 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.537 ' HZ3' ' HB3' ' A' ' 44' ' ' LYS . 8.6 mtpm? -104.59 -177.5 3.38 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.625 0.726 . . . . 0.0 112.34 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.77 -33.54 73.11 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.337 1.455 . . . . 0.0 109.683 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -58.85 -25.76 63.57 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.181 1.392 . . . . 0.0 112.051 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.21 -11.72 71.25 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.889 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.1 mt -72.54 131.23 42.23 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 123.742 0.817 . . . . 0.0 109.202 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -117.53 160.94 20.41 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.958 0.903 . . . . 0.0 110.156 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -173.56 155.7 22.7 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.646 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 46.1 p-90 -70.68 152.35 43.95 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.321 0.648 . . . . 0.0 110.958 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -134.08 138.01 29.57 Favored Pre-proline 0 C--O 1.243 0.745 0 C-N-CA 123.979 0.912 . . . . 0.0 109.101 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.435 ' HB2' ' HB2' ' A' ' 56' ' ' TYR . 9.1 Cg_exo -71.49 113.07 3.51 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.768 2.312 . . . . 0.0 110.378 172.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.99 -32.5 73.77 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.56 0.744 . . . . 0.0 112.11 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.3 t -73.45 -17.64 61.22 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.846 0.458 . . . . 0.0 111.576 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.435 ' HB2' ' HB2' ' A' ' 53' ' ' PRO . 35.1 t80 -75.67 -35.48 60.36 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.712 0.805 . . . . 0.0 110.383 -177.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.9 m -111.81 166.5 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.9 0.88 . . . . 0.0 110.765 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -83.24 125.4 31.53 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 63.9 mt -84.51 141.82 30.48 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.655 0.382 . . . . 0.0 110.529 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.701 ' HB2' ' HB2' ' A' ' 5' ' ' ARG . 96.5 mt . . . . . 0 C--O 1.253 1.255 0 C-N-CA 123.955 0.902 . . . . 0.0 108.877 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.364 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.02 99.5 0.87 Allowed 'General case' 0 C--N 1.35 0.621 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -117.55 156.08 28.69 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.418 0.687 . . . . 0.0 110.068 -176.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.9 m -139.44 156.2 47.11 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.609 1.164 . . . . 0.0 108.659 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -107.39 148.78 28.66 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.661 0.784 . . . . 0.0 109.222 176.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.0 p -91.26 130.17 37.16 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 122.82 0.448 . . . . 0.0 110.557 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.2 mt -63.09 -64.03 1.03 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.299 1.04 . . . . 0.0 111.02 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -129.29 158.41 73.16 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 123.988 0.915 . . . . 0.0 108.949 -177.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.627 ' HD3' ' HB1' ' A' ' 25' ' ' ALA . 72.7 Cg_endo -73.68 98.07 1.02 Allowed 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.067 1.845 . . . . 0.0 110.987 176.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -90.8 100.23 13.12 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.7 m -96.98 75.82 2.67 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.911 0.885 . . . . 0.0 109.788 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -134.51 153.67 21.13 Favored Glycine 0 C--O 1.244 0.757 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.611 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 56.64 73.5 0.45 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.268 1.027 . . . . 0.0 110.217 -175.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -85.81 32.35 0.6 Allowed 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.439 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -169.06 159.76 9.42 Favored 'General case' 0 C--O 1.247 0.936 0 C-N-CA 124.984 1.313 . . . . 0.0 108.84 -170.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.61 -123.31 19.32 Favored Glycine 0 C--N 1.344 0.993 0 O-C-N 123.388 0.43 . . . . 0.0 113.685 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -94.48 5.56 51.45 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.859 0.864 . . . . 0.0 112.267 -174.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.1 126.4 8.28 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.271 0.357 . . . . 0.0 112.877 -177.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.0 tp -105.23 117.75 34.81 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 173.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -87.39 149.42 24.48 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.124 0.97 . . . . 0.0 110.239 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -158.44 153.13 24.72 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.718 0.807 . . . . 0.0 110.814 -177.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.14 169.22 11.03 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.484 1.114 . . . . 0.0 110.667 172.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.627 ' HB1' ' HD3' ' A' ' 11' ' ' PRO . . . -61.06 125.71 24.7 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.279 0.631 . . . . 0.0 111.191 175.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.03 -4.71 65.54 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-O 119.203 -0.776 . . . . 0.0 114.116 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -52.39 120.0 5.07 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.037 0.935 . . . . 0.0 111.702 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.4 mt -82.52 99.62 9.6 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 48.9 mm -88.43 111.04 21.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 124.454 1.102 . . . . 0.0 108.079 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.5 m -87.51 107.48 18.59 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.553 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.519 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 41.4 mt -65.01 134.87 54.83 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.635 0.774 . . . . 0.0 109.624 175.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.2 mt -75.34 -47.77 26.19 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.276 0.631 . . . . 0.0 109.736 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -141.19 159.43 42.23 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.528 1.131 . . . . 0.0 108.396 174.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.0 m -119.59 84.81 31.09 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 171.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -72.07 169.27 21.81 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.761 2.307 . . . . 0.0 111.254 175.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -70.55 96.99 1.24 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.385 0.674 . . . . 0.0 110.019 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.95 173.56 23.15 Favored Glycine 0 C--N 1.344 0.985 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.808 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -91.99 28.6 8.46 Favored Glycine 0 C--N 1.345 1.052 0 C-N-CA 122.853 0.263 . . . . 0.0 113.12 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -127.16 116.71 21.06 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.571 1.148 . . . . 0.0 108.052 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 8.7 m0 -128.89 139.32 52.19 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -91.53 119.27 31.32 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 31' ' ' LEU . . . -110.44 136.34 13.52 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.236 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -104.11 141.17 36.7 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.181 0.593 . . . . 0.0 109.971 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -93.97 160.3 14.78 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.712 1.205 . . . . 0.0 109.565 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.88 -24.55 52.66 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.449 1.1 . . . . 0.0 111.977 175.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -60.35 -36.11 77.24 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.105 1.362 . . . . 0.0 111.95 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.78 -20.19 22.59 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 116.252 -0.431 . . . . 0.0 112.458 -177.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -76.63 134.17 39.4 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -119.27 139.83 51.26 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.34 1.056 . . . . 0.0 109.459 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -133.18 150.63 19.86 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 178.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 48.7 m95 -82.8 130.2 35.1 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.105 0.962 . . . . 0.0 108.999 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -140.07 151.71 65.67 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 122.973 0.509 . . . . 0.0 111.289 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -65.88 158.89 51.57 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.982 2.455 . . . . 0.0 112.043 168.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.96 -36.76 82.93 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.0 0.92 . . . . 0.0 111.861 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.7 t -79.66 -14.63 58.65 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.894 0.878 . . . . 0.0 111.71 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -71.93 -29.22 64.07 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.386 0.674 . . . . 0.0 110.519 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.1 m -111.72 172.67 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.253 1.021 . . . . 0.0 109.857 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -113.93 126.22 54.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.02 0.928 . . . . 0.0 109.478 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 75.0 mt -69.73 140.7 53.52 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.295 0.638 . . . . 0.0 109.925 176.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 CA--C 1.556 1.188 0 C-N-CA 123.243 0.617 . . . . 0.0 110.751 -179.369 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.926 0 CA-C-O 121.112 0.284 . . . . 0.0 112.743 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.658 ' HB2' ' HB2' ' A' ' 31' ' ' LEU . . . -78.43 83.35 4.65 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.492 0.717 . . . . 0.0 111.175 -175.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -127.99 134.45 49.26 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.143 0.977 . . . . 0.0 110.098 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.675 ' SG ' HD11 ' A' ' 31' ' ' LEU . 89.4 m -139.73 146.33 39.43 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.996 0.918 . . . . 0.0 108.65 165.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -105.43 137.97 42.38 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.1 p -70.59 119.21 14.41 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.169 0.988 . . . . 0.0 110.27 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.8 -56.8 7.81 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.484 0.713 . . . . 0.0 110.61 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -134.66 155.02 79.85 Favored Pre-proline 0 N--CA 1.482 1.14 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.481 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . 72.0 Cg_endo -73.04 88.07 0.97 Allowed 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.059 1.84 . . . . 0.0 111.993 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -91.83 100.15 12.89 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.9 t -160.63 84.81 0.7 Allowed 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.46 -3.15 88.72 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.846 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.35 105.42 8.52 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.45 1.1 . . . . 0.0 109.218 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -69.92 84.22 0.49 Allowed 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.859 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 78.8 m80 63.9 14.24 8.22 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.117 1.367 . . . . 0.0 112.721 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.77 66.98 1.89 Allowed Glycine 0 C--N 1.35 1.329 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 61.4 79.94 0.24 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.372 1.069 . . . . 0.0 110.551 -175.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.02 -176.69 39.99 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.807 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' A' ' 44' ' ' LYS . 32.4 tp -107.37 123.35 48.24 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.228 0.611 . . . . 0.0 109.737 -176.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -94.84 118.19 31.37 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -154.23 173.05 16.65 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.198 0.599 . . . . 0.0 111.301 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.481 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . . . -128.3 157.27 41.42 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.597 1.159 . . . . 0.0 109.376 175.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.14 134.59 55.15 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.511 0.724 . . . . 0.0 111.621 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.63 -14.31 29.81 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 123.334 0.396 . . . . 0.0 113.365 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -81.88 142.38 32.55 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.125 0.57 . . . . 0.0 111.819 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.433 HD13 HD13 ' A' ' 60' ' ' LEU . 1.9 mm? -95.37 105.18 17.11 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.299 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.6 mm -85.02 116.42 28.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.5 m -77.34 111.58 13.16 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.219 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.675 HD11 ' SG ' ' A' ' 6' ' ' CYS . 34.4 mt -70.46 139.46 51.73 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 123.867 0.729 . . . . 0.0 111.716 -171.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.518 ' HB2' ' HG3' ' A' ' 41' ' ' GLU . 70.3 mt -101.17 -30.99 11.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.632 0.773 . . . . 0.0 109.458 174.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.554 ' HG3' ' HG2' ' A' ' 41' ' ' GLU . 70.9 mt-30 -97.12 149.71 21.67 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.344 0.657 . . . . 0.0 110.854 172.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.6 m -142.93 54.64 3.43 Favored Pre-proline 0 CA--C 1.578 2.046 0 C-N-CA 124.81 1.244 . . . . 0.0 110.292 173.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 33' ' ' GLN . 63.7 Cg_endo -81.58 -170.24 0.94 Allowed 'Trans proline' 0 C--N 1.391 2.77 0 C-N-CA 122.754 2.302 . . . . 0.0 112.297 -175.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -74.6 77.76 1.99 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.922 0.889 . . . . 0.0 109.645 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.78 -128.16 45.95 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.198 -174.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.21 -87.1 0.19 Allowed Glycine 0 C--N 1.349 1.279 0 C-N-CA 123.109 0.385 . . . . 0.0 112.947 175.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -149.69 165.97 30.75 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.424 0.69 . . . . 0.0 110.482 -174.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -140.77 134.21 29.9 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.643 0.777 . . . . 0.0 109.147 173.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.554 ' HG2' ' HG3' ' A' ' 33' ' ' GLN . 10.6 pt-20 -91.34 160.53 15.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 163.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.55 178.33 41.57 Favored Glycine 0 C--O 1.243 0.673 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.646 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -104.79 139.96 38.79 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.787 0.835 . . . . 0.0 110.613 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.614 ' HB2' HD11 ' A' ' 21' ' ' LEU . 10.1 tmtt? -95.64 156.98 16.1 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.159 1.384 . . . . 0.0 107.61 176.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.524 ' H ' ' HD3' ' A' ' 44' ' ' LYS . 38.6 mm-40 -55.44 -33.98 64.06 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -177.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.85 -14.24 62.65 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.05 0.54 . . . . 0.0 112.367 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.08 -9.27 59.63 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.881 -174.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.3 tp -65.24 127.75 32.99 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 123.812 0.845 . . . . 0.0 109.538 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -104.81 131.88 51.74 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.662 0.785 . . . . 0.0 109.059 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.487 ' HA3' ' HB2' ' A' ' 21' ' ' LEU . . . -149.29 173.96 28.99 Favored Glycine 0 C--N 1.336 0.577 0 O-C-N 123.35 0.406 . . . . 0.0 112.343 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 41' ' ' GLU . 51.3 p-90 -141.79 142.24 33.2 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.916 0.887 . . . . 0.0 109.79 -173.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -157.01 149.94 18.43 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 123.905 0.882 . . . . 0.0 110.205 175.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -51.26 165.98 0.5 Allowed 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.462 2.775 . . . . 0.0 114.652 167.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.4 -15.55 49.72 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.416 1.086 . . . . 0.0 112.832 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.3 m -69.17 -21.79 63.96 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.006 0.923 . . . . 0.0 112.2 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -98.72 -47.75 5.21 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.515 0.726 . . . . 0.0 109.702 -175.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.7 m -112.09 130.11 66.35 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.696 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -123.57 126.7 47.12 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.779 0.832 . . . . 0.0 110.577 -171.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.513 HD21 ' SG ' ' A' ' 6' ' ' CYS . 90.3 mt -52.71 133.24 36.85 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.2 1.0 . . . . 0.0 111.862 177.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.433 HD13 HD13 ' A' ' 28' ' ' LEU . 7.1 mp . . . . . 0 C--O 1.252 1.214 0 C-N-CA 123.203 0.601 . . . . 0.0 110.987 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.611 0 N-CA-C 112.104 -0.398 . . . . 0.0 112.104 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.408 ' HB3' ' HB2' ' A' ' 31' ' ' LEU . . . -72.68 87.39 1.25 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 171.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -80.17 142.01 35.14 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.168 -176.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.549 ' HB3' ' HB ' ' A' ' 57' ' ' VAL . 71.6 m -133.08 141.27 48.11 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 172.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -106.63 127.39 53.31 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.457 HG21 ' HB2' ' A' ' 23' ' ' PHE . 37.6 p -68.81 130.39 42.68 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.933 0.893 . . . . 0.0 111.158 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.529 HD22 ' HB2' ' A' ' 58' ' ' GLN . 79.7 mt -86.28 -34.93 20.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.56 1.144 . . . . 0.0 110.474 -177.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -135.73 145.27 52.37 Favored Pre-proline 0 N--CA 1.487 1.389 0 C-N-CA 123.383 0.673 . . . . 0.0 110.453 -175.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.625 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . 63.4 Cg_endo -73.05 126.97 11.64 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.385 2.057 . . . . 0.0 110.71 166.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -150.34 133.52 16.25 Favored 'General case' 0 C--O 1.244 0.816 0 C-N-CA 122.947 0.499 . . . . 0.0 109.932 -174.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.3 m 65.81 117.79 0.03 OUTLIER 'General case' 0 C--N 1.36 1.055 0 C-N-CA 125.522 1.529 . . . . 0.0 112.151 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.85 29.91 1.68 Allowed Glycine 0 C--N 1.342 0.863 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 173.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -96.63 160.94 14.11 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.696 0.798 . . . . 0.0 110.559 -171.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -94.79 62.25 2.67 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.034 0.934 . . . . 0.0 109.674 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -79.35 -23.11 43.61 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.334 173.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 122.67 -118.86 3.74 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -77.09 134.36 38.77 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.985 0.514 . . . . 0.0 110.452 177.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.66 165.78 18.14 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.679 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.3 tp -105.81 121.58 44.33 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.272 0.558 . . . . 0.0 109.563 176.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -104.98 154.98 19.38 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.084 1.354 . . . . 0.0 107.945 177.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.457 ' HB2' HG21 ' A' ' 8' ' ' THR . 48.0 p90 -155.51 159.57 39.86 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -175.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.625 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . . . -135.36 143.24 45.97 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.556 1.543 . . . . 0.0 108.55 176.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.01 118.03 3.95 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 124.122 0.889 . . . . 0.0 111.748 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.03 7.0 22.08 Favored Glycine 0 CA--C 1.536 1.403 0 O-C-N 123.746 0.654 . . . . 0.0 113.267 -176.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -95.81 145.66 25.17 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.471 0.708 . . . . 0.0 110.529 171.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.499 HD23 HD13 ' A' ' 60' ' ' LEU . 48.0 mt -109.3 104.93 14.14 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.073 0.949 . . . . 0.0 109.381 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.9 mp -90.78 131.73 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.0 m -85.5 109.07 18.23 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.542 0.737 . . . . 0.0 109.428 177.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.481 HD12 ' SG ' ' A' ' 6' ' ' CYS . 84.6 mt -66.15 115.81 6.55 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.401 HD13 ' HB3' ' A' ' 43' ' ' GLU . 84.7 mt -76.55 -31.19 57.43 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.331 0.652 . . . . 0.0 111.533 -177.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.576 ' HG2' ' HD3' ' A' ' 35' ' ' PRO . 9.4 tt0 -137.58 136.34 37.48 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -177.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.441 ' HA ' ' HD1' ' A' ' 40' ' ' TRP . 6.1 m -133.33 69.44 77.54 Favored Pre-proline 0 CA--C 1.559 1.324 0 C-N-CA 124.731 1.213 . . . . 0.0 109.503 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.576 ' HD3' ' HG2' ' A' ' 33' ' ' GLN . 65.7 Cg_endo -81.15 -22.27 6.05 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.981 2.454 . . . . 0.0 112.881 -171.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -161.55 145.37 12.76 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.161 1.385 . . . . 0.0 107.949 -171.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -81.57 59.75 4.8 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 123.6 0.562 . . . . 0.0 113.384 -177.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.28 -89.84 1.0 Allowed Glycine 0 C--N 1.352 1.431 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 1.9 p-90 -132.11 148.18 52.47 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.441 ' HD1' ' HA ' ' A' ' 34' ' ' VAL . 6.5 m-90 -131.83 160.08 36.67 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.129 0.49 . . . . 0.0 110.952 -167.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -93.65 151.68 19.5 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.028 172.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.16 -179.43 27.77 Favored Glycine 0 C--O 1.242 0.635 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.158 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.401 ' HB3' HD13 ' A' ' 32' ' ' LEU . 5.8 pt-20 -140.86 167.67 21.62 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.999 0.904 . . . . 0.0 112.292 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.576 ' HD3' ' N ' ' A' ' 45' ' ' GLU . 11.2 tmtt? -114.87 156.81 24.26 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 113.459 -1.701 . . . . 0.0 106.996 166.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.576 ' N ' ' HD3' ' A' ' 44' ' ' LYS . 35.8 mt-10 -46.81 -31.14 2.84 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 125.675 1.59 . . . . 0.0 113.638 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.92 1.42 12.83 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.203 1.001 . . . . 0.0 112.983 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.48 -1.62 85.97 Favored Glycine 0 C--N 1.352 1.423 0 C-N-CA 122.688 0.185 . . . . 0.0 112.789 -177.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.2 119.94 12.35 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.561 0.744 . . . . 0.0 110.379 -177.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -104.48 141.32 36.58 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.456 0.703 . . . . 0.0 109.282 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.07 152.15 22.15 Favored Glycine 0 C--N 1.341 0.854 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 174.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -119.22 128.28 54.06 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.464 1.106 . . . . 0.0 108.126 -178.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -133.72 137.81 29.56 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 123.27 0.628 . . . . 0.0 110.675 -172.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -56.03 152.27 37.81 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.3 2.667 . . . . 0.0 112.513 165.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.87 -15.5 62.0 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.328 1.051 . . . . 0.0 112.404 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.8 t -67.21 -26.59 66.68 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.266 0.626 . . . . 0.0 111.68 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -82.98 -30.56 28.11 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.974 0.51 . . . . 0.0 111.266 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' A' ' 6' ' ' CYS . 15.6 m -134.45 124.86 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 123.254 0.622 . . . . 0.0 111.43 -168.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.529 ' HB2' HD22 ' A' ' 9' ' ' LEU . 6.6 tp-100 -80.75 130.86 35.31 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.337 0.655 . . . . 0.0 110.345 176.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.409 HD23 ' CZ3' ' A' ' 40' ' ' TRP . 81.9 mt -74.13 108.44 6.93 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.299 1.039 . . . . 0.0 111.252 -175.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.499 HD13 HD23 ' A' ' 28' ' ' LEU . 76.8 mt . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.626 -0.702 . . . . 0.0 109.816 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.155 0 CA-C-O 120.049 -0.306 . . . . 0.0 112.661 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.12 105.44 0.7 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.163 0.585 . . . . 0.0 110.269 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -109.02 172.57 6.77 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.46 ' SG ' ' HZ2' ' A' ' 51' ' ' TRP . 59.6 m -149.23 153.55 37.77 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.582 0.753 . . . . 0.0 110.409 -173.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.413 ' HG3' HD22 ' A' ' 60' ' ' LEU . 18.1 mtp180 -130.94 133.08 45.51 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.922 0.889 . . . . 0.0 109.262 175.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.5 p -78.84 122.13 25.69 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 173.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.526 HD22 ' HB2' ' A' ' 58' ' ' GLN . 87.9 mt -68.63 -47.04 67.66 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.016 0.527 . . . . 0.0 111.039 -174.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -144.53 155.24 57.06 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 124.863 1.265 . . . . 0.0 109.25 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.589 ' HD3' ' HB1' ' A' ' 25' ' ' ALA . 59.3 Cg_endo -83.06 167.57 14.07 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.545 2.163 . . . . 0.0 112.63 -174.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -120.02 100.09 7.01 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 173.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.4 m -98.47 84.06 3.13 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.116 0.566 . . . . 0.0 109.891 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.92 -164.53 36.6 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.74 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -82.15 118.0 22.73 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.406 1.082 . . . . 0.0 110.46 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -106.21 30.43 5.93 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.789 0.836 . . . . 0.0 109.973 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.5 m80 67.87 -76.06 0.06 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.883 1.673 . . . . 0.0 111.27 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.58 -86.17 0.05 OUTLIER Glycine 0 C--N 1.346 1.122 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -63.0 117.81 6.95 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.262 0.625 . . . . 0.0 110.756 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.89 -164.12 35.41 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.442 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.0 tp -137.51 142.51 41.46 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.008 0.923 . . . . 0.0 108.556 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -91.92 131.22 37.4 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 170.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -151.71 143.69 23.83 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.186 0.595 . . . . 0.0 112.001 -171.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.48 ' O ' ' HG2' ' A' ' 27' ' ' GLU . . . -87.88 170.95 10.72 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.915 1.286 . . . . 0.0 109.898 167.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.589 ' HB1' ' HD3' ' A' ' 11' ' ' PRO . . . -71.44 112.4 7.53 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.959 -0.463 . . . . 0.0 110.474 172.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.09 17.46 7.78 Favored Glycine 0 N--CA 1.475 1.255 0 C-N-CA 123.139 0.399 . . . . 0.0 113.721 174.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 24' ' ' ALA . 10.2 mm-40 -69.75 125.32 26.39 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 122.678 0.391 . . . . 0.0 110.958 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.7 mt -85.42 101.95 13.04 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.838 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.6 mm -105.59 140.41 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.5 m -113.5 118.94 35.88 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.546 0.612 . . . . 0.0 109.73 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.425 ' HG ' ' SG ' ' A' ' 6' ' ' CYS . 68.8 mt -58.99 121.43 11.2 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 123.695 0.622 . . . . 0.0 110.784 177.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' A' ' 43' ' ' GLU . 80.9 mt -75.15 -46.61 33.14 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.017 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -155.23 166.02 34.85 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.936 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.3 m -120.63 81.56 32.64 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 124.084 0.954 . . . . 0.0 109.052 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -83.31 -21.5 4.43 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.53 2.154 . . . . 0.0 114.076 -172.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -155.43 142.99 19.63 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.337 0.655 . . . . 0.0 110.632 -168.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.85 61.02 4.12 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.532 0.52 . . . . 0.0 112.622 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.34 -53.33 0.04 OUTLIER Glycine 0 C--N 1.342 0.869 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 49.2 m95 -118.94 128.0 54.01 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 170.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.445 ' HE3' ' HZ3' ' A' ' 51' ' ' TRP . 15.5 m-90 -119.09 170.57 8.94 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -132.48 133.0 43.28 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.133 0.492 . . . . 0.0 111.147 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.8 168.4 19.81 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 114.612 -1.177 . . . . 0.0 110.821 173.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.467 ' HB2' HD11 ' A' ' 32' ' ' LEU . 29.2 tt0 -125.7 151.28 46.82 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.184 0.593 . . . . 0.0 109.801 -178.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.441 ' HE3' ' HB3' ' A' ' 27' ' ' GLU . 1.3 mmtp -89.95 163.12 15.09 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.392 1.077 . . . . 0.0 110.244 176.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -63.84 -24.53 67.79 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.71 0.804 . . . . 0.0 111.243 170.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.84 -23.31 65.01 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.366 1.066 . . . . 0.0 111.685 174.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.32 -21.29 37.77 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.095 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.5 133.59 35.85 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.213 0.605 . . . . 0.0 109.606 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 28.5 ptt85 -105.78 147.18 28.91 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.363 0.601 . . . . 0.0 110.175 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 173.44 150.32 7.43 Favored Glycine 0 C--O 1.243 0.703 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 174.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.46 ' HZ2' ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -156.31 171.67 19.82 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.707 0.765 . . . . 0.0 110.888 -173.314 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -147.15 150.37 38.02 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 125.27 1.428 . . . . 0.0 107.841 -173.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -42.28 147.85 0.47 Allowed 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 123.773 2.982 . . . . 0.0 113.681 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.408 ' H ' ' HZ3' ' A' ' 40' ' ' TRP . . . -57.19 -22.02 37.57 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.812 0.845 . . . . 0.0 112.974 -171.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.1 m -58.44 -28.39 65.24 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.34 1.056 . . . . 0.0 112.791 177.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -79.88 -29.61 40.01 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.7 0.8 . . . . 0.0 111.776 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.406 HG22 ' CZ2' ' A' ' 51' ' ' TRP . 23.7 m -123.86 -171.8 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 123.247 0.619 . . . . 0.0 112.078 -166.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.526 ' HB2' HD22 ' A' ' 9' ' ' LEU . 7.7 tp60 -120.61 139.75 52.53 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.0 1.32 . . . . 0.0 108.594 174.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.7 mt -104.35 119.71 39.57 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.439 0.696 . . . . 0.0 109.648 176.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.413 HD22 ' HG3' ' A' ' 7' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--O 1.253 1.241 0 C-N-CA 124.107 0.963 . . . . 0.0 108.789 175.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.582 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.16 114.35 13.76 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.495 1.118 . . . . 0.0 109.034 -174.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -129.22 154.62 46.61 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.324 1.05 . . . . 0.0 109.341 176.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.575 ' SG ' HD12 ' A' ' 31' ' ' LEU . 84.0 m -122.97 175.89 6.33 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.854 -1.067 . . . . 0.0 108.773 173.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -156.32 129.01 7.76 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.557 HG21 HD11 ' A' ' 29' ' ' ILE . 34.3 p -66.77 147.73 52.86 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.064 0.946 . . . . 0.0 111.393 -175.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.5 mt -80.23 -62.57 1.64 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.815 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -141.51 164.56 34.2 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 123.991 0.917 . . . . 0.0 109.706 -172.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.549 ' HG3' ' HB1' ' A' ' 25' ' ' ALA . 26.5 Cg_exo -62.4 121.45 9.44 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 122.727 2.284 . . . . 0.0 112.37 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -91.43 142.99 27.07 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.6 m -125.77 -72.33 0.66 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.981 0.513 . . . . 0.0 109.886 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.15 153.2 19.67 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -170.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -74.79 -32.71 62.09 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.484 0.713 . . . . 0.0 111.141 -176.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -163.04 131.06 3.74 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.802 0.841 . . . . 0.0 109.205 -177.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -163.56 115.05 1.42 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.189 0.996 . . . . 0.0 109.604 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.68 -47.97 88.52 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.246 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -155.49 148.31 24.31 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.537 0.735 . . . . 0.0 110.063 175.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -152.94 -164.83 12.81 Favored Glycine 0 C--O 1.241 0.57 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 171.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.6 tp -99.9 125.02 45.82 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 175.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.56 133.62 37.32 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.881 0.872 . . . . 0.0 110.986 -174.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -134.0 147.8 51.04 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.031 0.933 . . . . 0.0 108.568 170.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.64 166.57 12.74 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.633 0.773 . . . . 0.0 109.274 169.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.549 ' HB1' ' HG3' ' A' ' 11' ' ' PRO . . . -66.2 120.8 13.87 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.222 0.609 . . . . 0.0 110.169 176.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.75 17.08 80.21 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 123.287 0.367 . . . . 0.0 113.237 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.76 143.51 26.65 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.165 0.586 . . . . 0.0 109.466 179.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 mp -74.7 164.63 26.36 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.362 1.065 . . . . 0.0 111.499 -175.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.557 HD11 HG21 ' A' ' 8' ' ' THR . 4.1 mp -131.8 123.39 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 174.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.1 m -85.6 106.19 16.72 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.575 HD12 ' SG ' ' A' ' 6' ' ' CYS . 88.5 mt -77.42 106.13 8.99 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.982 0.513 . . . . 0.0 109.906 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 86.0 mt -83.37 -51.59 7.27 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.805 0.842 . . . . 0.0 109.776 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.648 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 1.4 mp0 -106.48 146.62 30.34 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.692 0.797 . . . . 0.0 108.856 172.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.4 m -128.0 69.71 77.37 Favored Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 123.644 0.778 . . . . 0.0 110.232 172.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 40' ' ' TRP . 64.2 Cg_endo -71.25 132.2 20.53 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 122.392 2.061 . . . . 0.0 111.845 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.5 t70 60.91 -88.04 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.967 1.307 . . . . 0.0 112.074 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 161.11 40.55 0.02 OUTLIER Glycine 0 C--N 1.344 0.978 0 O-C-N 122.912 0.133 . . . . 0.0 112.838 -173.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.24 -86.64 0.07 OUTLIER Glycine 0 C--N 1.348 1.225 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 18.1 m95 -82.88 114.53 21.25 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.556 ' HZ3' HD23 ' A' ' 59' ' ' LEU . 18.6 m0 -113.32 144.86 42.03 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.409 0.684 . . . . 0.0 110.061 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.648 ' HB2' ' HB2' ' A' ' 33' ' ' GLN . 39.7 mt-10 -91.71 122.03 33.89 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.786 0.834 . . . . 0.0 109.841 -175.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.25 169.62 20.51 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.039 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -124.09 154.22 40.29 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.972 0.909 . . . . 0.0 108.886 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.601 ' HE3' ' HA ' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -129.84 172.83 11.25 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 122.967 0.507 . . . . 0.0 109.958 173.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.462 ' HG2' ' HE2' ' A' ' 44' ' ' LYS . 6.3 mm-40 -67.09 -10.57 51.45 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.466 1.106 . . . . 0.0 111.46 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -55.29 -25.6 35.08 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.865 1.266 . . . . 0.0 111.541 168.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.32 -24.15 32.78 Favored Glycine 0 C--N 1.354 1.552 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 177.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.58 173.99 7.76 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.725 0.81 . . . . 0.0 110.602 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 38.2 mtm-85 -123.54 157.59 33.28 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.122 0.969 . . . . 0.0 108.645 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.99 154.2 25.32 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.564 ' HB3' ' HG2' ' A' ' 41' ' ' GLU . 4.8 p-90 -111.34 126.8 55.3 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -138.25 148.24 58.89 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.879 0.872 . . . . 0.0 109.319 -172.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.537 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 57.1 Cg_endo -69.68 142.87 49.45 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.302 2.001 . . . . 0.0 111.24 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.95 -23.06 66.14 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.925 0.89 . . . . 0.0 110.758 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.5 m -64.71 -40.03 94.66 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.267 1.027 . . . . 0.0 111.622 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.537 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 17.3 t80 -74.01 -32.89 63.57 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 121.316 0.579 . . . . 0.0 110.996 -173.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.6 m -104.54 -169.14 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.345 1.058 . . . . 0.0 108.899 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -141.18 130.94 24.21 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.729 0.412 . . . . 0.0 110.263 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.556 HD23 ' HZ3' ' A' ' 40' ' ' TRP . 94.8 mt -71.57 141.75 50.04 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.662 0.785 . . . . 0.0 111.552 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.7 mt . . . . . 0 C--O 1.244 0.806 0 C-N-CA 124.14 0.976 . . . . 0.0 109.848 -179.956 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.539 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.79 137.49 47.67 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.37 0.668 . . . . 0.0 109.541 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -161.13 172.8 16.13 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.39 0.615 . . . . 0.0 111.501 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.64 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 20.6 p -141.41 171.82 13.54 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.315 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.465 ' HB2' HD21 ' A' ' 60' ' ' LEU . 28.2 tpt85 -117.51 128.64 55.18 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.742 1.217 . . . . 0.0 109.272 -172.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.0 p -80.15 112.68 17.7 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.366 0.666 . . . . 0.0 109.326 173.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.94 -58.98 3.21 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.348 0.659 . . . . 0.0 110.762 -175.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -137.36 156.64 75.07 Favored Pre-proline 0 N--CA 1.488 1.434 0 C-N-CA 123.617 0.767 . . . . 0.0 109.69 -175.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.678 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . 44.9 Cg_endo -66.22 125.31 13.83 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.532 2.155 . . . . 0.0 112.381 175.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -92.86 121.33 34.11 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.127 0.971 . . . . 0.0 108.599 176.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.7 t -124.76 -161.99 1.06 Allowed 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 175.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 161.52 -35.61 0.39 Allowed Glycine 0 C--N 1.339 0.74 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 66.67 2.98 2.76 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.4 1.08 . . . . 0.0 112.877 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -82.11 -41.74 20.1 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.217 1.007 . . . . 0.0 109.261 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 20.8 m80 -84.91 119.16 25.04 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.168 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.38 -52.32 36.47 Favored Glycine 0 C--N 1.346 1.088 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 171.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -122.59 144.02 49.37 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.571 1.149 . . . . 0.0 109.438 173.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.19 159.56 10.11 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.534 HD12 ' HD3' ' A' ' 44' ' ' LYS . 16.9 tp -88.25 132.71 34.27 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 117.971 0.886 . . . . 0.0 108.773 -177.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -123.47 169.21 11.62 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.389 1.076 . . . . 0.0 109.031 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -123.54 113.34 18.58 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.678 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . . . -95.73 160.45 14.48 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 173.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.83 128.07 34.59 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.312 0.645 . . . . 0.0 111.121 -170.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.16 -30.81 6.33 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-O 119.305 -0.719 . . . . 0.0 113.927 176.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -61.57 130.84 47.89 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 117.665 0.733 . . . . 0.0 112.039 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 61.3 mt -99.25 103.32 15.17 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 175.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.64 ' HB ' ' SG ' ' A' ' 6' ' ' CYS . 21.9 mm -88.07 109.2 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -169.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.2 m -74.38 109.54 7.95 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.481 0.488 . . . . 0.0 110.622 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.8 mt -69.81 104.34 2.43 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.849 -0.796 . . . . 0.0 108.849 175.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 70.5 mt -74.16 -30.63 62.34 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.658 0.783 . . . . 0.0 110.032 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -127.11 136.34 51.99 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.223 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.1 m -129.75 90.39 43.47 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.768 1.227 . . . . 0.0 108.576 175.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.62 -155.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.691 2.261 . . . . 0.0 110.926 177.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -63.21 -31.98 73.26 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.031 0.532 . . . . 0.0 111.171 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.34 -163.59 29.91 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 116.417 -0.356 . . . . 0.0 112.218 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.58 -76.49 2.1 Favored Glycine 0 C--N 1.345 1.04 0 C-N-CA 123.458 0.551 . . . . 0.0 112.11 177.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -114.41 132.52 56.21 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.304 0.642 . . . . 0.0 109.475 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -117.67 153.39 33.41 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.435 0.694 . . . . 0.0 109.432 173.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -91.69 120.4 32.41 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 173.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -123.03 135.47 10.04 Favored Glycine 0 C--N 1.342 0.874 0 O-C-N 123.379 0.425 . . . . 0.0 112.71 -175.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.569 ' HA ' ' HG2' ' A' ' 49' ' ' ARG . 10.6 tp10 -105.04 140.96 37.45 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.371 1.069 . . . . 0.0 110.228 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.609 ' HG2' HD13 ' A' ' 29' ' ' ILE . 22.3 mtpt -124.53 157.53 35.11 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.797 0.839 . . . . 0.0 110.27 176.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.81 0.68 26.07 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.42 0.688 . . . . 0.0 111.326 174.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.56 -27.66 68.6 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.423 1.089 . . . . 0.0 110.159 168.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.66 -17.21 57.85 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.011 -176.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -98.66 154.84 17.65 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.857 0.863 . . . . 0.0 110.119 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.569 ' HG2' ' HA ' ' A' ' 43' ' ' GLU . 72.1 mtm180 -124.62 169.04 12.33 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.488 1.115 . . . . 0.0 109.499 170.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.91 173.15 39.09 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.55 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -111.71 125.26 53.78 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -151.57 147.12 19.64 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 124.23 1.012 . . . . 0.0 109.492 -175.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -83.31 178.75 5.53 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.255 2.637 . . . . 0.0 111.539 172.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.02 -14.09 61.06 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.008 0.923 . . . . 0.0 112.046 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -59.68 -19.62 50.81 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.565 1.146 . . . . 0.0 113.155 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -113.05 -16.05 12.71 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.657 0.783 . . . . 0.0 111.868 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.15 136.22 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 122.973 0.509 . . . . 0.0 111.324 -172.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -91.87 112.79 24.85 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.765 0.826 . . . . 0.0 109.782 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.59 123.37 18.64 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.056 0.542 . . . . 0.0 110.764 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.465 HD21 ' HB2' ' A' ' 7' ' ' ARG . 86.7 mt . . . . . 0 CA--C 1.55 0.952 0 C-N-CA 123.747 0.819 . . . . 0.0 110.745 -177.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.833 0 CA-C-O 119.84 -0.422 . . . . 0.0 112.317 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.89 132.54 54.26 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.549 1.14 . . . . 0.0 110.721 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -142.46 153.43 43.67 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.478 0.711 . . . . 0.0 110.959 -172.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.437 ' SG ' HD12 ' A' ' 31' ' ' LEU . 81.2 m -139.15 148.89 43.82 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.875 1.27 . . . . 0.0 108.967 175.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -108.14 152.35 24.67 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.454 0.702 . . . . 0.0 109.778 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.474 HG23 ' HB2' ' A' ' 23' ' ' PHE . 24.5 p -87.89 130.19 34.99 Favored 'General case' 0 C--O 1.242 0.711 0 C-N-CA 123.47 0.708 . . . . 0.0 110.464 173.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.5 mt -79.35 -53.5 6.87 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.249 1.019 . . . . 0.0 110.012 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -134.89 155.12 79.53 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 123.599 0.76 . . . . 0.0 109.574 -173.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.533 ' HD3' ' HB1' ' A' ' 25' ' ' ALA . 64.6 Cg_endo -78.71 85.37 1.86 Allowed 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 121.874 1.716 . . . . 0.0 110.646 170.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -92.7 101.18 13.58 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.092 -175.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.9 m -153.9 63.29 0.72 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.816 1.246 . . . . 0.0 107.905 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.26 -33.25 86.73 Favored Glycine 0 C--N 1.357 1.732 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.4 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -127.39 138.27 52.96 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.55 1.14 . . . . 0.0 108.555 170.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -66.55 -51.93 51.2 Favored 'General case' 0 CA--C 1.55 0.973 0 O-C-N 123.784 0.678 . . . . 0.0 109.615 176.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.4 t60 64.55 -77.52 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.423 1.489 . . . . 0.0 111.791 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 145.17 -66.46 0.43 Allowed Glycine 0 C--N 1.34 0.782 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -76.84 103.95 7.07 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.243 0.617 . . . . 0.0 109.823 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.74 -162.59 34.13 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.423 HD23 ' HA3' ' A' ' 50' ' ' GLY . 20.7 tp -143.24 120.04 11.22 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 176.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -77.46 120.94 23.15 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.474 ' HB2' HG23 ' A' ' 8' ' ' THR . 33.1 p90 -120.75 130.02 53.86 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.179 0.991 . . . . 0.0 110.104 -178.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -104.31 153.98 20.37 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.056 0.943 . . . . 0.0 110.488 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.533 ' HB1' ' HD3' ' A' ' 11' ' ' PRO . . . -58.5 121.56 11.21 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.969 0.908 . . . . 0.0 111.99 -178.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.56 -23.96 16.56 Favored Glycine 0 C--N 1.347 1.164 0 C-N-CA 123.337 0.494 . . . . 0.0 113.661 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -60.9 128.48 36.69 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.552 0.741 . . . . 0.0 111.526 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.2 mt -96.24 125.13 40.54 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.8 mp -104.86 116.39 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 175.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.8 m -87.0 111.5 20.92 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.437 HD12 ' SG ' ' A' ' 6' ' ' CYS . 7.0 mp -65.69 115.96 6.4 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.044 0.938 . . . . 0.0 110.698 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.428 HD12 ' HB2' ' A' ' 43' ' ' GLU . 58.6 mt -84.72 -36.25 21.95 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.151 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -116.51 135.64 53.65 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.054 0.942 . . . . 0.0 109.309 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.5 m -143.71 66.41 15.22 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 124.046 0.938 . . . . 0.0 110.434 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -77.03 -173.12 1.64 Allowed 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 123.211 2.607 . . . . 0.0 112.73 174.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -77.37 101.18 6.22 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.566 0.747 . . . . 0.0 110.548 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.72 -154.94 26.08 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 116.371 -0.377 . . . . 0.0 112.647 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.9 -28.67 4.1 Favored Glycine 0 C--N 1.346 1.129 0 N-CA-C 112.236 -0.346 . . . . 0.0 112.236 176.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -81.06 110.62 16.76 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.593 0.757 . . . . 0.0 109.512 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -125.36 138.75 54.05 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.741 0.817 . . . . 0.0 109.726 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.567 ' HG2' ' HB3' ' A' ' 51' ' ' TRP . 28.2 mt-10 -94.87 138.32 32.8 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.687 0.395 . . . . 0.0 110.496 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.13 171.01 27.16 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.412 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.428 ' HB2' HD12 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -127.83 148.22 50.45 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.124 0.57 . . . . 0.0 110.17 -169.759 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.463 ' HE3' ' HB3' ' A' ' 46' ' ' ASP . 39.7 mtmt -88.3 -173.22 4.11 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.605 1.562 . . . . 0.0 110.24 176.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -86.6 62.1 7.21 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 165.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.463 ' HB3' ' HE3' ' A' ' 44' ' ' LYS . 38.0 t70 -148.56 -47.75 0.15 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -168.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.64 -9.76 28.05 Favored Glycine 0 N--CA 1.473 1.136 0 CA-C-O 119.848 -0.418 . . . . 0.0 113.683 -174.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.58 130.99 45.86 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 117.544 0.672 . . . . 0.0 110.1 172.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -103.14 143.07 33.09 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.778 0.831 . . . . 0.0 109.446 -175.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.423 ' HA3' HD23 ' A' ' 21' ' ' LEU . . . -134.34 155.15 21.74 Favored Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 177.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.567 ' HB3' ' HG2' ' A' ' 41' ' ' GLU . 1.1 p-90 -99.66 132.19 45.17 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.995 0.918 . . . . 0.0 109.88 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -133.26 129.39 20.78 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 123.657 0.783 . . . . 0.0 109.446 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.65 151.98 83.05 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.3 2.0 . . . . 0.0 111.15 162.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.603 ' HB1' HD12 ' A' ' 59' ' ' LEU . . . -60.0 -26.47 66.08 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.473 1.109 . . . . 0.0 112.178 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.1 m -73.14 -16.79 61.44 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.829 0.852 . . . . 0.0 113.118 -177.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -96.8 -24.71 15.78 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.002 0.521 . . . . 0.0 111.992 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.2 m -116.89 151.73 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.113 0.565 . . . . 0.0 110.963 -173.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -81.17 103.85 11.25 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.78 0.832 . . . . 0.0 109.288 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.603 HD12 ' HB1' ' A' ' 54' ' ' ALA . 43.8 mt -67.77 115.1 6.94 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.1 mt . . . . . 0 C--O 1.25 1.104 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -177.546 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.77 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' A' ' 31' ' ' LEU . . . -77.08 106.8 9.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.453 0.701 . . . . 0.0 109.651 -177.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -78.64 142.24 37.37 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.751 0.42 . . . . 0.0 110.359 -176.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 76.7 m -138.75 159.56 41.81 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.985 0.914 . . . . 0.0 109.229 174.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.549 ' HB2' ' HB3' ' A' ' 58' ' ' GLN . 19.9 mmt180 -106.69 147.72 29.24 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.643 1.177 . . . . 0.0 108.688 176.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 23' ' ' PHE . 21.8 p -94.68 118.16 31.28 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.098 175.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.467 HD22 ' HB2' ' A' ' 58' ' ' GLN . 86.0 mt -69.47 -50.62 43.68 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.945 0.498 . . . . 0.0 110.885 -177.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -135.2 148.29 65.87 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 123.569 0.748 . . . . 0.0 109.731 -178.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.538 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . 2.8 Cg_exo -74.9 121.68 6.77 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.792 2.328 . . . . 0.0 111.232 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -128.34 102.3 6.6 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.163 0.506 . . . . 0.0 109.89 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.1 m -153.22 30.61 0.48 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.874 1.27 . . . . 0.0 109.528 174.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.03 88.46 0.01 OUTLIER Glycine 0 C--N 1.356 1.644 0 O-C-N 124.44 1.088 . . . . 0.0 113.611 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 57.62 48.79 13.59 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.167 1.387 . . . . 0.0 110.347 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -98.9 80.11 2.46 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.055 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -90.99 -18.96 23.77 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.795 0.838 . . . . 0.0 111.106 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.56 -165.39 24.86 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.932 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -73.84 85.79 1.72 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.76 0.791 . . . . 0.0 110.627 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -164.64 143.4 8.49 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.721 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.593 HD11 ' HB3' ' A' ' 44' ' ' LYS . 27.0 tp -90.18 142.44 27.71 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.919 0.488 . . . . 0.0 110.822 -171.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -99.89 138.92 36.3 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.23 1.012 . . . . 0.0 110.655 -175.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.533 ' HB2' HG22 ' A' ' 8' ' ' THR . 28.1 p90 -154.16 121.98 5.93 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.592 0.757 . . . . 0.0 110.45 -174.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.538 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . . . -92.08 152.51 19.91 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.61 1.164 . . . . 0.0 109.654 171.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.99 125.02 22.38 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.719 0.808 . . . . 0.0 111.922 -175.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.87 -20.65 17.1 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 123.643 0.589 . . . . 0.0 113.343 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -72.23 142.91 48.97 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 121.329 0.585 . . . . 0.0 112.219 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.61 111.12 19.25 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.303 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.4 mm -91.36 120.76 40.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 123.471 0.708 . . . . 0.0 109.636 174.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.6 m -85.74 103.85 14.9 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.529 ' HB2' ' HB1' ' A' ' 4' ' ' ALA . 91.2 mt -71.86 107.45 4.64 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 67.2 mt -75.39 -48.46 22.81 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.591 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -126.45 136.94 53.28 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.067 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.3 m -115.22 91.45 27.88 Favored Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 124.259 1.024 . . . . 0.0 108.929 176.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.62 -49.65 15.23 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 123.298 2.665 . . . . 0.0 112.889 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -164.09 -79.29 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.693 0.797 . . . . 0.0 109.5 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -161.4 149.47 18.26 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 -174.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.37 -61.49 2.86 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 116.577 0.189 . . . . 0.0 112.761 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 40.9 m95 -121.3 99.73 6.65 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.927 0.491 . . . . 0.0 109.786 -172.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -112.12 146.22 38.4 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -90.12 117.2 28.72 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.13 148.58 18.24 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.678 177.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -103.36 160.49 14.65 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.561 0.696 . . . . 0.0 109.816 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.593 ' HB3' HD11 ' A' ' 21' ' ' LEU . 2.0 tmtp? -132.73 155.94 47.93 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 170.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.408 ' H ' ' HD3' ' A' ' 44' ' ' LYS . 9.6 pt-20 -66.52 6.33 0.47 Allowed 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -67.78 -15.66 63.74 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.332 0.653 . . . . 0.0 111.49 168.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.49 -15.24 61.36 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 112.37 -0.292 . . . . 0.0 112.37 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.442 ' HB2' HD12 ' A' ' 21' ' ' LEU . 89.0 mt -96.63 163.03 13.19 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.629 0.772 . . . . 0.0 110.099 176.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 35.9 ttp-105 -119.98 155.75 32.22 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 169.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -150.52 161.47 28.98 Favored Glycine 0 C--N 1.336 0.577 0 N-CA-C 112.343 -0.303 . . . . 0.0 112.343 177.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -88.76 129.87 35.46 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 171.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 59.2 m-85 -108.35 137.22 19.87 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 123.324 0.65 . . . . 0.0 111.035 -173.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 52' ' ' PHE . 6.4 Cg_exo -73.66 124.04 9.0 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 123.086 2.524 . . . . 0.0 111.199 177.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.83 -45.08 86.72 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.744 1.218 . . . . 0.0 113.098 -171.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.3 t -75.98 -25.48 55.86 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.189 0.596 . . . . 0.0 111.12 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -85.77 -18.24 33.54 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.416 0.686 . . . . 0.0 111.167 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.3 m -108.99 147.31 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.094 0.558 . . . . 0.0 109.553 173.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.549 ' HB3' ' HB2' ' A' ' 7' ' ' ARG . 34.1 tt0 -87.64 115.01 24.78 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 174.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.2 mt -76.95 128.66 34.94 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.771 0.429 . . . . 0.0 110.155 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.2 mt . . . . . 0 C--O 1.249 1.066 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 176.475 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.11 0 CA-C-O 120.312 -0.16 . . . . 0.0 113.104 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.91 86.97 2.87 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.871 0.868 . . . . 0.0 111.072 -173.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -110.28 151.78 26.96 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.352 1.061 . . . . 0.0 109.579 178.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.418 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 28.3 p -158.91 140.62 13.48 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.448 0.699 . . . . 0.0 109.154 171.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.503 ' HB2' HD12 ' A' ' 60' ' ' LEU . 40.2 ttp180 -112.68 130.4 56.06 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.287 0.635 . . . . 0.0 109.45 177.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 45.1 p -66.51 139.21 57.93 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 122.974 0.51 . . . . 0.0 111.468 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 86.0 mt -97.93 -22.53 16.27 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.328 1.051 . . . . 0.0 110.286 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -131.89 151.72 79.01 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 124.02 0.928 . . . . 0.0 109.574 -177.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.411 ' HD3' ' HB1' ' A' ' 25' ' ' ALA . 73.4 Cg_endo -74.86 164.37 33.64 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.304 2.002 . . . . 0.0 111.366 169.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -93.65 102.79 14.98 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.3 p -69.56 120.18 14.95 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 123.222 0.609 . . . . 0.0 109.399 174.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.35 -179.01 48.16 Favored Glycine 0 C--N 1.342 0.894 0 O-C-N 123.595 0.559 . . . . 0.0 112.535 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -83.63 169.15 15.65 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.127 0.571 . . . . 0.0 109.482 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 55.9 mtp85 -56.63 -56.25 23.75 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.503 0.721 . . . . 0.0 111.143 178.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 69.3 t60 66.97 171.14 0.25 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.809 1.243 . . . . 0.0 112.526 169.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.72 -68.86 1.52 Allowed Glycine 0 C--N 1.351 1.391 0 CA-C-N 116.487 -0.324 . . . . 0.0 112.874 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -153.74 148.23 26.13 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.2 0.6 . . . . 0.0 111.278 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 168.81 -175.3 43.34 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.8 tp -90.21 114.13 26.07 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 121.572 0.701 . . . . 0.0 109.614 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -122.58 151.84 41.02 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 125.033 1.333 . . . . 0.0 107.768 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -156.18 152.42 27.83 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.184 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 27' ' ' GLU . . . -96.48 169.46 9.89 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.828 1.251 . . . . 0.0 109.027 165.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.411 ' HB1' ' HD3' ' A' ' 11' ' ' PRO . . . -66.09 111.63 3.48 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 122.12 -0.363 . . . . 0.0 110.064 171.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.26 19.8 6.15 Favored Glycine 0 C--N 1.351 1.375 0 N-CA-C 114.388 0.515 . . . . 0.0 114.388 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 24' ' ' ALA . 10.9 mm-40 -92.0 136.69 32.97 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 117.772 0.786 . . . . 0.0 111.138 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.8 mt -84.16 103.06 13.05 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.523 0.729 . . . . 0.0 109.902 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.418 ' HB ' ' SG ' ' A' ' 6' ' ' CYS . 47.5 mm -92.1 124.11 44.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.586 1.154 . . . . 0.0 109.491 176.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.0 m -88.46 107.29 18.79 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.167 0.987 . . . . 0.0 109.112 174.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.98 111.98 6.78 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.3 mt -80.46 -53.95 6.13 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 123.151 0.58 . . . . 0.0 109.488 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.614 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 47.2 mt-30 -109.0 135.63 49.87 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.0 m -135.09 84.23 37.31 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 123.413 0.685 . . . . 0.0 110.205 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.12 161.72 37.97 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.583 2.189 . . . . 0.0 111.374 169.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -73.12 100.07 2.96 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.142 0.577 . . . . 0.0 110.11 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.18 -154.42 20.42 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.26 -16.21 23.55 Favored Glycine 0 N--CA 1.47 0.92 0 N-CA-C 112.101 -0.4 . . . . 0.0 112.101 172.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 53.9 m95 -92.14 119.22 31.59 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.272 1.029 . . . . 0.0 109.346 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -131.39 153.18 49.94 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.674 0.79 . . . . 0.0 109.781 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.614 ' HB3' ' HB2' ' A' ' 33' ' ' GLN . 3.1 tm-20 -102.79 132.33 49.03 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.76 152.17 23.88 Favored Glycine 0 CA--C 1.508 -0.388 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.088 -177.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 49' ' ' ARG . 9.8 pt-20 -103.67 152.5 21.72 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.113 0.565 . . . . 0.0 110.125 173.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -78.68 154.42 30.17 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 157.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -73.6 16.51 0.2 Allowed 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -170.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -97.24 -1.11 45.53 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.671 1.188 . . . . 0.0 111.282 169.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.81 3.4 68.41 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-O 120.115 -0.269 . . . . 0.0 113.737 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.6 mt -91.25 114.98 27.64 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 12.6 ptt180 -116.97 165.73 13.01 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.864 0.466 . . . . 0.0 111.863 -173.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 177.7 171.47 41.18 Favored Glycine 0 C--N 1.348 1.239 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.797 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -94.98 128.19 41.6 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.45 0.7 . . . . 0.0 110.315 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -147.7 145.24 20.73 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 124.161 0.985 . . . . 0.0 109.766 175.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -78.4 176.6 9.73 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.685 2.257 . . . . 0.0 111.518 173.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.27 -21.46 61.93 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.038 175.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.9 m -53.22 -33.66 53.79 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.273 1.429 . . . . 0.0 113.471 -176.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -96.2 -18.0 20.39 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.104 0.562 . . . . 0.0 112.431 -176.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 35.8 m -120.03 174.39 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-O 121.411 0.624 . . . . 0.0 112.0 -171.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -130.79 115.49 16.69 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.177 1.391 . . . . 0.0 107.819 174.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.03 126.37 27.11 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.929 0.768 . . . . 0.0 110.442 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.503 HD12 ' HB2' ' A' ' 7' ' ' ARG . 80.2 mt . . . . . 0 C--O 1.252 1.194 0 C-N-CA 124.15 0.98 . . . . 0.0 108.791 -176.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.611 0 N-CA-C 111.984 -0.447 . . . . 0.0 111.984 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 31' ' ' LEU . . . -75.38 90.48 2.67 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.193 0.597 . . . . 0.0 110.406 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -81.39 123.46 28.58 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.171 0.988 . . . . 0.0 109.372 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.713 ' HA ' ' HA ' ' A' ' 59' ' ' LEU . 48.6 t -124.14 155.7 37.97 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.223 0.535 . . . . 0.0 110.929 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -116.04 131.96 56.79 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.627 1.171 . . . . 0.0 109.175 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.547 ' HA ' HG11 ' A' ' 57' ' ' VAL . 16.5 p -77.37 121.29 23.56 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.488 0.715 . . . . 0.0 109.813 170.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.412 HD12 ' HG3' ' A' ' 58' ' ' GLN . 81.4 mt -73.06 -51.51 17.82 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.29 0.636 . . . . 0.0 109.676 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -137.8 152.85 73.22 Favored Pre-proline 0 N--CA 1.483 1.183 0 C-N-CA 123.662 0.785 . . . . 0.0 110.467 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.41 129.51 12.97 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.354 2.036 . . . . 0.0 111.72 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.401 ' HE2' ' HH2' ' A' ' 51' ' ' TRP . 2.1 t80 -117.22 101.6 8.58 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.4 t -92.75 -47.28 7.15 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.448 -171.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.79 -117.55 0.43 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -178.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 60.93 -74.34 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.621 1.568 . . . . 0.0 111.703 -177.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.487 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -79.91 -11.72 59.78 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.532 0.733 . . . . 0.0 111.942 -178.137 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -140.64 172.21 13.02 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.31 0.644 . . . . 0.0 110.476 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.72 -23.18 0.38 Allowed Glycine 0 C--N 1.346 1.123 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.081 175.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -125.28 21.94 7.89 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.769 0.827 . . . . 0.0 111.347 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.08 176.9 54.51 Favored Glycine 0 C--N 1.351 1.39 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 172.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.406 HD22 ' HG2' ' A' ' 44' ' ' LYS . 44.8 tp -89.87 124.79 35.0 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -79.49 136.96 37.05 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.549 0.74 . . . . 0.0 110.479 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -149.04 128.6 13.13 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.067 0.947 . . . . 0.0 109.245 177.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.8 150.82 20.28 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.3 1.04 . . . . 0.0 110.017 177.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.11 133.4 54.38 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.622 0.769 . . . . 0.0 111.716 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.56 -23.38 28.38 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 119.605 -0.553 . . . . 0.0 113.179 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -65.0 136.17 56.48 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-N 117.201 0.5 . . . . 0.0 111.69 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 73.9 mt -85.67 101.43 12.74 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.3 mm -88.62 111.18 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.929 0.891 . . . . 0.0 108.644 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.2 p -77.32 105.42 8.42 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.565 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 39.8 mt -67.56 142.19 56.59 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 173.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.8 mt -74.34 -43.04 58.32 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.968 0.507 . . . . 0.0 110.57 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -157.14 157.17 33.97 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.112 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.5 m -109.66 94.36 16.51 Favored Pre-proline 0 CA--C 1.557 1.24 0 C-N-CA 123.38 0.672 . . . . 0.0 110.944 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.413 ' HD2' ' CD1' ' A' ' 40' ' ' TRP . 79.3 Cg_endo -81.86 170.57 13.88 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.578 2.185 . . . . 0.0 111.174 167.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.4 143.84 54.94 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.108 0.48 . . . . 0.0 111.369 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.47 166.99 33.81 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.356 -177.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.0 55.26 4.98 Favored Glycine 0 C--N 1.348 1.199 0 C-N-CA 123.211 0.434 . . . . 0.0 112.584 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.411 ' HZ3' ' HG3' ' A' ' 53' ' ' PRO . 75.6 t-105 -143.79 114.76 7.81 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.437 1.095 . . . . 0.0 108.484 -177.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.413 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 12.9 m-90 -136.28 144.19 44.62 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.938 0.895 . . . . 0.0 109.712 -177.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -95.74 116.28 28.66 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 169.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 31' ' ' LEU . . . -108.76 143.76 16.28 Favored Glycine 0 C--N 1.337 0.635 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 49' ' ' ARG . 31.8 tt0 -115.52 136.9 52.61 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.007 0.523 . . . . 0.0 109.837 -178.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.406 ' HG2' HD22 ' A' ' 21' ' ' LEU . 30.2 mmmt -71.62 163.43 27.77 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.696 1.198 . . . . 0.0 109.787 170.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -64.71 -11.66 38.47 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.963 0.905 . . . . 0.0 112.685 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -89.22 -8.12 54.18 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.334 1.054 . . . . 0.0 112.49 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.43 -1.27 66.53 Favored Glycine 0 C--N 1.345 1.078 0 O-C-N 123.147 0.279 . . . . 0.0 112.842 -173.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.8 mt -83.05 104.99 13.67 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.665 0.786 . . . . 0.0 109.73 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 28.0 ptt180 -102.64 154.33 19.25 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -159.18 -178.28 33.04 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.908 -0.587 . . . . 0.0 113.062 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.401 ' HH2' ' HE2' ' A' ' 12' ' ' PHE . 49.8 p-90 -77.05 129.58 36.26 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.24 1.016 . . . . 0.0 110.47 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -135.39 94.28 15.67 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 123.914 0.886 . . . . 0.0 109.617 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.411 ' HG3' ' HZ3' ' A' ' 39' ' ' TRP . 11.8 Cg_exo -71.45 148.32 54.08 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.915 2.41 . . . . 0.0 110.37 168.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.31 -19.54 64.69 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.21 0.604 . . . . 0.0 112.396 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.5 m -62.32 -31.05 71.61 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.756 0.822 . . . . 0.0 111.631 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -98.71 -27.65 13.87 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.4 0.68 . . . . 0.0 111.586 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.577 ' HB ' ' SG ' ' A' ' 6' ' ' CYS . 26.1 m -138.79 139.34 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 122.94 0.496 . . . . 0.0 111.321 -174.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.412 ' HG3' HD12 ' A' ' 9' ' ' LEU . 53.1 mt-30 -128.82 133.16 47.92 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.546 0.738 . . . . 0.0 109.482 174.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.713 ' HA ' ' HA ' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -82.56 140.5 33.23 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.997 0.519 . . . . 0.0 112.312 -172.303 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 C--O 1.251 1.164 0 C-N-CA 124.772 1.229 . . . . 0.0 109.447 -178.114 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.703 0 N-CA-C 111.641 -0.583 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.89 76.31 1.16 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.849 0.86 . . . . 0.0 109.157 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.48 164.33 21.91 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.183 -173.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.438 ' SG ' HD21 ' A' ' 59' ' ' LEU . 78.2 m -145.12 166.86 24.18 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.981 0.913 . . . . 0.0 109.682 178.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.524 ' HG3' HD12 ' A' ' 60' ' ' LEU . 59.0 mtm180 -119.19 133.58 55.69 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.142 0.577 . . . . 0.0 109.98 175.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.581 HG23 HD12 ' A' ' 29' ' ' ILE . 8.9 p -73.45 121.65 20.87 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.428 0.455 . . . . 0.0 111.647 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.63 -15.98 27.73 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.788 0.835 . . . . 0.0 110.233 169.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -107.18 122.26 42.01 Favored Pre-proline 0 N--CA 1.48 1.073 0 C-N-CA 123.674 0.789 . . . . 0.0 110.58 171.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.414 ' HB3' ' N ' ' A' ' 25' ' ' ALA . 96.3 Cg_endo -83.44 49.93 3.1 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.928 2.418 . . . . 0.0 111.449 164.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -91.24 109.97 21.25 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -173.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.7 t -70.6 -21.37 62.67 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.524 1.13 . . . . 0.0 111.784 -177.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.35 -84.1 1.08 Allowed Glycine 0 C--N 1.347 1.185 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -171.86 161.33 5.8 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 124.999 1.32 . . . . 0.0 108.904 175.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -91.79 131.74 36.93 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 168.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -140.33 -64.22 0.47 Allowed 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.404 0.682 . . . . 0.0 109.495 -176.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.67 75.26 0.17 Allowed Glycine 0 C--N 1.346 1.106 0 CA-C-O 120.05 -0.305 . . . . 0.0 112.439 -175.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 66.29 21.71 10.97 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.549 1.14 . . . . 0.0 112.314 173.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.2 166.1 25.57 Favored Glycine 0 C--N 1.348 1.229 0 O-C-N 123.588 0.555 . . . . 0.0 113.591 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.433 HD12 ' HB2' ' A' ' 44' ' ' LYS . 27.5 tp -89.82 129.79 36.15 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.453 0.701 . . . . 0.0 109.492 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.25 161.14 19.44 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.964 1.306 . . . . 0.0 108.725 177.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -136.9 141.87 42.73 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.944 0.498 . . . . 0.0 111.741 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.62 169.96 10.1 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.777 1.231 . . . . 0.0 109.198 164.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.414 ' N ' ' HB3' ' A' ' 11' ' ' PRO . . . -72.72 115.92 12.58 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.94 19.9 8.77 Favored Glycine 0 N--CA 1.477 1.39 0 O-C-N 123.028 0.205 . . . . 0.0 113.483 177.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -72.85 149.99 43.06 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.917 0.487 . . . . 0.0 111.641 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.7 mt -106.37 108.1 19.44 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.581 HD12 HG23 ' A' ' 8' ' ' THR . 3.3 mp -103.21 107.79 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -175.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.0 m -75.8 108.06 8.4 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 173.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.24 123.51 19.73 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 123.704 0.628 . . . . 0.0 110.092 178.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.2 mt -73.84 -43.54 58.39 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.97 0.908 . . . . 0.0 109.12 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -126.45 155.46 42.19 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 124.912 1.285 . . . . 0.0 108.457 171.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.2 m -125.93 74.76 71.39 Favored Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 123.755 0.822 . . . . 0.0 110.939 176.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.39 164.38 35.38 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.427 2.084 . . . . 0.0 111.735 170.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -76.52 92.72 3.46 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.968 0.907 . . . . 0.0 109.85 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.93 -166.42 54.0 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-N 115.472 -0.785 . . . . 0.0 113.297 175.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.36 -104.24 1.02 Allowed Glycine 0 C--N 1.346 1.135 0 C-N-CA 123.74 0.685 . . . . 0.0 114.123 173.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -122.33 143.21 49.78 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.343 1.057 . . . . 0.0 109.901 -172.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.3 m-90 -124.57 145.31 49.66 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.169 0.988 . . . . 0.0 109.423 174.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -90.35 126.0 35.72 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 164.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.99 172.43 22.89 Favored Glycine 0 N--CA 1.467 0.766 0 O-C-N 123.621 0.575 . . . . 0.0 112.037 -176.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -131.87 145.13 51.35 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.228 0.537 . . . . 0.0 110.081 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.45 ' HG2' ' H ' ' A' ' 46' ' ' ASP . 64.9 tttp -71.75 154.8 41.08 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 164.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -64.41 -20.44 66.15 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.048 0.539 . . . . 0.0 111.856 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.45 ' H ' ' HG2' ' A' ' 44' ' ' LYS . 37.8 t70 -65.71 -20.36 66.25 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.166 0.987 . . . . 0.0 111.793 172.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.01 -16.13 30.58 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.196 176.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.3 mt -66.1 134.22 52.36 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 117.263 0.531 . . . . 0.0 110.501 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.9 mtt85 -113.38 142.54 45.75 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.287 1.035 . . . . 0.0 111.062 -174.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.17 154.91 25.94 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.646 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -96.05 127.57 42.18 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -146.76 148.77 34.31 Favored Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 124.18 0.992 . . . . 0.0 110.439 -173.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -84.82 -176.82 2.6 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.129 2.552 . . . . 0.0 111.911 174.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.39 -15.11 62.81 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.741 0.816 . . . . 0.0 111.926 176.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.5 m -55.45 -40.0 71.03 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.069 1.348 . . . . 0.0 113.335 -175.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -90.89 -29.05 17.72 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.999 0.52 . . . . 0.0 111.589 -175.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 35.3 m -105.39 -179.8 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.369 0.668 . . . . 0.0 110.52 -173.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -134.59 124.06 24.83 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.688 0.795 . . . . 0.0 109.128 175.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.438 HD21 ' SG ' ' A' ' 6' ' ' CYS . 74.0 mt -69.95 117.28 11.33 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.524 HD12 ' HG3' ' A' ' 7' ' ' ARG . 64.4 mt . . . . . 0 CA--C 1.548 0.879 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.516 0 CA-C-O 120.179 -0.234 . . . . 0.0 112.805 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.7 97.22 1.04 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 171.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -94.93 149.62 21.05 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.57 0.748 . . . . 0.0 110.57 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.583 ' SG ' HD23 ' A' ' 59' ' ' LEU . 49.3 m -128.89 143.8 51.0 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 173.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -105.89 127.68 53.28 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 74.4 p -68.71 127.25 32.4 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 123.924 0.765 . . . . 0.0 109.558 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.421 HD22 ' HB2' ' A' ' 58' ' ' GLN . 95.7 mt -70.1 -75.93 0.11 Allowed 'General case' 0 CA--C 1.537 0.468 0 O-C-N 123.459 0.474 . . . . 0.0 109.978 -177.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -151.37 137.92 11.59 Favored Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 123.634 0.774 . . . . 0.0 109.03 -177.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.37 95.53 0.61 Allowed 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.215 1.943 . . . . 0.0 111.756 175.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.524 ' HB2' ' HE1' ' A' ' 56' ' ' TYR . 52.9 m-85 -91.58 102.99 15.64 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 175.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.8 p -100.53 100.99 11.81 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.655 0.782 . . . . 0.0 109.073 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -155.84 18.36 0.49 Allowed Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.396 177.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -116.43 163.53 15.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.027 0.931 . . . . 0.0 109.813 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -70.35 161.51 30.31 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.737 0.415 . . . . 0.0 110.063 176.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 30.9 p80 -71.66 178.83 3.35 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.382 0.673 . . . . 0.0 111.285 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.11 89.94 2.09 Favored Glycine 0 C--N 1.343 0.923 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -174.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.8 58.89 2.25 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.871 1.268 . . . . 0.0 108.828 -176.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.45 99.92 1.83 Allowed Glycine 0 C--N 1.343 0.968 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 176.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.5 tp -88.53 127.73 35.54 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -177.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 49.3 ttt-85 -78.88 122.98 26.78 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -129.18 114.18 15.99 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.059 0.943 . . . . 0.0 109.208 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.56 143.74 51.49 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.49 0.716 . . . . 0.0 109.913 175.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.99 111.21 1.58 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.655 0.782 . . . . 0.0 111.572 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.22 3.64 24.29 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-O 119.096 -0.836 . . . . 0.0 114.794 173.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.63 127.3 32.47 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 118.232 1.016 . . . . 0.0 111.782 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.677 HD23 HD11 ' A' ' 60' ' ' LEU . 54.2 mt -85.37 102.15 13.18 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 175.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.565 HG22 ' HE1' ' A' ' 51' ' ' TRP . 34.8 mm -107.68 125.81 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.812 0.845 . . . . 0.0 109.448 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.1 m -81.77 136.95 35.4 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.542 0.737 . . . . 0.0 110.461 178.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.7 mt -76.71 129.4 36.28 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.846 0.858 . . . . 0.0 109.674 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.685 HD13 ' HG3' ' A' ' 43' ' ' GLU . 96.0 mt -77.02 -28.47 54.93 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.811 0.445 . . . . 0.0 110.631 174.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -155.01 147.7 24.34 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.823 0.849 . . . . 0.0 109.456 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.6 m -112.97 92.21 20.42 Favored Pre-proline 0 CA--C 1.559 1.299 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 166.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -68.58 -27.85 32.27 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.618 2.212 . . . . 0.0 111.908 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -175.85 -51.61 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.856 1.262 . . . . 0.0 109.169 175.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.93 176.84 28.53 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.851 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.25 -79.71 0.4 Allowed Glycine 0 C--N 1.347 1.153 0 N-CA-C 111.907 -0.477 . . . . 0.0 111.907 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -84.64 108.94 17.64 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.335 0.654 . . . . 0.0 109.565 171.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -113.16 178.18 4.37 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.059 0.944 . . . . 0.0 109.092 171.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 51' ' ' TRP . 0.9 OUTLIER -137.49 145.31 42.89 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.543 0.737 . . . . 0.0 109.36 173.272 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.521 ' HA2' ' HG ' ' A' ' 32' ' ' LEU . . . -154.48 178.57 31.2 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.794 -178.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.685 ' HG3' HD13 ' A' ' 32' ' ' LEU . 45.6 mt-10 -103.25 148.49 25.76 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.077 0.551 . . . . 0.0 109.799 176.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -112.83 145.09 41.24 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.693 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -69.29 -7.23 35.13 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.259 0.624 . . . . 0.0 112.432 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.69 -7.44 53.3 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.526 1.13 . . . . 0.0 111.878 172.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.76 -19.39 51.69 Favored Glycine 0 C--N 1.348 1.24 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 -177.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 65.0 mt -82.24 158.53 23.49 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.59 1.156 . . . . 0.0 110.25 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -120.53 177.76 4.93 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.898 0.879 . . . . 0.0 109.485 174.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.46 158.36 13.84 Favored Glycine 0 N--CA 1.467 0.714 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 -174.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.565 ' HE1' HG22 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -156.06 173.24 17.1 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.494 0.664 . . . . 0.0 111.833 -171.829 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -125.54 167.16 17.32 Favored Pre-proline 0 N--CA 1.48 1.056 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.798 -173.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.36 170.52 9.31 Favored 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 122.213 1.942 . . . . 0.0 112.87 174.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.23 -15.23 56.4 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.494 1.118 . . . . 0.0 113.416 -175.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.3 p -62.51 -30.17 71.09 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.325 1.05 . . . . 0.0 113.062 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.524 ' HE1' ' HB2' ' A' ' 12' ' ' PHE . 85.1 m-85 -94.99 -6.56 42.06 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -176.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.6 m -135.39 -179.85 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 123.768 0.827 . . . . 0.0 110.397 -177.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.421 ' HB2' HD22 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -152.4 131.76 12.88 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 173.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.583 HD23 ' SG ' ' A' ' 6' ' ' CYS . 85.8 mt -65.32 133.98 52.58 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.764 0.826 . . . . 0.0 111.025 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.677 HD11 HD23 ' A' ' 28' ' ' LEU . 69.3 mt . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.896 -0.574 . . . . 0.0 109.572 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.5 ttm . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 m -75.35 -40.27 58.39 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.4 0.68 . . . . 0.0 110.36 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -130.69 164.69 23.04 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.062 176.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.98 127.26 32.38 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 122.969 0.507 . . . . 0.0 110.451 -177.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.639 ' HG3' ' HB2' ' A' ' 60' ' ' LEU . 35.2 ptt180 -86.68 157.38 19.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.87 0.868 . . . . 0.0 110.149 175.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 28.5 p -152.18 146.84 25.78 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.218 1.007 . . . . 0.0 108.921 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -106.07 125.57 51.16 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.506 HG21 HG11 ' A' ' 57' ' ' VAL . 49.6 p -72.27 140.01 48.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.49 0.716 . . . . 0.0 109.337 177.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mp -85.16 -74.46 0.4 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -144.89 100.39 4.61 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -69.8 101.34 0.9 Allowed 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 123.322 2.681 . . . . 0.0 112.103 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -92.88 161.65 14.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.314 0.646 . . . . 0.0 110.017 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.0 p -152.1 176.96 11.0 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.552 0.741 . . . . 0.0 110.555 -173.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -171.51 -50.94 0.04 OUTLIER Glycine 0 C--N 1.34 0.774 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -85.67 86.23 7.37 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 173.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -100.56 100.09 10.76 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -142.91 123.36 13.94 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.8 -145.95 33.23 Favored Glycine 0 C--N 1.345 1.06 0 O-C-N 123.571 0.545 . . . . 0.0 112.022 -174.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -94.77 60.57 2.51 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.745 0.818 . . . . 0.0 111.297 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.53 136.65 44.7 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-O 119.393 -0.671 . . . . 0.0 111.589 174.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.437 ' HB3' ' HE2' ' A' ' 52' ' ' PHE . 47.4 tp -85.98 114.03 22.55 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 117.363 0.581 . . . . 0.0 109.769 -169.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -99.83 116.73 32.58 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.341 0.657 . . . . 0.0 109.841 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -86.43 157.15 19.89 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.274 0.63 . . . . 0.0 109.387 172.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.75 154.48 19.88 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 169.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.26 133.9 46.43 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.02 0.528 . . . . 0.0 110.538 173.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.92 5.82 88.76 Favored Glycine 0 N--CA 1.475 1.27 0 O-C-N 123.305 0.378 . . . . 0.0 113.474 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -77.13 140.73 40.31 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.028 0.931 . . . . 0.0 111.268 -173.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.1 mt -91.06 104.48 17.06 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.514 0.725 . . . . 0.0 109.2 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.5 mm -117.82 130.62 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.006 1.323 . . . . 0.0 109.666 -176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 87.7 m -90.45 138.52 31.49 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 171.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 pp -75.77 151.27 37.6 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.606 0.362 . . . . 0.0 110.692 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 93.6 mt -109.15 -2.41 18.06 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.016 0.926 . . . . 0.0 110.939 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.419 ' HG2' ' HD3' ' A' ' 35' ' ' PRO . 15.2 tt0 -143.48 152.54 41.61 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.51 56.15 21.29 Favored Pre-proline 0 CA--C 1.57 1.724 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.451 ' HD2' ' CD1' ' A' ' 40' ' ' TRP . 91.0 Cg_endo -77.16 126.29 8.46 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 121.727 1.618 . . . . 0.0 110.085 170.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -62.91 102.69 0.38 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.477 0.711 . . . . 0.0 109.699 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.9 54.22 7.37 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.237 -175.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -142.97 -172.55 14.07 Favored Glycine 0 C--N 1.343 0.951 0 C-N-CA 122.807 0.241 . . . . 0.0 112.68 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 25.0 m95 -81.38 140.74 34.55 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.451 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 12.5 m0 -117.64 136.63 53.19 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 2.2 mp0 -87.36 123.96 32.88 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 175.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.48 143.05 19.88 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -102.89 143.72 32.13 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 173.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -129.49 152.42 49.04 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.336 0.654 . . . . 0.0 110.296 173.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -67.26 -21.9 65.7 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.821 0.849 . . . . 0.0 109.997 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -51.35 -37.74 49.49 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.192 1.397 . . . . 0.0 111.15 169.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.02 -5.09 32.02 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-O 119.295 -0.725 . . . . 0.0 113.828 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 65.6 mt -92.23 172.6 8.31 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.076 0.938 . . . . 0.0 111.604 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -145.13 148.0 33.13 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.439 1.495 . . . . 0.0 109.05 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.403 ' N ' HD23 ' A' ' 21' ' ' LEU . . . -174.72 152.23 13.7 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 175.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.432 ' HB3' ' HG3' ' A' ' 41' ' ' GLU . 39.9 p-90 -97.23 129.98 44.5 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.862 0.865 . . . . 0.0 109.869 -174.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.437 ' HE2' ' HB3' ' A' ' 21' ' ' LEU . 78.8 m-85 -138.19 153.71 73.38 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 124.949 1.3 . . . . 0.0 109.041 -178.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -74.13 168.24 25.27 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.584 2.189 . . . . 0.0 112.457 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.47 -15.19 63.53 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.277 1.031 . . . . 0.0 111.787 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.8 m -55.64 -34.85 65.31 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.691 1.196 . . . . 0.0 112.658 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -97.03 -10.94 25.15 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.506 HG11 HG21 ' A' ' 8' ' ' THR . 34.5 m -122.53 161.1 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.44 0.696 . . . . 0.0 110.854 -177.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -131.18 115.58 16.56 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.346 1.058 . . . . 0.0 108.723 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.3 mt -58.49 132.42 53.69 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.335 0.654 . . . . 0.0 111.074 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.639 ' HB2' ' HG3' ' A' ' 5' ' ' ARG . 90.2 mt . . . . . 0 C--O 1.251 1.135 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tmm? . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.4 t -89.54 131.94 35.31 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 175.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -170.73 167.25 40.42 Favored Glycine 0 C--N 1.346 1.115 0 O-C-N 123.298 0.374 . . . . 0.0 112.48 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.44 134.79 54.44 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.936 0.894 . . . . 0.0 109.833 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -154.68 177.18 11.52 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.105 0.962 . . . . 0.0 109.572 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.7 m -123.94 -176.45 3.48 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -142.83 128.51 19.22 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.1 p -66.99 147.54 53.1 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.73 0.812 . . . . 0.0 112.344 -176.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.7 mt -84.2 -52.62 6.11 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.271 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -139.11 166.69 22.95 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 124.151 0.98 . . . . 0.0 109.149 -176.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.69 95.58 0.34 Allowed 'Trans proline' 0 C--N 1.388 2.629 0 C-N-CA 121.801 1.667 . . . . 0.0 110.515 175.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -96.85 154.99 16.97 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.32 0.648 . . . . 0.0 111.285 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.7 m -122.47 -10.69 8.39 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.286 1.034 . . . . 0.0 111.059 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.76 -46.62 1.91 Allowed Glycine 0 C--N 1.349 1.269 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -172.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 63.64 16.84 10.0 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.897 1.279 . . . . 0.0 112.254 178.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -121.62 154.61 36.55 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 124.424 1.089 . . . . 0.0 108.663 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -70.43 154.23 42.12 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.216 0.607 . . . . 0.0 110.889 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.43 -116.34 4.88 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -92.29 76.63 5.24 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-O 121.695 0.759 . . . . 0.0 109.151 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.94 93.08 1.82 Allowed Glycine 0 C--N 1.338 0.65 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.7 174.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.542 HD22 ' HB2' ' A' ' 44' ' ' LYS . 36.4 tp -98.66 130.3 45.17 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.231 0.612 . . . . 0.0 109.508 177.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.92 158.32 30.78 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 168.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -158.41 150.5 21.65 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 174.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.01 142.75 38.05 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.815 0.846 . . . . 0.0 110.72 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.54 145.4 50.84 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.464 0.705 . . . . 0.0 111.35 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.46 19.79 79.74 Favored Glycine 0 C--N 1.345 1.053 0 O-C-N 123.808 0.693 . . . . 0.0 113.196 173.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -109.16 156.28 20.03 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.35 0.66 . . . . 0.0 110.776 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.7 mt -79.89 124.38 28.61 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.929 -171.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.554 HG13 HG12 ' A' ' 57' ' ' VAL . 47.6 mm -88.66 106.58 16.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 172.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.9 p -73.5 108.3 6.28 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.5 mt -66.76 93.35 0.25 Allowed 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.163 0.914 . . . . 0.0 109.148 -175.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.588 HD13 HH11 ' A' ' 49' ' ' ARG . 83.3 mt -75.16 -51.89 12.31 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.965 0.906 . . . . 0.0 109.638 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -101.9 136.07 42.37 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.16 86.56 41.7 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.287 1.035 . . . . 0.0 109.216 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.57 -174.41 2.26 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.868 2.378 . . . . 0.0 112.082 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -73.46 -23.27 60.06 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.281 0.632 . . . . 0.0 110.343 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 179.19 174.85 45.68 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 109.74 -101.57 1.47 Allowed Glycine 0 C--N 1.341 0.819 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 14.5 p-90 -137.83 165.1 27.29 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.59 0.756 . . . . 0.0 109.755 -177.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -122.32 149.27 43.98 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.587 0.755 . . . . 0.0 109.183 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.442 ' HG2' HD11 ' A' ' 32' ' ' LEU . 43.2 tt0 -91.15 138.43 31.6 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.89 158.61 16.59 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.572 ' HB2' HD12 ' A' ' 32' ' ' LEU . 28.8 tt0 -110.1 119.36 39.05 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.063 0.545 . . . . 0.0 110.032 -176.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.542 ' HB2' HD22 ' A' ' 21' ' ' LEU . 56.5 tttm -78.76 155.12 29.47 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.439 0.696 . . . . 0.0 109.262 171.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -66.75 -7.02 18.2 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -173.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -78.24 -8.53 58.46 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.517 0.727 . . . . 0.0 111.236 172.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.96 -5.36 84.6 Favored Glycine 0 C--N 1.347 1.193 0 C-N-CA 123.298 0.475 . . . . 0.0 112.403 -171.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.1 mt -78.78 140.59 38.22 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 123.861 0.864 . . . . 0.0 110.584 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.588 HH11 HD13 ' A' ' 32' ' ' LEU . 58.8 mtt-85 -107.07 149.88 27.13 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.562 1.145 . . . . 0.0 108.139 177.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -156.25 -176.3 28.2 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 121.282 -0.485 . . . . 0.0 113.753 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -73.38 126.64 30.63 Favored 'General case' 0 C--N 1.346 0.438 0 C-N-CA 123.235 0.614 . . . . 0.0 110.418 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -139.27 85.26 15.66 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 123.661 0.784 . . . . 0.0 110.149 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.3 151.42 82.51 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.032 2.488 . . . . 0.0 112.023 170.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.24 -15.76 60.7 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.965 0.906 . . . . 0.0 110.79 171.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.3 m -67.75 -38.12 83.05 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 124.32 1.048 . . . . 0.0 111.117 173.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -80.94 -13.0 59.29 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.361 1.064 . . . . 0.0 112.205 -173.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.554 HG12 HG13 ' A' ' 29' ' ' ILE . 29.8 m -132.78 146.2 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.462 0.705 . . . . 0.0 111.091 -171.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.2 127.56 41.34 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 169.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.0 mt -69.06 123.6 21.51 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.928 0.891 . . . . 0.0 110.291 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 72.0 mt . . . . . 0 C--O 1.248 1.008 0 C-N-CA 122.727 0.411 . . . . 0.0 109.95 178.857 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.8 mtp . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.5 t -67.75 94.71 0.46 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.12 0.968 . . . . 0.0 111.399 -175.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.54 -38.48 2.91 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-N 116.067 -0.515 . . . . 0.0 113.79 174.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.27 103.84 0.21 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.507 0.723 . . . . 0.0 111.494 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.459 ' HG2' ' HA ' ' A' ' 30' ' ' THR . 61.2 mtt180 -143.02 170.4 15.77 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.847 0.859 . . . . 0.0 111.004 -177.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.605 ' SG ' HD22 ' A' ' 59' ' ' LEU . 81.9 m -133.93 172.13 13.23 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 113.882 -1.508 . . . . 0.0 108.352 172.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.553 ' HB2' HD23 ' A' ' 60' ' ' LEU . 36.1 ttm180 -124.61 140.36 53.01 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 172.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.8 p -82.0 136.19 35.28 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.501 0.72 . . . . 0.0 110.262 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 75.3 mt -74.89 -67.1 0.67 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.497 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -141.73 157.66 64.4 Favored Pre-proline 0 N--CA 1.48 1.026 0 C-N-CA 124.718 1.207 . . . . 0.0 108.366 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.518 ' HD3' ' HB1' ' A' ' 25' ' ' ALA . 56.5 Cg_endo -66.38 88.53 0.26 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.263 1.976 . . . . 0.0 111.533 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -91.83 146.87 23.41 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.449 0.7 . . . . 0.0 110.498 -177.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.0 p -153.51 161.26 42.41 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.578 1.151 . . . . 0.0 108.276 173.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.5 -84.23 0.13 Allowed Glycine 0 C--N 1.348 1.236 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -144.5 160.35 41.25 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.829 1.252 . . . . 0.0 108.811 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -74.93 82.55 2.19 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 122.74 0.416 . . . . 0.0 110.736 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.6 t60 171.82 -50.17 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.265 1.826 . . . . 0.0 107.17 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.24 149.74 51.26 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 114.915 -1.039 . . . . 0.0 113.776 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -81.31 163.64 22.76 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.905 0.882 . . . . 0.0 112.106 -175.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.08 160.89 11.69 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.261 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.9 tp -89.53 115.99 27.35 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.563 ' HD2' ' H ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -85.74 154.8 21.37 Favored 'General case' 0 C--O 1.247 0.944 0 C-N-CA 123.648 0.779 . . . . 0.0 111.063 -176.474 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.463 ' HZ ' ' HE1' ' A' ' 56' ' ' TYR . 21.4 p90 -156.42 149.57 24.24 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.192 -171.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.87 148.58 22.01 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.936 0.895 . . . . 0.0 109.657 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.518 ' HB1' ' HD3' ' A' ' 11' ' ' PRO . . . -61.35 114.55 3.25 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.414 0.686 . . . . 0.0 111.606 -178.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.09 -13.16 24.1 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-O 119.248 -0.751 . . . . 0.0 114.209 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -70.91 163.0 28.33 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 118.056 0.928 . . . . 0.0 111.03 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 mp -99.03 126.15 44.68 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.53 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.3 mm -92.89 108.66 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 169.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.459 ' HA ' ' HG2' ' A' ' 5' ' ' ARG . 54.5 m -77.8 107.93 10.66 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.458 HD22 ' SG ' ' A' ' 6' ' ' CYS . 42.6 mt -69.3 115.07 8.15 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.53 ' HB2' ' HG3' ' A' ' 41' ' ' GLU . 46.7 mt -74.72 -50.55 17.05 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.412 0.685 . . . . 0.0 110.091 -173.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.461 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 52.3 tt0 -147.22 166.38 27.18 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.074 0.949 . . . . 0.0 108.624 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.5 m -101.96 84.4 0.57 Allowed Pre-proline 0 CA--C 1.566 1.588 0 C-N-CA 124.347 1.059 . . . . 0.0 109.713 173.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 33' ' ' GLN . 4.8 Cg_exo -74.42 -36.88 2.76 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 122.888 2.392 . . . . 0.0 111.663 -174.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -109.15 -67.61 0.97 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.241 1.016 . . . . 0.0 109.15 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.36 -35.47 1.88 Allowed Glycine 0 C--N 1.35 1.324 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -100.83 -42.52 2.44 Favored Glycine 0 C--N 1.345 1.078 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 171.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -86.8 137.47 32.39 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 168.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -128.02 177.5 6.84 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.727 0.811 . . . . 0.0 109.747 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.53 ' HG3' ' HB2' ' A' ' 32' ' ' LEU . 15.8 pt-20 -118.66 149.64 41.06 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.166 0.986 . . . . 0.0 108.384 174.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.41 125.68 1.87 Allowed Glycine 0 C--N 1.335 0.491 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.408 ' HB2' HD13 ' A' ' 32' ' ' LEU . 35.5 tt0 -101.16 123.55 45.48 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -77.04 167.24 22.15 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.915 0.886 . . . . 0.0 110.072 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -52.21 -35.4 49.18 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.407 1.483 . . . . 0.0 113.505 -175.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -78.26 -16.38 57.85 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.145 0.578 . . . . 0.0 111.662 -175.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.56 -7.55 30.1 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-O 119.702 -0.499 . . . . 0.0 113.446 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.01 125.1 25.6 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 117.619 0.709 . . . . 0.0 110.295 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.2 mtp85 -105.26 128.67 53.55 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -135.38 155.3 22.08 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 29.3 p-90 -80.88 138.98 36.17 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.149 0.579 . . . . 0.0 109.695 174.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -140.58 104.96 6.41 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 123.925 0.89 . . . . 0.0 108.881 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.448 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 94.5 Cg_endo -80.31 165.04 21.38 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.975 2.45 . . . . 0.0 112.219 172.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.01 -30.0 71.1 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.772 0.829 . . . . 0.0 111.013 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.0 p -75.39 7.48 3.53 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.136 0.974 . . . . 0.0 112.541 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.463 ' HE1' ' HZ ' ' A' ' 23' ' ' PHE . 2.6 t80 -124.9 -45.14 1.9 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.6 m -130.51 141.1 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.223 1.009 . . . . 0.0 109.643 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -89.39 132.97 34.73 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 122.952 0.501 . . . . 0.0 111.326 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.605 HD22 ' SG ' ' A' ' 6' ' ' CYS . 93.2 mt -62.32 145.3 54.17 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.225 1.01 . . . . 0.0 111.9 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.553 HD23 ' HB2' ' A' ' 7' ' ' ARG . 95.0 mt . . . . . 0 C--O 1.245 0.84 0 C-N-CA 123.617 0.767 . . . . 0.0 109.832 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.701 0.286 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.5 t -94.88 82.91 3.9 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.742 0.817 . . . . 0.0 110.005 -169.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -172.28 -121.11 0.58 Allowed Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.472 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 31' ' ' LEU . . . -134.88 149.64 50.33 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.755 0.822 . . . . 0.0 109.375 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -128.04 155.0 45.03 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.89 0.876 . . . . 0.0 110.717 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.451 ' SG ' HD12 ' A' ' 31' ' ' LEU . 72.4 m -143.62 173.13 11.93 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.229 1.412 . . . . 0.0 108.795 175.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.9 ttt180 -142.84 131.09 22.05 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.608 HG21 ' HB3' ' A' ' 23' ' ' PHE . 35.2 p -68.12 125.91 27.84 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 124.018 0.927 . . . . 0.0 111.24 -176.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.518 HD22 ' HB2' ' A' ' 58' ' ' GLN . 93.1 mt -67.21 -59.99 2.98 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 123.708 0.63 . . . . 0.0 109.505 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -139.83 153.84 70.22 Favored Pre-proline 0 N--CA 1.476 0.853 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.14 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.423 ' HD3' ' HB3' ' A' ' 25' ' ' ALA . 48.2 Cg_endo -83.63 29.8 0.54 Allowed 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.621 2.214 . . . . 0.0 113.73 -172.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -90.88 101.0 13.76 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.524 ' HB2' ' HA ' ' A' ' 22' ' ' ARG . 25.2 m -148.04 134.39 19.56 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -178.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.21 53.08 4.01 Favored Glycine 0 C--N 1.341 0.824 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -171.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -59.88 104.16 0.27 Allowed 'General case' 0 C--O 1.245 0.841 0 C-N-CA 124.26 1.024 . . . . 0.0 111.414 -177.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 61.8 18.03 9.34 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.651 1.18 . . . . 0.0 112.34 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -156.28 117.9 3.91 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.874 0.869 . . . . 0.0 108.825 -171.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.02 -162.99 16.84 Favored Glycine 0 CA--C 1.533 1.167 0 O-C-N 123.21 0.319 . . . . 0.0 112.539 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 71.53 -2.92 2.28 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.009 1.323 . . . . 0.0 113.304 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.4 178.61 35.62 Favored Glycine 0 C--N 1.348 1.201 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' A' ' 44' ' ' LYS . 43.7 tp -90.36 112.93 24.7 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.524 ' HA ' ' HB2' ' A' ' 13' ' ' SER . 64.7 mtt180 -82.42 139.05 34.23 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.852 0.72 . . . . 0.0 109.374 174.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.608 ' HB3' HG21 ' A' ' 8' ' ' THR . 97.1 m-85 -113.11 135.4 53.85 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.371 0.668 . . . . 0.0 109.604 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.12 138.42 33.04 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 171.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.423 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -64.29 135.59 56.36 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.546 0.738 . . . . 0.0 111.657 -176.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.4 -13.09 67.41 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-O 119.552 -0.582 . . . . 0.0 114.021 177.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -64.96 129.92 41.49 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.183 0.593 . . . . 0.0 111.919 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.9 mt -80.44 100.35 8.45 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.9 mm -95.62 115.2 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.468 0.707 . . . . 0.0 109.502 -175.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.0 m -74.65 125.24 28.25 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 122.943 0.497 . . . . 0.0 109.755 175.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 4' ' ' ALA . 82.4 mt -76.88 126.09 30.4 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 170.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.52 -51.31 15.09 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.529 0.68 . . . . 0.0 110.342 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -153.27 162.42 41.32 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.469 -173.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.9 m -100.82 89.13 1.16 Allowed Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 124.032 0.933 . . . . 0.0 109.569 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -79.76 -4.22 13.31 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.288 2.659 . . . . 0.0 113.518 -171.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -162.6 -69.86 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.808 0.843 . . . . 0.0 109.645 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.24 -52.85 0.55 Allowed Glycine 0 C--N 1.341 0.831 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -174.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -72.31 -46.44 33.98 Favored Glycine 0 C--N 1.344 0.984 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 173.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -93.71 135.46 34.98 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.882 0.873 . . . . 0.0 109.21 174.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 14.5 m0 -133.17 150.39 52.01 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.071 0.949 . . . . 0.0 110.388 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 42.2 mt-10 -91.54 145.85 24.27 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.875 0.87 . . . . 0.0 110.689 -173.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -147.57 170.31 28.34 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.241 0.925 . . . . 0.0 110.99 177.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.407 ' HG2' ' HG2' ' A' ' 49' ' ' ARG . 45.4 mt-10 -126.05 167.23 15.63 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.528 0.731 . . . . 0.0 112.423 -177.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.626 ' HB2' HD12 ' A' ' 21' ' ' LEU . 3.3 tmtp? -126.4 146.64 49.99 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 164.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.435 ' H ' ' HD3' ' A' ' 44' ' ' LYS . 1.7 mp0 -66.45 -9.71 36.87 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.081 0.952 . . . . 0.0 111.647 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -77.76 -8.65 58.29 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 124.858 1.263 . . . . 0.0 111.537 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.87 -13.42 57.67 Favored Glycine 0 C--N 1.355 1.61 0 C-N-CA 123.159 0.409 . . . . 0.0 112.916 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.16 133.66 34.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.311 0.644 . . . . 0.0 109.841 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.407 ' HG2' ' HG2' ' A' ' 43' ' ' GLU . 39.0 mtm180 -111.62 173.81 6.17 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.134 0.974 . . . . 0.0 109.689 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -167.88 153.49 22.8 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.56 174.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -121.61 125.75 47.46 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -144.02 156.14 58.56 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 124.217 1.007 . . . . 0.0 109.718 -168.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -68.57 153.85 72.76 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 122.725 2.284 . . . . 0.0 112.719 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.66 -14.51 63.0 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.6 1.16 . . . . 0.0 112.288 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.7 t -55.94 -23.58 32.88 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.508 1.123 . . . . 0.0 112.969 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -106.72 -7.07 17.43 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.2 0.6 . . . . 0.0 112.392 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 6' ' ' CYS . 12.9 m -135.9 124.76 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.688 0.795 . . . . 0.0 110.206 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.518 ' HB2' HD22 ' A' ' 9' ' ' LEU . 63.2 tt0 -80.81 127.09 32.12 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 37.9 mt -73.59 133.89 43.61 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.761 0.824 . . . . 0.0 110.871 -173.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.0 mt . . . . . 0 C--O 1.251 1.151 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.864 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.9 m -72.79 104.95 4.15 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 170.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -145.72 163.67 28.23 Favored Glycine 0 C--N 1.343 0.946 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.55 140.69 55.62 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 81.9 mtm-85 -126.55 138.61 53.49 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.082 0.553 . . . . 0.0 110.137 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.665 ' SG ' HD22 ' A' ' 59' ' ' LEU . 77.3 m -128.49 170.47 13.13 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.475 1.11 . . . . 0.0 109.709 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -140.71 138.18 34.03 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.607 0.763 . . . . 0.0 109.153 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.635 HG22 HD12 ' A' ' 29' ' ' ILE . 1.6 p -66.91 128.81 37.73 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.579 0.751 . . . . 0.0 110.839 176.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.5 mp -74.38 -38.17 63.24 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -129.78 152.63 80.16 Favored Pre-proline 0 C--O 1.245 0.867 0 C-N-CA 125.405 1.482 . . . . 0.0 108.03 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.48 145.29 76.39 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.065 1.843 . . . . 0.0 111.843 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -89.92 106.64 18.61 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 173.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.8 m -59.34 138.69 57.54 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 124.323 1.014 . . . . 0.0 111.164 -176.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.78 72.04 1.83 Allowed Glycine 0 C--N 1.349 1.257 0 O-C-N 123.92 0.763 . . . . 0.0 111.439 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -70.56 96.99 1.25 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.287 1.035 . . . . 0.0 109.856 -176.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -77.45 75.78 4.0 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.92 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -169.1 95.85 0.34 Allowed 'General case' 0 C--O 1.241 0.641 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.78 -131.19 10.6 Favored Glycine 0 N--CA 1.469 0.844 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -174.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -155.0 142.22 19.42 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.217 0.607 . . . . 0.0 109.994 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.23 157.55 29.69 Favored Glycine 0 C--N 1.344 1.001 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.8 tp -90.15 126.0 35.65 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -88.96 134.22 34.05 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.1 0.96 . . . . 0.0 111.615 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -145.07 111.53 5.71 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 163.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.71 157.74 28.48 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.54 0.736 . . . . 0.0 109.939 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.98 119.52 7.39 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.309 0.643 . . . . 0.0 111.326 -174.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.93 -22.03 12.96 Favored Glycine 0 C--N 1.347 1.184 0 O-C-N 123.654 0.596 . . . . 0.0 113.148 -176.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -72.2 143.11 48.98 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.179 0.514 . . . . 0.0 111.427 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.29 117.3 30.05 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.317 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.635 HD12 HG22 ' A' ' 8' ' ' THR . 3.3 mp -85.4 108.27 17.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.4 m -85.06 102.35 13.16 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.539 HD12 ' SG ' ' A' ' 6' ' ' CYS . 90.2 mt -76.23 104.52 6.79 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.243 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.494 HD13 ' HB2' ' A' ' 43' ' ' GLU . 58.9 mt -77.95 -42.91 31.41 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.537 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.447 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 32.6 mm-40 -121.33 136.99 54.89 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.384 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.7 m -137.38 72.06 52.09 Favored Pre-proline 0 CA--C 1.557 1.217 0 C-N-CA 124.301 1.04 . . . . 0.0 109.643 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.42 169.54 20.59 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.52 2.147 . . . . 0.0 112.269 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.46 92.17 0.43 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.618 0.767 . . . . 0.0 110.196 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 166.68 -164.84 38.02 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.563 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.08 -29.52 9.62 Favored Glycine 0 N--CA 1.473 1.115 0 N-CA-C 113.403 0.121 . . . . 0.0 113.403 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -94.19 100.21 12.33 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.526 0.73 . . . . 0.0 110.159 -168.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -111.19 150.98 28.75 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.304 1.042 . . . . 0.0 109.248 -175.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 33' ' ' GLN . 35.5 tt0 -89.39 125.91 35.33 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -176.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -123.17 140.6 13.17 Favored Glycine 0 C--N 1.34 0.752 0 O-C-N 124.689 1.243 . . . . 0.0 110.1 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.494 ' HB2' HD13 ' A' ' 32' ' ' LEU . 37.8 tt0 -106.37 140.67 38.93 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.123 0.487 . . . . 0.0 110.717 -177.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -97.05 151.85 19.33 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.013 1.325 . . . . 0.0 108.085 172.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -68.2 -14.2 62.81 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.934 0.493 . . . . 0.0 111.93 -173.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -69.12 -20.71 64.05 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.52 0.728 . . . . 0.0 111.644 174.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.07 -9.4 36.59 Favored Glycine 0 C--N 1.344 1.008 0 C-N-CA 123.413 0.53 . . . . 0.0 112.406 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.1 mp -75.72 121.33 22.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.576 0.75 . . . . 0.0 109.795 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -104.59 158.37 16.54 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.858 0.863 . . . . 0.0 108.978 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -172.13 163.1 35.33 Favored Glycine 0 CA--C 1.507 -0.461 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.879 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 3.6 p-90 -86.06 138.35 32.01 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.591 0.757 . . . . 0.0 109.062 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -132.26 140.13 37.03 Favored Pre-proline 0 C--O 1.242 0.677 0 C-N-CA 124.105 0.962 . . . . 0.0 108.429 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.482 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 39.7 Cg_endo -69.45 134.5 28.81 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 121.843 1.695 . . . . 0.0 109.98 173.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.62 -24.9 65.87 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.371 1.068 . . . . 0.0 111.29 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.0 m -64.82 -35.82 82.33 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.263 1.025 . . . . 0.0 111.32 176.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.482 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 35.5 t80 -81.69 -19.69 41.05 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.377 0.671 . . . . 0.0 111.581 -173.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.467 ' HB ' ' HB3' ' A' ' 6' ' ' CYS . 35.4 m -115.41 149.71 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.237 0.615 . . . . 0.0 110.691 -176.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -110.64 117.58 33.87 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.79 0.836 . . . . 0.0 110.168 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.665 HD22 ' SG ' ' A' ' 6' ' ' CYS . 64.2 mt -66.46 123.23 19.44 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 171.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.2 mp . . . . . 0 C--O 1.248 1.021 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.162 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.0 mtt . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.9 p -77.95 -57.4 3.82 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.799 0.839 . . . . 0.0 109.945 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -110.65 -163.52 18.63 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.986 172.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.521 ' HB2' ' HB2' ' A' ' 31' ' ' LEU . . . -73.51 164.68 26.33 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.889 0.476 . . . . 0.0 109.95 173.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.466 ' HG3' ' HB2' ' A' ' 60' ' ' LEU . 15.6 ptt180 -141.89 149.55 40.36 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.445 0.698 . . . . 0.0 109.908 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.645 ' SG ' ' HA ' ' A' ' 59' ' ' LEU . 57.0 m -145.11 145.31 31.36 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.571 0.749 . . . . 0.0 109.503 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.53 ' HB2' HD11 ' A' ' 60' ' ' LEU . 6.7 tmm_? -106.77 136.56 46.38 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.44 ' HA ' HG12 ' A' ' 57' ' ' VAL . 52.5 p -75.59 127.46 33.12 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.779 1.232 . . . . 0.0 111.891 -174.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.401 ' HA ' ' NH1' ' A' ' 7' ' ' ARG . 96.1 mt -67.87 -56.47 8.98 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.443 0.697 . . . . 0.0 110.38 177.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -129.22 154.46 80.56 Favored Pre-proline 0 N--CA 1.478 0.949 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.249 -175.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.27 138.52 51.51 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.899 2.4 . . . . 0.0 111.983 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.425 ' HD2' ' HA ' ' A' ' 22' ' ' ARG . 50.4 t80 -111.38 101.24 9.71 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 172.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.0 m -138.27 70.16 1.39 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 169.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -106.27 -46.37 1.16 Allowed Glycine 0 C--N 1.34 0.786 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.977 176.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 56.74 31.81 20.06 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.337 1.055 . . . . 0.0 111.667 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -63.28 -36.41 83.58 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.73 0.812 . . . . 0.0 110.581 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -123.62 152.92 41.42 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.631 1.172 . . . . 0.0 109.36 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.62 -39.7 93.89 Favored Glycine 0 C--N 1.343 0.965 0 O-C-N 123.964 0.79 . . . . 0.0 112.234 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -82.15 89.3 6.47 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.37 136.24 2.89 Favored Glycine 0 C--N 1.345 1.082 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.0 tp -91.01 119.58 31.3 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.549 0.74 . . . . 0.0 109.685 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.425 ' HA ' ' HD2' ' A' ' 12' ' ' PHE . 15.3 ptm180 -92.23 146.68 23.52 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -158.96 174.59 14.72 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.073 0.949 . . . . 0.0 110.765 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.03 168.09 9.28 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.183 0.993 . . . . 0.0 108.855 170.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.79 146.65 49.62 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 172.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.86 -9.82 76.68 Favored Glycine 0 N--CA 1.468 0.799 0 CA-C-N 116.07 -0.514 . . . . 0.0 113.888 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -76.44 135.12 39.4 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.24 0.616 . . . . 0.0 111.019 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.411 HD22 ' HD2' ' A' ' 5' ' ' ARG . 6.9 mp -98.44 114.73 27.21 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.598 HG13 ' HD3' ' A' ' 44' ' ' LYS . 2.6 mp -102.24 125.34 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 174.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 87.0 m -76.3 126.88 31.79 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.77 0.828 . . . . 0.0 110.507 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.598 HD11 ' SG ' ' A' ' 6' ' ' CYS . 5.6 mp -76.2 140.56 41.73 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.907 174.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.3 mt -82.77 -47.24 12.15 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.593 177.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -146.83 156.67 43.3 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.126 0.97 . . . . 0.0 109.358 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.4 m -114.01 87.5 12.96 Favored Pre-proline 0 CA--C 1.561 1.377 0 C-N-CA 123.73 0.812 . . . . 0.0 109.968 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.57 82.89 1.6 Allowed 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.515 2.143 . . . . 0.0 111.584 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 59.03 -86.88 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.146 1.379 . . . . 0.0 111.553 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.55 -168.91 29.44 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-N 116.388 -0.369 . . . . 0.0 112.628 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.46 -71.86 2.61 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -124.0 136.91 54.6 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.076 0.95 . . . . 0.0 108.724 172.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -124.22 160.46 27.88 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 173.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -110.92 148.58 32.17 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.069 0.461 . . . . 0.0 110.635 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.82 175.31 31.41 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.531 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -139.4 144.73 38.26 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.598 ' HD3' HG13 ' A' ' 29' ' ' ILE . 27.6 tptp -101.99 156.36 17.58 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.724 -178.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -52.88 -25.76 12.68 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 125.535 1.534 . . . . 0.0 113.01 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.81 -16.07 63.46 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.36 1.064 . . . . 0.0 112.551 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.47 -0.96 75.3 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 -171.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.6 mt -85.5 124.21 31.82 Favored 'General case' 0 C--N 1.346 0.433 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 45.0 ttp85 -104.74 138.72 40.61 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 149.71 154.5 6.43 Favored Glycine 0 C--O 1.243 0.695 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.467 ' HZ2' ' HB2' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -154.73 172.47 17.88 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.518 0.675 . . . . 0.0 111.192 -174.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -138.87 153.09 71.61 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 124.591 1.157 . . . . 0.0 109.616 -168.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.99 172.98 3.41 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.564 2.176 . . . . 0.0 113.268 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.38 -15.4 10.47 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.728 1.211 . . . . 0.0 113.24 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.8 t -61.16 -34.06 74.42 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.688 0.795 . . . . 0.0 112.083 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -92.2 -33.06 14.85 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.277 0.631 . . . . 0.0 111.432 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 8' ' ' THR . 11.4 m -138.46 138.76 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.358 0.663 . . . . 0.0 111.069 -166.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -97.4 128.9 44.59 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.205 0.602 . . . . 0.0 110.466 174.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.645 ' HA ' ' SG ' ' A' ' 6' ' ' CYS . 5.0 mp -79.58 118.75 21.71 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.367 -173.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.53 HD11 ' HB2' ' A' ' 7' ' ' ARG . 85.9 mt . . . . . 0 C--O 1.249 1.079 0 C-N-CA 123.909 0.883 . . . . 0.0 109.863 -177.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.5 t 68.3 168.71 0.27 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.125 1.37 . . . . 0.0 112.228 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 112.01 -145.57 17.91 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.64 106.67 3.13 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.15 0.58 . . . . 0.0 110.2 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -136.52 139.4 42.23 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.576 ' SG ' HD23 ' A' ' 59' ' ' LEU . 54.4 m -129.71 154.44 47.17 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.959 0.904 . . . . 0.0 109.058 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.433 HH21 ' HA ' ' A' ' 9' ' ' LEU . 6.4 ttp180 -105.87 128.61 53.87 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 40.3 p -69.45 140.79 54.09 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.701 0.8 . . . . 0.0 110.976 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.51 HD21 ' HB2' ' A' ' 58' ' ' GLN . 91.0 mt -73.9 -68.03 0.55 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.024 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -144.7 157.76 54.56 Favored Pre-proline 0 N--CA 1.482 1.152 0 C-N-CA 124.131 0.972 . . . . 0.0 109.169 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 25' ' ' ALA . 10.9 Cg_exo -70.99 162.02 44.13 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 122.643 2.229 . . . . 0.0 110.919 173.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -91.93 155.44 18.15 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.979 0.511 . . . . 0.0 110.377 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.7 m -60.43 -31.11 70.09 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.201 0.601 . . . . 0.0 111.976 -175.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.2 -37.48 3.32 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-O 119.92 -0.378 . . . . 0.0 112.406 175.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -65.78 96.2 0.28 Allowed 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.111 0.565 . . . . 0.0 110.445 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.2 tpt180 -161.07 117.45 2.24 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.575 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -74.23 86.58 1.93 Allowed 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 121.894 0.854 . . . . 0.0 110.0 175.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.21 156.4 9.44 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.187 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.78 130.75 35.59 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -145.82 172.85 26.38 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 112.259 -0.336 . . . . 0.0 112.259 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.5 tp -90.91 136.56 32.99 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.445 0.698 . . . . 0.0 109.829 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -88.31 136.39 33.01 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 123.903 0.752 . . . . 0.0 110.272 174.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -160.18 176.11 12.14 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.174 0.989 . . . . 0.0 110.31 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.411 ' HA ' ' HG3' ' A' ' 11' ' ' PRO . . . -123.96 167.37 14.24 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.329 1.052 . . . . 0.0 109.874 176.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.582 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . . . -67.19 128.44 36.4 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.375 0.67 . . . . 0.0 110.686 175.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.22 1.46 59.41 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-O 119.738 -0.479 . . . . 0.0 113.671 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -78.93 116.69 19.41 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.967 0.507 . . . . 0.0 110.971 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 mp -76.63 100.61 5.41 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 172.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.5 mm -94.05 121.31 44.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 123.975 0.91 . . . . 0.0 109.274 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 31.6 m -74.95 125.38 28.76 Favored 'General case' 0 C--O 1.241 0.658 0 C-N-CA 123.158 0.583 . . . . 0.0 109.88 175.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.1 mt -73.48 128.68 36.16 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.568 HD12 HH11 ' A' ' 49' ' ' ARG . 74.2 mt -73.57 -52.2 14.31 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.871 0.868 . . . . 0.0 110.037 -174.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -139.0 144.57 38.96 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 173.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.5 m -110.01 108.89 59.19 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.661 0.784 . . . . 0.0 110.095 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -72.34 171.67 16.5 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.964 2.442 . . . . 0.0 111.549 171.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -81.47 -6.49 59.0 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.041 177.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.25 -176.81 39.05 Favored Glycine 0 C--N 1.351 1.397 0 O-C-N 123.18 0.3 . . . . 0.0 112.743 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -100.47 36.42 4.16 Favored Glycine 0 C--N 1.348 1.22 0 C-N-CA 123.395 0.522 . . . . 0.0 112.547 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -126.9 108.03 10.62 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 175.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 25.0 m0 -111.74 145.68 38.9 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.764 0.426 . . . . 0.0 110.459 -172.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.694 ' HG2' ' HB3' ' A' ' 51' ' ' TRP . 38.8 mt-10 -106.13 123.86 48.68 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.925 0.89 . . . . 0.0 109.602 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -118.6 -179.72 16.95 Favored Glycine 0 C--N 1.34 0.75 0 O-C-N 123.766 0.667 . . . . 0.0 112.468 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -145.86 159.61 42.96 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.069 0.947 . . . . 0.0 109.903 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.462 ' HE3' ' HG2' ' A' ' 45' ' ' GLU . 20.8 mmmt -121.02 170.4 9.55 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.908 0.883 . . . . 0.0 111.284 175.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.462 ' HG2' ' HE3' ' A' ' 44' ' ' LYS . 10.4 pt-20 -54.49 -28.67 46.41 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.614 1.566 . . . . 0.0 112.65 174.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -63.09 -34.17 77.03 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.844 1.257 . . . . 0.0 111.318 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.17 -22.61 24.8 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -173.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 51.7 tp -63.17 140.76 58.91 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 123.117 0.567 . . . . 0.0 109.877 175.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.568 HH11 HD12 ' A' ' 32' ' ' LEU . 49.9 mtt-85 -116.71 173.29 6.71 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.436 1.095 . . . . 0.0 108.491 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.65 175.66 45.9 Favored Glycine 0 CA--C 1.505 -0.537 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.694 ' HB3' ' HG2' ' A' ' 41' ' ' GLU . 33.0 p-90 -141.85 136.0 30.13 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.48 0.712 . . . . 0.0 109.765 -176.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -139.77 161.0 58.71 Favored Pre-proline 0 C--O 1.247 0.925 0 C-N-CA 124.603 1.161 . . . . 0.0 108.748 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.06 144.94 35.46 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.017 2.478 . . . . 0.0 113.095 171.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.22 -27.05 68.79 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.094 0.958 . . . . 0.0 111.404 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.1 m -68.62 -25.35 64.81 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.79 0.836 . . . . 0.0 111.468 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -77.37 -19.81 55.69 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.147 0.579 . . . . 0.0 111.276 -174.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.8 m -117.24 168.23 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.85 0.86 . . . . 0.0 109.837 175.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.51 ' HB2' HD21 ' A' ' 9' ' ' LEU . 24.6 tt0 -119.71 135.06 54.99 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.828 0.851 . . . . 0.0 108.796 177.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.576 HD23 ' SG ' ' A' ' 6' ' ' CYS . 96.6 mt -65.72 145.31 56.17 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.773 0.429 . . . . 0.0 110.206 172.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--O 1.251 1.18 0 C-N-CA 122.908 0.483 . . . . 0.0 109.992 177.941 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.502 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.4 t -72.27 117.79 14.35 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.35 75.75 1.35 Allowed Glycine 0 C--N 1.346 1.12 0 O-C-N 123.83 0.706 . . . . 0.0 112.55 -176.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.63 ' HB3' HD22 ' A' ' 31' ' ' LEU . . . -83.37 136.92 34.17 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.701 ' HB2' ' HB2' ' A' ' 60' ' ' LEU . 46.7 mtt-85 -120.97 169.52 10.4 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.682 0.753 . . . . 0.0 110.036 -167.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.1 m -135.32 148.29 49.42 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 169.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -123.53 128.92 50.44 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 175.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.2 p -79.73 125.88 30.23 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.528 -176.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.6 mt -72.47 -52.17 16.99 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.228 -174.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.426 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 71.3 m-85 -139.79 159.81 63.45 Favored Pre-proline 0 N--CA 1.483 1.207 0 C-N-CA 123.828 0.851 . . . . 0.0 109.656 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.414 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . 1.8 Cg_endo -79.17 99.95 1.3 Allowed 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 122.197 1.931 . . . . 0.0 109.886 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -99.72 140.49 33.84 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.314 0.646 . . . . 0.0 109.837 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.2 m -144.35 95.33 2.7 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.934 0.894 . . . . 0.0 108.819 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.34 -170.09 44.58 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.535 173.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -129.42 132.08 46.92 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.952 0.406 . . . . 0.0 110.65 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.8 mtt-85 -145.19 141.69 28.92 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.049 1.34 . . . . 0.0 108.895 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -68.95 99.56 1.08 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 171.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.8 -120.3 1.45 Allowed Glycine 0 C--N 1.341 0.849 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -176.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.412 HE21 ' HA ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -162.12 123.09 2.62 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.308 0.643 . . . . 0.0 110.054 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.27 163.69 21.09 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 169.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.6 tp -92.98 126.27 37.98 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 117.484 0.642 . . . . 0.0 109.499 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -77.76 150.19 34.4 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.218 1.007 . . . . 0.0 111.596 -171.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -152.35 148.46 27.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.584 0.753 . . . . 0.0 110.162 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.414 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . . . -110.06 167.09 10.43 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.648 1.179 . . . . 0.0 108.513 173.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.426 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . . . -75.98 142.74 41.85 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.636 0.375 . . . . 0.0 111.447 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.44 -21.49 45.27 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.753 170.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.77 162.4 22.93 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 121.267 0.556 . . . . 0.0 110.29 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 mp -108.16 119.81 40.55 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.427 -174.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.2 mm -85.84 114.86 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 174.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.5 m -89.42 131.07 35.65 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.391 0.676 . . . . 0.0 109.449 177.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.63 HD22 ' HB3' ' A' ' 4' ' ' ALA . 2.7 pp -76.15 148.85 37.51 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.29 0.567 . . . . 0.0 111.422 177.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.559 HD13 ' HB2' ' A' ' 43' ' ' GLU . 48.5 mt -99.66 -19.21 16.92 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.198 0.999 . . . . 0.0 109.664 176.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -153.53 150.54 28.81 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.642 0.777 . . . . 0.0 109.89 -173.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.8 m -119.62 86.57 35.08 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.088 0.955 . . . . 0.0 109.273 170.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -85.39 -168.35 0.49 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.693 2.262 . . . . 0.0 110.679 171.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -84.72 140.75 31.06 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 172.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.17 161.3 37.33 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 123.764 0.665 . . . . 0.0 111.788 -175.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.53 58.21 4.68 Favored Glycine 0 C--N 1.348 1.197 0 C-N-CA 123.134 0.397 . . . . 0.0 112.557 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -130.91 99.38 4.89 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 36.5 m0 -113.13 145.5 40.82 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.427 0.691 . . . . 0.0 109.432 -177.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.75 117.41 28.59 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -176.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.9 168.87 26.44 Favored Glycine 0 C--O 1.239 0.46 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 170.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.559 ' HB2' HD13 ' A' ' 32' ' ' LEU . 41.6 tt0 -149.79 146.71 27.32 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.889 0.476 . . . . 0.0 110.207 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.537 ' HZ3' ' HB3' ' A' ' 44' ' ' LYS . 8.6 mtpm? -104.59 -177.5 3.38 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.625 0.726 . . . . 0.0 112.34 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.77 -33.54 73.11 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.337 1.455 . . . . 0.0 109.683 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -58.85 -25.76 63.57 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.181 1.392 . . . . 0.0 112.051 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.21 -11.72 71.25 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.889 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.1 mt -72.54 131.23 42.23 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 123.742 0.817 . . . . 0.0 109.202 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -117.53 160.94 20.41 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.958 0.903 . . . . 0.0 110.156 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -173.56 155.7 22.7 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.646 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 46.1 p-90 -70.68 152.35 43.95 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.321 0.648 . . . . 0.0 110.958 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -134.08 138.01 29.57 Favored Pre-proline 0 C--O 1.243 0.745 0 C-N-CA 123.979 0.912 . . . . 0.0 109.101 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.435 ' HB2' ' HB2' ' A' ' 56' ' ' TYR . 9.1 Cg_exo -71.49 113.07 3.51 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.768 2.312 . . . . 0.0 110.378 172.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.99 -32.5 73.77 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.56 0.744 . . . . 0.0 112.11 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.3 t -73.45 -17.64 61.22 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.846 0.458 . . . . 0.0 111.576 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.435 ' HB2' ' HB2' ' A' ' 53' ' ' PRO . 35.1 t80 -75.67 -35.48 60.36 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.712 0.805 . . . . 0.0 110.383 -177.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.9 m -111.81 166.5 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.9 0.88 . . . . 0.0 110.765 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -83.24 125.4 31.53 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 63.9 mt -84.51 141.82 30.48 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.655 0.382 . . . . 0.0 110.529 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.701 ' HB2' ' HB2' ' A' ' 5' ' ' ARG . 96.5 mt . . . . . 0 C--O 1.253 1.255 0 C-N-CA 123.955 0.902 . . . . 0.0 108.877 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.6 ttp . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.5 p -64.36 -44.11 92.43 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.399 0.68 . . . . 0.0 110.229 175.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 144.95 95.33 0.19 Allowed Glycine 0 C--N 1.342 0.88 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.265 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.02 99.5 0.87 Allowed 'General case' 0 C--N 1.35 0.621 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -117.55 156.08 28.69 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.418 0.687 . . . . 0.0 110.068 -176.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.9 m -139.44 156.2 47.11 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.609 1.164 . . . . 0.0 108.659 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -107.39 148.78 28.66 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.661 0.784 . . . . 0.0 109.222 176.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.0 p -91.26 130.17 37.16 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 122.82 0.448 . . . . 0.0 110.557 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.2 mt -63.09 -64.03 1.03 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.299 1.04 . . . . 0.0 111.02 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -129.29 158.41 73.16 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 123.988 0.915 . . . . 0.0 108.949 -177.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.627 ' HD3' ' HB1' ' A' ' 25' ' ' ALA . 72.7 Cg_endo -73.68 98.07 1.02 Allowed 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.067 1.845 . . . . 0.0 110.987 176.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -90.8 100.23 13.12 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.7 m -96.98 75.82 2.67 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.911 0.885 . . . . 0.0 109.788 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -134.51 153.67 21.13 Favored Glycine 0 C--O 1.244 0.757 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.611 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 56.64 73.5 0.45 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.268 1.027 . . . . 0.0 110.217 -175.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -85.81 32.35 0.6 Allowed 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.439 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -169.06 159.76 9.42 Favored 'General case' 0 C--O 1.247 0.936 0 C-N-CA 124.984 1.313 . . . . 0.0 108.84 -170.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.61 -123.31 19.32 Favored Glycine 0 C--N 1.344 0.993 0 O-C-N 123.388 0.43 . . . . 0.0 113.685 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -94.48 5.56 51.45 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.859 0.864 . . . . 0.0 112.267 -174.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.1 126.4 8.28 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.271 0.357 . . . . 0.0 112.877 -177.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.0 tp -105.23 117.75 34.81 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 173.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -87.39 149.42 24.48 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.124 0.97 . . . . 0.0 110.239 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -158.44 153.13 24.72 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.718 0.807 . . . . 0.0 110.814 -177.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.14 169.22 11.03 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.484 1.114 . . . . 0.0 110.667 172.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.627 ' HB1' ' HD3' ' A' ' 11' ' ' PRO . . . -61.06 125.71 24.7 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.279 0.631 . . . . 0.0 111.191 175.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.03 -4.71 65.54 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-O 119.203 -0.776 . . . . 0.0 114.116 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -52.39 120.0 5.07 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.037 0.935 . . . . 0.0 111.702 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.4 mt -82.52 99.62 9.6 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 48.9 mm -88.43 111.04 21.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 124.454 1.102 . . . . 0.0 108.079 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.5 m -87.51 107.48 18.59 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.553 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.519 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 41.4 mt -65.01 134.87 54.83 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.635 0.774 . . . . 0.0 109.624 175.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.2 mt -75.34 -47.77 26.19 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.276 0.631 . . . . 0.0 109.736 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -141.19 159.43 42.23 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.528 1.131 . . . . 0.0 108.396 174.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.0 m -119.59 84.81 31.09 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 171.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -72.07 169.27 21.81 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.761 2.307 . . . . 0.0 111.254 175.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -70.55 96.99 1.24 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.385 0.674 . . . . 0.0 110.019 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.95 173.56 23.15 Favored Glycine 0 C--N 1.344 0.985 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.808 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -91.99 28.6 8.46 Favored Glycine 0 C--N 1.345 1.052 0 C-N-CA 122.853 0.263 . . . . 0.0 113.12 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -127.16 116.71 21.06 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.571 1.148 . . . . 0.0 108.052 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 8.7 m0 -128.89 139.32 52.19 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -91.53 119.27 31.32 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 31' ' ' LEU . . . -110.44 136.34 13.52 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.236 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -104.11 141.17 36.7 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.181 0.593 . . . . 0.0 109.971 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -93.97 160.3 14.78 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.712 1.205 . . . . 0.0 109.565 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.88 -24.55 52.66 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.449 1.1 . . . . 0.0 111.977 175.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -60.35 -36.11 77.24 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.105 1.362 . . . . 0.0 111.95 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.78 -20.19 22.59 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 116.252 -0.431 . . . . 0.0 112.458 -177.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -76.63 134.17 39.4 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -119.27 139.83 51.26 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.34 1.056 . . . . 0.0 109.459 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -133.18 150.63 19.86 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 178.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 48.7 m95 -82.8 130.2 35.1 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.105 0.962 . . . . 0.0 108.999 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -140.07 151.71 65.67 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 122.973 0.509 . . . . 0.0 111.289 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -65.88 158.89 51.57 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.982 2.455 . . . . 0.0 112.043 168.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.96 -36.76 82.93 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.0 0.92 . . . . 0.0 111.861 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.7 t -79.66 -14.63 58.65 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.894 0.878 . . . . 0.0 111.71 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -71.93 -29.22 64.07 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.386 0.674 . . . . 0.0 110.519 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.1 m -111.72 172.67 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.253 1.021 . . . . 0.0 109.857 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -113.93 126.22 54.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.02 0.928 . . . . 0.0 109.478 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 75.0 mt -69.73 140.7 53.52 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.295 0.638 . . . . 0.0 109.925 176.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 CA--C 1.556 1.188 0 C-N-CA 123.243 0.617 . . . . 0.0 110.751 -179.369 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.424 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 120.597 0.237 . . . . 0.0 110.453 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.8 p -109.01 177.96 4.61 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.668 0.787 . . . . 0.0 111.305 -175.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 89.74 -65.68 2.96 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.743 174.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.658 ' HB2' ' HB2' ' A' ' 31' ' ' LEU . . . -78.43 83.35 4.65 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.492 0.717 . . . . 0.0 111.175 -175.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -127.99 134.45 49.26 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.143 0.977 . . . . 0.0 110.098 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.675 ' SG ' HD11 ' A' ' 31' ' ' LEU . 89.4 m -139.73 146.33 39.43 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.996 0.918 . . . . 0.0 108.65 165.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -105.43 137.97 42.38 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.1 p -70.59 119.21 14.41 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.169 0.988 . . . . 0.0 110.27 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.8 -56.8 7.81 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.484 0.713 . . . . 0.0 110.61 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -134.66 155.02 79.85 Favored Pre-proline 0 N--CA 1.482 1.14 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.481 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . 72.0 Cg_endo -73.04 88.07 0.97 Allowed 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.059 1.84 . . . . 0.0 111.993 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -91.83 100.15 12.89 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.9 t -160.63 84.81 0.7 Allowed 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.46 -3.15 88.72 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.846 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.35 105.42 8.52 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.45 1.1 . . . . 0.0 109.218 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -69.92 84.22 0.49 Allowed 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.859 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 78.8 m80 63.9 14.24 8.22 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.117 1.367 . . . . 0.0 112.721 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.77 66.98 1.89 Allowed Glycine 0 C--N 1.35 1.329 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 61.4 79.94 0.24 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.372 1.069 . . . . 0.0 110.551 -175.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.02 -176.69 39.99 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.807 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' A' ' 44' ' ' LYS . 32.4 tp -107.37 123.35 48.24 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.228 0.611 . . . . 0.0 109.737 -176.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -94.84 118.19 31.37 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -154.23 173.05 16.65 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.198 0.599 . . . . 0.0 111.301 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.481 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . . . -128.3 157.27 41.42 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.597 1.159 . . . . 0.0 109.376 175.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.14 134.59 55.15 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.511 0.724 . . . . 0.0 111.621 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.63 -14.31 29.81 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 123.334 0.396 . . . . 0.0 113.365 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -81.88 142.38 32.55 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.125 0.57 . . . . 0.0 111.819 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.433 HD13 HD13 ' A' ' 60' ' ' LEU . 1.9 mm? -95.37 105.18 17.11 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.299 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.6 mm -85.02 116.42 28.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.5 m -77.34 111.58 13.16 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.219 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.675 HD11 ' SG ' ' A' ' 6' ' ' CYS . 34.4 mt -70.46 139.46 51.73 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 123.867 0.729 . . . . 0.0 111.716 -171.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.518 ' HB2' ' HG3' ' A' ' 41' ' ' GLU . 70.3 mt -101.17 -30.99 11.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.632 0.773 . . . . 0.0 109.458 174.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.554 ' HG3' ' HG2' ' A' ' 41' ' ' GLU . 70.9 mt-30 -97.12 149.71 21.67 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.344 0.657 . . . . 0.0 110.854 172.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.6 m -142.93 54.64 3.43 Favored Pre-proline 0 CA--C 1.578 2.046 0 C-N-CA 124.81 1.244 . . . . 0.0 110.292 173.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 33' ' ' GLN . 63.7 Cg_endo -81.58 -170.24 0.94 Allowed 'Trans proline' 0 C--N 1.391 2.77 0 C-N-CA 122.754 2.302 . . . . 0.0 112.297 -175.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -74.6 77.76 1.99 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.922 0.889 . . . . 0.0 109.645 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.78 -128.16 45.95 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.198 -174.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.21 -87.1 0.19 Allowed Glycine 0 C--N 1.349 1.279 0 C-N-CA 123.109 0.385 . . . . 0.0 112.947 175.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -149.69 165.97 30.75 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.424 0.69 . . . . 0.0 110.482 -174.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -140.77 134.21 29.9 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.643 0.777 . . . . 0.0 109.147 173.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.554 ' HG2' ' HG3' ' A' ' 33' ' ' GLN . 10.6 pt-20 -91.34 160.53 15.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 163.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.55 178.33 41.57 Favored Glycine 0 C--O 1.243 0.673 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.646 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -104.79 139.96 38.79 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.787 0.835 . . . . 0.0 110.613 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.614 ' HB2' HD11 ' A' ' 21' ' ' LEU . 10.1 tmtt? -95.64 156.98 16.1 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.159 1.384 . . . . 0.0 107.61 176.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.524 ' H ' ' HD3' ' A' ' 44' ' ' LYS . 38.6 mm-40 -55.44 -33.98 64.06 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -177.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.85 -14.24 62.65 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.05 0.54 . . . . 0.0 112.367 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.08 -9.27 59.63 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.881 -174.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.3 tp -65.24 127.75 32.99 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 123.812 0.845 . . . . 0.0 109.538 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -104.81 131.88 51.74 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.662 0.785 . . . . 0.0 109.059 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.487 ' HA3' ' HB2' ' A' ' 21' ' ' LEU . . . -149.29 173.96 28.99 Favored Glycine 0 C--N 1.336 0.577 0 O-C-N 123.35 0.406 . . . . 0.0 112.343 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.479 ' HA ' ' HA ' ' A' ' 41' ' ' GLU . 51.3 p-90 -141.79 142.24 33.2 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.916 0.887 . . . . 0.0 109.79 -173.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -157.01 149.94 18.43 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 123.905 0.882 . . . . 0.0 110.205 175.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -51.26 165.98 0.5 Allowed 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.462 2.775 . . . . 0.0 114.652 167.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.4 -15.55 49.72 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.416 1.086 . . . . 0.0 112.832 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.3 m -69.17 -21.79 63.96 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.006 0.923 . . . . 0.0 112.2 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -98.72 -47.75 5.21 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.515 0.726 . . . . 0.0 109.702 -175.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.7 m -112.09 130.11 66.35 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.696 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -123.57 126.7 47.12 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.779 0.832 . . . . 0.0 110.577 -171.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.513 HD21 ' SG ' ' A' ' 6' ' ' CYS . 90.3 mt -52.71 133.24 36.85 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.2 1.0 . . . . 0.0 111.862 177.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.433 HD13 HD13 ' A' ' 28' ' ' LEU . 7.1 mp . . . . . 0 C--O 1.252 1.214 0 C-N-CA 123.203 0.601 . . . . 0.0 110.987 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.403 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.7 mpt? . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.3 m -63.09 104.91 0.62 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.938 0.895 . . . . 0.0 110.962 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -105.86 147.62 16.29 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.104 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.408 ' HB3' ' HB2' ' A' ' 31' ' ' LEU . . . -72.68 87.39 1.25 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 171.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -80.17 142.01 35.14 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.168 -176.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.549 ' HB3' ' HB ' ' A' ' 57' ' ' VAL . 71.6 m -133.08 141.27 48.11 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 172.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -106.63 127.39 53.31 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.457 HG21 ' HB2' ' A' ' 23' ' ' PHE . 37.6 p -68.81 130.39 42.68 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.933 0.893 . . . . 0.0 111.158 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.529 HD22 ' HB2' ' A' ' 58' ' ' GLN . 79.7 mt -86.28 -34.93 20.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.56 1.144 . . . . 0.0 110.474 -177.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -135.73 145.27 52.37 Favored Pre-proline 0 N--CA 1.487 1.389 0 C-N-CA 123.383 0.673 . . . . 0.0 110.453 -175.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.625 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . 63.4 Cg_endo -73.05 126.97 11.64 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.385 2.057 . . . . 0.0 110.71 166.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -150.34 133.52 16.25 Favored 'General case' 0 C--O 1.244 0.816 0 C-N-CA 122.947 0.499 . . . . 0.0 109.932 -174.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.3 m 65.81 117.79 0.03 OUTLIER 'General case' 0 C--N 1.36 1.055 0 C-N-CA 125.522 1.529 . . . . 0.0 112.151 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.85 29.91 1.68 Allowed Glycine 0 C--N 1.342 0.863 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 173.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -96.63 160.94 14.11 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.696 0.798 . . . . 0.0 110.559 -171.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -94.79 62.25 2.67 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.034 0.934 . . . . 0.0 109.674 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -79.35 -23.11 43.61 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.334 173.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 122.67 -118.86 3.74 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -77.09 134.36 38.77 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.985 0.514 . . . . 0.0 110.452 177.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.66 165.78 18.14 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.679 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.3 tp -105.81 121.58 44.33 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.272 0.558 . . . . 0.0 109.563 176.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -104.98 154.98 19.38 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.084 1.354 . . . . 0.0 107.945 177.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.457 ' HB2' HG21 ' A' ' 8' ' ' THR . 48.0 p90 -155.51 159.57 39.86 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -175.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.625 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . . . -135.36 143.24 45.97 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.556 1.543 . . . . 0.0 108.55 176.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.01 118.03 3.95 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 124.122 0.889 . . . . 0.0 111.748 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.03 7.0 22.08 Favored Glycine 0 CA--C 1.536 1.403 0 O-C-N 123.746 0.654 . . . . 0.0 113.267 -176.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -95.81 145.66 25.17 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.471 0.708 . . . . 0.0 110.529 171.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.499 HD23 HD13 ' A' ' 60' ' ' LEU . 48.0 mt -109.3 104.93 14.14 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.073 0.949 . . . . 0.0 109.381 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.9 mp -90.78 131.73 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.0 m -85.5 109.07 18.23 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.542 0.737 . . . . 0.0 109.428 177.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.481 HD12 ' SG ' ' A' ' 6' ' ' CYS . 84.6 mt -66.15 115.81 6.55 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.401 HD13 ' HB3' ' A' ' 43' ' ' GLU . 84.7 mt -76.55 -31.19 57.43 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.331 0.652 . . . . 0.0 111.533 -177.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.576 ' HG2' ' HD3' ' A' ' 35' ' ' PRO . 9.4 tt0 -137.58 136.34 37.48 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -177.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.441 ' HA ' ' HD1' ' A' ' 40' ' ' TRP . 6.1 m -133.33 69.44 77.54 Favored Pre-proline 0 CA--C 1.559 1.324 0 C-N-CA 124.731 1.213 . . . . 0.0 109.503 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.576 ' HD3' ' HG2' ' A' ' 33' ' ' GLN . 65.7 Cg_endo -81.15 -22.27 6.05 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.981 2.454 . . . . 0.0 112.881 -171.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -161.55 145.37 12.76 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.161 1.385 . . . . 0.0 107.949 -171.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -81.57 59.75 4.8 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 123.6 0.562 . . . . 0.0 113.384 -177.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.28 -89.84 1.0 Allowed Glycine 0 C--N 1.352 1.431 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 1.9 p-90 -132.11 148.18 52.47 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.441 ' HD1' ' HA ' ' A' ' 34' ' ' VAL . 6.5 m-90 -131.83 160.08 36.67 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.129 0.49 . . . . 0.0 110.952 -167.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -93.65 151.68 19.5 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.028 172.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.16 -179.43 27.77 Favored Glycine 0 C--O 1.242 0.635 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.158 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.401 ' HB3' HD13 ' A' ' 32' ' ' LEU . 5.8 pt-20 -140.86 167.67 21.62 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.999 0.904 . . . . 0.0 112.292 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.576 ' HD3' ' N ' ' A' ' 45' ' ' GLU . 11.2 tmtt? -114.87 156.81 24.26 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 113.459 -1.701 . . . . 0.0 106.996 166.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.576 ' N ' ' HD3' ' A' ' 44' ' ' LYS . 35.8 mt-10 -46.81 -31.14 2.84 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 125.675 1.59 . . . . 0.0 113.638 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.92 1.42 12.83 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.203 1.001 . . . . 0.0 112.983 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.48 -1.62 85.97 Favored Glycine 0 C--N 1.352 1.423 0 C-N-CA 122.688 0.185 . . . . 0.0 112.789 -177.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.2 119.94 12.35 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.561 0.744 . . . . 0.0 110.379 -177.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -104.48 141.32 36.58 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.456 0.703 . . . . 0.0 109.282 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.07 152.15 22.15 Favored Glycine 0 C--N 1.341 0.854 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 174.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -119.22 128.28 54.06 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.464 1.106 . . . . 0.0 108.126 -178.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -133.72 137.81 29.56 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 123.27 0.628 . . . . 0.0 110.675 -172.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -56.03 152.27 37.81 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.3 2.667 . . . . 0.0 112.513 165.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.87 -15.5 62.0 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.328 1.051 . . . . 0.0 112.404 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.8 t -67.21 -26.59 66.68 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.266 0.626 . . . . 0.0 111.68 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -82.98 -30.56 28.11 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.974 0.51 . . . . 0.0 111.266 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' A' ' 6' ' ' CYS . 15.6 m -134.45 124.86 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 123.254 0.622 . . . . 0.0 111.43 -168.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.529 ' HB2' HD22 ' A' ' 9' ' ' LEU . 6.6 tp-100 -80.75 130.86 35.31 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.337 0.655 . . . . 0.0 110.345 176.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.409 HD23 ' CZ3' ' A' ' 40' ' ' TRP . 81.9 mt -74.13 108.44 6.93 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.299 1.039 . . . . 0.0 111.252 -175.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.499 HD13 HD23 ' A' ' 28' ' ' LEU . 76.8 mt . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.626 -0.702 . . . . 0.0 109.816 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tpt . . . . . 0 N--CA 1.484 1.267 0 CA-C-O 120.615 0.245 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -106.8 123.87 48.79 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.289 0.635 . . . . 0.0 110.084 -176.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.29 174.75 33.85 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 123.589 0.556 . . . . 0.0 112.661 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.12 105.44 0.7 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.163 0.585 . . . . 0.0 110.269 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -109.02 172.57 6.77 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.46 ' SG ' ' HZ2' ' A' ' 51' ' ' TRP . 59.6 m -149.23 153.55 37.77 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.582 0.753 . . . . 0.0 110.409 -173.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.413 ' HG3' HD22 ' A' ' 60' ' ' LEU . 18.1 mtp180 -130.94 133.08 45.51 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.922 0.889 . . . . 0.0 109.262 175.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.5 p -78.84 122.13 25.69 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 173.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.526 HD22 ' HB2' ' A' ' 58' ' ' GLN . 87.9 mt -68.63 -47.04 67.66 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.016 0.527 . . . . 0.0 111.039 -174.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -144.53 155.24 57.06 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 124.863 1.265 . . . . 0.0 109.25 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.589 ' HD3' ' HB1' ' A' ' 25' ' ' ALA . 59.3 Cg_endo -83.06 167.57 14.07 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.545 2.163 . . . . 0.0 112.63 -174.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -120.02 100.09 7.01 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 173.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.4 m -98.47 84.06 3.13 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.116 0.566 . . . . 0.0 109.891 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.92 -164.53 36.6 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.74 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -82.15 118.0 22.73 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.406 1.082 . . . . 0.0 110.46 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -106.21 30.43 5.93 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.789 0.836 . . . . 0.0 109.973 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.5 m80 67.87 -76.06 0.06 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.883 1.673 . . . . 0.0 111.27 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.58 -86.17 0.05 OUTLIER Glycine 0 C--N 1.346 1.122 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -63.0 117.81 6.95 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.262 0.625 . . . . 0.0 110.756 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.89 -164.12 35.41 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.442 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.0 tp -137.51 142.51 41.46 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.008 0.923 . . . . 0.0 108.556 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -91.92 131.22 37.4 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 170.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -151.71 143.69 23.83 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.186 0.595 . . . . 0.0 112.001 -171.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.48 ' O ' ' HG2' ' A' ' 27' ' ' GLU . . . -87.88 170.95 10.72 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.915 1.286 . . . . 0.0 109.898 167.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.589 ' HB1' ' HD3' ' A' ' 11' ' ' PRO . . . -71.44 112.4 7.53 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.959 -0.463 . . . . 0.0 110.474 172.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.09 17.46 7.78 Favored Glycine 0 N--CA 1.475 1.255 0 C-N-CA 123.139 0.399 . . . . 0.0 113.721 174.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 24' ' ' ALA . 10.2 mm-40 -69.75 125.32 26.39 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 122.678 0.391 . . . . 0.0 110.958 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.7 mt -85.42 101.95 13.04 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.838 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.6 mm -105.59 140.41 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.5 m -113.5 118.94 35.88 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.546 0.612 . . . . 0.0 109.73 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.425 ' HG ' ' SG ' ' A' ' 6' ' ' CYS . 68.8 mt -58.99 121.43 11.2 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 123.695 0.622 . . . . 0.0 110.784 177.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' A' ' 43' ' ' GLU . 80.9 mt -75.15 -46.61 33.14 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.017 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -155.23 166.02 34.85 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.936 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.3 m -120.63 81.56 32.64 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 124.084 0.954 . . . . 0.0 109.052 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -83.31 -21.5 4.43 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.53 2.154 . . . . 0.0 114.076 -172.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -155.43 142.99 19.63 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.337 0.655 . . . . 0.0 110.632 -168.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.85 61.02 4.12 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.532 0.52 . . . . 0.0 112.622 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.34 -53.33 0.04 OUTLIER Glycine 0 C--N 1.342 0.869 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 49.2 m95 -118.94 128.0 54.01 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 170.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.445 ' HE3' ' HZ3' ' A' ' 51' ' ' TRP . 15.5 m-90 -119.09 170.57 8.94 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -132.48 133.0 43.28 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.133 0.492 . . . . 0.0 111.147 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.8 168.4 19.81 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 114.612 -1.177 . . . . 0.0 110.821 173.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.467 ' HB2' HD11 ' A' ' 32' ' ' LEU . 29.2 tt0 -125.7 151.28 46.82 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.184 0.593 . . . . 0.0 109.801 -178.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.441 ' HE3' ' HB3' ' A' ' 27' ' ' GLU . 1.3 mmtp -89.95 163.12 15.09 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.392 1.077 . . . . 0.0 110.244 176.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -63.84 -24.53 67.79 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.71 0.804 . . . . 0.0 111.243 170.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.84 -23.31 65.01 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.366 1.066 . . . . 0.0 111.685 174.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.32 -21.29 37.77 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.095 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.5 133.59 35.85 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.213 0.605 . . . . 0.0 109.606 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 28.5 ptt85 -105.78 147.18 28.91 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.363 0.601 . . . . 0.0 110.175 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 173.44 150.32 7.43 Favored Glycine 0 C--O 1.243 0.703 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 174.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.46 ' HZ2' ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -156.31 171.67 19.82 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.707 0.765 . . . . 0.0 110.888 -173.314 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -147.15 150.37 38.02 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 125.27 1.428 . . . . 0.0 107.841 -173.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -42.28 147.85 0.47 Allowed 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 123.773 2.982 . . . . 0.0 113.681 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.408 ' H ' ' HZ3' ' A' ' 40' ' ' TRP . . . -57.19 -22.02 37.57 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.812 0.845 . . . . 0.0 112.974 -171.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.1 m -58.44 -28.39 65.24 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.34 1.056 . . . . 0.0 112.791 177.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -79.88 -29.61 40.01 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.7 0.8 . . . . 0.0 111.776 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.406 HG22 ' CZ2' ' A' ' 51' ' ' TRP . 23.7 m -123.86 -171.8 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 123.247 0.619 . . . . 0.0 112.078 -166.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.526 ' HB2' HD22 ' A' ' 9' ' ' LEU . 7.7 tp60 -120.61 139.75 52.53 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.0 1.32 . . . . 0.0 108.594 174.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.7 mt -104.35 119.71 39.57 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.439 0.696 . . . . 0.0 109.648 176.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.413 HD22 ' HG3' ' A' ' 7' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--O 1.253 1.241 0 C-N-CA 124.107 0.963 . . . . 0.0 108.789 175.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtm . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.9 t -144.41 87.17 1.86 Allowed 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.3 59.9 4.89 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 173.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.16 114.35 13.76 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.495 1.118 . . . . 0.0 109.034 -174.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -129.22 154.62 46.61 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.324 1.05 . . . . 0.0 109.341 176.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.575 ' SG ' HD12 ' A' ' 31' ' ' LEU . 84.0 m -122.97 175.89 6.33 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.854 -1.067 . . . . 0.0 108.773 173.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -156.32 129.01 7.76 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.557 HG21 HD11 ' A' ' 29' ' ' ILE . 34.3 p -66.77 147.73 52.86 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.064 0.946 . . . . 0.0 111.393 -175.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.5 mt -80.23 -62.57 1.64 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.815 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -141.51 164.56 34.2 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 123.991 0.917 . . . . 0.0 109.706 -172.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.549 ' HG3' ' HB1' ' A' ' 25' ' ' ALA . 26.5 Cg_exo -62.4 121.45 9.44 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 122.727 2.284 . . . . 0.0 112.37 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -91.43 142.99 27.07 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.6 m -125.77 -72.33 0.66 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.981 0.513 . . . . 0.0 109.886 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.15 153.2 19.67 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -170.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -74.79 -32.71 62.09 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.484 0.713 . . . . 0.0 111.141 -176.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -163.04 131.06 3.74 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.802 0.841 . . . . 0.0 109.205 -177.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -163.56 115.05 1.42 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.189 0.996 . . . . 0.0 109.604 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.68 -47.97 88.52 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.246 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -155.49 148.31 24.31 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.537 0.735 . . . . 0.0 110.063 175.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -152.94 -164.83 12.81 Favored Glycine 0 C--O 1.241 0.57 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 171.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.6 tp -99.9 125.02 45.82 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 175.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.56 133.62 37.32 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.881 0.872 . . . . 0.0 110.986 -174.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -134.0 147.8 51.04 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.031 0.933 . . . . 0.0 108.568 170.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.64 166.57 12.74 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.633 0.773 . . . . 0.0 109.274 169.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.549 ' HB1' ' HG3' ' A' ' 11' ' ' PRO . . . -66.2 120.8 13.87 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.222 0.609 . . . . 0.0 110.169 176.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.75 17.08 80.21 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 123.287 0.367 . . . . 0.0 113.237 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.76 143.51 26.65 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.165 0.586 . . . . 0.0 109.466 179.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 mp -74.7 164.63 26.36 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.362 1.065 . . . . 0.0 111.499 -175.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.557 HD11 HG21 ' A' ' 8' ' ' THR . 4.1 mp -131.8 123.39 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 174.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.1 m -85.6 106.19 16.72 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.575 HD12 ' SG ' ' A' ' 6' ' ' CYS . 88.5 mt -77.42 106.13 8.99 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.982 0.513 . . . . 0.0 109.906 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 86.0 mt -83.37 -51.59 7.27 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.805 0.842 . . . . 0.0 109.776 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.648 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 1.4 mp0 -106.48 146.62 30.34 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.692 0.797 . . . . 0.0 108.856 172.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.4 m -128.0 69.71 77.37 Favored Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 123.644 0.778 . . . . 0.0 110.232 172.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 40' ' ' TRP . 64.2 Cg_endo -71.25 132.2 20.53 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 122.392 2.061 . . . . 0.0 111.845 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.5 t70 60.91 -88.04 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.967 1.307 . . . . 0.0 112.074 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 161.11 40.55 0.02 OUTLIER Glycine 0 C--N 1.344 0.978 0 O-C-N 122.912 0.133 . . . . 0.0 112.838 -173.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.24 -86.64 0.07 OUTLIER Glycine 0 C--N 1.348 1.225 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 18.1 m95 -82.88 114.53 21.25 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.556 ' HZ3' HD23 ' A' ' 59' ' ' LEU . 18.6 m0 -113.32 144.86 42.03 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.409 0.684 . . . . 0.0 110.061 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.648 ' HB2' ' HB2' ' A' ' 33' ' ' GLN . 39.7 mt-10 -91.71 122.03 33.89 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.786 0.834 . . . . 0.0 109.841 -175.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.25 169.62 20.51 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.039 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -124.09 154.22 40.29 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.972 0.909 . . . . 0.0 108.886 177.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.601 ' HE3' ' HA ' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -129.84 172.83 11.25 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 122.967 0.507 . . . . 0.0 109.958 173.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.462 ' HG2' ' HE2' ' A' ' 44' ' ' LYS . 6.3 mm-40 -67.09 -10.57 51.45 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.466 1.106 . . . . 0.0 111.46 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -55.29 -25.6 35.08 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.865 1.266 . . . . 0.0 111.541 168.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.32 -24.15 32.78 Favored Glycine 0 C--N 1.354 1.552 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 177.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.58 173.99 7.76 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.725 0.81 . . . . 0.0 110.602 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 38.2 mtm-85 -123.54 157.59 33.28 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.122 0.969 . . . . 0.0 108.645 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.99 154.2 25.32 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.564 ' HB3' ' HG2' ' A' ' 41' ' ' GLU . 4.8 p-90 -111.34 126.8 55.3 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -138.25 148.24 58.89 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.879 0.872 . . . . 0.0 109.319 -172.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.537 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 57.1 Cg_endo -69.68 142.87 49.45 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.302 2.001 . . . . 0.0 111.24 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.95 -23.06 66.14 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.925 0.89 . . . . 0.0 110.758 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.5 m -64.71 -40.03 94.66 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.267 1.027 . . . . 0.0 111.622 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.537 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 17.3 t80 -74.01 -32.89 63.57 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 121.316 0.579 . . . . 0.0 110.996 -173.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.6 m -104.54 -169.14 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.345 1.058 . . . . 0.0 108.899 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -141.18 130.94 24.21 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.729 0.412 . . . . 0.0 110.263 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.556 HD23 ' HZ3' ' A' ' 40' ' ' TRP . 94.8 mt -71.57 141.75 50.04 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.662 0.785 . . . . 0.0 111.552 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.7 mt . . . . . 0 C--O 1.244 0.806 0 C-N-CA 124.14 0.976 . . . . 0.0 109.848 -179.956 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.0 m -66.99 137.91 56.86 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.434 0.693 . . . . 0.0 110.569 174.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -143.27 -117.57 1.24 Allowed Glycine 0 C--N 1.34 0.787 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 177.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.79 137.49 47.67 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.37 0.668 . . . . 0.0 109.541 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -161.13 172.8 16.13 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.39 0.615 . . . . 0.0 111.501 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.64 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 20.6 p -141.41 171.82 13.54 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.315 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.465 ' HB2' HD21 ' A' ' 60' ' ' LEU . 28.2 tpt85 -117.51 128.64 55.18 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.742 1.217 . . . . 0.0 109.272 -172.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.0 p -80.15 112.68 17.7 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.366 0.666 . . . . 0.0 109.326 173.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.94 -58.98 3.21 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.348 0.659 . . . . 0.0 110.762 -175.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -137.36 156.64 75.07 Favored Pre-proline 0 N--CA 1.488 1.434 0 C-N-CA 123.617 0.767 . . . . 0.0 109.69 -175.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.678 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . 44.9 Cg_endo -66.22 125.31 13.83 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.532 2.155 . . . . 0.0 112.381 175.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -92.86 121.33 34.11 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.127 0.971 . . . . 0.0 108.599 176.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.7 t -124.76 -161.99 1.06 Allowed 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 175.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 161.52 -35.61 0.39 Allowed Glycine 0 C--N 1.339 0.74 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 66.67 2.98 2.76 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.4 1.08 . . . . 0.0 112.877 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -82.11 -41.74 20.1 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.217 1.007 . . . . 0.0 109.261 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 20.8 m80 -84.91 119.16 25.04 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.168 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.38 -52.32 36.47 Favored Glycine 0 C--N 1.346 1.088 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 171.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -122.59 144.02 49.37 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.571 1.149 . . . . 0.0 109.438 173.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.19 159.56 10.11 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.534 HD12 ' HD3' ' A' ' 44' ' ' LYS . 16.9 tp -88.25 132.71 34.27 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 117.971 0.886 . . . . 0.0 108.773 -177.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -123.47 169.21 11.62 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.389 1.076 . . . . 0.0 109.031 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -123.54 113.34 18.58 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.678 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . . . -95.73 160.45 14.48 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 173.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.83 128.07 34.59 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.312 0.645 . . . . 0.0 111.121 -170.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.16 -30.81 6.33 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-O 119.305 -0.719 . . . . 0.0 113.927 176.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -61.57 130.84 47.89 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 117.665 0.733 . . . . 0.0 112.039 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 61.3 mt -99.25 103.32 15.17 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 175.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.64 ' HB ' ' SG ' ' A' ' 6' ' ' CYS . 21.9 mm -88.07 109.2 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -169.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.2 m -74.38 109.54 7.95 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.481 0.488 . . . . 0.0 110.622 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.8 mt -69.81 104.34 2.43 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.849 -0.796 . . . . 0.0 108.849 175.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 70.5 mt -74.16 -30.63 62.34 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.658 0.783 . . . . 0.0 110.032 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -127.11 136.34 51.99 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.223 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.1 m -129.75 90.39 43.47 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.768 1.227 . . . . 0.0 108.576 175.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.62 -155.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.691 2.261 . . . . 0.0 110.926 177.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -63.21 -31.98 73.26 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.031 0.532 . . . . 0.0 111.171 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.34 -163.59 29.91 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 116.417 -0.356 . . . . 0.0 112.218 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.58 -76.49 2.1 Favored Glycine 0 C--N 1.345 1.04 0 C-N-CA 123.458 0.551 . . . . 0.0 112.11 177.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -114.41 132.52 56.21 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.304 0.642 . . . . 0.0 109.475 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -117.67 153.39 33.41 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.435 0.694 . . . . 0.0 109.432 173.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -91.69 120.4 32.41 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 173.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -123.03 135.47 10.04 Favored Glycine 0 C--N 1.342 0.874 0 O-C-N 123.379 0.425 . . . . 0.0 112.71 -175.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.569 ' HA ' ' HG2' ' A' ' 49' ' ' ARG . 10.6 tp10 -105.04 140.96 37.45 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.371 1.069 . . . . 0.0 110.228 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.609 ' HG2' HD13 ' A' ' 29' ' ' ILE . 22.3 mtpt -124.53 157.53 35.11 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.797 0.839 . . . . 0.0 110.27 176.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.81 0.68 26.07 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.42 0.688 . . . . 0.0 111.326 174.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.56 -27.66 68.6 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.423 1.089 . . . . 0.0 110.159 168.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.66 -17.21 57.85 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.011 -176.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -98.66 154.84 17.65 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.857 0.863 . . . . 0.0 110.119 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.569 ' HG2' ' HA ' ' A' ' 43' ' ' GLU . 72.1 mtm180 -124.62 169.04 12.33 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.488 1.115 . . . . 0.0 109.499 170.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.91 173.15 39.09 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.55 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -111.71 125.26 53.78 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -151.57 147.12 19.64 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 124.23 1.012 . . . . 0.0 109.492 -175.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -83.31 178.75 5.53 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.255 2.637 . . . . 0.0 111.539 172.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.02 -14.09 61.06 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.008 0.923 . . . . 0.0 112.046 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -59.68 -19.62 50.81 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.565 1.146 . . . . 0.0 113.155 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -113.05 -16.05 12.71 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.657 0.783 . . . . 0.0 111.868 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.15 136.22 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 122.973 0.509 . . . . 0.0 111.324 -172.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -91.87 112.79 24.85 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.765 0.826 . . . . 0.0 109.782 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.59 123.37 18.64 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.056 0.542 . . . . 0.0 110.764 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.465 HD21 ' HB2' ' A' ' 7' ' ' ARG . 86.7 mt . . . . . 0 CA--C 1.55 0.952 0 C-N-CA 123.747 0.819 . . . . 0.0 110.745 -177.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.7 t -138.82 155.34 48.23 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.803 0.841 . . . . 0.0 110.078 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.69 91.18 0.77 Allowed Glycine 0 C--N 1.354 1.57 0 O-C-N 123.958 0.786 . . . . 0.0 112.317 -178.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.89 132.54 54.26 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.549 1.14 . . . . 0.0 110.721 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -142.46 153.43 43.67 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.478 0.711 . . . . 0.0 110.959 -172.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.437 ' SG ' HD12 ' A' ' 31' ' ' LEU . 81.2 m -139.15 148.89 43.82 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.875 1.27 . . . . 0.0 108.967 175.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -108.14 152.35 24.67 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.454 0.702 . . . . 0.0 109.778 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.474 HG23 ' HB2' ' A' ' 23' ' ' PHE . 24.5 p -87.89 130.19 34.99 Favored 'General case' 0 C--O 1.242 0.711 0 C-N-CA 123.47 0.708 . . . . 0.0 110.464 173.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.5 mt -79.35 -53.5 6.87 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.249 1.019 . . . . 0.0 110.012 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -134.89 155.12 79.53 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 123.599 0.76 . . . . 0.0 109.574 -173.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.533 ' HD3' ' HB1' ' A' ' 25' ' ' ALA . 64.6 Cg_endo -78.71 85.37 1.86 Allowed 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 121.874 1.716 . . . . 0.0 110.646 170.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -92.7 101.18 13.58 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.092 -175.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.9 m -153.9 63.29 0.72 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.816 1.246 . . . . 0.0 107.905 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.26 -33.25 86.73 Favored Glycine 0 C--N 1.357 1.732 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.4 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -127.39 138.27 52.96 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.55 1.14 . . . . 0.0 108.555 170.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -66.55 -51.93 51.2 Favored 'General case' 0 CA--C 1.55 0.973 0 O-C-N 123.784 0.678 . . . . 0.0 109.615 176.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.4 t60 64.55 -77.52 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.423 1.489 . . . . 0.0 111.791 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 145.17 -66.46 0.43 Allowed Glycine 0 C--N 1.34 0.782 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -76.84 103.95 7.07 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.243 0.617 . . . . 0.0 109.823 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.74 -162.59 34.13 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.423 HD23 ' HA3' ' A' ' 50' ' ' GLY . 20.7 tp -143.24 120.04 11.22 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 176.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -77.46 120.94 23.15 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.474 ' HB2' HG23 ' A' ' 8' ' ' THR . 33.1 p90 -120.75 130.02 53.86 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.179 0.991 . . . . 0.0 110.104 -178.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -104.31 153.98 20.37 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.056 0.943 . . . . 0.0 110.488 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.533 ' HB1' ' HD3' ' A' ' 11' ' ' PRO . . . -58.5 121.56 11.21 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.969 0.908 . . . . 0.0 111.99 -178.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.56 -23.96 16.56 Favored Glycine 0 C--N 1.347 1.164 0 C-N-CA 123.337 0.494 . . . . 0.0 113.661 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -60.9 128.48 36.69 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.552 0.741 . . . . 0.0 111.526 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.2 mt -96.24 125.13 40.54 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.8 mp -104.86 116.39 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 175.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.8 m -87.0 111.5 20.92 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.437 HD12 ' SG ' ' A' ' 6' ' ' CYS . 7.0 mp -65.69 115.96 6.4 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.044 0.938 . . . . 0.0 110.698 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.428 HD12 ' HB2' ' A' ' 43' ' ' GLU . 58.6 mt -84.72 -36.25 21.95 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.151 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -116.51 135.64 53.65 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.054 0.942 . . . . 0.0 109.309 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.5 m -143.71 66.41 15.22 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 124.046 0.938 . . . . 0.0 110.434 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -77.03 -173.12 1.64 Allowed 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 123.211 2.607 . . . . 0.0 112.73 174.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -77.37 101.18 6.22 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.566 0.747 . . . . 0.0 110.548 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.72 -154.94 26.08 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 116.371 -0.377 . . . . 0.0 112.647 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.9 -28.67 4.1 Favored Glycine 0 C--N 1.346 1.129 0 N-CA-C 112.236 -0.346 . . . . 0.0 112.236 176.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -81.06 110.62 16.76 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.593 0.757 . . . . 0.0 109.512 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -125.36 138.75 54.05 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.741 0.817 . . . . 0.0 109.726 178.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.567 ' HG2' ' HB3' ' A' ' 51' ' ' TRP . 28.2 mt-10 -94.87 138.32 32.8 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.687 0.395 . . . . 0.0 110.496 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.13 171.01 27.16 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.412 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.428 ' HB2' HD12 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -127.83 148.22 50.45 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.124 0.57 . . . . 0.0 110.17 -169.759 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.463 ' HE3' ' HB3' ' A' ' 46' ' ' ASP . 39.7 mtmt -88.3 -173.22 4.11 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.605 1.562 . . . . 0.0 110.24 176.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -86.6 62.1 7.21 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 165.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.463 ' HB3' ' HE3' ' A' ' 44' ' ' LYS . 38.0 t70 -148.56 -47.75 0.15 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -168.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.64 -9.76 28.05 Favored Glycine 0 N--CA 1.473 1.136 0 CA-C-O 119.848 -0.418 . . . . 0.0 113.683 -174.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.58 130.99 45.86 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 117.544 0.672 . . . . 0.0 110.1 172.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -103.14 143.07 33.09 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.778 0.831 . . . . 0.0 109.446 -175.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.423 ' HA3' HD23 ' A' ' 21' ' ' LEU . . . -134.34 155.15 21.74 Favored Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 177.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.567 ' HB3' ' HG2' ' A' ' 41' ' ' GLU . 1.1 p-90 -99.66 132.19 45.17 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.995 0.918 . . . . 0.0 109.88 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -133.26 129.39 20.78 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 123.657 0.783 . . . . 0.0 109.446 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.65 151.98 83.05 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.3 2.0 . . . . 0.0 111.15 162.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.603 ' HB1' HD12 ' A' ' 59' ' ' LEU . . . -60.0 -26.47 66.08 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.473 1.109 . . . . 0.0 112.178 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.1 m -73.14 -16.79 61.44 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.829 0.852 . . . . 0.0 113.118 -177.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -96.8 -24.71 15.78 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.002 0.521 . . . . 0.0 111.992 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.2 m -116.89 151.73 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.113 0.565 . . . . 0.0 110.963 -173.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -81.17 103.85 11.25 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.78 0.832 . . . . 0.0 109.288 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.603 HD12 ' HB1' ' A' ' 54' ' ' ALA . 43.8 mt -67.77 115.1 6.94 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.1 mt . . . . . 0 C--O 1.25 1.104 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -177.546 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtm . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 72.7 p -85.09 141.91 29.9 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.521 0.728 . . . . 0.0 111.094 -176.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -118.26 120.48 4.73 Favored Glycine 0 C--N 1.346 1.106 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' A' ' 31' ' ' LEU . . . -77.08 106.8 9.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.453 0.701 . . . . 0.0 109.651 -177.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -78.64 142.24 37.37 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.751 0.42 . . . . 0.0 110.359 -176.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 76.7 m -138.75 159.56 41.81 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.985 0.914 . . . . 0.0 109.229 174.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.549 ' HB2' ' HB3' ' A' ' 58' ' ' GLN . 19.9 mmt180 -106.69 147.72 29.24 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.643 1.177 . . . . 0.0 108.688 176.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 23' ' ' PHE . 21.8 p -94.68 118.16 31.28 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.098 175.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.467 HD22 ' HB2' ' A' ' 58' ' ' GLN . 86.0 mt -69.47 -50.62 43.68 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.945 0.498 . . . . 0.0 110.885 -177.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -135.2 148.29 65.87 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 123.569 0.748 . . . . 0.0 109.731 -178.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.538 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . 2.8 Cg_exo -74.9 121.68 6.77 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.792 2.328 . . . . 0.0 111.232 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -128.34 102.3 6.6 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.163 0.506 . . . . 0.0 109.89 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.1 m -153.22 30.61 0.48 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.874 1.27 . . . . 0.0 109.528 174.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.03 88.46 0.01 OUTLIER Glycine 0 C--N 1.356 1.644 0 O-C-N 124.44 1.088 . . . . 0.0 113.611 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 57.62 48.79 13.59 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.167 1.387 . . . . 0.0 110.347 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -98.9 80.11 2.46 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.055 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -90.99 -18.96 23.77 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.795 0.838 . . . . 0.0 111.106 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.56 -165.39 24.86 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.932 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -73.84 85.79 1.72 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.76 0.791 . . . . 0.0 110.627 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -164.64 143.4 8.49 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.721 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.593 HD11 ' HB3' ' A' ' 44' ' ' LYS . 27.0 tp -90.18 142.44 27.71 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.919 0.488 . . . . 0.0 110.822 -171.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -99.89 138.92 36.3 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.23 1.012 . . . . 0.0 110.655 -175.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.533 ' HB2' HG22 ' A' ' 8' ' ' THR . 28.1 p90 -154.16 121.98 5.93 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.592 0.757 . . . . 0.0 110.45 -174.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.538 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . . . -92.08 152.51 19.91 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.61 1.164 . . . . 0.0 109.654 171.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.99 125.02 22.38 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.719 0.808 . . . . 0.0 111.922 -175.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.87 -20.65 17.1 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 123.643 0.589 . . . . 0.0 113.343 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -72.23 142.91 48.97 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 121.329 0.585 . . . . 0.0 112.219 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.61 111.12 19.25 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.303 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.4 mm -91.36 120.76 40.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 123.471 0.708 . . . . 0.0 109.636 174.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.6 m -85.74 103.85 14.9 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.529 ' HB2' ' HB1' ' A' ' 4' ' ' ALA . 91.2 mt -71.86 107.45 4.64 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 67.2 mt -75.39 -48.46 22.81 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.591 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -126.45 136.94 53.28 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.067 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.3 m -115.22 91.45 27.88 Favored Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 124.259 1.024 . . . . 0.0 108.929 176.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.62 -49.65 15.23 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 123.298 2.665 . . . . 0.0 112.889 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -164.09 -79.29 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.693 0.797 . . . . 0.0 109.5 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -161.4 149.47 18.26 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 -174.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.37 -61.49 2.86 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 116.577 0.189 . . . . 0.0 112.761 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 40.9 m95 -121.3 99.73 6.65 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.927 0.491 . . . . 0.0 109.786 -172.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -112.12 146.22 38.4 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -90.12 117.2 28.72 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.13 148.58 18.24 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.678 177.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -103.36 160.49 14.65 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.561 0.696 . . . . 0.0 109.816 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.593 ' HB3' HD11 ' A' ' 21' ' ' LEU . 2.0 tmtp? -132.73 155.94 47.93 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 170.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.408 ' H ' ' HD3' ' A' ' 44' ' ' LYS . 9.6 pt-20 -66.52 6.33 0.47 Allowed 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -67.78 -15.66 63.74 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.332 0.653 . . . . 0.0 111.49 168.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.49 -15.24 61.36 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 112.37 -0.292 . . . . 0.0 112.37 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.442 ' HB2' HD12 ' A' ' 21' ' ' LEU . 89.0 mt -96.63 163.03 13.19 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.629 0.772 . . . . 0.0 110.099 176.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 35.9 ttp-105 -119.98 155.75 32.22 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 169.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -150.52 161.47 28.98 Favored Glycine 0 C--N 1.336 0.577 0 N-CA-C 112.343 -0.303 . . . . 0.0 112.343 177.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -88.76 129.87 35.46 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 171.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 59.2 m-85 -108.35 137.22 19.87 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 123.324 0.65 . . . . 0.0 111.035 -173.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 52' ' ' PHE . 6.4 Cg_exo -73.66 124.04 9.0 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 123.086 2.524 . . . . 0.0 111.199 177.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.83 -45.08 86.72 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.744 1.218 . . . . 0.0 113.098 -171.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.3 t -75.98 -25.48 55.86 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.189 0.596 . . . . 0.0 111.12 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -85.77 -18.24 33.54 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.416 0.686 . . . . 0.0 111.167 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.3 m -108.99 147.31 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.094 0.558 . . . . 0.0 109.553 173.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.549 ' HB3' ' HB2' ' A' ' 7' ' ' ARG . 34.1 tt0 -87.64 115.01 24.78 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 174.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.2 mt -76.95 128.66 34.94 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.771 0.429 . . . . 0.0 110.155 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.2 mt . . . . . 0 C--O 1.249 1.066 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 176.475 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 ttm . . . . . 0 CA--C 1.542 0.666 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.6 t -167.91 164.3 13.91 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.92 0.888 . . . . 0.0 109.838 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 72.29 24.81 75.77 Favored Glycine 0 C--N 1.35 1.35 0 CA-C-N 115.843 -0.617 . . . . 0.0 113.104 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.91 86.97 2.87 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.871 0.868 . . . . 0.0 111.072 -173.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -110.28 151.78 26.96 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.352 1.061 . . . . 0.0 109.579 178.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.418 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 28.3 p -158.91 140.62 13.48 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.448 0.699 . . . . 0.0 109.154 171.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.503 ' HB2' HD12 ' A' ' 60' ' ' LEU . 40.2 ttp180 -112.68 130.4 56.06 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.287 0.635 . . . . 0.0 109.45 177.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 45.1 p -66.51 139.21 57.93 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 122.974 0.51 . . . . 0.0 111.468 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 86.0 mt -97.93 -22.53 16.27 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.328 1.051 . . . . 0.0 110.286 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -131.89 151.72 79.01 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 124.02 0.928 . . . . 0.0 109.574 -177.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.411 ' HD3' ' HB1' ' A' ' 25' ' ' ALA . 73.4 Cg_endo -74.86 164.37 33.64 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.304 2.002 . . . . 0.0 111.366 169.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -93.65 102.79 14.98 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.3 p -69.56 120.18 14.95 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 123.222 0.609 . . . . 0.0 109.399 174.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.35 -179.01 48.16 Favored Glycine 0 C--N 1.342 0.894 0 O-C-N 123.595 0.559 . . . . 0.0 112.535 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -83.63 169.15 15.65 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.127 0.571 . . . . 0.0 109.482 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 55.9 mtp85 -56.63 -56.25 23.75 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.503 0.721 . . . . 0.0 111.143 178.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 69.3 t60 66.97 171.14 0.25 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.809 1.243 . . . . 0.0 112.526 169.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.72 -68.86 1.52 Allowed Glycine 0 C--N 1.351 1.391 0 CA-C-N 116.487 -0.324 . . . . 0.0 112.874 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -153.74 148.23 26.13 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.2 0.6 . . . . 0.0 111.278 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 168.81 -175.3 43.34 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.8 tp -90.21 114.13 26.07 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 121.572 0.701 . . . . 0.0 109.614 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -122.58 151.84 41.02 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 125.033 1.333 . . . . 0.0 107.768 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -156.18 152.42 27.83 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.184 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 27' ' ' GLU . . . -96.48 169.46 9.89 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.828 1.251 . . . . 0.0 109.027 165.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.411 ' HB1' ' HD3' ' A' ' 11' ' ' PRO . . . -66.09 111.63 3.48 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 122.12 -0.363 . . . . 0.0 110.064 171.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.26 19.8 6.15 Favored Glycine 0 C--N 1.351 1.375 0 N-CA-C 114.388 0.515 . . . . 0.0 114.388 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 24' ' ' ALA . 10.9 mm-40 -92.0 136.69 32.97 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 117.772 0.786 . . . . 0.0 111.138 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.8 mt -84.16 103.06 13.05 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.523 0.729 . . . . 0.0 109.902 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.418 ' HB ' ' SG ' ' A' ' 6' ' ' CYS . 47.5 mm -92.1 124.11 44.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.586 1.154 . . . . 0.0 109.491 176.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.0 m -88.46 107.29 18.79 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.167 0.987 . . . . 0.0 109.112 174.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.98 111.98 6.78 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.3 mt -80.46 -53.95 6.13 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 123.151 0.58 . . . . 0.0 109.488 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.614 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 47.2 mt-30 -109.0 135.63 49.87 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.0 m -135.09 84.23 37.31 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 123.413 0.685 . . . . 0.0 110.205 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.12 161.72 37.97 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.583 2.189 . . . . 0.0 111.374 169.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -73.12 100.07 2.96 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.142 0.577 . . . . 0.0 110.11 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.18 -154.42 20.42 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.26 -16.21 23.55 Favored Glycine 0 N--CA 1.47 0.92 0 N-CA-C 112.101 -0.4 . . . . 0.0 112.101 172.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 53.9 m95 -92.14 119.22 31.59 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.272 1.029 . . . . 0.0 109.346 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -131.39 153.18 49.94 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.674 0.79 . . . . 0.0 109.781 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.614 ' HB3' ' HB2' ' A' ' 33' ' ' GLN . 3.1 tm-20 -102.79 132.33 49.03 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.76 152.17 23.88 Favored Glycine 0 CA--C 1.508 -0.388 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.088 -177.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 49' ' ' ARG . 9.8 pt-20 -103.67 152.5 21.72 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.113 0.565 . . . . 0.0 110.125 173.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -78.68 154.42 30.17 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 157.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -73.6 16.51 0.2 Allowed 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -170.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -97.24 -1.11 45.53 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.671 1.188 . . . . 0.0 111.282 169.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.81 3.4 68.41 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-O 120.115 -0.269 . . . . 0.0 113.737 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.6 mt -91.25 114.98 27.64 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 12.6 ptt180 -116.97 165.73 13.01 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.864 0.466 . . . . 0.0 111.863 -173.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 177.7 171.47 41.18 Favored Glycine 0 C--N 1.348 1.239 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.797 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -94.98 128.19 41.6 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.45 0.7 . . . . 0.0 110.315 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -147.7 145.24 20.73 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 124.161 0.985 . . . . 0.0 109.766 175.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -78.4 176.6 9.73 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.685 2.257 . . . . 0.0 111.518 173.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.27 -21.46 61.93 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.038 175.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.9 m -53.22 -33.66 53.79 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.273 1.429 . . . . 0.0 113.471 -176.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -96.2 -18.0 20.39 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.104 0.562 . . . . 0.0 112.431 -176.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 35.8 m -120.03 174.39 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-O 121.411 0.624 . . . . 0.0 112.0 -171.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -130.79 115.49 16.69 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.177 1.391 . . . . 0.0 107.819 174.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.03 126.37 27.11 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.929 0.768 . . . . 0.0 110.442 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.503 HD12 ' HB2' ' A' ' 7' ' ' ARG . 80.2 mt . . . . . 0 C--O 1.252 1.194 0 C-N-CA 124.15 0.98 . . . . 0.0 108.791 -176.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.0 tmm? . . . . . 0 N--CA 1.485 1.277 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.4 p -135.53 -164.8 1.59 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.148 0.979 . . . . 0.0 110.066 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 92.18 -59.72 2.69 Favored Glycine 0 C--N 1.353 1.495 0 N-CA-C 111.984 -0.447 . . . . 0.0 111.984 176.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 31' ' ' LEU . . . -75.38 90.48 2.67 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.193 0.597 . . . . 0.0 110.406 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -81.39 123.46 28.58 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.171 0.988 . . . . 0.0 109.372 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.713 ' HA ' ' HA ' ' A' ' 59' ' ' LEU . 48.6 t -124.14 155.7 37.97 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.223 0.535 . . . . 0.0 110.929 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -116.04 131.96 56.79 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.627 1.171 . . . . 0.0 109.175 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.547 ' HA ' HG11 ' A' ' 57' ' ' VAL . 16.5 p -77.37 121.29 23.56 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.488 0.715 . . . . 0.0 109.813 170.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.412 HD12 ' HG3' ' A' ' 58' ' ' GLN . 81.4 mt -73.06 -51.51 17.82 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.29 0.636 . . . . 0.0 109.676 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -137.8 152.85 73.22 Favored Pre-proline 0 N--CA 1.483 1.183 0 C-N-CA 123.662 0.785 . . . . 0.0 110.467 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.41 129.51 12.97 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.354 2.036 . . . . 0.0 111.72 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.401 ' HE2' ' HH2' ' A' ' 51' ' ' TRP . 2.1 t80 -117.22 101.6 8.58 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.4 t -92.75 -47.28 7.15 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.448 -171.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.79 -117.55 0.43 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -178.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 60.93 -74.34 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.621 1.568 . . . . 0.0 111.703 -177.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.487 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -79.91 -11.72 59.78 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.532 0.733 . . . . 0.0 111.942 -178.137 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -140.64 172.21 13.02 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.31 0.644 . . . . 0.0 110.476 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.72 -23.18 0.38 Allowed Glycine 0 C--N 1.346 1.123 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.081 175.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -125.28 21.94 7.89 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.769 0.827 . . . . 0.0 111.347 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.08 176.9 54.51 Favored Glycine 0 C--N 1.351 1.39 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 172.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.406 HD22 ' HG2' ' A' ' 44' ' ' LYS . 44.8 tp -89.87 124.79 35.0 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -79.49 136.96 37.05 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.549 0.74 . . . . 0.0 110.479 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -149.04 128.6 13.13 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.067 0.947 . . . . 0.0 109.245 177.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.8 150.82 20.28 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.3 1.04 . . . . 0.0 110.017 177.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.11 133.4 54.38 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.622 0.769 . . . . 0.0 111.716 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.56 -23.38 28.38 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 119.605 -0.553 . . . . 0.0 113.179 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -65.0 136.17 56.48 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-N 117.201 0.5 . . . . 0.0 111.69 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 73.9 mt -85.67 101.43 12.74 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.3 mm -88.62 111.18 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.929 0.891 . . . . 0.0 108.644 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.2 p -77.32 105.42 8.42 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.565 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 39.8 mt -67.56 142.19 56.59 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 173.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.8 mt -74.34 -43.04 58.32 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.968 0.507 . . . . 0.0 110.57 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -157.14 157.17 33.97 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.112 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.5 m -109.66 94.36 16.51 Favored Pre-proline 0 CA--C 1.557 1.24 0 C-N-CA 123.38 0.672 . . . . 0.0 110.944 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.413 ' HD2' ' CD1' ' A' ' 40' ' ' TRP . 79.3 Cg_endo -81.86 170.57 13.88 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.578 2.185 . . . . 0.0 111.174 167.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.4 143.84 54.94 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.108 0.48 . . . . 0.0 111.369 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.47 166.99 33.81 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.356 -177.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.0 55.26 4.98 Favored Glycine 0 C--N 1.348 1.199 0 C-N-CA 123.211 0.434 . . . . 0.0 112.584 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.411 ' HZ3' ' HG3' ' A' ' 53' ' ' PRO . 75.6 t-105 -143.79 114.76 7.81 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.437 1.095 . . . . 0.0 108.484 -177.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.413 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 12.9 m-90 -136.28 144.19 44.62 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.938 0.895 . . . . 0.0 109.712 -177.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -95.74 116.28 28.66 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 169.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 31' ' ' LEU . . . -108.76 143.76 16.28 Favored Glycine 0 C--N 1.337 0.635 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 49' ' ' ARG . 31.8 tt0 -115.52 136.9 52.61 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.007 0.523 . . . . 0.0 109.837 -178.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.406 ' HG2' HD22 ' A' ' 21' ' ' LEU . 30.2 mmmt -71.62 163.43 27.77 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.696 1.198 . . . . 0.0 109.787 170.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -64.71 -11.66 38.47 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.963 0.905 . . . . 0.0 112.685 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -89.22 -8.12 54.18 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.334 1.054 . . . . 0.0 112.49 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.43 -1.27 66.53 Favored Glycine 0 C--N 1.345 1.078 0 O-C-N 123.147 0.279 . . . . 0.0 112.842 -173.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.8 mt -83.05 104.99 13.67 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.665 0.786 . . . . 0.0 109.73 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 28.0 ptt180 -102.64 154.33 19.25 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -159.18 -178.28 33.04 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.908 -0.587 . . . . 0.0 113.062 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.401 ' HH2' ' HE2' ' A' ' 12' ' ' PHE . 49.8 p-90 -77.05 129.58 36.26 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.24 1.016 . . . . 0.0 110.47 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -135.39 94.28 15.67 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 123.914 0.886 . . . . 0.0 109.617 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.411 ' HG3' ' HZ3' ' A' ' 39' ' ' TRP . 11.8 Cg_exo -71.45 148.32 54.08 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.915 2.41 . . . . 0.0 110.37 168.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.31 -19.54 64.69 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.21 0.604 . . . . 0.0 112.396 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.5 m -62.32 -31.05 71.61 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.756 0.822 . . . . 0.0 111.631 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -98.71 -27.65 13.87 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.4 0.68 . . . . 0.0 111.586 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.577 ' HB ' ' SG ' ' A' ' 6' ' ' CYS . 26.1 m -138.79 139.34 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 122.94 0.496 . . . . 0.0 111.321 -174.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.412 ' HG3' HD12 ' A' ' 9' ' ' LEU . 53.1 mt-30 -128.82 133.16 47.92 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.546 0.738 . . . . 0.0 109.482 174.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.713 ' HA ' ' HA ' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -82.56 140.5 33.23 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.997 0.519 . . . . 0.0 112.312 -172.303 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 C--O 1.251 1.164 0 C-N-CA 124.772 1.229 . . . . 0.0 109.447 -178.114 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.3 m -73.88 145.88 44.49 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 171.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.12 76.81 1.4 Allowed Glycine 0 C--N 1.346 1.106 0 O-C-N 123.658 0.599 . . . . 0.0 111.641 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.89 76.31 1.16 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.849 0.86 . . . . 0.0 109.157 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.48 164.33 21.91 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.183 -173.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.438 ' SG ' HD21 ' A' ' 59' ' ' LEU . 78.2 m -145.12 166.86 24.18 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.981 0.913 . . . . 0.0 109.682 178.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.524 ' HG3' HD12 ' A' ' 60' ' ' LEU . 59.0 mtm180 -119.19 133.58 55.69 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.142 0.577 . . . . 0.0 109.98 175.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.581 HG23 HD12 ' A' ' 29' ' ' ILE . 8.9 p -73.45 121.65 20.87 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.428 0.455 . . . . 0.0 111.647 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.63 -15.98 27.73 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.788 0.835 . . . . 0.0 110.233 169.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -107.18 122.26 42.01 Favored Pre-proline 0 N--CA 1.48 1.073 0 C-N-CA 123.674 0.789 . . . . 0.0 110.58 171.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.414 ' HB3' ' N ' ' A' ' 25' ' ' ALA . 96.3 Cg_endo -83.44 49.93 3.1 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.928 2.418 . . . . 0.0 111.449 164.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -91.24 109.97 21.25 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -173.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.7 t -70.6 -21.37 62.67 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.524 1.13 . . . . 0.0 111.784 -177.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.35 -84.1 1.08 Allowed Glycine 0 C--N 1.347 1.185 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -171.86 161.33 5.8 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 124.999 1.32 . . . . 0.0 108.904 175.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -91.79 131.74 36.93 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 168.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -140.33 -64.22 0.47 Allowed 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.404 0.682 . . . . 0.0 109.495 -176.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.67 75.26 0.17 Allowed Glycine 0 C--N 1.346 1.106 0 CA-C-O 120.05 -0.305 . . . . 0.0 112.439 -175.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 66.29 21.71 10.97 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.549 1.14 . . . . 0.0 112.314 173.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.2 166.1 25.57 Favored Glycine 0 C--N 1.348 1.229 0 O-C-N 123.588 0.555 . . . . 0.0 113.591 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.433 HD12 ' HB2' ' A' ' 44' ' ' LYS . 27.5 tp -89.82 129.79 36.15 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.453 0.701 . . . . 0.0 109.492 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.25 161.14 19.44 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.964 1.306 . . . . 0.0 108.725 177.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -136.9 141.87 42.73 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.944 0.498 . . . . 0.0 111.741 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.62 169.96 10.1 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.777 1.231 . . . . 0.0 109.198 164.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.414 ' N ' ' HB3' ' A' ' 11' ' ' PRO . . . -72.72 115.92 12.58 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.94 19.9 8.77 Favored Glycine 0 N--CA 1.477 1.39 0 O-C-N 123.028 0.205 . . . . 0.0 113.483 177.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -72.85 149.99 43.06 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.917 0.487 . . . . 0.0 111.641 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.7 mt -106.37 108.1 19.44 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.581 HD12 HG23 ' A' ' 8' ' ' THR . 3.3 mp -103.21 107.79 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -175.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.0 m -75.8 108.06 8.4 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 173.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.24 123.51 19.73 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 123.704 0.628 . . . . 0.0 110.092 178.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.2 mt -73.84 -43.54 58.39 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.97 0.908 . . . . 0.0 109.12 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -126.45 155.46 42.19 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 124.912 1.285 . . . . 0.0 108.457 171.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.2 m -125.93 74.76 71.39 Favored Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 123.755 0.822 . . . . 0.0 110.939 176.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.39 164.38 35.38 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.427 2.084 . . . . 0.0 111.735 170.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -76.52 92.72 3.46 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.968 0.907 . . . . 0.0 109.85 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.93 -166.42 54.0 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-N 115.472 -0.785 . . . . 0.0 113.297 175.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.36 -104.24 1.02 Allowed Glycine 0 C--N 1.346 1.135 0 C-N-CA 123.74 0.685 . . . . 0.0 114.123 173.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -122.33 143.21 49.78 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.343 1.057 . . . . 0.0 109.901 -172.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.3 m-90 -124.57 145.31 49.66 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.169 0.988 . . . . 0.0 109.423 174.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -90.35 126.0 35.72 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 164.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.99 172.43 22.89 Favored Glycine 0 N--CA 1.467 0.766 0 O-C-N 123.621 0.575 . . . . 0.0 112.037 -176.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -131.87 145.13 51.35 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.228 0.537 . . . . 0.0 110.081 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.45 ' HG2' ' H ' ' A' ' 46' ' ' ASP . 64.9 tttp -71.75 154.8 41.08 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 164.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -64.41 -20.44 66.15 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.048 0.539 . . . . 0.0 111.856 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.45 ' H ' ' HG2' ' A' ' 44' ' ' LYS . 37.8 t70 -65.71 -20.36 66.25 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.166 0.987 . . . . 0.0 111.793 172.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.01 -16.13 30.58 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.196 176.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.3 mt -66.1 134.22 52.36 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 117.263 0.531 . . . . 0.0 110.501 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.9 mtt85 -113.38 142.54 45.75 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.287 1.035 . . . . 0.0 111.062 -174.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.17 154.91 25.94 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.646 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -96.05 127.57 42.18 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -146.76 148.77 34.31 Favored Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 124.18 0.992 . . . . 0.0 110.439 -173.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -84.82 -176.82 2.6 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.129 2.552 . . . . 0.0 111.911 174.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.39 -15.11 62.81 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.741 0.816 . . . . 0.0 111.926 176.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.5 m -55.45 -40.0 71.03 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.069 1.348 . . . . 0.0 113.335 -175.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -90.89 -29.05 17.72 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.999 0.52 . . . . 0.0 111.589 -175.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 35.3 m -105.39 -179.8 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.369 0.668 . . . . 0.0 110.52 -173.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -134.59 124.06 24.83 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.688 0.795 . . . . 0.0 109.128 175.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.438 HD21 ' SG ' ' A' ' 6' ' ' CYS . 74.0 mt -69.95 117.28 11.33 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.524 HD12 ' HG3' ' A' ' 7' ' ' ARG . 64.4 mt . . . . . 0 CA--C 1.548 0.879 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptp . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.7 t 60.18 82.32 0.16 Allowed 'General case' 0 CA--C 1.548 0.875 0 O-C-N 124.662 1.226 . . . . 0.0 111.09 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.13 84.72 1.24 Allowed Glycine 0 C--N 1.345 1.054 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.805 -174.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.7 97.22 1.04 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 171.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -94.93 149.62 21.05 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.57 0.748 . . . . 0.0 110.57 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.583 ' SG ' HD23 ' A' ' 59' ' ' LEU . 49.3 m -128.89 143.8 51.0 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 173.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -105.89 127.68 53.28 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 74.4 p -68.71 127.25 32.4 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 123.924 0.765 . . . . 0.0 109.558 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.421 HD22 ' HB2' ' A' ' 58' ' ' GLN . 95.7 mt -70.1 -75.93 0.11 Allowed 'General case' 0 CA--C 1.537 0.468 0 O-C-N 123.459 0.474 . . . . 0.0 109.978 -177.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -151.37 137.92 11.59 Favored Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 123.634 0.774 . . . . 0.0 109.03 -177.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.37 95.53 0.61 Allowed 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.215 1.943 . . . . 0.0 111.756 175.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.524 ' HB2' ' HE1' ' A' ' 56' ' ' TYR . 52.9 m-85 -91.58 102.99 15.64 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 175.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.8 p -100.53 100.99 11.81 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.655 0.782 . . . . 0.0 109.073 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -155.84 18.36 0.49 Allowed Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.396 177.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -116.43 163.53 15.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.027 0.931 . . . . 0.0 109.813 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -70.35 161.51 30.31 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.737 0.415 . . . . 0.0 110.063 176.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 30.9 p80 -71.66 178.83 3.35 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.382 0.673 . . . . 0.0 111.285 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.11 89.94 2.09 Favored Glycine 0 C--N 1.343 0.923 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -174.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.8 58.89 2.25 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.871 1.268 . . . . 0.0 108.828 -176.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.45 99.92 1.83 Allowed Glycine 0 C--N 1.343 0.968 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 176.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.5 tp -88.53 127.73 35.54 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -177.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 49.3 ttt-85 -78.88 122.98 26.78 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -129.18 114.18 15.99 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.059 0.943 . . . . 0.0 109.208 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.56 143.74 51.49 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.49 0.716 . . . . 0.0 109.913 175.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.99 111.21 1.58 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.655 0.782 . . . . 0.0 111.572 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.22 3.64 24.29 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-O 119.096 -0.836 . . . . 0.0 114.794 173.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.63 127.3 32.47 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 118.232 1.016 . . . . 0.0 111.782 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.677 HD23 HD11 ' A' ' 60' ' ' LEU . 54.2 mt -85.37 102.15 13.18 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 175.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.565 HG22 ' HE1' ' A' ' 51' ' ' TRP . 34.8 mm -107.68 125.81 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.812 0.845 . . . . 0.0 109.448 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.1 m -81.77 136.95 35.4 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.542 0.737 . . . . 0.0 110.461 178.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.7 mt -76.71 129.4 36.28 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.846 0.858 . . . . 0.0 109.674 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.685 HD13 ' HG3' ' A' ' 43' ' ' GLU . 96.0 mt -77.02 -28.47 54.93 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.811 0.445 . . . . 0.0 110.631 174.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -155.01 147.7 24.34 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.823 0.849 . . . . 0.0 109.456 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.6 m -112.97 92.21 20.42 Favored Pre-proline 0 CA--C 1.559 1.299 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 166.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -68.58 -27.85 32.27 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.618 2.212 . . . . 0.0 111.908 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -175.85 -51.61 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.856 1.262 . . . . 0.0 109.169 175.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.93 176.84 28.53 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.851 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.25 -79.71 0.4 Allowed Glycine 0 C--N 1.347 1.153 0 N-CA-C 111.907 -0.477 . . . . 0.0 111.907 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -84.64 108.94 17.64 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.335 0.654 . . . . 0.0 109.565 171.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -113.16 178.18 4.37 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.059 0.944 . . . . 0.0 109.092 171.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 51' ' ' TRP . 0.9 OUTLIER -137.49 145.31 42.89 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.543 0.737 . . . . 0.0 109.36 173.272 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.521 ' HA2' ' HG ' ' A' ' 32' ' ' LEU . . . -154.48 178.57 31.2 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.794 -178.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.685 ' HG3' HD13 ' A' ' 32' ' ' LEU . 45.6 mt-10 -103.25 148.49 25.76 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.077 0.551 . . . . 0.0 109.799 176.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -112.83 145.09 41.24 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.693 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -69.29 -7.23 35.13 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.259 0.624 . . . . 0.0 112.432 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.69 -7.44 53.3 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.526 1.13 . . . . 0.0 111.878 172.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.76 -19.39 51.69 Favored Glycine 0 C--N 1.348 1.24 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 -177.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 65.0 mt -82.24 158.53 23.49 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.59 1.156 . . . . 0.0 110.25 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -120.53 177.76 4.93 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.898 0.879 . . . . 0.0 109.485 174.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.46 158.36 13.84 Favored Glycine 0 N--CA 1.467 0.714 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 -174.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.565 ' HE1' HG22 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -156.06 173.24 17.1 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.494 0.664 . . . . 0.0 111.833 -171.829 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -125.54 167.16 17.32 Favored Pre-proline 0 N--CA 1.48 1.056 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.798 -173.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.36 170.52 9.31 Favored 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 122.213 1.942 . . . . 0.0 112.87 174.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.23 -15.23 56.4 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.494 1.118 . . . . 0.0 113.416 -175.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.3 p -62.51 -30.17 71.09 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.325 1.05 . . . . 0.0 113.062 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.524 ' HE1' ' HB2' ' A' ' 12' ' ' PHE . 85.1 m-85 -94.99 -6.56 42.06 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -176.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.6 m -135.39 -179.85 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 123.768 0.827 . . . . 0.0 110.397 -177.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.421 ' HB2' HD22 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -152.4 131.76 12.88 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 173.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.583 HD23 ' SG ' ' A' ' 6' ' ' CYS . 85.8 mt -65.32 133.98 52.58 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.764 0.826 . . . . 0.0 111.025 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.677 HD11 HD23 ' A' ' 28' ' ' LEU . 69.3 mt . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.896 -0.574 . . . . 0.0 109.572 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.512 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.404 ' HB3' HD11 ' A' ' 31' ' ' LEU . . . -76.98 127.26 32.38 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 122.969 0.507 . . . . 0.0 110.451 -177.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.645 ' HG3' ' HB2' ' A' ' 60' ' ' LEU . 35.2 ptt180 -86.68 157.38 19.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.87 0.868 . . . . 0.0 110.149 175.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 28.5 p -152.18 146.84 25.78 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.218 1.007 . . . . 0.0 108.921 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.414 ' HB2' HD11 ' A' ' 60' ' ' LEU . 61.9 ttt180 -106.07 125.57 51.16 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.524 HG22 HG12 ' A' ' 57' ' ' VAL . 49.6 p -72.27 140.01 48.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.49 0.716 . . . . 0.0 109.337 177.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mp -85.16 -74.46 0.4 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -144.89 100.39 4.61 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -69.8 101.34 0.9 Allowed 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 123.322 2.681 . . . . 0.0 112.103 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -92.88 161.65 14.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.314 0.646 . . . . 0.0 110.017 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.0 p -152.1 176.96 11.0 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.552 0.741 . . . . 0.0 110.555 -173.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -171.51 -50.94 0.04 OUTLIER Glycine 0 C--N 1.34 0.774 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -85.67 86.23 7.37 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 173.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -100.56 100.09 10.76 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -142.91 123.36 13.94 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.8 -145.95 33.23 Favored Glycine 0 C--N 1.345 1.06 0 O-C-N 123.571 0.545 . . . . 0.0 112.022 -174.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -94.77 60.57 2.51 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.745 0.818 . . . . 0.0 111.297 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.53 136.65 44.7 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-O 119.393 -0.671 . . . . 0.0 111.589 174.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.446 ' HB3' ' HE2' ' A' ' 52' ' ' PHE . 47.4 tp -85.98 114.03 22.55 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 117.363 0.581 . . . . 0.0 109.769 -169.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -99.83 116.73 32.58 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.341 0.657 . . . . 0.0 109.841 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -86.43 157.15 19.89 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.274 0.63 . . . . 0.0 109.387 172.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.75 154.48 19.88 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 169.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.26 133.9 46.43 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.02 0.528 . . . . 0.0 110.538 173.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.92 5.82 88.76 Favored Glycine 0 N--CA 1.475 1.27 0 O-C-N 123.305 0.378 . . . . 0.0 113.474 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -77.13 140.73 40.31 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.028 0.931 . . . . 0.0 111.268 -173.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.1 mt -91.06 104.48 17.06 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.514 0.725 . . . . 0.0 109.2 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.5 mm -117.82 130.62 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.006 1.323 . . . . 0.0 109.666 -176.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 87.7 m -90.45 138.52 31.49 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 171.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.404 HD11 ' HB3' ' A' ' 4' ' ' ALA . 1.4 pp -75.77 151.27 37.6 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.606 0.362 . . . . 0.0 110.692 174.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 93.6 mt -109.15 -2.41 18.06 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.016 0.926 . . . . 0.0 110.939 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.407 ' HG2' ' HD3' ' A' ' 35' ' ' PRO . 15.2 tt0 -143.48 152.54 41.61 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.51 56.15 21.29 Favored Pre-proline 0 CA--C 1.57 1.724 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.459 ' HD2' ' CD1' ' A' ' 40' ' ' TRP . 91.0 Cg_endo -77.16 126.29 8.46 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 121.727 1.618 . . . . 0.0 110.085 170.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -62.91 102.69 0.38 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.477 0.711 . . . . 0.0 109.699 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.9 54.22 7.37 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.237 -175.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -142.97 -172.55 14.07 Favored Glycine 0 C--N 1.343 0.951 0 C-N-CA 122.807 0.241 . . . . 0.0 112.68 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 25.0 m95 -81.38 140.74 34.55 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.459 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 12.5 m0 -117.64 136.63 53.19 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 2.2 mp0 -87.36 123.96 32.88 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 175.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.48 143.05 19.88 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -102.89 143.72 32.13 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 173.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -129.49 152.42 49.04 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.336 0.654 . . . . 0.0 110.296 173.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -67.26 -21.9 65.7 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.821 0.849 . . . . 0.0 109.997 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -51.35 -37.74 49.49 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.192 1.397 . . . . 0.0 111.15 169.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.02 -5.09 32.02 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-O 119.295 -0.725 . . . . 0.0 113.828 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 65.6 mt -92.23 172.6 8.31 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.076 0.938 . . . . 0.0 111.604 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -145.13 148.0 33.13 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.439 1.495 . . . . 0.0 109.05 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.435 ' N ' HD22 ' A' ' 21' ' ' LEU . . . -174.72 152.23 13.7 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 175.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.444 ' HB3' ' HG3' ' A' ' 41' ' ' GLU . 39.9 p-90 -97.23 129.98 44.5 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.862 0.865 . . . . 0.0 109.869 -174.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.446 ' HE2' ' HB3' ' A' ' 21' ' ' LEU . 78.8 m-85 -138.19 153.71 73.38 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 124.949 1.3 . . . . 0.0 109.041 -178.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -74.13 168.24 25.27 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.584 2.189 . . . . 0.0 112.457 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.47 -15.19 63.53 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.277 1.031 . . . . 0.0 111.787 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.8 m -55.64 -34.85 65.31 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.691 1.196 . . . . 0.0 112.658 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -97.03 -10.94 25.15 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.524 HG12 HG22 ' A' ' 8' ' ' THR . 34.5 m -122.53 161.1 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.44 0.696 . . . . 0.0 110.854 -177.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -131.18 115.58 16.56 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.346 1.058 . . . . 0.0 108.723 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.3 mt -58.49 132.42 53.69 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.335 0.654 . . . . 0.0 111.074 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.645 ' HB2' ' HG3' ' A' ' 5' ' ' ARG . 90.2 mt . . . . . 0 C--O 1.251 1.135 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.673 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.44 134.79 54.44 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.936 0.894 . . . . 0.0 109.833 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -154.68 177.18 11.52 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.105 0.962 . . . . 0.0 109.572 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.7 m -123.94 -176.45 3.48 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -142.83 128.51 19.22 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.1 p -66.99 147.54 53.1 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.73 0.812 . . . . 0.0 112.344 -176.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.7 mt -84.2 -52.62 6.11 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.271 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -139.11 166.69 22.95 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 124.151 0.98 . . . . 0.0 109.149 -176.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.69 95.58 0.34 Allowed 'Trans proline' 0 C--N 1.388 2.629 0 C-N-CA 121.801 1.667 . . . . 0.0 110.515 175.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -96.85 154.99 16.97 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.32 0.648 . . . . 0.0 111.285 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.7 m -122.47 -10.69 8.39 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.286 1.034 . . . . 0.0 111.059 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.76 -46.62 1.91 Allowed Glycine 0 C--N 1.349 1.269 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -172.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 63.64 16.84 10.0 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.897 1.279 . . . . 0.0 112.254 178.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -121.62 154.61 36.55 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 124.424 1.089 . . . . 0.0 108.663 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -70.43 154.23 42.12 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.216 0.607 . . . . 0.0 110.889 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.43 -116.34 4.88 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -92.29 76.63 5.24 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-O 121.695 0.759 . . . . 0.0 109.151 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.94 93.08 1.82 Allowed Glycine 0 C--N 1.338 0.65 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.7 174.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.565 HD21 ' HB2' ' A' ' 44' ' ' LYS . 36.4 tp -98.66 130.3 45.17 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.231 0.612 . . . . 0.0 109.508 177.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.92 158.32 30.78 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 168.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -158.41 150.5 21.65 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 174.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.01 142.75 38.05 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.815 0.846 . . . . 0.0 110.72 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.54 145.4 50.84 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.464 0.705 . . . . 0.0 111.35 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.46 19.79 79.74 Favored Glycine 0 C--N 1.345 1.053 0 O-C-N 123.808 0.693 . . . . 0.0 113.196 173.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -109.16 156.28 20.03 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.35 0.66 . . . . 0.0 110.776 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.7 mt -79.89 124.38 28.61 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.929 -171.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.593 HG13 HG11 ' A' ' 57' ' ' VAL . 47.6 mm -88.66 106.58 16.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 172.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.9 p -73.5 108.3 6.28 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.5 mt -66.76 93.35 0.25 Allowed 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.163 0.914 . . . . 0.0 109.148 -175.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.587 HD11 ' HB2' ' A' ' 43' ' ' GLU . 83.3 mt -75.16 -51.89 12.31 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.965 0.906 . . . . 0.0 109.638 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -101.9 136.07 42.37 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.16 86.56 41.7 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.287 1.035 . . . . 0.0 109.216 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.57 -174.41 2.26 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.868 2.378 . . . . 0.0 112.082 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -73.46 -23.27 60.06 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.281 0.632 . . . . 0.0 110.343 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 179.19 174.85 45.68 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 109.74 -101.57 1.47 Allowed Glycine 0 C--N 1.341 0.819 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 14.5 p-90 -137.83 165.1 27.29 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.59 0.756 . . . . 0.0 109.755 -177.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -122.32 149.27 43.98 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.587 0.755 . . . . 0.0 109.183 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.44 ' HG2' HD12 ' A' ' 32' ' ' LEU . 43.2 tt0 -91.15 138.43 31.6 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.4 ' H ' ' HD2' ' A' ' 52' ' ' PHE . . . -121.89 158.61 16.59 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 177.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.587 ' HB2' HD11 ' A' ' 32' ' ' LEU . 28.8 tt0 -110.1 119.36 39.05 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.063 0.545 . . . . 0.0 110.032 -176.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.565 ' HB2' HD21 ' A' ' 21' ' ' LEU . 56.5 tttm -78.76 155.12 29.47 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.439 0.696 . . . . 0.0 109.262 171.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -66.75 -7.02 18.2 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -173.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -78.24 -8.53 58.46 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.517 0.727 . . . . 0.0 111.236 172.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.96 -5.36 84.6 Favored Glycine 0 C--N 1.347 1.193 0 C-N-CA 123.298 0.475 . . . . 0.0 112.403 -171.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.1 mt -78.78 140.59 38.22 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 123.861 0.864 . . . . 0.0 110.584 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.581 HH11 HD13 ' A' ' 32' ' ' LEU . 58.8 mtt-85 -107.07 149.88 27.13 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.562 1.145 . . . . 0.0 108.139 177.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -156.25 -176.3 28.2 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 121.282 -0.485 . . . . 0.0 113.753 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -73.38 126.64 30.63 Favored 'General case' 0 C--N 1.346 0.438 0 C-N-CA 123.235 0.614 . . . . 0.0 110.418 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.4 ' HD2' ' H ' ' A' ' 42' ' ' GLY . 75.3 m-85 -139.27 85.26 15.66 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 123.661 0.784 . . . . 0.0 110.149 174.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.3 151.42 82.51 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.032 2.488 . . . . 0.0 112.023 170.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.24 -15.76 60.7 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.965 0.906 . . . . 0.0 110.79 171.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.3 m -67.75 -38.12 83.05 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 124.32 1.048 . . . . 0.0 111.117 173.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -80.94 -13.0 59.29 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.361 1.064 . . . . 0.0 112.205 -173.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.593 HG11 HG13 ' A' ' 29' ' ' ILE . 29.8 m -132.78 146.2 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.462 0.705 . . . . 0.0 111.091 -171.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.2 127.56 41.34 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 169.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.0 mt -69.06 123.6 21.51 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.928 0.891 . . . . 0.0 110.291 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 72.0 mt . . . . . 0 C--O 1.248 1.008 0 C-N-CA 122.727 0.411 . . . . 0.0 109.95 178.857 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.894 0 CA-C-O 119.79 -0.45 . . . . 0.0 113.79 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.27 103.84 0.21 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.507 0.723 . . . . 0.0 111.494 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.463 ' HG2' ' HA ' ' A' ' 30' ' ' THR . 61.2 mtt180 -143.02 170.4 15.77 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.847 0.859 . . . . 0.0 111.004 -177.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.608 ' SG ' HD23 ' A' ' 59' ' ' LEU . 81.9 m -133.93 172.13 13.23 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 113.882 -1.508 . . . . 0.0 108.352 172.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.6 ' HB2' HD21 ' A' ' 60' ' ' LEU . 36.1 ttm180 -124.61 140.36 53.01 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 172.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.8 p -82.0 136.19 35.28 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.501 0.72 . . . . 0.0 110.262 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.403 HD21 ' HG3' ' A' ' 58' ' ' GLN . 75.3 mt -74.89 -67.1 0.67 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.497 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -141.73 157.66 64.4 Favored Pre-proline 0 N--CA 1.48 1.026 0 C-N-CA 124.718 1.207 . . . . 0.0 108.366 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 25' ' ' ALA . 56.5 Cg_endo -66.38 88.53 0.26 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.263 1.976 . . . . 0.0 111.533 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -91.83 146.87 23.41 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.449 0.7 . . . . 0.0 110.498 -177.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.0 p -153.51 161.26 42.41 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.578 1.151 . . . . 0.0 108.276 173.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.5 -84.23 0.13 Allowed Glycine 0 C--N 1.348 1.236 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -144.5 160.35 41.25 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.829 1.252 . . . . 0.0 108.811 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -74.93 82.55 2.19 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 122.74 0.416 . . . . 0.0 110.736 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.6 t60 171.82 -50.17 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.265 1.826 . . . . 0.0 107.17 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.24 149.74 51.26 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 114.915 -1.039 . . . . 0.0 113.776 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -81.31 163.64 22.76 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.905 0.882 . . . . 0.0 112.106 -175.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.08 160.89 11.69 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.261 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.419 HD21 ' HB2' ' A' ' 44' ' ' LYS . 33.9 tp -89.53 115.99 27.35 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.627 ' HD2' ' H ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -85.74 154.8 21.37 Favored 'General case' 0 C--O 1.247 0.944 0 C-N-CA 123.648 0.779 . . . . 0.0 111.063 -176.474 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.462 ' HZ ' ' HE1' ' A' ' 56' ' ' TYR . 21.4 p90 -156.42 149.57 24.24 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.192 -171.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.87 148.58 22.01 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.936 0.895 . . . . 0.0 109.657 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.539 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . . . -61.35 114.55 3.25 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.414 0.686 . . . . 0.0 111.606 -178.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.09 -13.16 24.1 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-O 119.248 -0.751 . . . . 0.0 114.209 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -70.91 163.0 28.33 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 118.056 0.928 . . . . 0.0 111.03 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 mp -99.03 126.15 44.68 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.53 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.3 mm -92.89 108.66 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 169.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.463 ' HA ' ' HG2' ' A' ' 5' ' ' ARG . 54.5 m -77.8 107.93 10.66 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.467 HD21 ' SG ' ' A' ' 6' ' ' CYS . 42.6 mt -69.3 115.07 8.15 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.525 ' HB2' ' HG3' ' A' ' 41' ' ' GLU . 46.7 mt -74.72 -50.55 17.05 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.412 0.685 . . . . 0.0 110.091 -173.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.467 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 52.3 tt0 -147.22 166.38 27.18 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.074 0.949 . . . . 0.0 108.624 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.5 m -101.96 84.4 0.57 Allowed Pre-proline 0 CA--C 1.566 1.588 0 C-N-CA 124.347 1.059 . . . . 0.0 109.713 173.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 33' ' ' GLN . 4.8 Cg_exo -74.42 -36.88 2.76 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 122.888 2.392 . . . . 0.0 111.663 -174.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -109.15 -67.61 0.97 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.241 1.016 . . . . 0.0 109.15 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.36 -35.47 1.88 Allowed Glycine 0 C--N 1.35 1.324 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -100.83 -42.52 2.44 Favored Glycine 0 C--N 1.345 1.078 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 171.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -86.8 137.47 32.39 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 168.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -128.02 177.5 6.84 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.727 0.811 . . . . 0.0 109.747 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.525 ' HG3' ' HB2' ' A' ' 32' ' ' LEU . 15.8 pt-20 -118.66 149.64 41.06 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.166 0.986 . . . . 0.0 108.384 174.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.41 125.68 1.87 Allowed Glycine 0 C--N 1.335 0.491 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.454 ' HB2' HD11 ' A' ' 32' ' ' LEU . 35.5 tt0 -101.16 123.55 45.48 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.419 ' HB2' HD21 ' A' ' 21' ' ' LEU . 17.9 tptm -77.04 167.24 22.15 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.915 0.886 . . . . 0.0 110.072 175.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -52.21 -35.4 49.18 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.407 1.483 . . . . 0.0 113.505 -175.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -78.26 -16.38 57.85 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.145 0.578 . . . . 0.0 111.662 -175.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.56 -7.55 30.1 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-O 119.702 -0.499 . . . . 0.0 113.446 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.01 125.1 25.6 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 117.619 0.709 . . . . 0.0 110.295 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.2 mtp85 -105.26 128.67 53.55 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -135.38 155.3 22.08 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 29.3 p-90 -80.88 138.98 36.17 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.149 0.579 . . . . 0.0 109.695 174.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -140.58 104.96 6.41 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 123.925 0.89 . . . . 0.0 108.881 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.468 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 94.5 Cg_endo -80.31 165.04 21.38 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.975 2.45 . . . . 0.0 112.219 172.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.01 -30.0 71.1 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.772 0.829 . . . . 0.0 111.013 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.0 p -75.39 7.48 3.53 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.136 0.974 . . . . 0.0 112.541 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.468 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 2.6 t80 -124.9 -45.14 1.9 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.6 m -130.51 141.1 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.223 1.009 . . . . 0.0 109.643 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.403 ' HG3' HD21 ' A' ' 9' ' ' LEU . 54.3 mt-30 -89.39 132.97 34.73 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 122.952 0.501 . . . . 0.0 111.326 -175.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.608 HD23 ' SG ' ' A' ' 6' ' ' CYS . 93.2 mt -62.32 145.3 54.17 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.225 1.01 . . . . 0.0 111.9 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.6 HD21 ' HB2' ' A' ' 7' ' ' ARG . 95.0 mt . . . . . 0 C--O 1.245 0.84 0 C-N-CA 123.617 0.767 . . . . 0.0 109.832 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.459 0.209 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.534 ' HB3' ' HB2' ' A' ' 31' ' ' LEU . . . -134.88 149.64 50.33 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.755 0.822 . . . . 0.0 109.375 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.401 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 4.4 mmt85 -128.04 155.0 45.03 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.89 0.876 . . . . 0.0 110.717 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.449 ' SG ' HD11 ' A' ' 31' ' ' LEU . 72.4 m -143.62 173.13 11.93 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.229 1.412 . . . . 0.0 108.795 175.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.9 ttt180 -142.84 131.09 22.05 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.623 HG21 ' HB3' ' A' ' 23' ' ' PHE . 35.2 p -68.12 125.91 27.84 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 124.018 0.927 . . . . 0.0 111.24 -176.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.539 HD21 ' HB2' ' A' ' 58' ' ' GLN . 93.1 mt -67.21 -59.99 2.98 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 123.708 0.63 . . . . 0.0 109.505 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -139.83 153.84 70.22 Favored Pre-proline 0 N--CA 1.476 0.853 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.14 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.42 ' HD3' ' HB2' ' A' ' 25' ' ' ALA . 48.2 Cg_endo -83.63 29.8 0.54 Allowed 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.621 2.214 . . . . 0.0 113.73 -172.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -90.88 101.0 13.76 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.564 ' HB2' ' HA ' ' A' ' 22' ' ' ARG . 25.2 m -148.04 134.39 19.56 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -178.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.21 53.08 4.01 Favored Glycine 0 C--N 1.341 0.824 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -171.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -59.88 104.16 0.27 Allowed 'General case' 0 C--O 1.245 0.841 0 C-N-CA 124.26 1.024 . . . . 0.0 111.414 -177.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 61.8 18.03 9.34 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.651 1.18 . . . . 0.0 112.34 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -156.28 117.9 3.91 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.874 0.869 . . . . 0.0 108.825 -171.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.02 -162.99 16.84 Favored Glycine 0 CA--C 1.533 1.167 0 O-C-N 123.21 0.319 . . . . 0.0 112.539 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 71.53 -2.92 2.28 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.009 1.323 . . . . 0.0 113.304 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.4 178.61 35.62 Favored Glycine 0 C--N 1.348 1.201 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 44' ' ' LYS . 43.7 tp -90.36 112.93 24.7 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.564 ' HA ' ' HB2' ' A' ' 13' ' ' SER . 64.7 mtt180 -82.42 139.05 34.23 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.852 0.72 . . . . 0.0 109.374 174.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.623 ' HB3' HG21 ' A' ' 8' ' ' THR . 97.1 m-85 -113.11 135.4 53.85 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.371 0.668 . . . . 0.0 109.604 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.12 138.42 33.04 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 171.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.42 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . . . -64.29 135.59 56.36 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.546 0.738 . . . . 0.0 111.657 -176.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.4 -13.09 67.41 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-O 119.552 -0.582 . . . . 0.0 114.021 177.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -64.96 129.92 41.49 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.183 0.593 . . . . 0.0 111.919 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.9 mt -80.44 100.35 8.45 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.9 mm -95.62 115.2 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.468 0.707 . . . . 0.0 109.502 -175.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.0 m -74.65 125.24 28.25 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 122.943 0.497 . . . . 0.0 109.755 175.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.534 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 82.4 mt -76.88 126.09 30.4 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 170.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.52 -51.31 15.09 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.529 0.68 . . . . 0.0 110.342 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -153.27 162.42 41.32 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.469 -173.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.9 m -100.82 89.13 1.16 Allowed Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 124.032 0.933 . . . . 0.0 109.569 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -79.76 -4.22 13.31 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.288 2.659 . . . . 0.0 113.518 -171.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -162.6 -69.86 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.808 0.843 . . . . 0.0 109.645 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.24 -52.85 0.55 Allowed Glycine 0 C--N 1.341 0.831 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -174.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -72.31 -46.44 33.98 Favored Glycine 0 C--N 1.344 0.984 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 173.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -93.71 135.46 34.98 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.882 0.873 . . . . 0.0 109.21 174.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 14.5 m0 -133.17 150.39 52.01 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.071 0.949 . . . . 0.0 110.388 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 42.2 mt-10 -91.54 145.85 24.27 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.875 0.87 . . . . 0.0 110.689 -173.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -147.57 170.31 28.34 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.241 0.925 . . . . 0.0 110.99 177.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -126.05 167.23 15.63 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.528 0.731 . . . . 0.0 112.423 -177.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.652 ' HB2' HD11 ' A' ' 21' ' ' LEU . 3.3 tmtp? -126.4 146.64 49.99 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 164.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.433 ' H ' ' HD3' ' A' ' 44' ' ' LYS . 1.7 mp0 -66.45 -9.71 36.87 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.081 0.952 . . . . 0.0 111.647 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.415 ' H ' ' HD2' ' A' ' 44' ' ' LYS . 30.6 t70 -77.76 -8.65 58.29 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 124.858 1.263 . . . . 0.0 111.537 178.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.87 -13.42 57.67 Favored Glycine 0 C--N 1.355 1.61 0 C-N-CA 123.159 0.409 . . . . 0.0 112.916 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.16 133.66 34.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.311 0.644 . . . . 0.0 109.841 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -111.62 173.81 6.17 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.134 0.974 . . . . 0.0 109.689 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -167.88 153.49 22.8 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.56 174.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -121.61 125.75 47.46 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -144.02 156.14 58.56 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 124.217 1.007 . . . . 0.0 109.718 -168.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -68.57 153.85 72.76 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 122.725 2.284 . . . . 0.0 112.719 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.66 -14.51 63.0 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.6 1.16 . . . . 0.0 112.288 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.7 t -55.94 -23.58 32.88 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.508 1.123 . . . . 0.0 112.969 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -106.72 -7.07 17.43 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.2 0.6 . . . . 0.0 112.392 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' A' ' 6' ' ' CYS . 12.9 m -135.9 124.76 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.688 0.795 . . . . 0.0 110.206 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.539 ' HB2' HD21 ' A' ' 9' ' ' LEU . 63.2 tt0 -80.81 127.09 32.12 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 37.9 mt -73.59 133.89 43.61 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.761 0.824 . . . . 0.0 110.871 -173.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 5' ' ' ARG . 74.0 mt . . . . . 0 C--O 1.251 1.151 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.777 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 31' ' ' LEU . . . -68.55 140.69 55.62 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 81.9 mtm-85 -126.55 138.61 53.49 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.082 0.553 . . . . 0.0 110.137 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.676 ' SG ' HD23 ' A' ' 59' ' ' LEU . 77.3 m -128.49 170.47 13.13 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.475 1.11 . . . . 0.0 109.709 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -140.71 138.18 34.03 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.607 0.763 . . . . 0.0 109.153 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.645 HG23 HD11 ' A' ' 29' ' ' ILE . 1.6 p -66.91 128.81 37.73 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.579 0.751 . . . . 0.0 110.839 176.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.462 ' H ' HD12 ' A' ' 9' ' ' LEU . 3.5 mp -74.38 -38.17 63.24 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -129.78 152.63 80.16 Favored Pre-proline 0 C--O 1.245 0.867 0 C-N-CA 125.405 1.482 . . . . 0.0 108.03 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.48 145.29 76.39 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.065 1.843 . . . . 0.0 111.843 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -89.92 106.64 18.61 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 173.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.8 m -59.34 138.69 57.54 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 124.323 1.014 . . . . 0.0 111.164 -176.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.78 72.04 1.83 Allowed Glycine 0 C--N 1.349 1.257 0 O-C-N 123.92 0.763 . . . . 0.0 111.439 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -70.56 96.99 1.25 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.287 1.035 . . . . 0.0 109.856 -176.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -77.45 75.78 4.0 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.92 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -169.1 95.85 0.34 Allowed 'General case' 0 C--O 1.241 0.641 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.78 -131.19 10.6 Favored Glycine 0 N--CA 1.469 0.844 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -174.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -155.0 142.22 19.42 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.217 0.607 . . . . 0.0 109.994 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.23 157.55 29.69 Favored Glycine 0 C--N 1.344 1.001 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.8 tp -90.15 126.0 35.65 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -88.96 134.22 34.05 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.1 0.96 . . . . 0.0 111.615 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -145.07 111.53 5.71 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 163.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.71 157.74 28.48 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.54 0.736 . . . . 0.0 109.939 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.98 119.52 7.39 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.309 0.643 . . . . 0.0 111.326 -174.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.93 -22.03 12.96 Favored Glycine 0 C--N 1.347 1.184 0 O-C-N 123.654 0.596 . . . . 0.0 113.148 -176.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -72.2 143.11 48.98 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.179 0.514 . . . . 0.0 111.427 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.29 117.3 30.05 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.317 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.645 HD11 HG23 ' A' ' 8' ' ' THR . 3.3 mp -85.4 108.27 17.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.4 m -85.06 102.35 13.16 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.54 HD11 ' SG ' ' A' ' 6' ' ' CYS . 90.2 mt -76.23 104.52 6.79 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.243 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.563 HD11 ' HB2' ' A' ' 43' ' ' GLU . 58.9 mt -77.95 -42.91 31.41 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.537 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 32.6 mm-40 -121.33 136.99 54.89 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.384 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.7 m -137.38 72.06 52.09 Favored Pre-proline 0 CA--C 1.557 1.217 0 C-N-CA 124.301 1.04 . . . . 0.0 109.643 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.42 169.54 20.59 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.52 2.147 . . . . 0.0 112.269 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.46 92.17 0.43 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.618 0.767 . . . . 0.0 110.196 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 166.68 -164.84 38.02 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.563 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.08 -29.52 9.62 Favored Glycine 0 N--CA 1.473 1.115 0 N-CA-C 113.403 0.121 . . . . 0.0 113.403 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -94.19 100.21 12.33 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.526 0.73 . . . . 0.0 110.159 -168.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -111.19 150.98 28.75 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.304 1.042 . . . . 0.0 109.248 -175.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 33' ' ' GLN . 35.5 tt0 -89.39 125.91 35.33 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -176.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -123.17 140.6 13.17 Favored Glycine 0 C--N 1.34 0.752 0 O-C-N 124.689 1.243 . . . . 0.0 110.1 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.563 ' HB2' HD11 ' A' ' 32' ' ' LEU . 37.8 tt0 -106.37 140.67 38.93 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.123 0.487 . . . . 0.0 110.717 -177.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -97.05 151.85 19.33 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.013 1.325 . . . . 0.0 108.085 172.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -68.2 -14.2 62.81 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.934 0.493 . . . . 0.0 111.93 -173.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -69.12 -20.71 64.05 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.52 0.728 . . . . 0.0 111.644 174.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.07 -9.4 36.59 Favored Glycine 0 C--N 1.344 1.008 0 C-N-CA 123.413 0.53 . . . . 0.0 112.406 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.1 mp -75.72 121.33 22.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.576 0.75 . . . . 0.0 109.795 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -104.59 158.37 16.54 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.858 0.863 . . . . 0.0 108.978 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -172.13 163.1 35.33 Favored Glycine 0 CA--C 1.507 -0.461 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.879 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 3.6 p-90 -86.06 138.35 32.01 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.591 0.757 . . . . 0.0 109.062 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -132.26 140.13 37.03 Favored Pre-proline 0 C--O 1.242 0.677 0 C-N-CA 124.105 0.962 . . . . 0.0 108.429 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.518 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 39.7 Cg_endo -69.45 134.5 28.81 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 121.843 1.695 . . . . 0.0 109.98 173.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.62 -24.9 65.87 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.371 1.068 . . . . 0.0 111.29 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.0 m -64.82 -35.82 82.33 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.263 1.025 . . . . 0.0 111.32 176.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.518 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 35.5 t80 -81.69 -19.69 41.05 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.377 0.671 . . . . 0.0 111.581 -173.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 6' ' ' CYS . 35.4 m -115.41 149.71 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.237 0.615 . . . . 0.0 110.691 -176.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -110.64 117.58 33.87 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.79 0.836 . . . . 0.0 110.168 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.676 HD23 ' SG ' ' A' ' 6' ' ' CYS . 64.2 mt -66.46 123.23 19.44 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 171.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.2 mp . . . . . 0 C--O 1.248 1.021 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.162 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.774 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 31' ' ' LEU . . . -73.51 164.68 26.33 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.889 0.476 . . . . 0.0 109.95 173.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.475 ' HG3' ' HB2' ' A' ' 60' ' ' LEU . 15.6 ptt180 -141.89 149.55 40.36 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.445 0.698 . . . . 0.0 109.908 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.652 ' SG ' ' HA ' ' A' ' 59' ' ' LEU . 57.0 m -145.11 145.31 31.36 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.571 0.749 . . . . 0.0 109.503 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.54 ' HB2' HD11 ' A' ' 60' ' ' LEU . 6.7 tmm_? -106.77 136.56 46.38 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.416 ' HA ' HG12 ' A' ' 57' ' ' VAL . 52.5 p -75.59 127.46 33.12 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.779 1.232 . . . . 0.0 111.891 -174.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.427 HD21 ' HG2' ' A' ' 58' ' ' GLN . 96.1 mt -67.87 -56.47 8.98 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.443 0.697 . . . . 0.0 110.38 177.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -129.22 154.46 80.56 Favored Pre-proline 0 N--CA 1.478 0.949 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.249 -175.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.27 138.52 51.51 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.899 2.4 . . . . 0.0 111.983 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.424 ' HD2' ' HA ' ' A' ' 22' ' ' ARG . 50.4 t80 -111.38 101.24 9.71 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 172.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.0 m -138.27 70.16 1.39 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 169.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -106.27 -46.37 1.16 Allowed Glycine 0 C--N 1.34 0.786 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.977 176.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 56.74 31.81 20.06 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.337 1.055 . . . . 0.0 111.667 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -63.28 -36.41 83.58 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.73 0.812 . . . . 0.0 110.581 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -123.62 152.92 41.42 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.631 1.172 . . . . 0.0 109.36 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.62 -39.7 93.89 Favored Glycine 0 C--N 1.343 0.965 0 O-C-N 123.964 0.79 . . . . 0.0 112.234 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -82.15 89.3 6.47 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.37 136.24 2.89 Favored Glycine 0 C--N 1.345 1.082 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.0 tp -91.01 119.58 31.3 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.549 0.74 . . . . 0.0 109.685 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.424 ' HA ' ' HD2' ' A' ' 12' ' ' PHE . 15.3 ptm180 -92.23 146.68 23.52 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -158.96 174.59 14.72 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.073 0.949 . . . . 0.0 110.765 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.03 168.09 9.28 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.183 0.993 . . . . 0.0 108.855 170.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.79 146.65 49.62 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 172.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.86 -9.82 76.68 Favored Glycine 0 N--CA 1.468 0.799 0 CA-C-N 116.07 -0.514 . . . . 0.0 113.888 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -76.44 135.12 39.4 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.24 0.616 . . . . 0.0 111.019 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.426 HD23 ' HD2' ' A' ' 5' ' ' ARG . 6.9 mp -98.44 114.73 27.21 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.621 HG13 ' HD3' ' A' ' 44' ' ' LYS . 2.6 mp -102.24 125.34 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 174.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 87.0 m -76.3 126.88 31.79 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.77 0.828 . . . . 0.0 110.507 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.614 HD11 ' SG ' ' A' ' 6' ' ' CYS . 5.6 mp -76.2 140.56 41.73 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.907 174.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.3 mt -82.77 -47.24 12.15 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.593 177.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -146.83 156.67 43.3 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.126 0.97 . . . . 0.0 109.358 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.4 m -114.01 87.5 12.96 Favored Pre-proline 0 CA--C 1.561 1.377 0 C-N-CA 123.73 0.812 . . . . 0.0 109.968 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 40' ' ' TRP . 72.6 Cg_endo -73.57 82.89 1.6 Allowed 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.515 2.143 . . . . 0.0 111.584 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 59.03 -86.88 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.146 1.379 . . . . 0.0 111.553 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.55 -168.91 29.44 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-N 116.388 -0.369 . . . . 0.0 112.628 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.46 -71.86 2.61 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -124.0 136.91 54.6 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.076 0.95 . . . . 0.0 108.724 172.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . 11.4 m-90 -124.22 160.46 27.88 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 173.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -110.92 148.58 32.17 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.069 0.461 . . . . 0.0 110.635 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.82 175.31 31.41 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.531 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -139.4 144.73 38.26 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.621 ' HD3' HG13 ' A' ' 29' ' ' ILE . 27.6 tptp -101.99 156.36 17.58 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.724 -178.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -52.88 -25.76 12.68 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 125.535 1.534 . . . . 0.0 113.01 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.81 -16.07 63.46 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.36 1.064 . . . . 0.0 112.551 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.47 -0.96 75.3 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 -171.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.6 mt -85.5 124.21 31.82 Favored 'General case' 0 C--N 1.346 0.433 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 45.0 ttp85 -104.74 138.72 40.61 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 149.71 154.5 6.43 Favored Glycine 0 C--O 1.243 0.695 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.439 ' HZ2' ' HB2' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -154.73 172.47 17.88 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.518 0.675 . . . . 0.0 111.192 -174.944 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -138.87 153.09 71.61 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 124.591 1.157 . . . . 0.0 109.616 -168.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.99 172.98 3.41 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.564 2.176 . . . . 0.0 113.268 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.38 -15.4 10.47 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.728 1.211 . . . . 0.0 113.24 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.8 t -61.16 -34.06 74.42 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.688 0.795 . . . . 0.0 112.083 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -92.2 -33.06 14.85 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.277 0.631 . . . . 0.0 111.432 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 8' ' ' THR . 11.4 m -138.46 138.76 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.358 0.663 . . . . 0.0 111.069 -166.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.427 ' HG2' HD21 ' A' ' 9' ' ' LEU . 13.6 mm100 -97.4 128.9 44.59 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.205 0.602 . . . . 0.0 110.466 174.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.652 ' HA ' ' SG ' ' A' ' 6' ' ' CYS . 5.0 mp -79.58 118.75 21.71 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.367 -173.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 7' ' ' ARG . 85.9 mt . . . . . 0 C--O 1.249 1.079 0 C-N-CA 123.909 0.883 . . . . 0.0 109.863 -177.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.805 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.64 106.67 3.13 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.15 0.58 . . . . 0.0 110.2 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -136.52 139.4 42.23 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.577 ' SG ' HD23 ' A' ' 59' ' ' LEU . 54.4 m -129.71 154.44 47.17 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.959 0.904 . . . . 0.0 109.058 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.423 HH21 ' HA ' ' A' ' 9' ' ' LEU . 6.4 ttp180 -105.87 128.61 53.87 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 40.3 p -69.45 140.79 54.09 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.701 0.8 . . . . 0.0 110.976 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.543 HD21 ' HB2' ' A' ' 58' ' ' GLN . 91.0 mt -73.9 -68.03 0.55 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.024 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -144.7 157.76 54.56 Favored Pre-proline 0 N--CA 1.482 1.152 0 C-N-CA 124.131 0.972 . . . . 0.0 109.169 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.603 ' HD3' ' HB2' ' A' ' 25' ' ' ALA . 10.9 Cg_exo -70.99 162.02 44.13 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 122.643 2.229 . . . . 0.0 110.919 173.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -91.93 155.44 18.15 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.979 0.511 . . . . 0.0 110.377 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.7 m -60.43 -31.11 70.09 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.201 0.601 . . . . 0.0 111.976 -175.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.2 -37.48 3.32 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-O 119.92 -0.378 . . . . 0.0 112.406 175.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -65.78 96.2 0.28 Allowed 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.111 0.565 . . . . 0.0 110.445 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.425 ' HD2' ' HA ' ' A' ' 16' ' ' ARG . 18.2 tpt180 -161.07 117.45 2.24 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.575 173.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -74.23 86.58 1.93 Allowed 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 121.894 0.854 . . . . 0.0 110.0 175.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.21 156.4 9.44 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.187 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.78 130.75 35.59 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -145.82 172.85 26.38 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 112.259 -0.336 . . . . 0.0 112.259 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.5 tp -90.91 136.56 32.99 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.445 0.698 . . . . 0.0 109.829 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -88.31 136.39 33.01 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 123.903 0.752 . . . . 0.0 110.272 174.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -160.18 176.11 12.14 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.174 0.989 . . . . 0.0 110.31 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.422 ' HA ' ' HG3' ' A' ' 11' ' ' PRO . . . -123.96 167.37 14.24 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.329 1.052 . . . . 0.0 109.874 176.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.603 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . . . -67.19 128.44 36.4 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.375 0.67 . . . . 0.0 110.686 175.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.22 1.46 59.41 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-O 119.738 -0.479 . . . . 0.0 113.671 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -78.93 116.69 19.41 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.967 0.507 . . . . 0.0 110.971 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 mp -76.63 100.61 5.41 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 172.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.5 mm -94.05 121.31 44.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 123.975 0.91 . . . . 0.0 109.274 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 31.6 m -74.95 125.38 28.76 Favored 'General case' 0 C--O 1.241 0.658 0 C-N-CA 123.158 0.583 . . . . 0.0 109.88 175.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.1 mt -73.48 128.68 36.16 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.586 HD13 HH11 ' A' ' 49' ' ' ARG . 74.2 mt -73.57 -52.2 14.31 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.871 0.868 . . . . 0.0 110.037 -174.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -139.0 144.57 38.96 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 173.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.5 m -110.01 108.89 59.19 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.661 0.784 . . . . 0.0 110.095 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -72.34 171.67 16.5 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.964 2.442 . . . . 0.0 111.549 171.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -81.47 -6.49 59.0 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.041 177.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.25 -176.81 39.05 Favored Glycine 0 C--N 1.351 1.397 0 O-C-N 123.18 0.3 . . . . 0.0 112.743 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -100.47 36.42 4.16 Favored Glycine 0 C--N 1.348 1.22 0 C-N-CA 123.395 0.522 . . . . 0.0 112.547 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -126.9 108.03 10.62 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 175.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 25.0 m0 -111.74 145.68 38.9 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.764 0.426 . . . . 0.0 110.459 -172.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.71 ' HG2' ' HB3' ' A' ' 51' ' ' TRP . 38.8 mt-10 -106.13 123.86 48.68 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.925 0.89 . . . . 0.0 109.602 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -118.6 -179.72 16.95 Favored Glycine 0 C--N 1.34 0.75 0 O-C-N 123.766 0.667 . . . . 0.0 112.468 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.405 ' HB2' HD21 ' A' ' 32' ' ' LEU . 28.2 tt0 -145.86 159.61 42.96 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.069 0.947 . . . . 0.0 109.903 -176.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.464 ' HE3' ' HG2' ' A' ' 45' ' ' GLU . 20.8 mmmt -121.02 170.4 9.55 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.908 0.883 . . . . 0.0 111.284 175.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.464 ' HG2' ' HE3' ' A' ' 44' ' ' LYS . 10.4 pt-20 -54.49 -28.67 46.41 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.614 1.566 . . . . 0.0 112.65 174.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -63.09 -34.17 77.03 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.844 1.257 . . . . 0.0 111.318 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.17 -22.61 24.8 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -173.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 51.7 tp -63.17 140.76 58.91 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 123.117 0.567 . . . . 0.0 109.877 175.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.586 HH11 HD13 ' A' ' 32' ' ' LEU . 49.9 mtt-85 -116.71 173.29 6.71 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.436 1.095 . . . . 0.0 108.491 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.65 175.66 45.9 Favored Glycine 0 CA--C 1.505 -0.537 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.71 ' HB3' ' HG2' ' A' ' 41' ' ' GLU . 33.0 p-90 -141.85 136.0 30.13 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.48 0.712 . . . . 0.0 109.765 -176.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -139.77 161.0 58.71 Favored Pre-proline 0 C--O 1.247 0.925 0 C-N-CA 124.603 1.161 . . . . 0.0 108.748 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.06 144.94 35.46 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.017 2.478 . . . . 0.0 113.095 171.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.22 -27.05 68.79 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.094 0.958 . . . . 0.0 111.404 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.1 m -68.62 -25.35 64.81 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.79 0.836 . . . . 0.0 111.468 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -77.37 -19.81 55.69 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.147 0.579 . . . . 0.0 111.276 -174.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.8 m -117.24 168.23 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.85 0.86 . . . . 0.0 109.837 175.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.543 ' HB2' HD21 ' A' ' 9' ' ' LEU . 24.6 tt0 -119.71 135.06 54.99 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.828 0.851 . . . . 0.0 108.796 177.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.577 HD23 ' SG ' ' A' ' 6' ' ' CYS . 96.6 mt -65.72 145.31 56.17 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.773 0.429 . . . . 0.0 110.206 172.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--O 1.251 1.18 0 C-N-CA 122.908 0.483 . . . . 0.0 109.992 177.941 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.374 0 N-CA-C 112.55 -0.22 . . . . 0.0 112.55 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.651 ' HB3' HD21 ' A' ' 31' ' ' LEU . . . -83.37 136.92 34.17 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.711 ' HB2' ' HB2' ' A' ' 60' ' ' LEU . 46.7 mtt-85 -120.97 169.52 10.4 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.682 0.753 . . . . 0.0 110.036 -167.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.1 m -135.32 148.29 49.42 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 169.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.411 ' HD2' HD21 ' A' ' 60' ' ' LEU . 17.5 ptm180 -123.53 128.92 50.44 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 175.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.2 p -79.73 125.88 30.23 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.528 -176.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.6 mt -72.47 -52.17 16.99 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.228 -174.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.446 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 71.3 m-85 -139.79 159.81 63.45 Favored Pre-proline 0 N--CA 1.483 1.207 0 C-N-CA 123.828 0.851 . . . . 0.0 109.656 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.41 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . 1.8 Cg_endo -79.17 99.95 1.3 Allowed 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 122.197 1.931 . . . . 0.0 109.886 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -99.72 140.49 33.84 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.314 0.646 . . . . 0.0 109.837 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.2 m -144.35 95.33 2.7 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.934 0.894 . . . . 0.0 108.819 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.34 -170.09 44.58 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.535 173.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -129.42 132.08 46.92 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.952 0.406 . . . . 0.0 110.65 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.8 mtt-85 -145.19 141.69 28.92 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.049 1.34 . . . . 0.0 108.895 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -68.95 99.56 1.08 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 171.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.8 -120.3 1.45 Allowed Glycine 0 C--N 1.341 0.849 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -176.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -162.12 123.09 2.62 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.308 0.643 . . . . 0.0 110.054 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.27 163.69 21.09 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 169.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.6 tp -92.98 126.27 37.98 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 117.484 0.642 . . . . 0.0 109.499 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -77.76 150.19 34.4 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.218 1.007 . . . . 0.0 111.596 -171.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -152.35 148.46 27.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.584 0.753 . . . . 0.0 110.162 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . . . -110.06 167.09 10.43 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.648 1.179 . . . . 0.0 108.513 173.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . . . -75.98 142.74 41.85 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.636 0.375 . . . . 0.0 111.447 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.44 -21.49 45.27 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.753 170.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.77 162.4 22.93 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 121.267 0.556 . . . . 0.0 110.29 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 mp -108.16 119.81 40.55 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.427 -174.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.2 mm -85.84 114.86 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 174.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.5 m -89.42 131.07 35.65 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.391 0.676 . . . . 0.0 109.449 177.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.651 HD21 ' HB3' ' A' ' 4' ' ' ALA . 2.7 pp -76.15 148.85 37.51 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.29 0.567 . . . . 0.0 111.422 177.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.58 HD11 ' HB2' ' A' ' 43' ' ' GLU . 48.5 mt -99.66 -19.21 16.92 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.198 0.999 . . . . 0.0 109.664 176.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -153.53 150.54 28.81 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.642 0.777 . . . . 0.0 109.89 -173.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.8 m -119.62 86.57 35.08 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.088 0.955 . . . . 0.0 109.273 170.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -85.39 -168.35 0.49 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.693 2.262 . . . . 0.0 110.679 171.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -84.72 140.75 31.06 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 172.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.17 161.3 37.33 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 123.764 0.665 . . . . 0.0 111.788 -175.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.53 58.21 4.68 Favored Glycine 0 C--N 1.348 1.197 0 C-N-CA 123.134 0.397 . . . . 0.0 112.557 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -130.91 99.38 4.89 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 36.5 m0 -113.13 145.5 40.82 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.427 0.691 . . . . 0.0 109.432 -177.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.75 117.41 28.59 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -176.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.9 168.87 26.44 Favored Glycine 0 C--O 1.239 0.46 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 170.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.58 ' HB2' HD11 ' A' ' 32' ' ' LEU . 41.6 tt0 -149.79 146.71 27.32 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.889 0.476 . . . . 0.0 110.207 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -104.59 -177.5 3.38 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.625 0.726 . . . . 0.0 112.34 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.77 -33.54 73.11 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.337 1.455 . . . . 0.0 109.683 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -58.85 -25.76 63.57 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.181 1.392 . . . . 0.0 112.051 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.21 -11.72 71.25 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.889 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.1 mt -72.54 131.23 42.23 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 123.742 0.817 . . . . 0.0 109.202 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -117.53 160.94 20.41 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.958 0.903 . . . . 0.0 110.156 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -173.56 155.7 22.7 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.646 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 46.1 p-90 -70.68 152.35 43.95 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.321 0.648 . . . . 0.0 110.958 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -134.08 138.01 29.57 Favored Pre-proline 0 C--O 1.243 0.745 0 C-N-CA 123.979 0.912 . . . . 0.0 109.101 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.473 ' HB2' ' HB2' ' A' ' 56' ' ' TYR . 9.1 Cg_exo -71.49 113.07 3.51 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.768 2.312 . . . . 0.0 110.378 172.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.99 -32.5 73.77 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.56 0.744 . . . . 0.0 112.11 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.3 t -73.45 -17.64 61.22 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.846 0.458 . . . . 0.0 111.576 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.473 ' HB2' ' HB2' ' A' ' 53' ' ' PRO . 35.1 t80 -75.67 -35.48 60.36 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.712 0.805 . . . . 0.0 110.383 -177.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.9 m -111.81 166.5 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.9 0.88 . . . . 0.0 110.765 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -83.24 125.4 31.53 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 63.9 mt -84.51 141.82 30.48 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.655 0.382 . . . . 0.0 110.529 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.711 ' HB2' ' HB2' ' A' ' 5' ' ' ARG . 96.5 mt . . . . . 0 C--O 1.253 1.255 0 C-N-CA 123.955 0.902 . . . . 0.0 108.877 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.364 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.02 99.5 0.87 Allowed 'General case' 0 C--N 1.35 0.621 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -117.55 156.08 28.69 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.418 0.687 . . . . 0.0 110.068 -176.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.9 m -139.44 156.2 47.11 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.609 1.164 . . . . 0.0 108.659 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -107.39 148.78 28.66 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.661 0.784 . . . . 0.0 109.222 176.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.0 p -91.26 130.17 37.16 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 122.82 0.448 . . . . 0.0 110.557 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.2 mt -63.09 -64.03 1.03 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.299 1.04 . . . . 0.0 111.02 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -129.29 158.41 73.16 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 123.988 0.915 . . . . 0.0 108.949 -177.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.653 ' HD3' ' HB2' ' A' ' 25' ' ' ALA . 72.7 Cg_endo -73.68 98.07 1.02 Allowed 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.067 1.845 . . . . 0.0 110.987 176.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -90.8 100.23 13.12 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.7 m -96.98 75.82 2.67 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.911 0.885 . . . . 0.0 109.788 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -134.51 153.67 21.13 Favored Glycine 0 C--O 1.244 0.757 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.611 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 56.64 73.5 0.45 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.268 1.027 . . . . 0.0 110.217 -175.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -85.81 32.35 0.6 Allowed 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.439 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -169.06 159.76 9.42 Favored 'General case' 0 C--O 1.247 0.936 0 C-N-CA 124.984 1.313 . . . . 0.0 108.84 -170.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.61 -123.31 19.32 Favored Glycine 0 C--N 1.344 0.993 0 O-C-N 123.388 0.43 . . . . 0.0 113.685 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -94.48 5.56 51.45 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.859 0.864 . . . . 0.0 112.267 -174.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.1 126.4 8.28 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.271 0.357 . . . . 0.0 112.877 -177.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.0 tp -105.23 117.75 34.81 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 173.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -87.39 149.42 24.48 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.124 0.97 . . . . 0.0 110.239 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -158.44 153.13 24.72 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.718 0.807 . . . . 0.0 110.814 -177.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.14 169.22 11.03 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.484 1.114 . . . . 0.0 110.667 172.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.653 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . . . -61.06 125.71 24.7 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.279 0.631 . . . . 0.0 111.191 175.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.03 -4.71 65.54 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-O 119.203 -0.776 . . . . 0.0 114.116 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -52.39 120.0 5.07 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.037 0.935 . . . . 0.0 111.702 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.4 mt -82.52 99.62 9.6 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 48.9 mm -88.43 111.04 21.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 124.454 1.102 . . . . 0.0 108.079 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.5 m -87.51 107.48 18.59 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.553 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.51 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 41.4 mt -65.01 134.87 54.83 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.635 0.774 . . . . 0.0 109.624 175.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.2 mt -75.34 -47.77 26.19 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.276 0.631 . . . . 0.0 109.736 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -141.19 159.43 42.23 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.528 1.131 . . . . 0.0 108.396 174.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.0 m -119.59 84.81 31.09 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 171.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -72.07 169.27 21.81 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.761 2.307 . . . . 0.0 111.254 175.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -70.55 96.99 1.24 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.385 0.674 . . . . 0.0 110.019 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.95 173.56 23.15 Favored Glycine 0 C--N 1.344 0.985 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.808 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -91.99 28.6 8.46 Favored Glycine 0 C--N 1.345 1.052 0 C-N-CA 122.853 0.263 . . . . 0.0 113.12 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -127.16 116.71 21.06 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.571 1.148 . . . . 0.0 108.052 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 8.7 m0 -128.89 139.32 52.19 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -91.53 119.27 31.32 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' A' ' 31' ' ' LEU . . . -110.44 136.34 13.52 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.236 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -104.11 141.17 36.7 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.181 0.593 . . . . 0.0 109.971 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.433 ' HG2' ' H ' ' A' ' 46' ' ' ASP . 88.7 tttt -93.97 160.3 14.78 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.712 1.205 . . . . 0.0 109.565 177.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.88 -24.55 52.66 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.449 1.1 . . . . 0.0 111.977 175.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.433 ' H ' ' HG2' ' A' ' 44' ' ' LYS . 15.1 t70 -60.35 -36.11 77.24 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.105 1.362 . . . . 0.0 111.95 175.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.78 -20.19 22.59 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 116.252 -0.431 . . . . 0.0 112.458 -177.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -76.63 134.17 39.4 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -119.27 139.83 51.26 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.34 1.056 . . . . 0.0 109.459 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -133.18 150.63 19.86 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 178.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 48.7 m95 -82.8 130.2 35.1 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.105 0.962 . . . . 0.0 108.999 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -140.07 151.71 65.67 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 122.973 0.509 . . . . 0.0 111.289 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -65.88 158.89 51.57 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.982 2.455 . . . . 0.0 112.043 168.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.96 -36.76 82.93 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.0 0.92 . . . . 0.0 111.861 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.7 t -79.66 -14.63 58.65 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.894 0.878 . . . . 0.0 111.71 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -71.93 -29.22 64.07 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.386 0.674 . . . . 0.0 110.519 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.1 m -111.72 172.67 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.253 1.021 . . . . 0.0 109.857 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -113.93 126.22 54.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.02 0.928 . . . . 0.0 109.478 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 75.0 mt -69.73 140.7 53.52 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.295 0.638 . . . . 0.0 109.925 176.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 CA--C 1.556 1.188 0 C-N-CA 123.243 0.617 . . . . 0.0 110.751 -179.369 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.926 0 CA-C-O 121.112 0.284 . . . . 0.0 112.743 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.65 ' HB1' ' HB2' ' A' ' 31' ' ' LEU . . . -78.43 83.35 4.65 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.492 0.717 . . . . 0.0 111.175 -175.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -127.99 134.45 49.26 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.143 0.977 . . . . 0.0 110.098 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.701 ' SG ' HD11 ' A' ' 31' ' ' LEU . 89.4 m -139.73 146.33 39.43 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.996 0.918 . . . . 0.0 108.65 165.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -105.43 137.97 42.38 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.1 p -70.59 119.21 14.41 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.169 0.988 . . . . 0.0 110.27 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.8 -56.8 7.81 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.484 0.713 . . . . 0.0 110.61 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -134.66 155.02 79.85 Favored Pre-proline 0 N--CA 1.482 1.14 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.487 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . 72.0 Cg_endo -73.04 88.07 0.97 Allowed 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.059 1.84 . . . . 0.0 111.993 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -91.83 100.15 12.89 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.9 t -160.63 84.81 0.7 Allowed 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.46 -3.15 88.72 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.846 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.35 105.42 8.52 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.45 1.1 . . . . 0.0 109.218 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -69.92 84.22 0.49 Allowed 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.859 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 78.8 m80 63.9 14.24 8.22 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.117 1.367 . . . . 0.0 112.721 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.77 66.98 1.89 Allowed Glycine 0 C--N 1.35 1.329 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 61.4 79.94 0.24 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.372 1.069 . . . . 0.0 110.551 -175.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.02 -176.69 39.99 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.807 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' A' ' 44' ' ' LYS . 32.4 tp -107.37 123.35 48.24 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.228 0.611 . . . . 0.0 109.737 -176.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -94.84 118.19 31.37 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -154.23 173.05 16.65 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.198 0.599 . . . . 0.0 111.301 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.487 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . . . -128.3 157.27 41.42 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.597 1.159 . . . . 0.0 109.376 175.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.14 134.59 55.15 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.511 0.724 . . . . 0.0 111.621 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.63 -14.31 29.81 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 123.334 0.396 . . . . 0.0 113.365 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -81.88 142.38 32.55 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.125 0.57 . . . . 0.0 111.819 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.466 HD12 HD11 ' A' ' 60' ' ' LEU . 1.9 mm? -95.37 105.18 17.11 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.299 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.6 mm -85.02 116.42 28.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.5 m -77.34 111.58 13.16 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.219 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.701 HD11 ' SG ' ' A' ' 6' ' ' CYS . 34.4 mt -70.46 139.46 51.73 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 123.867 0.729 . . . . 0.0 111.716 -171.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.524 ' HB2' ' HG3' ' A' ' 41' ' ' GLU . 70.3 mt -101.17 -30.99 11.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.632 0.773 . . . . 0.0 109.458 174.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.542 ' HG3' ' HG2' ' A' ' 41' ' ' GLU . 70.9 mt-30 -97.12 149.71 21.67 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.344 0.657 . . . . 0.0 110.854 172.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.6 m -142.93 54.64 3.43 Favored Pre-proline 0 CA--C 1.578 2.046 0 C-N-CA 124.81 1.244 . . . . 0.0 110.292 173.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 33' ' ' GLN . 63.7 Cg_endo -81.58 -170.24 0.94 Allowed 'Trans proline' 0 C--N 1.391 2.77 0 C-N-CA 122.754 2.302 . . . . 0.0 112.297 -175.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -74.6 77.76 1.99 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.922 0.889 . . . . 0.0 109.645 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.78 -128.16 45.95 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.198 -174.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.21 -87.1 0.19 Allowed Glycine 0 C--N 1.349 1.279 0 C-N-CA 123.109 0.385 . . . . 0.0 112.947 175.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.8 OUTLIER -149.69 165.97 30.75 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.424 0.69 . . . . 0.0 110.482 -174.755 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -140.77 134.21 29.9 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.643 0.777 . . . . 0.0 109.147 173.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.542 ' HG2' ' HG3' ' A' ' 33' ' ' GLN . 10.6 pt-20 -91.34 160.53 15.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 163.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.55 178.33 41.57 Favored Glycine 0 C--O 1.243 0.673 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.646 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -104.79 139.96 38.79 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.787 0.835 . . . . 0.0 110.613 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.615 ' HB2' HD11 ' A' ' 21' ' ' LEU . 10.1 tmtt? -95.64 156.98 16.1 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.159 1.384 . . . . 0.0 107.61 176.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.553 ' H ' ' HD3' ' A' ' 44' ' ' LYS . 38.6 mm-40 -55.44 -33.98 64.06 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -177.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.85 -14.24 62.65 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.05 0.54 . . . . 0.0 112.367 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.08 -9.27 59.63 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.881 -174.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.3 tp -65.24 127.75 32.99 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 123.812 0.845 . . . . 0.0 109.538 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -104.81 131.88 51.74 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.662 0.785 . . . . 0.0 109.059 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.503 ' HA3' ' HB2' ' A' ' 21' ' ' LEU . . . -149.29 173.96 28.99 Favored Glycine 0 C--N 1.336 0.577 0 O-C-N 123.35 0.406 . . . . 0.0 112.343 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 41' ' ' GLU . 51.3 p-90 -141.79 142.24 33.2 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.916 0.887 . . . . 0.0 109.79 -173.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -157.01 149.94 18.43 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 123.905 0.882 . . . . 0.0 110.205 175.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 39' ' ' TRP . 82.7 Cg_exo -51.26 165.98 0.5 Allowed 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.462 2.775 . . . . 0.0 114.652 167.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.4 -15.55 49.72 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.416 1.086 . . . . 0.0 112.832 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.3 m -69.17 -21.79 63.96 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.006 0.923 . . . . 0.0 112.2 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -98.72 -47.75 5.21 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.515 0.726 . . . . 0.0 109.702 -175.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.7 m -112.09 130.11 66.35 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.696 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -123.57 126.7 47.12 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.779 0.832 . . . . 0.0 110.577 -171.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.538 HD23 ' SG ' ' A' ' 6' ' ' CYS . 90.3 mt -52.71 133.24 36.85 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.2 1.0 . . . . 0.0 111.862 177.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.466 HD11 HD12 ' A' ' 28' ' ' LEU . 7.1 mp . . . . . 0 C--O 1.252 1.214 0 C-N-CA 123.203 0.601 . . . . 0.0 110.987 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.611 0 N-CA-C 112.104 -0.398 . . . . 0.0 112.104 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.401 ' HB3' ' HB2' ' A' ' 31' ' ' LEU . . . -72.68 87.39 1.25 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 171.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -80.17 142.01 35.14 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.168 -176.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.573 ' HB3' ' HB ' ' A' ' 57' ' ' VAL . 71.6 m -133.08 141.27 48.11 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 172.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -106.63 127.39 53.31 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.466 HG21 ' HB2' ' A' ' 23' ' ' PHE . 37.6 p -68.81 130.39 42.68 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.933 0.893 . . . . 0.0 111.158 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.56 HD21 ' HB2' ' A' ' 58' ' ' GLN . 79.7 mt -86.28 -34.93 20.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.56 1.144 . . . . 0.0 110.474 -177.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -135.73 145.27 52.37 Favored Pre-proline 0 N--CA 1.487 1.389 0 C-N-CA 123.383 0.673 . . . . 0.0 110.453 -175.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . 63.4 Cg_endo -73.05 126.97 11.64 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.385 2.057 . . . . 0.0 110.71 166.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -150.34 133.52 16.25 Favored 'General case' 0 C--O 1.244 0.816 0 C-N-CA 122.947 0.499 . . . . 0.0 109.932 -174.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.3 m 65.81 117.79 0.03 OUTLIER 'General case' 0 C--N 1.36 1.055 0 C-N-CA 125.522 1.529 . . . . 0.0 112.151 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.85 29.91 1.68 Allowed Glycine 0 C--N 1.342 0.863 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 173.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -96.63 160.94 14.11 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.696 0.798 . . . . 0.0 110.559 -171.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -94.79 62.25 2.67 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.034 0.934 . . . . 0.0 109.674 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -79.35 -23.11 43.61 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.334 173.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 122.67 -118.86 3.74 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -77.09 134.36 38.77 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.985 0.514 . . . . 0.0 110.452 177.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.66 165.78 18.14 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.679 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.3 tp -105.81 121.58 44.33 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.272 0.558 . . . . 0.0 109.563 176.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -104.98 154.98 19.38 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.084 1.354 . . . . 0.0 107.945 177.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.466 ' HB2' HG21 ' A' ' 8' ' ' THR . 48.0 p90 -155.51 159.57 39.86 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -175.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . . . -135.36 143.24 45.97 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.556 1.543 . . . . 0.0 108.55 176.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.01 118.03 3.95 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 124.122 0.889 . . . . 0.0 111.748 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.03 7.0 22.08 Favored Glycine 0 CA--C 1.536 1.403 0 O-C-N 123.746 0.654 . . . . 0.0 113.267 -176.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -95.81 145.66 25.17 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.471 0.708 . . . . 0.0 110.529 171.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.504 HD22 HD11 ' A' ' 60' ' ' LEU . 48.0 mt -109.3 104.93 14.14 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.073 0.949 . . . . 0.0 109.381 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.9 mp -90.78 131.73 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.0 m -85.5 109.07 18.23 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.542 0.737 . . . . 0.0 109.428 177.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.486 HD11 ' SG ' ' A' ' 6' ' ' CYS . 84.6 mt -66.15 115.81 6.55 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.419 HD11 ' HB3' ' A' ' 43' ' ' GLU . 84.7 mt -76.55 -31.19 57.43 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.331 0.652 . . . . 0.0 111.533 -177.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.573 ' HG2' ' HD3' ' A' ' 35' ' ' PRO . 9.4 tt0 -137.58 136.34 37.48 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -177.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.441 ' HA ' ' HD1' ' A' ' 40' ' ' TRP . 6.1 m -133.33 69.44 77.54 Favored Pre-proline 0 CA--C 1.559 1.324 0 C-N-CA 124.731 1.213 . . . . 0.0 109.503 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.573 ' HD3' ' HG2' ' A' ' 33' ' ' GLN . 65.7 Cg_endo -81.15 -22.27 6.05 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.981 2.454 . . . . 0.0 112.881 -171.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -161.55 145.37 12.76 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.161 1.385 . . . . 0.0 107.949 -171.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -81.57 59.75 4.8 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 123.6 0.562 . . . . 0.0 113.384 -177.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.28 -89.84 1.0 Allowed Glycine 0 C--N 1.352 1.431 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 1.9 p-90 -132.11 148.18 52.47 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.441 ' HD1' ' HA ' ' A' ' 34' ' ' VAL . 6.5 m-90 -131.83 160.08 36.67 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.129 0.49 . . . . 0.0 110.952 -167.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -93.65 151.68 19.5 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.028 172.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.16 -179.43 27.77 Favored Glycine 0 C--O 1.242 0.635 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.158 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB3' HD11 ' A' ' 32' ' ' LEU . 5.8 pt-20 -140.86 167.67 21.62 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.999 0.904 . . . . 0.0 112.292 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.585 ' HD3' ' N ' ' A' ' 45' ' ' GLU . 11.2 tmtt? -114.87 156.81 24.26 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 113.459 -1.701 . . . . 0.0 106.996 166.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.585 ' N ' ' HD3' ' A' ' 44' ' ' LYS . 35.8 mt-10 -46.81 -31.14 2.84 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 125.675 1.59 . . . . 0.0 113.638 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.92 1.42 12.83 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.203 1.001 . . . . 0.0 112.983 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.48 -1.62 85.97 Favored Glycine 0 C--N 1.352 1.423 0 C-N-CA 122.688 0.185 . . . . 0.0 112.789 -177.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.2 119.94 12.35 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.561 0.744 . . . . 0.0 110.379 -177.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -104.48 141.32 36.58 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.456 0.703 . . . . 0.0 109.282 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.07 152.15 22.15 Favored Glycine 0 C--N 1.341 0.854 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 174.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -119.22 128.28 54.06 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.464 1.106 . . . . 0.0 108.126 -178.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -133.72 137.81 29.56 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 123.27 0.628 . . . . 0.0 110.675 -172.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -56.03 152.27 37.81 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.3 2.667 . . . . 0.0 112.513 165.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.87 -15.5 62.0 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.328 1.051 . . . . 0.0 112.404 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.8 t -67.21 -26.59 66.68 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.266 0.626 . . . . 0.0 111.68 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -82.98 -30.56 28.11 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.974 0.51 . . . . 0.0 111.266 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 6' ' ' CYS . 15.6 m -134.45 124.86 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 123.254 0.622 . . . . 0.0 111.43 -168.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.56 ' HB2' HD21 ' A' ' 9' ' ' LEU . 6.6 tp-100 -80.75 130.86 35.31 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.337 0.655 . . . . 0.0 110.345 176.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.434 HD21 ' CZ3' ' A' ' 40' ' ' TRP . 81.9 mt -74.13 108.44 6.93 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.299 1.039 . . . . 0.0 111.252 -175.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.504 HD11 HD22 ' A' ' 28' ' ' LEU . 76.8 mt . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.626 -0.702 . . . . 0.0 109.816 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.155 0 CA-C-O 120.049 -0.306 . . . . 0.0 112.661 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.12 105.44 0.7 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.163 0.585 . . . . 0.0 110.269 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -109.02 172.57 6.77 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.465 ' SG ' ' HZ2' ' A' ' 51' ' ' TRP . 59.6 m -149.23 153.55 37.77 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.582 0.753 . . . . 0.0 110.409 -173.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.428 ' HG3' HD21 ' A' ' 60' ' ' LEU . 18.1 mtp180 -130.94 133.08 45.51 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.922 0.889 . . . . 0.0 109.262 175.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.5 p -78.84 122.13 25.69 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 173.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.557 HD21 ' HB2' ' A' ' 58' ' ' GLN . 87.9 mt -68.63 -47.04 67.66 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.016 0.527 . . . . 0.0 111.039 -174.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -144.53 155.24 57.06 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 124.863 1.265 . . . . 0.0 109.25 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.592 ' HD3' ' HB2' ' A' ' 25' ' ' ALA . 59.3 Cg_endo -83.06 167.57 14.07 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.545 2.163 . . . . 0.0 112.63 -174.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -120.02 100.09 7.01 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 173.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.4 m -98.47 84.06 3.13 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.116 0.566 . . . . 0.0 109.891 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.92 -164.53 36.6 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.74 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -82.15 118.0 22.73 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.406 1.082 . . . . 0.0 110.46 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -106.21 30.43 5.93 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.789 0.836 . . . . 0.0 109.973 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.5 m80 67.87 -76.06 0.06 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.883 1.673 . . . . 0.0 111.27 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.58 -86.17 0.05 OUTLIER Glycine 0 C--N 1.346 1.122 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -63.0 117.81 6.95 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.262 0.625 . . . . 0.0 110.756 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.89 -164.12 35.41 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.442 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.0 tp -137.51 142.51 41.46 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.008 0.923 . . . . 0.0 108.556 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -91.92 131.22 37.4 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 170.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -151.71 143.69 23.83 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.186 0.595 . . . . 0.0 112.001 -171.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.491 ' O ' ' HG2' ' A' ' 27' ' ' GLU . . . -87.88 170.95 10.72 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.915 1.286 . . . . 0.0 109.898 167.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.592 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . . . -71.44 112.4 7.53 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.959 -0.463 . . . . 0.0 110.474 172.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.09 17.46 7.78 Favored Glycine 0 N--CA 1.475 1.255 0 C-N-CA 123.139 0.399 . . . . 0.0 113.721 174.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 24' ' ' ALA . 10.2 mm-40 -69.75 125.32 26.39 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 122.678 0.391 . . . . 0.0 110.958 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.7 mt -85.42 101.95 13.04 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.838 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.6 mm -105.59 140.41 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.5 m -113.5 118.94 35.88 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.546 0.612 . . . . 0.0 109.73 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.419 ' HG ' ' SG ' ' A' ' 6' ' ' CYS . 68.8 mt -58.99 121.43 11.2 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 123.695 0.622 . . . . 0.0 110.784 177.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.479 HD11 ' HB2' ' A' ' 43' ' ' GLU . 80.9 mt -75.15 -46.61 33.14 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.017 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -155.23 166.02 34.85 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.936 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.3 m -120.63 81.56 32.64 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 124.084 0.954 . . . . 0.0 109.052 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -83.31 -21.5 4.43 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.53 2.154 . . . . 0.0 114.076 -172.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -155.43 142.99 19.63 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.337 0.655 . . . . 0.0 110.632 -168.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.85 61.02 4.12 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.532 0.52 . . . . 0.0 112.622 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.34 -53.33 0.04 OUTLIER Glycine 0 C--N 1.342 0.869 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 49.2 m95 -118.94 128.0 54.01 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 170.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.452 ' HE3' ' HZ3' ' A' ' 51' ' ' TRP . 15.5 m-90 -119.09 170.57 8.94 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -132.48 133.0 43.28 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.133 0.492 . . . . 0.0 111.147 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.8 168.4 19.81 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 114.612 -1.177 . . . . 0.0 110.821 173.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.479 ' HB2' HD11 ' A' ' 32' ' ' LEU . 29.2 tt0 -125.7 151.28 46.82 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.184 0.593 . . . . 0.0 109.801 -178.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.451 ' HE3' ' HB3' ' A' ' 27' ' ' GLU . 1.3 mmtp -89.95 163.12 15.09 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.392 1.077 . . . . 0.0 110.244 176.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -63.84 -24.53 67.79 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.71 0.804 . . . . 0.0 111.243 170.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.84 -23.31 65.01 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.366 1.066 . . . . 0.0 111.685 174.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.32 -21.29 37.77 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.095 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.5 133.59 35.85 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.213 0.605 . . . . 0.0 109.606 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 28.5 ptt85 -105.78 147.18 28.91 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.363 0.601 . . . . 0.0 110.175 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 173.44 150.32 7.43 Favored Glycine 0 C--O 1.243 0.703 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 174.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.465 ' HZ2' ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -156.31 171.67 19.82 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.707 0.765 . . . . 0.0 110.888 -173.314 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -147.15 150.37 38.02 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 125.27 1.428 . . . . 0.0 107.841 -173.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -42.28 147.85 0.47 Allowed 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 123.773 2.982 . . . . 0.0 113.681 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.448 ' H ' ' HZ3' ' A' ' 40' ' ' TRP . . . -57.19 -22.02 37.57 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.812 0.845 . . . . 0.0 112.974 -171.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.1 m -58.44 -28.39 65.24 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.34 1.056 . . . . 0.0 112.791 177.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -79.88 -29.61 40.01 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.7 0.8 . . . . 0.0 111.776 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.411 HG21 ' CZ2' ' A' ' 51' ' ' TRP . 23.7 m -123.86 -171.8 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 123.247 0.619 . . . . 0.0 112.078 -166.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.557 ' HB2' HD21 ' A' ' 9' ' ' LEU . 7.7 tp60 -120.61 139.75 52.53 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.0 1.32 . . . . 0.0 108.594 174.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.413 HD21 ' HH2' ' A' ' 51' ' ' TRP . 96.7 mt -104.35 119.71 39.57 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.439 0.696 . . . . 0.0 109.648 176.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.428 HD21 ' HG3' ' A' ' 7' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--O 1.253 1.241 0 C-N-CA 124.107 0.963 . . . . 0.0 108.789 175.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.582 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.16 114.35 13.76 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.495 1.118 . . . . 0.0 109.034 -174.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -129.22 154.62 46.61 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.324 1.05 . . . . 0.0 109.341 176.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.579 ' SG ' HD11 ' A' ' 31' ' ' LEU . 84.0 m -122.97 175.89 6.33 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.854 -1.067 . . . . 0.0 108.773 173.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -156.32 129.01 7.76 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.58 HG23 HD11 ' A' ' 29' ' ' ILE . 34.3 p -66.77 147.73 52.86 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.064 0.946 . . . . 0.0 111.393 -175.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.5 mt -80.23 -62.57 1.64 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.815 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -141.51 164.56 34.2 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 123.991 0.917 . . . . 0.0 109.706 -172.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.548 ' HG3' ' HB2' ' A' ' 25' ' ' ALA . 26.5 Cg_exo -62.4 121.45 9.44 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 122.727 2.284 . . . . 0.0 112.37 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -91.43 142.99 27.07 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.6 m -125.77 -72.33 0.66 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.981 0.513 . . . . 0.0 109.886 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.15 153.2 19.67 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -170.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -74.79 -32.71 62.09 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.484 0.713 . . . . 0.0 111.141 -176.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -163.04 131.06 3.74 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.802 0.841 . . . . 0.0 109.205 -177.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -163.56 115.05 1.42 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.189 0.996 . . . . 0.0 109.604 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.68 -47.97 88.52 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.246 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -155.49 148.31 24.31 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.537 0.735 . . . . 0.0 110.063 175.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -152.94 -164.83 12.81 Favored Glycine 0 C--O 1.241 0.57 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 171.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.6 tp -99.9 125.02 45.82 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 175.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.56 133.62 37.32 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.881 0.872 . . . . 0.0 110.986 -174.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -134.0 147.8 51.04 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.031 0.933 . . . . 0.0 108.568 170.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.64 166.57 12.74 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.633 0.773 . . . . 0.0 109.274 169.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.548 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -66.2 120.8 13.87 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.222 0.609 . . . . 0.0 110.169 176.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.75 17.08 80.21 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 123.287 0.367 . . . . 0.0 113.237 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.76 143.51 26.65 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.165 0.586 . . . . 0.0 109.466 179.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 mp -74.7 164.63 26.36 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.362 1.065 . . . . 0.0 111.499 -175.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.58 HD11 HG23 ' A' ' 8' ' ' THR . 4.1 mp -131.8 123.39 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 174.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.1 m -85.6 106.19 16.72 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.579 HD11 ' SG ' ' A' ' 6' ' ' CYS . 88.5 mt -77.42 106.13 8.99 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.982 0.513 . . . . 0.0 109.906 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.436 HD11 ' HB2' ' A' ' 43' ' ' GLU . 86.0 mt -83.37 -51.59 7.27 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.805 0.842 . . . . 0.0 109.776 -178.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.649 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 1.4 mp0 -106.48 146.62 30.34 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.692 0.797 . . . . 0.0 108.856 172.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.4 m -128.0 69.71 77.37 Favored Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 123.644 0.778 . . . . 0.0 110.232 172.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 40' ' ' TRP . 64.2 Cg_endo -71.25 132.2 20.53 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 122.392 2.061 . . . . 0.0 111.845 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.5 t70 60.91 -88.04 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.967 1.307 . . . . 0.0 112.074 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 161.11 40.55 0.02 OUTLIER Glycine 0 C--N 1.344 0.978 0 O-C-N 122.912 0.133 . . . . 0.0 112.838 -173.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.24 -86.64 0.07 OUTLIER Glycine 0 C--N 1.348 1.225 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 18.1 m95 -82.88 114.53 21.25 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.569 ' HZ3' HD21 ' A' ' 59' ' ' LEU . 18.6 m0 -113.32 144.86 42.03 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.409 0.684 . . . . 0.0 110.061 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.649 ' HB2' ' HB2' ' A' ' 33' ' ' GLN . 39.7 mt-10 -91.71 122.03 33.89 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.786 0.834 . . . . 0.0 109.841 -175.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.25 169.62 20.51 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.039 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.436 ' HB2' HD11 ' A' ' 32' ' ' LEU . 35.5 tt0 -124.09 154.22 40.29 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.972 0.909 . . . . 0.0 108.886 177.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.634 ' HE3' ' HA ' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -129.84 172.83 11.25 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 122.967 0.507 . . . . 0.0 109.958 173.819 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.478 ' HG2' ' HE2' ' A' ' 44' ' ' LYS . 6.3 mm-40 -67.09 -10.57 51.45 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.466 1.106 . . . . 0.0 111.46 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -55.29 -25.6 35.08 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.865 1.266 . . . . 0.0 111.541 168.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.32 -24.15 32.78 Favored Glycine 0 C--N 1.354 1.552 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 177.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.58 173.99 7.76 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.725 0.81 . . . . 0.0 110.602 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 38.2 mtm-85 -123.54 157.59 33.28 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.122 0.969 . . . . 0.0 108.645 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.99 154.2 25.32 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.586 ' HB3' ' HG2' ' A' ' 41' ' ' GLU . 4.8 p-90 -111.34 126.8 55.3 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -138.25 148.24 58.89 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.879 0.872 . . . . 0.0 109.319 -172.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.582 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 57.1 Cg_endo -69.68 142.87 49.45 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.302 2.001 . . . . 0.0 111.24 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.95 -23.06 66.14 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.925 0.89 . . . . 0.0 110.758 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.5 m -64.71 -40.03 94.66 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.267 1.027 . . . . 0.0 111.622 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.582 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 17.3 t80 -74.01 -32.89 63.57 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 121.316 0.579 . . . . 0.0 110.996 -173.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.6 m -104.54 -169.14 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.345 1.058 . . . . 0.0 108.899 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -141.18 130.94 24.21 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.729 0.412 . . . . 0.0 110.263 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.569 HD21 ' HZ3' ' A' ' 40' ' ' TRP . 94.8 mt -71.57 141.75 50.04 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.662 0.785 . . . . 0.0 111.552 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.7 mt . . . . . 0 C--O 1.244 0.806 0 C-N-CA 124.14 0.976 . . . . 0.0 109.848 -179.956 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.539 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.79 137.49 47.67 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.37 0.668 . . . . 0.0 109.541 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -161.13 172.8 16.13 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.39 0.615 . . . . 0.0 111.501 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.641 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 20.6 p -141.41 171.82 13.54 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.315 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.461 ' HB2' HD21 ' A' ' 60' ' ' LEU . 28.2 tpt85 -117.51 128.64 55.18 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.742 1.217 . . . . 0.0 109.272 -172.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.0 p -80.15 112.68 17.7 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.366 0.666 . . . . 0.0 109.326 173.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.94 -58.98 3.21 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.348 0.659 . . . . 0.0 110.762 -175.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -137.36 156.64 75.07 Favored Pre-proline 0 N--CA 1.488 1.434 0 C-N-CA 123.617 0.767 . . . . 0.0 109.69 -175.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . 44.9 Cg_endo -66.22 125.31 13.83 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.532 2.155 . . . . 0.0 112.381 175.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -92.86 121.33 34.11 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.127 0.971 . . . . 0.0 108.599 176.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.7 t -124.76 -161.99 1.06 Allowed 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 175.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 161.52 -35.61 0.39 Allowed Glycine 0 C--N 1.339 0.74 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 66.67 2.98 2.76 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.4 1.08 . . . . 0.0 112.877 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -82.11 -41.74 20.1 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.217 1.007 . . . . 0.0 109.261 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 20.8 m80 -84.91 119.16 25.04 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.168 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.38 -52.32 36.47 Favored Glycine 0 C--N 1.346 1.088 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 171.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -122.59 144.02 49.37 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.571 1.149 . . . . 0.0 109.438 173.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.19 159.56 10.11 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.54 HD11 ' HD3' ' A' ' 44' ' ' LYS . 16.9 tp -88.25 132.71 34.27 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 117.971 0.886 . . . . 0.0 108.773 -177.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -123.47 169.21 11.62 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.389 1.076 . . . . 0.0 109.031 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -123.54 113.34 18.58 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.612 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . . . -95.73 160.45 14.48 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 173.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.83 128.07 34.59 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.312 0.645 . . . . 0.0 111.121 -170.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.16 -30.81 6.33 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-O 119.305 -0.719 . . . . 0.0 113.927 176.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -61.57 130.84 47.89 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 117.665 0.733 . . . . 0.0 112.039 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 61.3 mt -99.25 103.32 15.17 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 175.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.641 ' HB ' ' SG ' ' A' ' 6' ' ' CYS . 21.9 mm -88.07 109.2 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -169.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.2 m -74.38 109.54 7.95 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.481 0.488 . . . . 0.0 110.622 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.8 mt -69.81 104.34 2.43 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.849 -0.796 . . . . 0.0 108.849 175.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 70.5 mt -74.16 -30.63 62.34 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.658 0.783 . . . . 0.0 110.032 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -127.11 136.34 51.99 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.223 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.1 m -129.75 90.39 43.47 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.768 1.227 . . . . 0.0 108.576 175.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.62 -155.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.691 2.261 . . . . 0.0 110.926 177.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -63.21 -31.98 73.26 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.031 0.532 . . . . 0.0 111.171 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.34 -163.59 29.91 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 116.417 -0.356 . . . . 0.0 112.218 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.58 -76.49 2.1 Favored Glycine 0 C--N 1.345 1.04 0 C-N-CA 123.458 0.551 . . . . 0.0 112.11 177.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -114.41 132.52 56.21 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.304 0.642 . . . . 0.0 109.475 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -117.67 153.39 33.41 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.435 0.694 . . . . 0.0 109.432 173.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -91.69 120.4 32.41 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 173.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -123.03 135.47 10.04 Favored Glycine 0 C--N 1.342 0.874 0 O-C-N 123.379 0.425 . . . . 0.0 112.71 -175.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.573 ' HA ' ' HG2' ' A' ' 49' ' ' ARG . 10.6 tp10 -105.04 140.96 37.45 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.371 1.069 . . . . 0.0 110.228 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.615 ' HG2' HD12 ' A' ' 29' ' ' ILE . 22.3 mtpt -124.53 157.53 35.11 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.797 0.839 . . . . 0.0 110.27 176.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.81 0.68 26.07 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.42 0.688 . . . . 0.0 111.326 174.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.56 -27.66 68.6 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.423 1.089 . . . . 0.0 110.159 168.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.66 -17.21 57.85 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.011 -176.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -98.66 154.84 17.65 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.857 0.863 . . . . 0.0 110.119 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.573 ' HG2' ' HA ' ' A' ' 43' ' ' GLU . 72.1 mtm180 -124.62 169.04 12.33 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.488 1.115 . . . . 0.0 109.499 170.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.91 173.15 39.09 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.55 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -111.71 125.26 53.78 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -151.57 147.12 19.64 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 124.23 1.012 . . . . 0.0 109.492 -175.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -83.31 178.75 5.53 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.255 2.637 . . . . 0.0 111.539 172.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.02 -14.09 61.06 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.008 0.923 . . . . 0.0 112.046 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -59.68 -19.62 50.81 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.565 1.146 . . . . 0.0 113.155 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -113.05 -16.05 12.71 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.657 0.783 . . . . 0.0 111.868 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.15 136.22 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 122.973 0.509 . . . . 0.0 111.324 -172.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -91.87 112.79 24.85 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.765 0.826 . . . . 0.0 109.782 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.59 123.37 18.64 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.056 0.542 . . . . 0.0 110.764 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.461 HD21 ' HB2' ' A' ' 7' ' ' ARG . 86.7 mt . . . . . 0 CA--C 1.55 0.952 0 C-N-CA 123.747 0.819 . . . . 0.0 110.745 -177.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.833 0 CA-C-O 119.84 -0.422 . . . . 0.0 112.317 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.89 132.54 54.26 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.549 1.14 . . . . 0.0 110.721 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -142.46 153.43 43.67 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.478 0.711 . . . . 0.0 110.959 -172.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.462 ' SG ' HD11 ' A' ' 31' ' ' LEU . 81.2 m -139.15 148.89 43.82 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.875 1.27 . . . . 0.0 108.967 175.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -108.14 152.35 24.67 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.454 0.702 . . . . 0.0 109.778 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.491 HG21 ' HB2' ' A' ' 23' ' ' PHE . 24.5 p -87.89 130.19 34.99 Favored 'General case' 0 C--O 1.242 0.711 0 C-N-CA 123.47 0.708 . . . . 0.0 110.464 173.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.5 mt -79.35 -53.5 6.87 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.249 1.019 . . . . 0.0 110.012 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -134.89 155.12 79.53 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 123.599 0.76 . . . . 0.0 109.574 -173.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.516 ' HD3' ' HB2' ' A' ' 25' ' ' ALA . 64.6 Cg_endo -78.71 85.37 1.86 Allowed 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 121.874 1.716 . . . . 0.0 110.646 170.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -92.7 101.18 13.58 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.092 -175.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.9 m -153.9 63.29 0.72 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.816 1.246 . . . . 0.0 107.905 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.26 -33.25 86.73 Favored Glycine 0 C--N 1.357 1.732 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.4 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -127.39 138.27 52.96 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.55 1.14 . . . . 0.0 108.555 170.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -66.55 -51.93 51.2 Favored 'General case' 0 CA--C 1.55 0.973 0 O-C-N 123.784 0.678 . . . . 0.0 109.615 176.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.4 t60 64.55 -77.52 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.423 1.489 . . . . 0.0 111.791 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 145.17 -66.46 0.43 Allowed Glycine 0 C--N 1.34 0.782 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -76.84 103.95 7.07 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.243 0.617 . . . . 0.0 109.823 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.74 -162.59 34.13 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.442 HD22 ' HA3' ' A' ' 50' ' ' GLY . 20.7 tp -143.24 120.04 11.22 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 176.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -77.46 120.94 23.15 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.491 ' HB2' HG21 ' A' ' 8' ' ' THR . 33.1 p90 -120.75 130.02 53.86 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.179 0.991 . . . . 0.0 110.104 -178.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -104.31 153.98 20.37 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.056 0.943 . . . . 0.0 110.488 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.516 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . . . -58.5 121.56 11.21 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.969 0.908 . . . . 0.0 111.99 -178.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.56 -23.96 16.56 Favored Glycine 0 C--N 1.347 1.164 0 C-N-CA 123.337 0.494 . . . . 0.0 113.661 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -60.9 128.48 36.69 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.552 0.741 . . . . 0.0 111.526 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.2 mt -96.24 125.13 40.54 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.8 mp -104.86 116.39 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 175.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.8 m -87.0 111.5 20.92 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.462 HD11 ' SG ' ' A' ' 6' ' ' CYS . 7.0 mp -65.69 115.96 6.4 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.044 0.938 . . . . 0.0 110.698 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.421 HD11 ' HB2' ' A' ' 43' ' ' GLU . 58.6 mt -84.72 -36.25 21.95 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.151 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -116.51 135.64 53.65 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.054 0.942 . . . . 0.0 109.309 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.5 m -143.71 66.41 15.22 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 124.046 0.938 . . . . 0.0 110.434 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.402 ' HD2' ' HD1' ' A' ' 40' ' ' TRP . 7.6 Cg_exo -77.03 -173.12 1.64 Allowed 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 123.211 2.607 . . . . 0.0 112.73 174.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -77.37 101.18 6.22 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.566 0.747 . . . . 0.0 110.548 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.72 -154.94 26.08 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 116.371 -0.377 . . . . 0.0 112.647 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.9 -28.67 4.1 Favored Glycine 0 C--N 1.346 1.129 0 N-CA-C 112.236 -0.346 . . . . 0.0 112.236 176.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -81.06 110.62 16.76 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.593 0.757 . . . . 0.0 109.512 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.402 ' HD1' ' HD2' ' A' ' 35' ' ' PRO . 7.0 m0 -125.36 138.75 54.05 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.741 0.817 . . . . 0.0 109.726 178.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.577 ' HG2' ' HB3' ' A' ' 51' ' ' TRP . 28.2 mt-10 -94.87 138.32 32.8 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.687 0.395 . . . . 0.0 110.496 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.13 171.01 27.16 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.412 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.421 ' HB2' HD11 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -127.83 148.22 50.45 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.124 0.57 . . . . 0.0 110.17 -169.759 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.467 ' HE3' ' HB3' ' A' ' 46' ' ' ASP . 39.7 mtmt -88.3 -173.22 4.11 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.605 1.562 . . . . 0.0 110.24 176.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -86.6 62.1 7.21 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 165.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.467 ' HB3' ' HE3' ' A' ' 44' ' ' LYS . 38.0 t70 -148.56 -47.75 0.15 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -168.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.64 -9.76 28.05 Favored Glycine 0 N--CA 1.473 1.136 0 CA-C-O 119.848 -0.418 . . . . 0.0 113.683 -174.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.58 130.99 45.86 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 117.544 0.672 . . . . 0.0 110.1 172.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -103.14 143.07 33.09 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.778 0.831 . . . . 0.0 109.446 -175.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.442 ' HA3' HD22 ' A' ' 21' ' ' LEU . . . -134.34 155.15 21.74 Favored Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 177.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.577 ' HB3' ' HG2' ' A' ' 41' ' ' GLU . 1.1 p-90 -99.66 132.19 45.17 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.995 0.918 . . . . 0.0 109.88 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -133.26 129.39 20.78 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 123.657 0.783 . . . . 0.0 109.446 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.65 151.98 83.05 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.3 2.0 . . . . 0.0 111.15 162.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.572 ' HB1' HD11 ' A' ' 59' ' ' LEU . . . -60.0 -26.47 66.08 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.473 1.109 . . . . 0.0 112.178 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.1 m -73.14 -16.79 61.44 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.829 0.852 . . . . 0.0 113.118 -177.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -96.8 -24.71 15.78 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.002 0.521 . . . . 0.0 111.992 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.2 m -116.89 151.73 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.113 0.565 . . . . 0.0 110.963 -173.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -81.17 103.85 11.25 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.78 0.832 . . . . 0.0 109.288 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.572 HD11 ' HB1' ' A' ' 54' ' ' ALA . 43.8 mt -67.77 115.1 6.94 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.1 mt . . . . . 0 C--O 1.25 1.104 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -177.546 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.77 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.533 ' HB3' ' HB2' ' A' ' 31' ' ' LEU . . . -77.08 106.8 9.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.453 0.701 . . . . 0.0 109.651 -177.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -78.64 142.24 37.37 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.751 0.42 . . . . 0.0 110.359 -176.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 76.7 m -138.75 159.56 41.81 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.985 0.914 . . . . 0.0 109.229 174.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.568 ' HB2' ' HB3' ' A' ' 58' ' ' GLN . 19.9 mmt180 -106.69 147.72 29.24 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.643 1.177 . . . . 0.0 108.688 176.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.543 HG21 ' HB2' ' A' ' 23' ' ' PHE . 21.8 p -94.68 118.16 31.28 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.098 175.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.476 HD21 ' HB2' ' A' ' 58' ' ' GLN . 86.0 mt -69.47 -50.62 43.68 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.945 0.498 . . . . 0.0 110.885 -177.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -135.2 148.29 65.87 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 123.569 0.748 . . . . 0.0 109.731 -178.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . 2.8 Cg_exo -74.9 121.68 6.77 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.792 2.328 . . . . 0.0 111.232 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -128.34 102.3 6.6 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.163 0.506 . . . . 0.0 109.89 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.1 m -153.22 30.61 0.48 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.874 1.27 . . . . 0.0 109.528 174.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.03 88.46 0.01 OUTLIER Glycine 0 C--N 1.356 1.644 0 O-C-N 124.44 1.088 . . . . 0.0 113.611 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 57.62 48.79 13.59 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.167 1.387 . . . . 0.0 110.347 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -98.9 80.11 2.46 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.055 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -90.99 -18.96 23.77 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.795 0.838 . . . . 0.0 111.106 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.56 -165.39 24.86 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.932 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -73.84 85.79 1.72 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.76 0.791 . . . . 0.0 110.627 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -164.64 143.4 8.49 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.721 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.595 HD11 ' HB3' ' A' ' 44' ' ' LYS . 27.0 tp -90.18 142.44 27.71 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.919 0.488 . . . . 0.0 110.822 -171.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -99.89 138.92 36.3 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.23 1.012 . . . . 0.0 110.655 -175.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.543 ' HB2' HG21 ' A' ' 8' ' ' THR . 28.1 p90 -154.16 121.98 5.93 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.592 0.757 . . . . 0.0 110.45 -174.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . . . -92.08 152.51 19.91 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.61 1.164 . . . . 0.0 109.654 171.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.409 ' H ' ' HG3' ' A' ' 11' ' ' PRO . . . -61.99 125.02 22.38 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.719 0.808 . . . . 0.0 111.922 -175.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.87 -20.65 17.1 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 123.643 0.589 . . . . 0.0 113.343 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -72.23 142.91 48.97 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 121.329 0.585 . . . . 0.0 112.219 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.61 111.12 19.25 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.303 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.4 mm -91.36 120.76 40.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 123.471 0.708 . . . . 0.0 109.636 174.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.6 m -85.74 103.85 14.9 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 91.2 mt -71.86 107.45 4.64 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 67.2 mt -75.39 -48.46 22.81 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.591 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -126.45 136.94 53.28 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.067 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.3 m -115.22 91.45 27.88 Favored Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 124.259 1.024 . . . . 0.0 108.929 176.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.62 -49.65 15.23 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 123.298 2.665 . . . . 0.0 112.889 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -164.09 -79.29 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.693 0.797 . . . . 0.0 109.5 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -161.4 149.47 18.26 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 -174.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.37 -61.49 2.86 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 116.577 0.189 . . . . 0.0 112.761 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 40.9 m95 -121.3 99.73 6.65 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.927 0.491 . . . . 0.0 109.786 -172.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -112.12 146.22 38.4 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -90.12 117.2 28.72 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.13 148.58 18.24 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.678 177.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -103.36 160.49 14.65 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.561 0.696 . . . . 0.0 109.816 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.595 ' HB3' HD11 ' A' ' 21' ' ' LEU . 2.0 tmtp? -132.73 155.94 47.93 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 170.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.44 ' H ' ' HD3' ' A' ' 44' ' ' LYS . 9.6 pt-20 -66.52 6.33 0.47 Allowed 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -67.78 -15.66 63.74 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.332 0.653 . . . . 0.0 111.49 168.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.49 -15.24 61.36 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 112.37 -0.292 . . . . 0.0 112.37 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.443 ' HB2' HD13 ' A' ' 21' ' ' LEU . 89.0 mt -96.63 163.03 13.19 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.629 0.772 . . . . 0.0 110.099 176.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 35.9 ttp-105 -119.98 155.75 32.22 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 169.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -150.52 161.47 28.98 Favored Glycine 0 C--N 1.336 0.577 0 N-CA-C 112.343 -0.303 . . . . 0.0 112.343 177.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -88.76 129.87 35.46 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 171.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 59.2 m-85 -108.35 137.22 19.87 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 123.324 0.65 . . . . 0.0 111.035 -173.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 52' ' ' PHE . 6.4 Cg_exo -73.66 124.04 9.0 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 123.086 2.524 . . . . 0.0 111.199 177.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.83 -45.08 86.72 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.744 1.218 . . . . 0.0 113.098 -171.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.3 t -75.98 -25.48 55.86 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.189 0.596 . . . . 0.0 111.12 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -85.77 -18.24 33.54 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.416 0.686 . . . . 0.0 111.167 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.3 m -108.99 147.31 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.094 0.558 . . . . 0.0 109.553 173.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.568 ' HB3' ' HB2' ' A' ' 7' ' ' ARG . 34.1 tt0 -87.64 115.01 24.78 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 174.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.2 mt -76.95 128.66 34.94 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.771 0.429 . . . . 0.0 110.155 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.2 mt . . . . . 0 C--O 1.249 1.066 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 176.475 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.11 0 CA-C-O 120.312 -0.16 . . . . 0.0 113.104 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 31' ' ' LEU . . . -75.91 86.97 2.87 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.871 0.868 . . . . 0.0 111.072 -173.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.419 ' HB2' ' HB2' ' A' ' 60' ' ' LEU . 93.6 mtt180 -110.28 151.78 26.96 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.352 1.061 . . . . 0.0 109.579 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.417 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 28.3 p -158.91 140.62 13.48 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.448 0.699 . . . . 0.0 109.154 171.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.524 ' HB2' HD11 ' A' ' 60' ' ' LEU . 40.2 ttp180 -112.68 130.4 56.06 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.287 0.635 . . . . 0.0 109.45 177.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 45.1 p -66.51 139.21 57.93 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 122.974 0.51 . . . . 0.0 111.468 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.41 HD21 ' HB2' ' A' ' 58' ' ' GLN . 86.0 mt -97.93 -22.53 16.27 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.328 1.051 . . . . 0.0 110.286 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -131.89 151.72 79.01 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 124.02 0.928 . . . . 0.0 109.574 -177.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.86 164.37 33.64 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.304 2.002 . . . . 0.0 111.366 169.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -93.65 102.79 14.98 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.3 p -69.56 120.18 14.95 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 123.222 0.609 . . . . 0.0 109.399 174.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.35 -179.01 48.16 Favored Glycine 0 C--N 1.342 0.894 0 O-C-N 123.595 0.559 . . . . 0.0 112.535 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -83.63 169.15 15.65 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.127 0.571 . . . . 0.0 109.482 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 55.9 mtp85 -56.63 -56.25 23.75 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.503 0.721 . . . . 0.0 111.143 178.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 69.3 t60 66.97 171.14 0.25 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.809 1.243 . . . . 0.0 112.526 169.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.72 -68.86 1.52 Allowed Glycine 0 C--N 1.351 1.391 0 CA-C-N 116.487 -0.324 . . . . 0.0 112.874 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -153.74 148.23 26.13 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.2 0.6 . . . . 0.0 111.278 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 168.81 -175.3 43.34 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.8 tp -90.21 114.13 26.07 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 121.572 0.701 . . . . 0.0 109.614 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -122.58 151.84 41.02 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 125.033 1.333 . . . . 0.0 107.768 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -156.18 152.42 27.83 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.184 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.473 ' O ' ' HG2' ' A' ' 27' ' ' GLU . . . -96.48 169.46 9.89 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.828 1.251 . . . . 0.0 109.027 165.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.09 111.63 3.48 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 122.12 -0.363 . . . . 0.0 110.064 171.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.26 19.8 6.15 Favored Glycine 0 C--N 1.351 1.375 0 N-CA-C 114.388 0.515 . . . . 0.0 114.388 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 24' ' ' ALA . 10.9 mm-40 -92.0 136.69 32.97 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 117.772 0.786 . . . . 0.0 111.138 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.8 mt -84.16 103.06 13.05 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.523 0.729 . . . . 0.0 109.902 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.417 ' HB ' ' SG ' ' A' ' 6' ' ' CYS . 47.5 mm -92.1 124.11 44.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.586 1.154 . . . . 0.0 109.491 176.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.0 m -88.46 107.29 18.79 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.167 0.987 . . . . 0.0 109.112 174.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.465 ' HB2' ' HB1' ' A' ' 4' ' ' ALA . 96.2 mt -70.98 111.98 6.78 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.409 ' H ' ' HA2' ' A' ' 42' ' ' GLY . 82.3 mt -80.46 -53.95 6.13 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 123.151 0.58 . . . . 0.0 109.488 -178.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.606 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 47.2 mt-30 -109.0 135.63 49.87 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.0 m -135.09 84.23 37.31 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 123.413 0.685 . . . . 0.0 110.205 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.12 161.72 37.97 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.583 2.189 . . . . 0.0 111.374 169.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -73.12 100.07 2.96 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.142 0.577 . . . . 0.0 110.11 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.18 -154.42 20.42 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.26 -16.21 23.55 Favored Glycine 0 N--CA 1.47 0.92 0 N-CA-C 112.101 -0.4 . . . . 0.0 112.101 172.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 53.9 m95 -92.14 119.22 31.59 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.272 1.029 . . . . 0.0 109.346 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.4 ' CZ3' HD21 ' A' ' 59' ' ' LEU . 5.2 m-90 -131.39 153.18 49.94 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.674 0.79 . . . . 0.0 109.781 178.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.606 ' HB3' ' HB2' ' A' ' 33' ' ' GLN . 3.1 tm-20 -102.79 132.33 49.03 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.409 ' HA2' ' H ' ' A' ' 32' ' ' LEU . . . -152.76 152.17 23.88 Favored Glycine 0 CA--C 1.508 -0.388 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.088 -177.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 49' ' ' ARG . 9.8 pt-20 -103.67 152.5 21.72 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.113 0.565 . . . . 0.0 110.125 173.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -78.68 154.42 30.17 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 157.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -73.6 16.51 0.2 Allowed 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -170.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -97.24 -1.11 45.53 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.671 1.188 . . . . 0.0 111.282 169.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.81 3.4 68.41 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-O 120.115 -0.269 . . . . 0.0 113.737 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.6 mt -91.25 114.98 27.64 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.541 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 12.6 ptt180 -116.97 165.73 13.01 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.864 0.466 . . . . 0.0 111.863 -173.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 177.7 171.47 41.18 Favored Glycine 0 C--N 1.348 1.239 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.797 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -94.98 128.19 41.6 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.45 0.7 . . . . 0.0 110.315 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -147.7 145.24 20.73 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 124.161 0.985 . . . . 0.0 109.766 175.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -78.4 176.6 9.73 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.685 2.257 . . . . 0.0 111.518 173.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.27 -21.46 61.93 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.038 175.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.9 m -53.22 -33.66 53.79 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.273 1.429 . . . . 0.0 113.471 -176.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -96.2 -18.0 20.39 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.104 0.562 . . . . 0.0 112.431 -176.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 35.8 m -120.03 174.39 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-O 121.411 0.624 . . . . 0.0 112.0 -171.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.41 ' HB2' HD21 ' A' ' 9' ' ' LEU . 22.5 tp60 -130.79 115.49 16.69 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.177 1.391 . . . . 0.0 107.819 174.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.4 HD21 ' CZ3' ' A' ' 40' ' ' TRP . 78.3 mt -63.03 126.37 27.11 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.929 0.768 . . . . 0.0 110.442 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 7' ' ' ARG . 80.2 mt . . . . . 0 C--O 1.252 1.194 0 C-N-CA 124.15 0.98 . . . . 0.0 108.791 -176.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.611 0 N-CA-C 111.984 -0.447 . . . . 0.0 111.984 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 31' ' ' LEU . . . -75.38 90.48 2.67 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.193 0.597 . . . . 0.0 110.406 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -81.39 123.46 28.58 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.171 0.988 . . . . 0.0 109.372 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 59' ' ' LEU . 48.6 t -124.14 155.7 37.97 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.223 0.535 . . . . 0.0 110.929 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -116.04 131.96 56.79 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.627 1.171 . . . . 0.0 109.175 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.54 ' HA ' HG12 ' A' ' 57' ' ' VAL . 16.5 p -77.37 121.29 23.56 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.488 0.715 . . . . 0.0 109.813 170.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.42 HD11 ' HG3' ' A' ' 58' ' ' GLN . 81.4 mt -73.06 -51.51 17.82 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.29 0.636 . . . . 0.0 109.676 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -137.8 152.85 73.22 Favored Pre-proline 0 N--CA 1.483 1.183 0 C-N-CA 123.662 0.785 . . . . 0.0 110.467 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.41 129.51 12.97 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.354 2.036 . . . . 0.0 111.72 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -117.22 101.6 8.58 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.4 t -92.75 -47.28 7.15 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.448 -171.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.79 -117.55 0.43 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -178.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 60.93 -74.34 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.621 1.568 . . . . 0.0 111.703 -177.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.481 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -79.91 -11.72 59.78 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.532 0.733 . . . . 0.0 111.942 -178.137 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -140.64 172.21 13.02 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.31 0.644 . . . . 0.0 110.476 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.72 -23.18 0.38 Allowed Glycine 0 C--N 1.346 1.123 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.081 175.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -125.28 21.94 7.89 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.769 0.827 . . . . 0.0 111.347 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.08 176.9 54.51 Favored Glycine 0 C--N 1.351 1.39 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 172.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.424 HD21 ' HG2' ' A' ' 44' ' ' LYS . 44.8 tp -89.87 124.79 35.0 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -79.49 136.96 37.05 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.549 0.74 . . . . 0.0 110.479 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -149.04 128.6 13.13 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.067 0.947 . . . . 0.0 109.245 177.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.8 150.82 20.28 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.3 1.04 . . . . 0.0 110.017 177.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.11 133.4 54.38 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.622 0.769 . . . . 0.0 111.716 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.56 -23.38 28.38 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 119.605 -0.553 . . . . 0.0 113.179 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -65.0 136.17 56.48 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-N 117.201 0.5 . . . . 0.0 111.69 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 73.9 mt -85.67 101.43 12.74 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.3 mm -88.62 111.18 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.929 0.891 . . . . 0.0 108.644 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.2 p -77.32 105.42 8.42 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.553 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 39.8 mt -67.56 142.19 56.59 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 173.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.8 mt -74.34 -43.04 58.32 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.968 0.507 . . . . 0.0 110.57 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -157.14 157.17 33.97 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.112 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.5 m -109.66 94.36 16.51 Favored Pre-proline 0 CA--C 1.557 1.24 0 C-N-CA 123.38 0.672 . . . . 0.0 110.944 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.42 ' HD2' ' CD1' ' A' ' 40' ' ' TRP . 79.3 Cg_endo -81.86 170.57 13.88 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.578 2.185 . . . . 0.0 111.174 167.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.4 143.84 54.94 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.108 0.48 . . . . 0.0 111.369 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.47 166.99 33.81 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.356 -177.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.0 55.26 4.98 Favored Glycine 0 C--N 1.348 1.199 0 C-N-CA 123.211 0.434 . . . . 0.0 112.584 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.401 ' HZ3' ' HG3' ' A' ' 53' ' ' PRO . 75.6 t-105 -143.79 114.76 7.81 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.437 1.095 . . . . 0.0 108.484 -177.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.42 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 12.9 m-90 -136.28 144.19 44.62 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.938 0.895 . . . . 0.0 109.712 -177.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -95.74 116.28 28.66 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 169.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 31' ' ' LEU . . . -108.76 143.76 16.28 Favored Glycine 0 C--N 1.337 0.635 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 49' ' ' ARG . 31.8 tt0 -115.52 136.9 52.61 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.007 0.523 . . . . 0.0 109.837 -178.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.424 ' HG2' HD21 ' A' ' 21' ' ' LEU . 30.2 mmmt -71.62 163.43 27.77 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.696 1.198 . . . . 0.0 109.787 170.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -64.71 -11.66 38.47 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.963 0.905 . . . . 0.0 112.685 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -89.22 -8.12 54.18 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.334 1.054 . . . . 0.0 112.49 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.43 -1.27 66.53 Favored Glycine 0 C--N 1.345 1.078 0 O-C-N 123.147 0.279 . . . . 0.0 112.842 -173.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.8 mt -83.05 104.99 13.67 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.665 0.786 . . . . 0.0 109.73 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 28.0 ptt180 -102.64 154.33 19.25 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -159.18 -178.28 33.04 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.908 -0.587 . . . . 0.0 113.062 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -77.05 129.58 36.26 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.24 1.016 . . . . 0.0 110.47 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -135.39 94.28 15.67 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 123.914 0.886 . . . . 0.0 109.617 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HG3' ' HZ3' ' A' ' 39' ' ' TRP . 11.8 Cg_exo -71.45 148.32 54.08 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.915 2.41 . . . . 0.0 110.37 168.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.41 ' HB2' ' HZ3' ' A' ' 40' ' ' TRP . . . -63.31 -19.54 64.69 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.21 0.604 . . . . 0.0 112.396 -178.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.5 m -62.32 -31.05 71.61 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.756 0.822 . . . . 0.0 111.631 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -98.71 -27.65 13.87 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.4 0.68 . . . . 0.0 111.586 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.581 ' HB ' ' SG ' ' A' ' 6' ' ' CYS . 26.1 m -138.79 139.34 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 122.94 0.496 . . . . 0.0 111.321 -174.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.42 ' HG3' HD11 ' A' ' 9' ' ' LEU . 53.1 mt-30 -128.82 133.16 47.92 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.546 0.738 . . . . 0.0 109.482 174.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.736 ' HA ' ' HA ' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -82.56 140.5 33.23 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.997 0.519 . . . . 0.0 112.312 -172.303 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 C--O 1.251 1.164 0 C-N-CA 124.772 1.229 . . . . 0.0 109.447 -178.114 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.703 0 N-CA-C 111.641 -0.583 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.89 76.31 1.16 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.849 0.86 . . . . 0.0 109.157 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.48 164.33 21.91 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.183 -173.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.447 ' SG ' HD23 ' A' ' 59' ' ' LEU . 78.2 m -145.12 166.86 24.18 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.981 0.913 . . . . 0.0 109.682 178.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.527 ' HG3' HD11 ' A' ' 60' ' ' LEU . 59.0 mtm180 -119.19 133.58 55.69 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.142 0.577 . . . . 0.0 109.98 175.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.603 HG23 HD11 ' A' ' 29' ' ' ILE . 8.9 p -73.45 121.65 20.87 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.428 0.455 . . . . 0.0 111.647 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.63 -15.98 27.73 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.788 0.835 . . . . 0.0 110.233 169.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -107.18 122.26 42.01 Favored Pre-proline 0 N--CA 1.48 1.073 0 C-N-CA 123.674 0.789 . . . . 0.0 110.58 171.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.408 ' HB3' ' N ' ' A' ' 25' ' ' ALA . 96.3 Cg_endo -83.44 49.93 3.1 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.928 2.418 . . . . 0.0 111.449 164.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -91.24 109.97 21.25 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -173.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.7 t -70.6 -21.37 62.67 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.524 1.13 . . . . 0.0 111.784 -177.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.35 -84.1 1.08 Allowed Glycine 0 C--N 1.347 1.185 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -171.86 161.33 5.8 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 124.999 1.32 . . . . 0.0 108.904 175.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -91.79 131.74 36.93 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 168.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -140.33 -64.22 0.47 Allowed 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.404 0.682 . . . . 0.0 109.495 -176.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.67 75.26 0.17 Allowed Glycine 0 C--N 1.346 1.106 0 CA-C-O 120.05 -0.305 . . . . 0.0 112.439 -175.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 66.29 21.71 10.97 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.549 1.14 . . . . 0.0 112.314 173.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.2 166.1 25.57 Favored Glycine 0 C--N 1.348 1.229 0 O-C-N 123.588 0.555 . . . . 0.0 113.591 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.46 HD11 ' HB2' ' A' ' 44' ' ' LYS . 27.5 tp -89.82 129.79 36.15 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.453 0.701 . . . . 0.0 109.492 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.25 161.14 19.44 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.964 1.306 . . . . 0.0 108.725 177.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -136.9 141.87 42.73 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.944 0.498 . . . . 0.0 111.741 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.62 169.96 10.1 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.777 1.231 . . . . 0.0 109.198 164.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.408 ' N ' ' HB3' ' A' ' 11' ' ' PRO . . . -72.72 115.92 12.58 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.94 19.9 8.77 Favored Glycine 0 N--CA 1.477 1.39 0 O-C-N 123.028 0.205 . . . . 0.0 113.483 177.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -72.85 149.99 43.06 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.917 0.487 . . . . 0.0 111.641 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.7 mt -106.37 108.1 19.44 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.603 HD11 HG23 ' A' ' 8' ' ' THR . 3.3 mp -103.21 107.79 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -175.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.0 m -75.8 108.06 8.4 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 173.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.24 123.51 19.73 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 123.704 0.628 . . . . 0.0 110.092 178.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.2 mt -73.84 -43.54 58.39 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.97 0.908 . . . . 0.0 109.12 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -126.45 155.46 42.19 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 124.912 1.285 . . . . 0.0 108.457 171.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.2 m -125.93 74.76 71.39 Favored Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 123.755 0.822 . . . . 0.0 110.939 176.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.39 164.38 35.38 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.427 2.084 . . . . 0.0 111.735 170.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -76.52 92.72 3.46 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.968 0.907 . . . . 0.0 109.85 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.93 -166.42 54.0 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-N 115.472 -0.785 . . . . 0.0 113.297 175.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.36 -104.24 1.02 Allowed Glycine 0 C--N 1.346 1.135 0 C-N-CA 123.74 0.685 . . . . 0.0 114.123 173.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -122.33 143.21 49.78 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.343 1.057 . . . . 0.0 109.901 -172.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.3 m-90 -124.57 145.31 49.66 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.169 0.988 . . . . 0.0 109.423 174.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -90.35 126.0 35.72 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 164.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.99 172.43 22.89 Favored Glycine 0 N--CA 1.467 0.766 0 O-C-N 123.621 0.575 . . . . 0.0 112.037 -176.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -131.87 145.13 51.35 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.228 0.537 . . . . 0.0 110.081 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.509 ' HG2' ' H ' ' A' ' 46' ' ' ASP . 64.9 tttp -71.75 154.8 41.08 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 164.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -64.41 -20.44 66.15 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.048 0.539 . . . . 0.0 111.856 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.509 ' H ' ' HG2' ' A' ' 44' ' ' LYS . 37.8 t70 -65.71 -20.36 66.25 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.166 0.987 . . . . 0.0 111.793 172.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.01 -16.13 30.58 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.196 176.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.3 mt -66.1 134.22 52.36 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 117.263 0.531 . . . . 0.0 110.501 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.9 mtt85 -113.38 142.54 45.75 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.287 1.035 . . . . 0.0 111.062 -174.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.17 154.91 25.94 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.646 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -96.05 127.57 42.18 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -146.76 148.77 34.31 Favored Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 124.18 0.992 . . . . 0.0 110.439 -173.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -84.82 -176.82 2.6 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.129 2.552 . . . . 0.0 111.911 174.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.39 -15.11 62.81 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.741 0.816 . . . . 0.0 111.926 176.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.5 m -55.45 -40.0 71.03 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.069 1.348 . . . . 0.0 113.335 -175.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -90.89 -29.05 17.72 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.999 0.52 . . . . 0.0 111.589 -175.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.55 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 35.3 m -105.39 -179.8 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.369 0.668 . . . . 0.0 110.52 -173.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -134.59 124.06 24.83 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.688 0.795 . . . . 0.0 109.128 175.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.447 HD23 ' SG ' ' A' ' 6' ' ' CYS . 74.0 mt -69.95 117.28 11.33 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.527 HD11 ' HG3' ' A' ' 7' ' ' ARG . 64.4 mt . . . . . 0 CA--C 1.548 0.879 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.516 0 CA-C-O 120.179 -0.234 . . . . 0.0 112.805 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.7 97.22 1.04 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 171.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.427 ' HB2' HD12 ' A' ' 60' ' ' LEU . 99.3 mtt180 -94.93 149.62 21.05 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.57 0.748 . . . . 0.0 110.57 -177.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.592 ' SG ' HD23 ' A' ' 59' ' ' LEU . 49.3 m -128.89 143.8 51.0 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 173.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -105.89 127.68 53.28 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 74.4 p -68.71 127.25 32.4 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 123.924 0.765 . . . . 0.0 109.558 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 58' ' ' GLN . 95.7 mt -70.1 -75.93 0.11 Allowed 'General case' 0 CA--C 1.537 0.468 0 O-C-N 123.459 0.474 . . . . 0.0 109.978 -177.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -151.37 137.92 11.59 Favored Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 123.634 0.774 . . . . 0.0 109.03 -177.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.37 95.53 0.61 Allowed 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.215 1.943 . . . . 0.0 111.756 175.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.52 ' HB2' ' HE1' ' A' ' 56' ' ' TYR . 52.9 m-85 -91.58 102.99 15.64 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 175.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.8 p -100.53 100.99 11.81 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.655 0.782 . . . . 0.0 109.073 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -155.84 18.36 0.49 Allowed Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.396 177.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -116.43 163.53 15.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.027 0.931 . . . . 0.0 109.813 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -70.35 161.51 30.31 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.737 0.415 . . . . 0.0 110.063 176.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 30.9 p80 -71.66 178.83 3.35 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.382 0.673 . . . . 0.0 111.285 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.11 89.94 2.09 Favored Glycine 0 C--N 1.343 0.923 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -174.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.8 58.89 2.25 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.871 1.268 . . . . 0.0 108.828 -176.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.45 99.92 1.83 Allowed Glycine 0 C--N 1.343 0.968 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 176.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.5 tp -88.53 127.73 35.54 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -177.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 49.3 ttt-85 -78.88 122.98 26.78 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -129.18 114.18 15.99 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.059 0.943 . . . . 0.0 109.208 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.56 143.74 51.49 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.49 0.716 . . . . 0.0 109.913 175.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.99 111.21 1.58 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.655 0.782 . . . . 0.0 111.572 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.22 3.64 24.29 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-O 119.096 -0.836 . . . . 0.0 114.794 173.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.63 127.3 32.47 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 118.232 1.016 . . . . 0.0 111.782 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.699 HD22 HD11 ' A' ' 60' ' ' LEU . 54.2 mt -85.37 102.15 13.18 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 175.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.595 HG21 ' HE1' ' A' ' 51' ' ' TRP . 34.8 mm -107.68 125.81 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.812 0.845 . . . . 0.0 109.448 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.1 m -81.77 136.95 35.4 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.542 0.737 . . . . 0.0 110.461 178.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.7 mt -76.71 129.4 36.28 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.846 0.858 . . . . 0.0 109.674 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.717 HD11 ' HG3' ' A' ' 43' ' ' GLU . 96.0 mt -77.02 -28.47 54.93 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.811 0.445 . . . . 0.0 110.631 174.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -155.01 147.7 24.34 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.823 0.849 . . . . 0.0 109.456 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.6 m -112.97 92.21 20.42 Favored Pre-proline 0 CA--C 1.559 1.299 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 166.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -68.58 -27.85 32.27 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.618 2.212 . . . . 0.0 111.908 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -175.85 -51.61 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.856 1.262 . . . . 0.0 109.169 175.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.93 176.84 28.53 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.851 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.25 -79.71 0.4 Allowed Glycine 0 C--N 1.347 1.153 0 N-CA-C 111.907 -0.477 . . . . 0.0 111.907 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -84.64 108.94 17.64 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.335 0.654 . . . . 0.0 109.565 171.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -113.16 178.18 4.37 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.059 0.944 . . . . 0.0 109.092 171.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 51' ' ' TRP . 0.9 OUTLIER -137.49 145.31 42.89 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.543 0.737 . . . . 0.0 109.36 173.272 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.514 ' HA2' ' HG ' ' A' ' 32' ' ' LEU . . . -154.48 178.57 31.2 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.794 -178.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.717 ' HG3' HD11 ' A' ' 32' ' ' LEU . 45.6 mt-10 -103.25 148.49 25.76 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.077 0.551 . . . . 0.0 109.799 176.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -112.83 145.09 41.24 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.693 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -69.29 -7.23 35.13 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.259 0.624 . . . . 0.0 112.432 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.69 -7.44 53.3 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.526 1.13 . . . . 0.0 111.878 172.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.76 -19.39 51.69 Favored Glycine 0 C--N 1.348 1.24 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 -177.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 65.0 mt -82.24 158.53 23.49 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.59 1.156 . . . . 0.0 110.25 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -120.53 177.76 4.93 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.898 0.879 . . . . 0.0 109.485 174.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.46 158.36 13.84 Favored Glycine 0 N--CA 1.467 0.714 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 -174.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.595 ' HE1' HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -156.06 173.24 17.1 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.494 0.664 . . . . 0.0 111.833 -171.829 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -125.54 167.16 17.32 Favored Pre-proline 0 N--CA 1.48 1.056 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.798 -173.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.36 170.52 9.31 Favored 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 122.213 1.942 . . . . 0.0 112.87 174.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.23 -15.23 56.4 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.494 1.118 . . . . 0.0 113.416 -175.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.3 p -62.51 -30.17 71.09 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.325 1.05 . . . . 0.0 113.062 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.52 ' HE1' ' HB2' ' A' ' 12' ' ' PHE . 85.1 m-85 -94.99 -6.56 42.06 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -176.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.6 m -135.39 -179.85 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 123.768 0.827 . . . . 0.0 110.397 -177.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.401 ' HB2' HD21 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -152.4 131.76 12.88 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 173.739 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.592 HD23 ' SG ' ' A' ' 6' ' ' CYS . 85.8 mt -65.32 133.98 52.58 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.764 0.826 . . . . 0.0 111.025 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.699 HD11 HD22 ' A' ' 28' ' ' LEU . 69.3 mt . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.896 -0.574 . . . . 0.0 109.572 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.5 ttm . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 m -75.35 -40.27 58.39 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.4 0.68 . . . . 0.0 110.36 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -130.69 164.69 23.04 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.062 176.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.404 ' HB3' HD11 ' A' ' 31' ' ' LEU . . . -76.98 127.26 32.38 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 122.969 0.507 . . . . 0.0 110.451 -177.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.645 ' HG3' ' HB2' ' A' ' 60' ' ' LEU . 35.2 ptt180 -86.68 157.38 19.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.87 0.868 . . . . 0.0 110.149 175.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 28.5 p -152.18 146.84 25.78 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.218 1.007 . . . . 0.0 108.921 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.414 ' HB2' HD11 ' A' ' 60' ' ' LEU . 61.9 ttt180 -106.07 125.57 51.16 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.524 HG22 HG12 ' A' ' 57' ' ' VAL . 49.6 p -72.27 140.01 48.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.49 0.716 . . . . 0.0 109.337 177.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mp -85.16 -74.46 0.4 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -144.89 100.39 4.61 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -69.8 101.34 0.9 Allowed 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 123.322 2.681 . . . . 0.0 112.103 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -92.88 161.65 14.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.314 0.646 . . . . 0.0 110.017 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.0 p -152.1 176.96 11.0 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.552 0.741 . . . . 0.0 110.555 -173.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -171.51 -50.94 0.04 OUTLIER Glycine 0 C--N 1.34 0.774 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -85.67 86.23 7.37 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 173.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -100.56 100.09 10.76 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -142.91 123.36 13.94 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.8 -145.95 33.23 Favored Glycine 0 C--N 1.345 1.06 0 O-C-N 123.571 0.545 . . . . 0.0 112.022 -174.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -94.77 60.57 2.51 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.745 0.818 . . . . 0.0 111.297 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.53 136.65 44.7 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-O 119.393 -0.671 . . . . 0.0 111.589 174.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.446 ' HB3' ' HE2' ' A' ' 52' ' ' PHE . 47.4 tp -85.98 114.03 22.55 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 117.363 0.581 . . . . 0.0 109.769 -169.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -99.83 116.73 32.58 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.341 0.657 . . . . 0.0 109.841 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -86.43 157.15 19.89 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.274 0.63 . . . . 0.0 109.387 172.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.75 154.48 19.88 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 169.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.26 133.9 46.43 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.02 0.528 . . . . 0.0 110.538 173.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.92 5.82 88.76 Favored Glycine 0 N--CA 1.475 1.27 0 O-C-N 123.305 0.378 . . . . 0.0 113.474 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -77.13 140.73 40.31 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.028 0.931 . . . . 0.0 111.268 -173.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.1 mt -91.06 104.48 17.06 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.514 0.725 . . . . 0.0 109.2 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.5 mm -117.82 130.62 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.006 1.323 . . . . 0.0 109.666 -176.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 87.7 m -90.45 138.52 31.49 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 171.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.404 HD11 ' HB3' ' A' ' 4' ' ' ALA . 1.4 pp -75.77 151.27 37.6 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.606 0.362 . . . . 0.0 110.692 174.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 93.6 mt -109.15 -2.41 18.06 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.016 0.926 . . . . 0.0 110.939 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.407 ' HG2' ' HD3' ' A' ' 35' ' ' PRO . 15.2 tt0 -143.48 152.54 41.61 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.51 56.15 21.29 Favored Pre-proline 0 CA--C 1.57 1.724 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.459 ' HD2' ' CD1' ' A' ' 40' ' ' TRP . 91.0 Cg_endo -77.16 126.29 8.46 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 121.727 1.618 . . . . 0.0 110.085 170.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -62.91 102.69 0.38 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.477 0.711 . . . . 0.0 109.699 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.9 54.22 7.37 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.237 -175.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -142.97 -172.55 14.07 Favored Glycine 0 C--N 1.343 0.951 0 C-N-CA 122.807 0.241 . . . . 0.0 112.68 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 25.0 m95 -81.38 140.74 34.55 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.459 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 12.5 m0 -117.64 136.63 53.19 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 2.2 mp0 -87.36 123.96 32.88 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 175.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.48 143.05 19.88 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -102.89 143.72 32.13 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 173.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -129.49 152.42 49.04 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.336 0.654 . . . . 0.0 110.296 173.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -67.26 -21.9 65.7 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.821 0.849 . . . . 0.0 109.997 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -51.35 -37.74 49.49 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.192 1.397 . . . . 0.0 111.15 169.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.02 -5.09 32.02 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-O 119.295 -0.725 . . . . 0.0 113.828 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 65.6 mt -92.23 172.6 8.31 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.076 0.938 . . . . 0.0 111.604 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -145.13 148.0 33.13 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.439 1.495 . . . . 0.0 109.05 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.435 ' N ' HD22 ' A' ' 21' ' ' LEU . . . -174.72 152.23 13.7 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 175.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.444 ' HB3' ' HG3' ' A' ' 41' ' ' GLU . 39.9 p-90 -97.23 129.98 44.5 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.862 0.865 . . . . 0.0 109.869 -174.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.446 ' HE2' ' HB3' ' A' ' 21' ' ' LEU . 78.8 m-85 -138.19 153.71 73.38 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 124.949 1.3 . . . . 0.0 109.041 -178.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -74.13 168.24 25.27 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.584 2.189 . . . . 0.0 112.457 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.47 -15.19 63.53 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.277 1.031 . . . . 0.0 111.787 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.8 m -55.64 -34.85 65.31 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.691 1.196 . . . . 0.0 112.658 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -97.03 -10.94 25.15 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.524 HG12 HG22 ' A' ' 8' ' ' THR . 34.5 m -122.53 161.1 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.44 0.696 . . . . 0.0 110.854 -177.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -131.18 115.58 16.56 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.346 1.058 . . . . 0.0 108.723 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.3 mt -58.49 132.42 53.69 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.335 0.654 . . . . 0.0 111.074 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.645 ' HB2' ' HG3' ' A' ' 5' ' ' ARG . 90.2 mt . . . . . 0 C--O 1.251 1.135 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tmm? . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.4 t -89.54 131.94 35.31 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 175.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -170.73 167.25 40.42 Favored Glycine 0 C--N 1.346 1.115 0 O-C-N 123.298 0.374 . . . . 0.0 112.48 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.44 134.79 54.44 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.936 0.894 . . . . 0.0 109.833 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -154.68 177.18 11.52 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.105 0.962 . . . . 0.0 109.572 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.7 m -123.94 -176.45 3.48 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -142.83 128.51 19.22 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.1 p -66.99 147.54 53.1 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.73 0.812 . . . . 0.0 112.344 -176.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.7 mt -84.2 -52.62 6.11 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.271 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -139.11 166.69 22.95 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 124.151 0.98 . . . . 0.0 109.149 -176.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.69 95.58 0.34 Allowed 'Trans proline' 0 C--N 1.388 2.629 0 C-N-CA 121.801 1.667 . . . . 0.0 110.515 175.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -96.85 154.99 16.97 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.32 0.648 . . . . 0.0 111.285 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.7 m -122.47 -10.69 8.39 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.286 1.034 . . . . 0.0 111.059 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.76 -46.62 1.91 Allowed Glycine 0 C--N 1.349 1.269 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -172.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 63.64 16.84 10.0 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.897 1.279 . . . . 0.0 112.254 178.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -121.62 154.61 36.55 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 124.424 1.089 . . . . 0.0 108.663 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -70.43 154.23 42.12 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.216 0.607 . . . . 0.0 110.889 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.43 -116.34 4.88 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -92.29 76.63 5.24 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-O 121.695 0.759 . . . . 0.0 109.151 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.94 93.08 1.82 Allowed Glycine 0 C--N 1.338 0.65 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.7 174.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.565 HD21 ' HB2' ' A' ' 44' ' ' LYS . 36.4 tp -98.66 130.3 45.17 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.231 0.612 . . . . 0.0 109.508 177.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.92 158.32 30.78 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 168.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -158.41 150.5 21.65 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 174.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.01 142.75 38.05 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.815 0.846 . . . . 0.0 110.72 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.54 145.4 50.84 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.464 0.705 . . . . 0.0 111.35 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.46 19.79 79.74 Favored Glycine 0 C--N 1.345 1.053 0 O-C-N 123.808 0.693 . . . . 0.0 113.196 173.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -109.16 156.28 20.03 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.35 0.66 . . . . 0.0 110.776 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.7 mt -79.89 124.38 28.61 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.929 -171.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.593 HG13 HG11 ' A' ' 57' ' ' VAL . 47.6 mm -88.66 106.58 16.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 172.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.9 p -73.5 108.3 6.28 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.5 mt -66.76 93.35 0.25 Allowed 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.163 0.914 . . . . 0.0 109.148 -175.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.587 HD11 ' HB2' ' A' ' 43' ' ' GLU . 83.3 mt -75.16 -51.89 12.31 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.965 0.906 . . . . 0.0 109.638 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -101.9 136.07 42.37 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.16 86.56 41.7 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.287 1.035 . . . . 0.0 109.216 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.57 -174.41 2.26 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.868 2.378 . . . . 0.0 112.082 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -73.46 -23.27 60.06 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.281 0.632 . . . . 0.0 110.343 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 179.19 174.85 45.68 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 109.74 -101.57 1.47 Allowed Glycine 0 C--N 1.341 0.819 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 14.5 p-90 -137.83 165.1 27.29 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.59 0.756 . . . . 0.0 109.755 -177.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -122.32 149.27 43.98 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.587 0.755 . . . . 0.0 109.183 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.44 ' HG2' HD12 ' A' ' 32' ' ' LEU . 43.2 tt0 -91.15 138.43 31.6 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.4 ' H ' ' HD2' ' A' ' 52' ' ' PHE . . . -121.89 158.61 16.59 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 177.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.587 ' HB2' HD11 ' A' ' 32' ' ' LEU . 28.8 tt0 -110.1 119.36 39.05 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.063 0.545 . . . . 0.0 110.032 -176.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.565 ' HB2' HD21 ' A' ' 21' ' ' LEU . 56.5 tttm -78.76 155.12 29.47 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.439 0.696 . . . . 0.0 109.262 171.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -66.75 -7.02 18.2 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -173.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -78.24 -8.53 58.46 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.517 0.727 . . . . 0.0 111.236 172.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.96 -5.36 84.6 Favored Glycine 0 C--N 1.347 1.193 0 C-N-CA 123.298 0.475 . . . . 0.0 112.403 -171.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.1 mt -78.78 140.59 38.22 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 123.861 0.864 . . . . 0.0 110.584 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.581 HH11 HD13 ' A' ' 32' ' ' LEU . 58.8 mtt-85 -107.07 149.88 27.13 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.562 1.145 . . . . 0.0 108.139 177.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -156.25 -176.3 28.2 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 121.282 -0.485 . . . . 0.0 113.753 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -73.38 126.64 30.63 Favored 'General case' 0 C--N 1.346 0.438 0 C-N-CA 123.235 0.614 . . . . 0.0 110.418 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.4 ' HD2' ' H ' ' A' ' 42' ' ' GLY . 75.3 m-85 -139.27 85.26 15.66 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 123.661 0.784 . . . . 0.0 110.149 174.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.3 151.42 82.51 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.032 2.488 . . . . 0.0 112.023 170.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.24 -15.76 60.7 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.965 0.906 . . . . 0.0 110.79 171.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.3 m -67.75 -38.12 83.05 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 124.32 1.048 . . . . 0.0 111.117 173.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -80.94 -13.0 59.29 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.361 1.064 . . . . 0.0 112.205 -173.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.593 HG11 HG13 ' A' ' 29' ' ' ILE . 29.8 m -132.78 146.2 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.462 0.705 . . . . 0.0 111.091 -171.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.2 127.56 41.34 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 169.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.0 mt -69.06 123.6 21.51 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.928 0.891 . . . . 0.0 110.291 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 72.0 mt . . . . . 0 C--O 1.248 1.008 0 C-N-CA 122.727 0.411 . . . . 0.0 109.95 178.857 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.8 mtp . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.5 t -67.75 94.71 0.46 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.12 0.968 . . . . 0.0 111.399 -175.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.54 -38.48 2.91 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-N 116.067 -0.515 . . . . 0.0 113.79 174.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.27 103.84 0.21 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.507 0.723 . . . . 0.0 111.494 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.463 ' HG2' ' HA ' ' A' ' 30' ' ' THR . 61.2 mtt180 -143.02 170.4 15.77 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.847 0.859 . . . . 0.0 111.004 -177.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.608 ' SG ' HD23 ' A' ' 59' ' ' LEU . 81.9 m -133.93 172.13 13.23 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 113.882 -1.508 . . . . 0.0 108.352 172.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.6 ' HB2' HD21 ' A' ' 60' ' ' LEU . 36.1 ttm180 -124.61 140.36 53.01 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 172.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.8 p -82.0 136.19 35.28 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.501 0.72 . . . . 0.0 110.262 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.403 HD21 ' HG3' ' A' ' 58' ' ' GLN . 75.3 mt -74.89 -67.1 0.67 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.497 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -141.73 157.66 64.4 Favored Pre-proline 0 N--CA 1.48 1.026 0 C-N-CA 124.718 1.207 . . . . 0.0 108.366 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 25' ' ' ALA . 56.5 Cg_endo -66.38 88.53 0.26 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.263 1.976 . . . . 0.0 111.533 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -91.83 146.87 23.41 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.449 0.7 . . . . 0.0 110.498 -177.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.0 p -153.51 161.26 42.41 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.578 1.151 . . . . 0.0 108.276 173.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.5 -84.23 0.13 Allowed Glycine 0 C--N 1.348 1.236 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -144.5 160.35 41.25 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.829 1.252 . . . . 0.0 108.811 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -74.93 82.55 2.19 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 122.74 0.416 . . . . 0.0 110.736 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.6 t60 171.82 -50.17 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.265 1.826 . . . . 0.0 107.17 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.24 149.74 51.26 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 114.915 -1.039 . . . . 0.0 113.776 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -81.31 163.64 22.76 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.905 0.882 . . . . 0.0 112.106 -175.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.08 160.89 11.69 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.261 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.419 HD21 ' HB2' ' A' ' 44' ' ' LYS . 33.9 tp -89.53 115.99 27.35 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.627 ' HD2' ' H ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -85.74 154.8 21.37 Favored 'General case' 0 C--O 1.247 0.944 0 C-N-CA 123.648 0.779 . . . . 0.0 111.063 -176.474 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.462 ' HZ ' ' HE1' ' A' ' 56' ' ' TYR . 21.4 p90 -156.42 149.57 24.24 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.192 -171.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.87 148.58 22.01 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.936 0.895 . . . . 0.0 109.657 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.539 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . . . -61.35 114.55 3.25 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.414 0.686 . . . . 0.0 111.606 -178.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.09 -13.16 24.1 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-O 119.248 -0.751 . . . . 0.0 114.209 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -70.91 163.0 28.33 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 118.056 0.928 . . . . 0.0 111.03 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 mp -99.03 126.15 44.68 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.53 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.3 mm -92.89 108.66 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 169.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.463 ' HA ' ' HG2' ' A' ' 5' ' ' ARG . 54.5 m -77.8 107.93 10.66 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.467 HD21 ' SG ' ' A' ' 6' ' ' CYS . 42.6 mt -69.3 115.07 8.15 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.525 ' HB2' ' HG3' ' A' ' 41' ' ' GLU . 46.7 mt -74.72 -50.55 17.05 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.412 0.685 . . . . 0.0 110.091 -173.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.467 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 52.3 tt0 -147.22 166.38 27.18 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.074 0.949 . . . . 0.0 108.624 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.5 m -101.96 84.4 0.57 Allowed Pre-proline 0 CA--C 1.566 1.588 0 C-N-CA 124.347 1.059 . . . . 0.0 109.713 173.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 33' ' ' GLN . 4.8 Cg_exo -74.42 -36.88 2.76 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 122.888 2.392 . . . . 0.0 111.663 -174.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -109.15 -67.61 0.97 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.241 1.016 . . . . 0.0 109.15 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.36 -35.47 1.88 Allowed Glycine 0 C--N 1.35 1.324 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -100.83 -42.52 2.44 Favored Glycine 0 C--N 1.345 1.078 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 171.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -86.8 137.47 32.39 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 168.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -128.02 177.5 6.84 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.727 0.811 . . . . 0.0 109.747 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.525 ' HG3' ' HB2' ' A' ' 32' ' ' LEU . 15.8 pt-20 -118.66 149.64 41.06 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.166 0.986 . . . . 0.0 108.384 174.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.41 125.68 1.87 Allowed Glycine 0 C--N 1.335 0.491 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.454 ' HB2' HD11 ' A' ' 32' ' ' LEU . 35.5 tt0 -101.16 123.55 45.48 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.419 ' HB2' HD21 ' A' ' 21' ' ' LEU . 17.9 tptm -77.04 167.24 22.15 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.915 0.886 . . . . 0.0 110.072 175.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -52.21 -35.4 49.18 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.407 1.483 . . . . 0.0 113.505 -175.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -78.26 -16.38 57.85 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.145 0.578 . . . . 0.0 111.662 -175.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.56 -7.55 30.1 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-O 119.702 -0.499 . . . . 0.0 113.446 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.01 125.1 25.6 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 117.619 0.709 . . . . 0.0 110.295 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.2 mtp85 -105.26 128.67 53.55 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -135.38 155.3 22.08 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 29.3 p-90 -80.88 138.98 36.17 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.149 0.579 . . . . 0.0 109.695 174.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -140.58 104.96 6.41 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 123.925 0.89 . . . . 0.0 108.881 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.468 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 94.5 Cg_endo -80.31 165.04 21.38 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.975 2.45 . . . . 0.0 112.219 172.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.01 -30.0 71.1 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.772 0.829 . . . . 0.0 111.013 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.0 p -75.39 7.48 3.53 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.136 0.974 . . . . 0.0 112.541 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.468 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 2.6 t80 -124.9 -45.14 1.9 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.6 m -130.51 141.1 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.223 1.009 . . . . 0.0 109.643 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.403 ' HG3' HD21 ' A' ' 9' ' ' LEU . 54.3 mt-30 -89.39 132.97 34.73 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 122.952 0.501 . . . . 0.0 111.326 -175.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.608 HD23 ' SG ' ' A' ' 6' ' ' CYS . 93.2 mt -62.32 145.3 54.17 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.225 1.01 . . . . 0.0 111.9 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.6 HD21 ' HB2' ' A' ' 7' ' ' ARG . 95.0 mt . . . . . 0 C--O 1.245 0.84 0 C-N-CA 123.617 0.767 . . . . 0.0 109.832 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.701 0.286 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.5 t -94.88 82.91 3.9 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.742 0.817 . . . . 0.0 110.005 -169.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -172.28 -121.11 0.58 Allowed Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.472 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.534 ' HB3' ' HB2' ' A' ' 31' ' ' LEU . . . -134.88 149.64 50.33 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.755 0.822 . . . . 0.0 109.375 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.401 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 4.4 mmt85 -128.04 155.0 45.03 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.89 0.876 . . . . 0.0 110.717 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.449 ' SG ' HD11 ' A' ' 31' ' ' LEU . 72.4 m -143.62 173.13 11.93 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.229 1.412 . . . . 0.0 108.795 175.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.9 ttt180 -142.84 131.09 22.05 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.623 HG21 ' HB3' ' A' ' 23' ' ' PHE . 35.2 p -68.12 125.91 27.84 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 124.018 0.927 . . . . 0.0 111.24 -176.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.539 HD21 ' HB2' ' A' ' 58' ' ' GLN . 93.1 mt -67.21 -59.99 2.98 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 123.708 0.63 . . . . 0.0 109.505 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -139.83 153.84 70.22 Favored Pre-proline 0 N--CA 1.476 0.853 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.14 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.42 ' HD3' ' HB2' ' A' ' 25' ' ' ALA . 48.2 Cg_endo -83.63 29.8 0.54 Allowed 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.621 2.214 . . . . 0.0 113.73 -172.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -90.88 101.0 13.76 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.564 ' HB2' ' HA ' ' A' ' 22' ' ' ARG . 25.2 m -148.04 134.39 19.56 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -178.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.21 53.08 4.01 Favored Glycine 0 C--N 1.341 0.824 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -171.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -59.88 104.16 0.27 Allowed 'General case' 0 C--O 1.245 0.841 0 C-N-CA 124.26 1.024 . . . . 0.0 111.414 -177.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 61.8 18.03 9.34 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.651 1.18 . . . . 0.0 112.34 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -156.28 117.9 3.91 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.874 0.869 . . . . 0.0 108.825 -171.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.02 -162.99 16.84 Favored Glycine 0 CA--C 1.533 1.167 0 O-C-N 123.21 0.319 . . . . 0.0 112.539 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 71.53 -2.92 2.28 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.009 1.323 . . . . 0.0 113.304 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.4 178.61 35.62 Favored Glycine 0 C--N 1.348 1.201 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 44' ' ' LYS . 43.7 tp -90.36 112.93 24.7 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.564 ' HA ' ' HB2' ' A' ' 13' ' ' SER . 64.7 mtt180 -82.42 139.05 34.23 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.852 0.72 . . . . 0.0 109.374 174.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.623 ' HB3' HG21 ' A' ' 8' ' ' THR . 97.1 m-85 -113.11 135.4 53.85 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.371 0.668 . . . . 0.0 109.604 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.12 138.42 33.04 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 171.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.42 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . . . -64.29 135.59 56.36 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.546 0.738 . . . . 0.0 111.657 -176.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.4 -13.09 67.41 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-O 119.552 -0.582 . . . . 0.0 114.021 177.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -64.96 129.92 41.49 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.183 0.593 . . . . 0.0 111.919 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.9 mt -80.44 100.35 8.45 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.9 mm -95.62 115.2 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.468 0.707 . . . . 0.0 109.502 -175.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.0 m -74.65 125.24 28.25 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 122.943 0.497 . . . . 0.0 109.755 175.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.534 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 82.4 mt -76.88 126.09 30.4 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 170.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.52 -51.31 15.09 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.529 0.68 . . . . 0.0 110.342 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -153.27 162.42 41.32 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.469 -173.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.9 m -100.82 89.13 1.16 Allowed Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 124.032 0.933 . . . . 0.0 109.569 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -79.76 -4.22 13.31 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.288 2.659 . . . . 0.0 113.518 -171.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -162.6 -69.86 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.808 0.843 . . . . 0.0 109.645 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.24 -52.85 0.55 Allowed Glycine 0 C--N 1.341 0.831 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -174.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -72.31 -46.44 33.98 Favored Glycine 0 C--N 1.344 0.984 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 173.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -93.71 135.46 34.98 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.882 0.873 . . . . 0.0 109.21 174.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 14.5 m0 -133.17 150.39 52.01 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.071 0.949 . . . . 0.0 110.388 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 42.2 mt-10 -91.54 145.85 24.27 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.875 0.87 . . . . 0.0 110.689 -173.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -147.57 170.31 28.34 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.241 0.925 . . . . 0.0 110.99 177.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -126.05 167.23 15.63 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.528 0.731 . . . . 0.0 112.423 -177.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.652 ' HB2' HD11 ' A' ' 21' ' ' LEU . 3.3 tmtp? -126.4 146.64 49.99 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 164.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.433 ' H ' ' HD3' ' A' ' 44' ' ' LYS . 1.7 mp0 -66.45 -9.71 36.87 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.081 0.952 . . . . 0.0 111.647 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.415 ' H ' ' HD2' ' A' ' 44' ' ' LYS . 30.6 t70 -77.76 -8.65 58.29 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 124.858 1.263 . . . . 0.0 111.537 178.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.87 -13.42 57.67 Favored Glycine 0 C--N 1.355 1.61 0 C-N-CA 123.159 0.409 . . . . 0.0 112.916 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.16 133.66 34.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.311 0.644 . . . . 0.0 109.841 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -111.62 173.81 6.17 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.134 0.974 . . . . 0.0 109.689 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -167.88 153.49 22.8 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.56 174.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -121.61 125.75 47.46 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -144.02 156.14 58.56 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 124.217 1.007 . . . . 0.0 109.718 -168.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -68.57 153.85 72.76 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 122.725 2.284 . . . . 0.0 112.719 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.66 -14.51 63.0 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.6 1.16 . . . . 0.0 112.288 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.7 t -55.94 -23.58 32.88 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.508 1.123 . . . . 0.0 112.969 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -106.72 -7.07 17.43 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.2 0.6 . . . . 0.0 112.392 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' A' ' 6' ' ' CYS . 12.9 m -135.9 124.76 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.688 0.795 . . . . 0.0 110.206 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.539 ' HB2' HD21 ' A' ' 9' ' ' LEU . 63.2 tt0 -80.81 127.09 32.12 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 37.9 mt -73.59 133.89 43.61 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.761 0.824 . . . . 0.0 110.871 -173.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 5' ' ' ARG . 74.0 mt . . . . . 0 C--O 1.251 1.151 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.9 m -72.79 104.95 4.15 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 170.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -145.72 163.67 28.23 Favored Glycine 0 C--N 1.343 0.946 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 31' ' ' LEU . . . -68.55 140.69 55.62 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 81.9 mtm-85 -126.55 138.61 53.49 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.082 0.553 . . . . 0.0 110.137 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.676 ' SG ' HD23 ' A' ' 59' ' ' LEU . 77.3 m -128.49 170.47 13.13 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.475 1.11 . . . . 0.0 109.709 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -140.71 138.18 34.03 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.607 0.763 . . . . 0.0 109.153 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.645 HG23 HD11 ' A' ' 29' ' ' ILE . 1.6 p -66.91 128.81 37.73 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.579 0.751 . . . . 0.0 110.839 176.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.462 ' H ' HD12 ' A' ' 9' ' ' LEU . 3.5 mp -74.38 -38.17 63.24 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -129.78 152.63 80.16 Favored Pre-proline 0 C--O 1.245 0.867 0 C-N-CA 125.405 1.482 . . . . 0.0 108.03 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.48 145.29 76.39 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.065 1.843 . . . . 0.0 111.843 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -89.92 106.64 18.61 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 173.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.8 m -59.34 138.69 57.54 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 124.323 1.014 . . . . 0.0 111.164 -176.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.78 72.04 1.83 Allowed Glycine 0 C--N 1.349 1.257 0 O-C-N 123.92 0.763 . . . . 0.0 111.439 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -70.56 96.99 1.25 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.287 1.035 . . . . 0.0 109.856 -176.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -77.45 75.78 4.0 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.92 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -169.1 95.85 0.34 Allowed 'General case' 0 C--O 1.241 0.641 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.78 -131.19 10.6 Favored Glycine 0 N--CA 1.469 0.844 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -174.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -155.0 142.22 19.42 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.217 0.607 . . . . 0.0 109.994 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.23 157.55 29.69 Favored Glycine 0 C--N 1.344 1.001 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.8 tp -90.15 126.0 35.65 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -88.96 134.22 34.05 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.1 0.96 . . . . 0.0 111.615 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -145.07 111.53 5.71 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 163.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.71 157.74 28.48 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.54 0.736 . . . . 0.0 109.939 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.98 119.52 7.39 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.309 0.643 . . . . 0.0 111.326 -174.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.93 -22.03 12.96 Favored Glycine 0 C--N 1.347 1.184 0 O-C-N 123.654 0.596 . . . . 0.0 113.148 -176.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -72.2 143.11 48.98 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.179 0.514 . . . . 0.0 111.427 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.29 117.3 30.05 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.317 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.645 HD11 HG23 ' A' ' 8' ' ' THR . 3.3 mp -85.4 108.27 17.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.4 m -85.06 102.35 13.16 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.54 HD11 ' SG ' ' A' ' 6' ' ' CYS . 90.2 mt -76.23 104.52 6.79 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.243 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.563 HD11 ' HB2' ' A' ' 43' ' ' GLU . 58.9 mt -77.95 -42.91 31.41 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.537 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 32.6 mm-40 -121.33 136.99 54.89 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.384 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.7 m -137.38 72.06 52.09 Favored Pre-proline 0 CA--C 1.557 1.217 0 C-N-CA 124.301 1.04 . . . . 0.0 109.643 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.42 169.54 20.59 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.52 2.147 . . . . 0.0 112.269 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.46 92.17 0.43 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.618 0.767 . . . . 0.0 110.196 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 166.68 -164.84 38.02 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.563 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.08 -29.52 9.62 Favored Glycine 0 N--CA 1.473 1.115 0 N-CA-C 113.403 0.121 . . . . 0.0 113.403 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -94.19 100.21 12.33 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.526 0.73 . . . . 0.0 110.159 -168.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -111.19 150.98 28.75 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.304 1.042 . . . . 0.0 109.248 -175.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 33' ' ' GLN . 35.5 tt0 -89.39 125.91 35.33 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -176.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -123.17 140.6 13.17 Favored Glycine 0 C--N 1.34 0.752 0 O-C-N 124.689 1.243 . . . . 0.0 110.1 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.563 ' HB2' HD11 ' A' ' 32' ' ' LEU . 37.8 tt0 -106.37 140.67 38.93 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.123 0.487 . . . . 0.0 110.717 -177.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -97.05 151.85 19.33 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.013 1.325 . . . . 0.0 108.085 172.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -68.2 -14.2 62.81 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.934 0.493 . . . . 0.0 111.93 -173.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -69.12 -20.71 64.05 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.52 0.728 . . . . 0.0 111.644 174.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.07 -9.4 36.59 Favored Glycine 0 C--N 1.344 1.008 0 C-N-CA 123.413 0.53 . . . . 0.0 112.406 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.1 mp -75.72 121.33 22.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.576 0.75 . . . . 0.0 109.795 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -104.59 158.37 16.54 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.858 0.863 . . . . 0.0 108.978 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -172.13 163.1 35.33 Favored Glycine 0 CA--C 1.507 -0.461 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.879 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 3.6 p-90 -86.06 138.35 32.01 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.591 0.757 . . . . 0.0 109.062 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -132.26 140.13 37.03 Favored Pre-proline 0 C--O 1.242 0.677 0 C-N-CA 124.105 0.962 . . . . 0.0 108.429 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.518 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 39.7 Cg_endo -69.45 134.5 28.81 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 121.843 1.695 . . . . 0.0 109.98 173.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.62 -24.9 65.87 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.371 1.068 . . . . 0.0 111.29 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.0 m -64.82 -35.82 82.33 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.263 1.025 . . . . 0.0 111.32 176.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.518 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 35.5 t80 -81.69 -19.69 41.05 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.377 0.671 . . . . 0.0 111.581 -173.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 6' ' ' CYS . 35.4 m -115.41 149.71 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.237 0.615 . . . . 0.0 110.691 -176.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -110.64 117.58 33.87 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.79 0.836 . . . . 0.0 110.168 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.676 HD23 ' SG ' ' A' ' 6' ' ' CYS . 64.2 mt -66.46 123.23 19.44 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 171.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.2 mp . . . . . 0 C--O 1.248 1.021 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.162 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.0 mtt . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.9 p -77.95 -57.4 3.82 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.799 0.839 . . . . 0.0 109.945 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -110.65 -163.52 18.63 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.986 172.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 31' ' ' LEU . . . -73.51 164.68 26.33 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.889 0.476 . . . . 0.0 109.95 173.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.475 ' HG3' ' HB2' ' A' ' 60' ' ' LEU . 15.6 ptt180 -141.89 149.55 40.36 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.445 0.698 . . . . 0.0 109.908 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.652 ' SG ' ' HA ' ' A' ' 59' ' ' LEU . 57.0 m -145.11 145.31 31.36 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.571 0.749 . . . . 0.0 109.503 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.54 ' HB2' HD11 ' A' ' 60' ' ' LEU . 6.7 tmm_? -106.77 136.56 46.38 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.416 ' HA ' HG12 ' A' ' 57' ' ' VAL . 52.5 p -75.59 127.46 33.12 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.779 1.232 . . . . 0.0 111.891 -174.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.427 HD21 ' HG2' ' A' ' 58' ' ' GLN . 96.1 mt -67.87 -56.47 8.98 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.443 0.697 . . . . 0.0 110.38 177.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -129.22 154.46 80.56 Favored Pre-proline 0 N--CA 1.478 0.949 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.249 -175.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.27 138.52 51.51 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.899 2.4 . . . . 0.0 111.983 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.424 ' HD2' ' HA ' ' A' ' 22' ' ' ARG . 50.4 t80 -111.38 101.24 9.71 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 172.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.0 m -138.27 70.16 1.39 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 169.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -106.27 -46.37 1.16 Allowed Glycine 0 C--N 1.34 0.786 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.977 176.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 56.74 31.81 20.06 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.337 1.055 . . . . 0.0 111.667 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -63.28 -36.41 83.58 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.73 0.812 . . . . 0.0 110.581 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -123.62 152.92 41.42 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.631 1.172 . . . . 0.0 109.36 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.62 -39.7 93.89 Favored Glycine 0 C--N 1.343 0.965 0 O-C-N 123.964 0.79 . . . . 0.0 112.234 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -82.15 89.3 6.47 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.37 136.24 2.89 Favored Glycine 0 C--N 1.345 1.082 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.0 tp -91.01 119.58 31.3 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.549 0.74 . . . . 0.0 109.685 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.424 ' HA ' ' HD2' ' A' ' 12' ' ' PHE . 15.3 ptm180 -92.23 146.68 23.52 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -158.96 174.59 14.72 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.073 0.949 . . . . 0.0 110.765 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.03 168.09 9.28 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.183 0.993 . . . . 0.0 108.855 170.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.79 146.65 49.62 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 172.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.86 -9.82 76.68 Favored Glycine 0 N--CA 1.468 0.799 0 CA-C-N 116.07 -0.514 . . . . 0.0 113.888 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -76.44 135.12 39.4 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.24 0.616 . . . . 0.0 111.019 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.426 HD23 ' HD2' ' A' ' 5' ' ' ARG . 6.9 mp -98.44 114.73 27.21 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.621 HG13 ' HD3' ' A' ' 44' ' ' LYS . 2.6 mp -102.24 125.34 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 174.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 87.0 m -76.3 126.88 31.79 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.77 0.828 . . . . 0.0 110.507 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.614 HD11 ' SG ' ' A' ' 6' ' ' CYS . 5.6 mp -76.2 140.56 41.73 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.907 174.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.3 mt -82.77 -47.24 12.15 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.593 177.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -146.83 156.67 43.3 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.126 0.97 . . . . 0.0 109.358 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.4 m -114.01 87.5 12.96 Favored Pre-proline 0 CA--C 1.561 1.377 0 C-N-CA 123.73 0.812 . . . . 0.0 109.968 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 40' ' ' TRP . 72.6 Cg_endo -73.57 82.89 1.6 Allowed 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.515 2.143 . . . . 0.0 111.584 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 59.03 -86.88 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.146 1.379 . . . . 0.0 111.553 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.55 -168.91 29.44 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-N 116.388 -0.369 . . . . 0.0 112.628 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.46 -71.86 2.61 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -124.0 136.91 54.6 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.076 0.95 . . . . 0.0 108.724 172.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . 11.4 m-90 -124.22 160.46 27.88 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 173.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -110.92 148.58 32.17 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.069 0.461 . . . . 0.0 110.635 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.82 175.31 31.41 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.531 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -139.4 144.73 38.26 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.621 ' HD3' HG13 ' A' ' 29' ' ' ILE . 27.6 tptp -101.99 156.36 17.58 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.724 -178.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -52.88 -25.76 12.68 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 125.535 1.534 . . . . 0.0 113.01 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.81 -16.07 63.46 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.36 1.064 . . . . 0.0 112.551 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.47 -0.96 75.3 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 -171.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.6 mt -85.5 124.21 31.82 Favored 'General case' 0 C--N 1.346 0.433 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 45.0 ttp85 -104.74 138.72 40.61 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 149.71 154.5 6.43 Favored Glycine 0 C--O 1.243 0.695 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.439 ' HZ2' ' HB2' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -154.73 172.47 17.88 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.518 0.675 . . . . 0.0 111.192 -174.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -138.87 153.09 71.61 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 124.591 1.157 . . . . 0.0 109.616 -168.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.99 172.98 3.41 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.564 2.176 . . . . 0.0 113.268 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.38 -15.4 10.47 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.728 1.211 . . . . 0.0 113.24 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.8 t -61.16 -34.06 74.42 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.688 0.795 . . . . 0.0 112.083 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -92.2 -33.06 14.85 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.277 0.631 . . . . 0.0 111.432 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 8' ' ' THR . 11.4 m -138.46 138.76 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.358 0.663 . . . . 0.0 111.069 -166.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.427 ' HG2' HD21 ' A' ' 9' ' ' LEU . 13.6 mm100 -97.4 128.9 44.59 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.205 0.602 . . . . 0.0 110.466 174.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.652 ' HA ' ' SG ' ' A' ' 6' ' ' CYS . 5.0 mp -79.58 118.75 21.71 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.367 -173.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 7' ' ' ARG . 85.9 mt . . . . . 0 C--O 1.249 1.079 0 C-N-CA 123.909 0.883 . . . . 0.0 109.863 -177.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.5 t 68.3 168.71 0.27 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.125 1.37 . . . . 0.0 112.228 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 112.01 -145.57 17.91 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.64 106.67 3.13 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.15 0.58 . . . . 0.0 110.2 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -136.52 139.4 42.23 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.577 ' SG ' HD23 ' A' ' 59' ' ' LEU . 54.4 m -129.71 154.44 47.17 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.959 0.904 . . . . 0.0 109.058 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.423 HH21 ' HA ' ' A' ' 9' ' ' LEU . 6.4 ttp180 -105.87 128.61 53.87 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 40.3 p -69.45 140.79 54.09 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.701 0.8 . . . . 0.0 110.976 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.543 HD21 ' HB2' ' A' ' 58' ' ' GLN . 91.0 mt -73.9 -68.03 0.55 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.024 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -144.7 157.76 54.56 Favored Pre-proline 0 N--CA 1.482 1.152 0 C-N-CA 124.131 0.972 . . . . 0.0 109.169 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.603 ' HD3' ' HB2' ' A' ' 25' ' ' ALA . 10.9 Cg_exo -70.99 162.02 44.13 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 122.643 2.229 . . . . 0.0 110.919 173.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -91.93 155.44 18.15 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.979 0.511 . . . . 0.0 110.377 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.7 m -60.43 -31.11 70.09 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.201 0.601 . . . . 0.0 111.976 -175.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.2 -37.48 3.32 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-O 119.92 -0.378 . . . . 0.0 112.406 175.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -65.78 96.2 0.28 Allowed 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.111 0.565 . . . . 0.0 110.445 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.425 ' HD2' ' HA ' ' A' ' 16' ' ' ARG . 18.2 tpt180 -161.07 117.45 2.24 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.575 173.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -74.23 86.58 1.93 Allowed 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 121.894 0.854 . . . . 0.0 110.0 175.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.21 156.4 9.44 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.187 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.78 130.75 35.59 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -145.82 172.85 26.38 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 112.259 -0.336 . . . . 0.0 112.259 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.5 tp -90.91 136.56 32.99 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.445 0.698 . . . . 0.0 109.829 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -88.31 136.39 33.01 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 123.903 0.752 . . . . 0.0 110.272 174.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -160.18 176.11 12.14 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.174 0.989 . . . . 0.0 110.31 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.422 ' HA ' ' HG3' ' A' ' 11' ' ' PRO . . . -123.96 167.37 14.24 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.329 1.052 . . . . 0.0 109.874 176.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.603 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . . . -67.19 128.44 36.4 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.375 0.67 . . . . 0.0 110.686 175.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.22 1.46 59.41 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-O 119.738 -0.479 . . . . 0.0 113.671 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -78.93 116.69 19.41 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.967 0.507 . . . . 0.0 110.971 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 mp -76.63 100.61 5.41 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 172.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.5 mm -94.05 121.31 44.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 123.975 0.91 . . . . 0.0 109.274 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 31.6 m -74.95 125.38 28.76 Favored 'General case' 0 C--O 1.241 0.658 0 C-N-CA 123.158 0.583 . . . . 0.0 109.88 175.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.1 mt -73.48 128.68 36.16 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.586 HD13 HH11 ' A' ' 49' ' ' ARG . 74.2 mt -73.57 -52.2 14.31 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.871 0.868 . . . . 0.0 110.037 -174.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -139.0 144.57 38.96 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 173.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.5 m -110.01 108.89 59.19 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.661 0.784 . . . . 0.0 110.095 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -72.34 171.67 16.5 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.964 2.442 . . . . 0.0 111.549 171.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -81.47 -6.49 59.0 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.041 177.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.25 -176.81 39.05 Favored Glycine 0 C--N 1.351 1.397 0 O-C-N 123.18 0.3 . . . . 0.0 112.743 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -100.47 36.42 4.16 Favored Glycine 0 C--N 1.348 1.22 0 C-N-CA 123.395 0.522 . . . . 0.0 112.547 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -126.9 108.03 10.62 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 175.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 25.0 m0 -111.74 145.68 38.9 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.764 0.426 . . . . 0.0 110.459 -172.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.71 ' HG2' ' HB3' ' A' ' 51' ' ' TRP . 38.8 mt-10 -106.13 123.86 48.68 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.925 0.89 . . . . 0.0 109.602 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -118.6 -179.72 16.95 Favored Glycine 0 C--N 1.34 0.75 0 O-C-N 123.766 0.667 . . . . 0.0 112.468 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.405 ' HB2' HD21 ' A' ' 32' ' ' LEU . 28.2 tt0 -145.86 159.61 42.96 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.069 0.947 . . . . 0.0 109.903 -176.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.464 ' HE3' ' HG2' ' A' ' 45' ' ' GLU . 20.8 mmmt -121.02 170.4 9.55 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.908 0.883 . . . . 0.0 111.284 175.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.464 ' HG2' ' HE3' ' A' ' 44' ' ' LYS . 10.4 pt-20 -54.49 -28.67 46.41 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.614 1.566 . . . . 0.0 112.65 174.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -63.09 -34.17 77.03 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.844 1.257 . . . . 0.0 111.318 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.17 -22.61 24.8 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -173.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 51.7 tp -63.17 140.76 58.91 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 123.117 0.567 . . . . 0.0 109.877 175.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.586 HH11 HD13 ' A' ' 32' ' ' LEU . 49.9 mtt-85 -116.71 173.29 6.71 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.436 1.095 . . . . 0.0 108.491 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.65 175.66 45.9 Favored Glycine 0 CA--C 1.505 -0.537 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.71 ' HB3' ' HG2' ' A' ' 41' ' ' GLU . 33.0 p-90 -141.85 136.0 30.13 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.48 0.712 . . . . 0.0 109.765 -176.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -139.77 161.0 58.71 Favored Pre-proline 0 C--O 1.247 0.925 0 C-N-CA 124.603 1.161 . . . . 0.0 108.748 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.06 144.94 35.46 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.017 2.478 . . . . 0.0 113.095 171.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.22 -27.05 68.79 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.094 0.958 . . . . 0.0 111.404 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.1 m -68.62 -25.35 64.81 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.79 0.836 . . . . 0.0 111.468 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -77.37 -19.81 55.69 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.147 0.579 . . . . 0.0 111.276 -174.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.8 m -117.24 168.23 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.85 0.86 . . . . 0.0 109.837 175.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.543 ' HB2' HD21 ' A' ' 9' ' ' LEU . 24.6 tt0 -119.71 135.06 54.99 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.828 0.851 . . . . 0.0 108.796 177.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.577 HD23 ' SG ' ' A' ' 6' ' ' CYS . 96.6 mt -65.72 145.31 56.17 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.773 0.429 . . . . 0.0 110.206 172.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--O 1.251 1.18 0 C-N-CA 122.908 0.483 . . . . 0.0 109.992 177.941 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.4 t -72.27 117.79 14.35 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.35 75.75 1.35 Allowed Glycine 0 C--N 1.346 1.12 0 O-C-N 123.83 0.706 . . . . 0.0 112.55 -176.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.651 ' HB3' HD21 ' A' ' 31' ' ' LEU . . . -83.37 136.92 34.17 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.711 ' HB2' ' HB2' ' A' ' 60' ' ' LEU . 46.7 mtt-85 -120.97 169.52 10.4 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.682 0.753 . . . . 0.0 110.036 -167.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.1 m -135.32 148.29 49.42 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 169.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.411 ' HD2' HD21 ' A' ' 60' ' ' LEU . 17.5 ptm180 -123.53 128.92 50.44 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 175.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.2 p -79.73 125.88 30.23 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.528 -176.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.6 mt -72.47 -52.17 16.99 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.228 -174.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.446 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 71.3 m-85 -139.79 159.81 63.45 Favored Pre-proline 0 N--CA 1.483 1.207 0 C-N-CA 123.828 0.851 . . . . 0.0 109.656 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.41 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . 1.8 Cg_endo -79.17 99.95 1.3 Allowed 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 122.197 1.931 . . . . 0.0 109.886 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -99.72 140.49 33.84 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.314 0.646 . . . . 0.0 109.837 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.2 m -144.35 95.33 2.7 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.934 0.894 . . . . 0.0 108.819 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.34 -170.09 44.58 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.535 173.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -129.42 132.08 46.92 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.952 0.406 . . . . 0.0 110.65 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.8 mtt-85 -145.19 141.69 28.92 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.049 1.34 . . . . 0.0 108.895 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -68.95 99.56 1.08 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 171.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.8 -120.3 1.45 Allowed Glycine 0 C--N 1.341 0.849 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -176.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -162.12 123.09 2.62 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.308 0.643 . . . . 0.0 110.054 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.27 163.69 21.09 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 169.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.6 tp -92.98 126.27 37.98 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 117.484 0.642 . . . . 0.0 109.499 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -77.76 150.19 34.4 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.218 1.007 . . . . 0.0 111.596 -171.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -152.35 148.46 27.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.584 0.753 . . . . 0.0 110.162 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . . . -110.06 167.09 10.43 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.648 1.179 . . . . 0.0 108.513 173.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . . . -75.98 142.74 41.85 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.636 0.375 . . . . 0.0 111.447 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.44 -21.49 45.27 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.753 170.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.77 162.4 22.93 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 121.267 0.556 . . . . 0.0 110.29 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 mp -108.16 119.81 40.55 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.427 -174.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.2 mm -85.84 114.86 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 174.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.5 m -89.42 131.07 35.65 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.391 0.676 . . . . 0.0 109.449 177.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.651 HD21 ' HB3' ' A' ' 4' ' ' ALA . 2.7 pp -76.15 148.85 37.51 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.29 0.567 . . . . 0.0 111.422 177.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.58 HD11 ' HB2' ' A' ' 43' ' ' GLU . 48.5 mt -99.66 -19.21 16.92 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.198 0.999 . . . . 0.0 109.664 176.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -153.53 150.54 28.81 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.642 0.777 . . . . 0.0 109.89 -173.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.8 m -119.62 86.57 35.08 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.088 0.955 . . . . 0.0 109.273 170.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -85.39 -168.35 0.49 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.693 2.262 . . . . 0.0 110.679 171.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -84.72 140.75 31.06 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 172.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.17 161.3 37.33 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 123.764 0.665 . . . . 0.0 111.788 -175.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.53 58.21 4.68 Favored Glycine 0 C--N 1.348 1.197 0 C-N-CA 123.134 0.397 . . . . 0.0 112.557 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -130.91 99.38 4.89 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 36.5 m0 -113.13 145.5 40.82 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.427 0.691 . . . . 0.0 109.432 -177.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.75 117.41 28.59 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -176.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.9 168.87 26.44 Favored Glycine 0 C--O 1.239 0.46 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 170.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.58 ' HB2' HD11 ' A' ' 32' ' ' LEU . 41.6 tt0 -149.79 146.71 27.32 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.889 0.476 . . . . 0.0 110.207 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -104.59 -177.5 3.38 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.625 0.726 . . . . 0.0 112.34 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.77 -33.54 73.11 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.337 1.455 . . . . 0.0 109.683 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -58.85 -25.76 63.57 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.181 1.392 . . . . 0.0 112.051 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.21 -11.72 71.25 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.889 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.1 mt -72.54 131.23 42.23 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 123.742 0.817 . . . . 0.0 109.202 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -117.53 160.94 20.41 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.958 0.903 . . . . 0.0 110.156 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -173.56 155.7 22.7 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.646 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 46.1 p-90 -70.68 152.35 43.95 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.321 0.648 . . . . 0.0 110.958 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -134.08 138.01 29.57 Favored Pre-proline 0 C--O 1.243 0.745 0 C-N-CA 123.979 0.912 . . . . 0.0 109.101 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.473 ' HB2' ' HB2' ' A' ' 56' ' ' TYR . 9.1 Cg_exo -71.49 113.07 3.51 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.768 2.312 . . . . 0.0 110.378 172.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.99 -32.5 73.77 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.56 0.744 . . . . 0.0 112.11 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.3 t -73.45 -17.64 61.22 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.846 0.458 . . . . 0.0 111.576 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.473 ' HB2' ' HB2' ' A' ' 53' ' ' PRO . 35.1 t80 -75.67 -35.48 60.36 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.712 0.805 . . . . 0.0 110.383 -177.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.9 m -111.81 166.5 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.9 0.88 . . . . 0.0 110.765 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -83.24 125.4 31.53 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 63.9 mt -84.51 141.82 30.48 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.655 0.382 . . . . 0.0 110.529 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.711 ' HB2' ' HB2' ' A' ' 5' ' ' ARG . 96.5 mt . . . . . 0 C--O 1.253 1.255 0 C-N-CA 123.955 0.902 . . . . 0.0 108.877 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.6 ttp . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.5 p -64.36 -44.11 92.43 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.399 0.68 . . . . 0.0 110.229 175.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 144.95 95.33 0.19 Allowed Glycine 0 C--N 1.342 0.88 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.265 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.02 99.5 0.87 Allowed 'General case' 0 C--N 1.35 0.621 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -117.55 156.08 28.69 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.418 0.687 . . . . 0.0 110.068 -176.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.9 m -139.44 156.2 47.11 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.609 1.164 . . . . 0.0 108.659 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -107.39 148.78 28.66 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.661 0.784 . . . . 0.0 109.222 176.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.0 p -91.26 130.17 37.16 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 122.82 0.448 . . . . 0.0 110.557 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.2 mt -63.09 -64.03 1.03 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.299 1.04 . . . . 0.0 111.02 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -129.29 158.41 73.16 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 123.988 0.915 . . . . 0.0 108.949 -177.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.653 ' HD3' ' HB2' ' A' ' 25' ' ' ALA . 72.7 Cg_endo -73.68 98.07 1.02 Allowed 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.067 1.845 . . . . 0.0 110.987 176.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -90.8 100.23 13.12 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.7 m -96.98 75.82 2.67 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.911 0.885 . . . . 0.0 109.788 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -134.51 153.67 21.13 Favored Glycine 0 C--O 1.244 0.757 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.611 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 56.64 73.5 0.45 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.268 1.027 . . . . 0.0 110.217 -175.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -85.81 32.35 0.6 Allowed 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.439 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -169.06 159.76 9.42 Favored 'General case' 0 C--O 1.247 0.936 0 C-N-CA 124.984 1.313 . . . . 0.0 108.84 -170.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.61 -123.31 19.32 Favored Glycine 0 C--N 1.344 0.993 0 O-C-N 123.388 0.43 . . . . 0.0 113.685 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -94.48 5.56 51.45 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.859 0.864 . . . . 0.0 112.267 -174.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.1 126.4 8.28 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.271 0.357 . . . . 0.0 112.877 -177.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.0 tp -105.23 117.75 34.81 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 173.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -87.39 149.42 24.48 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.124 0.97 . . . . 0.0 110.239 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -158.44 153.13 24.72 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.718 0.807 . . . . 0.0 110.814 -177.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.14 169.22 11.03 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.484 1.114 . . . . 0.0 110.667 172.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.653 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . . . -61.06 125.71 24.7 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.279 0.631 . . . . 0.0 111.191 175.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.03 -4.71 65.54 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-O 119.203 -0.776 . . . . 0.0 114.116 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -52.39 120.0 5.07 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.037 0.935 . . . . 0.0 111.702 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.4 mt -82.52 99.62 9.6 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 48.9 mm -88.43 111.04 21.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 124.454 1.102 . . . . 0.0 108.079 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.5 m -87.51 107.48 18.59 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.553 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.51 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 41.4 mt -65.01 134.87 54.83 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.635 0.774 . . . . 0.0 109.624 175.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.2 mt -75.34 -47.77 26.19 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.276 0.631 . . . . 0.0 109.736 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -141.19 159.43 42.23 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.528 1.131 . . . . 0.0 108.396 174.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.0 m -119.59 84.81 31.09 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 171.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -72.07 169.27 21.81 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.761 2.307 . . . . 0.0 111.254 175.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -70.55 96.99 1.24 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.385 0.674 . . . . 0.0 110.019 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.95 173.56 23.15 Favored Glycine 0 C--N 1.344 0.985 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.808 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -91.99 28.6 8.46 Favored Glycine 0 C--N 1.345 1.052 0 C-N-CA 122.853 0.263 . . . . 0.0 113.12 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -127.16 116.71 21.06 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.571 1.148 . . . . 0.0 108.052 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 8.7 m0 -128.89 139.32 52.19 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -91.53 119.27 31.32 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' A' ' 31' ' ' LEU . . . -110.44 136.34 13.52 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.236 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -104.11 141.17 36.7 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.181 0.593 . . . . 0.0 109.971 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.433 ' HG2' ' H ' ' A' ' 46' ' ' ASP . 88.7 tttt -93.97 160.3 14.78 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.712 1.205 . . . . 0.0 109.565 177.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.88 -24.55 52.66 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.449 1.1 . . . . 0.0 111.977 175.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.433 ' H ' ' HG2' ' A' ' 44' ' ' LYS . 15.1 t70 -60.35 -36.11 77.24 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.105 1.362 . . . . 0.0 111.95 175.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.78 -20.19 22.59 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 116.252 -0.431 . . . . 0.0 112.458 -177.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -76.63 134.17 39.4 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -119.27 139.83 51.26 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.34 1.056 . . . . 0.0 109.459 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -133.18 150.63 19.86 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 178.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 48.7 m95 -82.8 130.2 35.1 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.105 0.962 . . . . 0.0 108.999 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -140.07 151.71 65.67 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 122.973 0.509 . . . . 0.0 111.289 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -65.88 158.89 51.57 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.982 2.455 . . . . 0.0 112.043 168.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.96 -36.76 82.93 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.0 0.92 . . . . 0.0 111.861 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.7 t -79.66 -14.63 58.65 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.894 0.878 . . . . 0.0 111.71 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -71.93 -29.22 64.07 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.386 0.674 . . . . 0.0 110.519 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.1 m -111.72 172.67 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.253 1.021 . . . . 0.0 109.857 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -113.93 126.22 54.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.02 0.928 . . . . 0.0 109.478 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 75.0 mt -69.73 140.7 53.52 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.295 0.638 . . . . 0.0 109.925 176.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 CA--C 1.556 1.188 0 C-N-CA 123.243 0.617 . . . . 0.0 110.751 -179.369 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 120.597 0.237 . . . . 0.0 110.453 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.8 p -109.01 177.96 4.61 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.668 0.787 . . . . 0.0 111.305 -175.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 89.74 -65.68 2.96 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.743 174.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.65 ' HB1' ' HB2' ' A' ' 31' ' ' LEU . . . -78.43 83.35 4.65 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.492 0.717 . . . . 0.0 111.175 -175.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -127.99 134.45 49.26 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.143 0.977 . . . . 0.0 110.098 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.701 ' SG ' HD11 ' A' ' 31' ' ' LEU . 89.4 m -139.73 146.33 39.43 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.996 0.918 . . . . 0.0 108.65 165.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -105.43 137.97 42.38 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.1 p -70.59 119.21 14.41 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.169 0.988 . . . . 0.0 110.27 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.8 -56.8 7.81 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.484 0.713 . . . . 0.0 110.61 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -134.66 155.02 79.85 Favored Pre-proline 0 N--CA 1.482 1.14 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.487 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . 72.0 Cg_endo -73.04 88.07 0.97 Allowed 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.059 1.84 . . . . 0.0 111.993 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -91.83 100.15 12.89 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.9 t -160.63 84.81 0.7 Allowed 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.46 -3.15 88.72 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.846 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.35 105.42 8.52 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.45 1.1 . . . . 0.0 109.218 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -69.92 84.22 0.49 Allowed 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.859 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 78.8 m80 63.9 14.24 8.22 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.117 1.367 . . . . 0.0 112.721 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.77 66.98 1.89 Allowed Glycine 0 C--N 1.35 1.329 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 61.4 79.94 0.24 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.372 1.069 . . . . 0.0 110.551 -175.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.02 -176.69 39.99 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.807 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' A' ' 44' ' ' LYS . 32.4 tp -107.37 123.35 48.24 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.228 0.611 . . . . 0.0 109.737 -176.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -94.84 118.19 31.37 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -154.23 173.05 16.65 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.198 0.599 . . . . 0.0 111.301 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.487 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . . . -128.3 157.27 41.42 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.597 1.159 . . . . 0.0 109.376 175.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.14 134.59 55.15 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.511 0.724 . . . . 0.0 111.621 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.63 -14.31 29.81 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 123.334 0.396 . . . . 0.0 113.365 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -81.88 142.38 32.55 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.125 0.57 . . . . 0.0 111.819 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.466 HD12 HD11 ' A' ' 60' ' ' LEU . 1.9 mm? -95.37 105.18 17.11 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.299 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.6 mm -85.02 116.42 28.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.5 m -77.34 111.58 13.16 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.219 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.701 HD11 ' SG ' ' A' ' 6' ' ' CYS . 34.4 mt -70.46 139.46 51.73 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 123.867 0.729 . . . . 0.0 111.716 -171.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.524 ' HB2' ' HG3' ' A' ' 41' ' ' GLU . 70.3 mt -101.17 -30.99 11.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.632 0.773 . . . . 0.0 109.458 174.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.542 ' HG3' ' HG2' ' A' ' 41' ' ' GLU . 70.9 mt-30 -97.12 149.71 21.67 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.344 0.657 . . . . 0.0 110.854 172.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.6 m -142.93 54.64 3.43 Favored Pre-proline 0 CA--C 1.578 2.046 0 C-N-CA 124.81 1.244 . . . . 0.0 110.292 173.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 33' ' ' GLN . 63.7 Cg_endo -81.58 -170.24 0.94 Allowed 'Trans proline' 0 C--N 1.391 2.77 0 C-N-CA 122.754 2.302 . . . . 0.0 112.297 -175.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -74.6 77.76 1.99 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.922 0.889 . . . . 0.0 109.645 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.78 -128.16 45.95 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.198 -174.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.21 -87.1 0.19 Allowed Glycine 0 C--N 1.349 1.279 0 C-N-CA 123.109 0.385 . . . . 0.0 112.947 175.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.8 OUTLIER -149.69 165.97 30.75 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.424 0.69 . . . . 0.0 110.482 -174.755 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -140.77 134.21 29.9 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.643 0.777 . . . . 0.0 109.147 173.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.542 ' HG2' ' HG3' ' A' ' 33' ' ' GLN . 10.6 pt-20 -91.34 160.53 15.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 163.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.55 178.33 41.57 Favored Glycine 0 C--O 1.243 0.673 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.646 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -104.79 139.96 38.79 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.787 0.835 . . . . 0.0 110.613 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.615 ' HB2' HD11 ' A' ' 21' ' ' LEU . 10.1 tmtt? -95.64 156.98 16.1 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.159 1.384 . . . . 0.0 107.61 176.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.553 ' H ' ' HD3' ' A' ' 44' ' ' LYS . 38.6 mm-40 -55.44 -33.98 64.06 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -177.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.85 -14.24 62.65 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.05 0.54 . . . . 0.0 112.367 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.08 -9.27 59.63 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.881 -174.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.3 tp -65.24 127.75 32.99 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 123.812 0.845 . . . . 0.0 109.538 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -104.81 131.88 51.74 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.662 0.785 . . . . 0.0 109.059 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.503 ' HA3' ' HB2' ' A' ' 21' ' ' LEU . . . -149.29 173.96 28.99 Favored Glycine 0 C--N 1.336 0.577 0 O-C-N 123.35 0.406 . . . . 0.0 112.343 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 41' ' ' GLU . 51.3 p-90 -141.79 142.24 33.2 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.916 0.887 . . . . 0.0 109.79 -173.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -157.01 149.94 18.43 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 123.905 0.882 . . . . 0.0 110.205 175.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 39' ' ' TRP . 82.7 Cg_exo -51.26 165.98 0.5 Allowed 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.462 2.775 . . . . 0.0 114.652 167.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.4 -15.55 49.72 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.416 1.086 . . . . 0.0 112.832 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.3 m -69.17 -21.79 63.96 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.006 0.923 . . . . 0.0 112.2 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -98.72 -47.75 5.21 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.515 0.726 . . . . 0.0 109.702 -175.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.7 m -112.09 130.11 66.35 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.696 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -123.57 126.7 47.12 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.779 0.832 . . . . 0.0 110.577 -171.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.538 HD23 ' SG ' ' A' ' 6' ' ' CYS . 90.3 mt -52.71 133.24 36.85 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.2 1.0 . . . . 0.0 111.862 177.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.466 HD11 HD12 ' A' ' 28' ' ' LEU . 7.1 mp . . . . . 0 C--O 1.252 1.214 0 C-N-CA 123.203 0.601 . . . . 0.0 110.987 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.3 m -63.09 104.91 0.62 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.938 0.895 . . . . 0.0 110.962 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -105.86 147.62 16.29 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.104 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.401 ' HB3' ' HB2' ' A' ' 31' ' ' LEU . . . -72.68 87.39 1.25 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 171.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -80.17 142.01 35.14 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.168 -176.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.573 ' HB3' ' HB ' ' A' ' 57' ' ' VAL . 71.6 m -133.08 141.27 48.11 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 172.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -106.63 127.39 53.31 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.466 HG21 ' HB2' ' A' ' 23' ' ' PHE . 37.6 p -68.81 130.39 42.68 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.933 0.893 . . . . 0.0 111.158 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.56 HD21 ' HB2' ' A' ' 58' ' ' GLN . 79.7 mt -86.28 -34.93 20.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.56 1.144 . . . . 0.0 110.474 -177.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -135.73 145.27 52.37 Favored Pre-proline 0 N--CA 1.487 1.389 0 C-N-CA 123.383 0.673 . . . . 0.0 110.453 -175.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . 63.4 Cg_endo -73.05 126.97 11.64 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.385 2.057 . . . . 0.0 110.71 166.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -150.34 133.52 16.25 Favored 'General case' 0 C--O 1.244 0.816 0 C-N-CA 122.947 0.499 . . . . 0.0 109.932 -174.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.3 m 65.81 117.79 0.03 OUTLIER 'General case' 0 C--N 1.36 1.055 0 C-N-CA 125.522 1.529 . . . . 0.0 112.151 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.85 29.91 1.68 Allowed Glycine 0 C--N 1.342 0.863 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 173.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -96.63 160.94 14.11 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.696 0.798 . . . . 0.0 110.559 -171.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -94.79 62.25 2.67 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.034 0.934 . . . . 0.0 109.674 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -79.35 -23.11 43.61 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.334 173.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 122.67 -118.86 3.74 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -77.09 134.36 38.77 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.985 0.514 . . . . 0.0 110.452 177.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.66 165.78 18.14 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.679 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.3 tp -105.81 121.58 44.33 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.272 0.558 . . . . 0.0 109.563 176.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -104.98 154.98 19.38 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.084 1.354 . . . . 0.0 107.945 177.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.466 ' HB2' HG21 ' A' ' 8' ' ' THR . 48.0 p90 -155.51 159.57 39.86 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -175.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . . . -135.36 143.24 45.97 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.556 1.543 . . . . 0.0 108.55 176.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.01 118.03 3.95 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 124.122 0.889 . . . . 0.0 111.748 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.03 7.0 22.08 Favored Glycine 0 CA--C 1.536 1.403 0 O-C-N 123.746 0.654 . . . . 0.0 113.267 -176.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -95.81 145.66 25.17 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.471 0.708 . . . . 0.0 110.529 171.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.504 HD22 HD11 ' A' ' 60' ' ' LEU . 48.0 mt -109.3 104.93 14.14 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.073 0.949 . . . . 0.0 109.381 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.9 mp -90.78 131.73 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.0 m -85.5 109.07 18.23 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.542 0.737 . . . . 0.0 109.428 177.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.486 HD11 ' SG ' ' A' ' 6' ' ' CYS . 84.6 mt -66.15 115.81 6.55 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.419 HD11 ' HB3' ' A' ' 43' ' ' GLU . 84.7 mt -76.55 -31.19 57.43 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.331 0.652 . . . . 0.0 111.533 -177.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.573 ' HG2' ' HD3' ' A' ' 35' ' ' PRO . 9.4 tt0 -137.58 136.34 37.48 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -177.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.441 ' HA ' ' HD1' ' A' ' 40' ' ' TRP . 6.1 m -133.33 69.44 77.54 Favored Pre-proline 0 CA--C 1.559 1.324 0 C-N-CA 124.731 1.213 . . . . 0.0 109.503 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.573 ' HD3' ' HG2' ' A' ' 33' ' ' GLN . 65.7 Cg_endo -81.15 -22.27 6.05 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.981 2.454 . . . . 0.0 112.881 -171.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -161.55 145.37 12.76 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.161 1.385 . . . . 0.0 107.949 -171.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -81.57 59.75 4.8 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 123.6 0.562 . . . . 0.0 113.384 -177.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.28 -89.84 1.0 Allowed Glycine 0 C--N 1.352 1.431 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 1.9 p-90 -132.11 148.18 52.47 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.441 ' HD1' ' HA ' ' A' ' 34' ' ' VAL . 6.5 m-90 -131.83 160.08 36.67 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.129 0.49 . . . . 0.0 110.952 -167.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -93.65 151.68 19.5 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.028 172.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.16 -179.43 27.77 Favored Glycine 0 C--O 1.242 0.635 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.158 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB3' HD11 ' A' ' 32' ' ' LEU . 5.8 pt-20 -140.86 167.67 21.62 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.999 0.904 . . . . 0.0 112.292 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.585 ' HD3' ' N ' ' A' ' 45' ' ' GLU . 11.2 tmtt? -114.87 156.81 24.26 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 113.459 -1.701 . . . . 0.0 106.996 166.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.585 ' N ' ' HD3' ' A' ' 44' ' ' LYS . 35.8 mt-10 -46.81 -31.14 2.84 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 125.675 1.59 . . . . 0.0 113.638 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.92 1.42 12.83 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.203 1.001 . . . . 0.0 112.983 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.48 -1.62 85.97 Favored Glycine 0 C--N 1.352 1.423 0 C-N-CA 122.688 0.185 . . . . 0.0 112.789 -177.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.2 119.94 12.35 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.561 0.744 . . . . 0.0 110.379 -177.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -104.48 141.32 36.58 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.456 0.703 . . . . 0.0 109.282 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.07 152.15 22.15 Favored Glycine 0 C--N 1.341 0.854 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 174.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -119.22 128.28 54.06 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.464 1.106 . . . . 0.0 108.126 -178.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -133.72 137.81 29.56 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 123.27 0.628 . . . . 0.0 110.675 -172.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -56.03 152.27 37.81 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.3 2.667 . . . . 0.0 112.513 165.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.87 -15.5 62.0 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.328 1.051 . . . . 0.0 112.404 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.8 t -67.21 -26.59 66.68 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.266 0.626 . . . . 0.0 111.68 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -82.98 -30.56 28.11 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.974 0.51 . . . . 0.0 111.266 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 6' ' ' CYS . 15.6 m -134.45 124.86 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 123.254 0.622 . . . . 0.0 111.43 -168.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.56 ' HB2' HD21 ' A' ' 9' ' ' LEU . 6.6 tp-100 -80.75 130.86 35.31 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.337 0.655 . . . . 0.0 110.345 176.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.434 HD21 ' CZ3' ' A' ' 40' ' ' TRP . 81.9 mt -74.13 108.44 6.93 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.299 1.039 . . . . 0.0 111.252 -175.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.504 HD11 HD22 ' A' ' 28' ' ' LEU . 76.8 mt . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.626 -0.702 . . . . 0.0 109.816 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tpt . . . . . 0 N--CA 1.484 1.267 0 CA-C-O 120.615 0.245 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -106.8 123.87 48.79 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.289 0.635 . . . . 0.0 110.084 -176.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.29 174.75 33.85 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 123.589 0.556 . . . . 0.0 112.661 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.12 105.44 0.7 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.163 0.585 . . . . 0.0 110.269 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -109.02 172.57 6.77 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.465 ' SG ' ' HZ2' ' A' ' 51' ' ' TRP . 59.6 m -149.23 153.55 37.77 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.582 0.753 . . . . 0.0 110.409 -173.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.428 ' HG3' HD21 ' A' ' 60' ' ' LEU . 18.1 mtp180 -130.94 133.08 45.51 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.922 0.889 . . . . 0.0 109.262 175.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.5 p -78.84 122.13 25.69 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 173.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.557 HD21 ' HB2' ' A' ' 58' ' ' GLN . 87.9 mt -68.63 -47.04 67.66 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.016 0.527 . . . . 0.0 111.039 -174.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -144.53 155.24 57.06 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 124.863 1.265 . . . . 0.0 109.25 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.592 ' HD3' ' HB2' ' A' ' 25' ' ' ALA . 59.3 Cg_endo -83.06 167.57 14.07 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.545 2.163 . . . . 0.0 112.63 -174.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -120.02 100.09 7.01 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 173.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.4 m -98.47 84.06 3.13 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.116 0.566 . . . . 0.0 109.891 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.92 -164.53 36.6 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.74 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -82.15 118.0 22.73 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.406 1.082 . . . . 0.0 110.46 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -106.21 30.43 5.93 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.789 0.836 . . . . 0.0 109.973 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.5 m80 67.87 -76.06 0.06 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.883 1.673 . . . . 0.0 111.27 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.58 -86.17 0.05 OUTLIER Glycine 0 C--N 1.346 1.122 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -63.0 117.81 6.95 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.262 0.625 . . . . 0.0 110.756 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.89 -164.12 35.41 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.442 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.0 tp -137.51 142.51 41.46 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.008 0.923 . . . . 0.0 108.556 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -91.92 131.22 37.4 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 170.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -151.71 143.69 23.83 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.186 0.595 . . . . 0.0 112.001 -171.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.491 ' O ' ' HG2' ' A' ' 27' ' ' GLU . . . -87.88 170.95 10.72 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.915 1.286 . . . . 0.0 109.898 167.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.592 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . . . -71.44 112.4 7.53 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.959 -0.463 . . . . 0.0 110.474 172.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.09 17.46 7.78 Favored Glycine 0 N--CA 1.475 1.255 0 C-N-CA 123.139 0.399 . . . . 0.0 113.721 174.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 24' ' ' ALA . 10.2 mm-40 -69.75 125.32 26.39 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 122.678 0.391 . . . . 0.0 110.958 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.7 mt -85.42 101.95 13.04 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.838 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.6 mm -105.59 140.41 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.5 m -113.5 118.94 35.88 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.546 0.612 . . . . 0.0 109.73 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.419 ' HG ' ' SG ' ' A' ' 6' ' ' CYS . 68.8 mt -58.99 121.43 11.2 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 123.695 0.622 . . . . 0.0 110.784 177.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.479 HD11 ' HB2' ' A' ' 43' ' ' GLU . 80.9 mt -75.15 -46.61 33.14 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.017 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -155.23 166.02 34.85 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.936 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.3 m -120.63 81.56 32.64 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 124.084 0.954 . . . . 0.0 109.052 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -83.31 -21.5 4.43 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.53 2.154 . . . . 0.0 114.076 -172.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -155.43 142.99 19.63 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.337 0.655 . . . . 0.0 110.632 -168.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.85 61.02 4.12 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.532 0.52 . . . . 0.0 112.622 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.34 -53.33 0.04 OUTLIER Glycine 0 C--N 1.342 0.869 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 49.2 m95 -118.94 128.0 54.01 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 170.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.452 ' HE3' ' HZ3' ' A' ' 51' ' ' TRP . 15.5 m-90 -119.09 170.57 8.94 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -132.48 133.0 43.28 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.133 0.492 . . . . 0.0 111.147 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.8 168.4 19.81 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 114.612 -1.177 . . . . 0.0 110.821 173.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.479 ' HB2' HD11 ' A' ' 32' ' ' LEU . 29.2 tt0 -125.7 151.28 46.82 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.184 0.593 . . . . 0.0 109.801 -178.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.451 ' HE3' ' HB3' ' A' ' 27' ' ' GLU . 1.3 mmtp -89.95 163.12 15.09 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.392 1.077 . . . . 0.0 110.244 176.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -63.84 -24.53 67.79 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.71 0.804 . . . . 0.0 111.243 170.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.84 -23.31 65.01 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.366 1.066 . . . . 0.0 111.685 174.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.32 -21.29 37.77 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.095 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.5 133.59 35.85 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.213 0.605 . . . . 0.0 109.606 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 28.5 ptt85 -105.78 147.18 28.91 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.363 0.601 . . . . 0.0 110.175 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 173.44 150.32 7.43 Favored Glycine 0 C--O 1.243 0.703 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 174.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.465 ' HZ2' ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -156.31 171.67 19.82 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.707 0.765 . . . . 0.0 110.888 -173.314 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -147.15 150.37 38.02 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 125.27 1.428 . . . . 0.0 107.841 -173.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -42.28 147.85 0.47 Allowed 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 123.773 2.982 . . . . 0.0 113.681 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.448 ' H ' ' HZ3' ' A' ' 40' ' ' TRP . . . -57.19 -22.02 37.57 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.812 0.845 . . . . 0.0 112.974 -171.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.1 m -58.44 -28.39 65.24 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.34 1.056 . . . . 0.0 112.791 177.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -79.88 -29.61 40.01 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.7 0.8 . . . . 0.0 111.776 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.411 HG21 ' CZ2' ' A' ' 51' ' ' TRP . 23.7 m -123.86 -171.8 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 123.247 0.619 . . . . 0.0 112.078 -166.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.557 ' HB2' HD21 ' A' ' 9' ' ' LEU . 7.7 tp60 -120.61 139.75 52.53 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.0 1.32 . . . . 0.0 108.594 174.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.413 HD21 ' HH2' ' A' ' 51' ' ' TRP . 96.7 mt -104.35 119.71 39.57 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.439 0.696 . . . . 0.0 109.648 176.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.428 HD21 ' HG3' ' A' ' 7' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--O 1.253 1.241 0 C-N-CA 124.107 0.963 . . . . 0.0 108.789 175.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtm . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.9 t -144.41 87.17 1.86 Allowed 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.3 59.9 4.89 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 173.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.16 114.35 13.76 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.495 1.118 . . . . 0.0 109.034 -174.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -129.22 154.62 46.61 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.324 1.05 . . . . 0.0 109.341 176.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.579 ' SG ' HD11 ' A' ' 31' ' ' LEU . 84.0 m -122.97 175.89 6.33 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.854 -1.067 . . . . 0.0 108.773 173.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -156.32 129.01 7.76 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.58 HG23 HD11 ' A' ' 29' ' ' ILE . 34.3 p -66.77 147.73 52.86 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.064 0.946 . . . . 0.0 111.393 -175.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.5 mt -80.23 -62.57 1.64 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.815 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -141.51 164.56 34.2 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 123.991 0.917 . . . . 0.0 109.706 -172.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.548 ' HG3' ' HB2' ' A' ' 25' ' ' ALA . 26.5 Cg_exo -62.4 121.45 9.44 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 122.727 2.284 . . . . 0.0 112.37 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -91.43 142.99 27.07 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.6 m -125.77 -72.33 0.66 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.981 0.513 . . . . 0.0 109.886 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.15 153.2 19.67 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -170.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -74.79 -32.71 62.09 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.484 0.713 . . . . 0.0 111.141 -176.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -163.04 131.06 3.74 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.802 0.841 . . . . 0.0 109.205 -177.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -163.56 115.05 1.42 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.189 0.996 . . . . 0.0 109.604 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.68 -47.97 88.52 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.246 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -155.49 148.31 24.31 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.537 0.735 . . . . 0.0 110.063 175.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -152.94 -164.83 12.81 Favored Glycine 0 C--O 1.241 0.57 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 171.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.6 tp -99.9 125.02 45.82 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 175.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.56 133.62 37.32 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.881 0.872 . . . . 0.0 110.986 -174.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -134.0 147.8 51.04 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.031 0.933 . . . . 0.0 108.568 170.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.64 166.57 12.74 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.633 0.773 . . . . 0.0 109.274 169.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.548 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -66.2 120.8 13.87 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.222 0.609 . . . . 0.0 110.169 176.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.75 17.08 80.21 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 123.287 0.367 . . . . 0.0 113.237 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.76 143.51 26.65 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.165 0.586 . . . . 0.0 109.466 179.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 mp -74.7 164.63 26.36 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.362 1.065 . . . . 0.0 111.499 -175.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.58 HD11 HG23 ' A' ' 8' ' ' THR . 4.1 mp -131.8 123.39 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 174.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.1 m -85.6 106.19 16.72 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.579 HD11 ' SG ' ' A' ' 6' ' ' CYS . 88.5 mt -77.42 106.13 8.99 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.982 0.513 . . . . 0.0 109.906 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.436 HD11 ' HB2' ' A' ' 43' ' ' GLU . 86.0 mt -83.37 -51.59 7.27 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.805 0.842 . . . . 0.0 109.776 -178.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.649 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 1.4 mp0 -106.48 146.62 30.34 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.692 0.797 . . . . 0.0 108.856 172.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.4 m -128.0 69.71 77.37 Favored Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 123.644 0.778 . . . . 0.0 110.232 172.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 40' ' ' TRP . 64.2 Cg_endo -71.25 132.2 20.53 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 122.392 2.061 . . . . 0.0 111.845 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.5 t70 60.91 -88.04 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.967 1.307 . . . . 0.0 112.074 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 161.11 40.55 0.02 OUTLIER Glycine 0 C--N 1.344 0.978 0 O-C-N 122.912 0.133 . . . . 0.0 112.838 -173.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.24 -86.64 0.07 OUTLIER Glycine 0 C--N 1.348 1.225 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 18.1 m95 -82.88 114.53 21.25 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.569 ' HZ3' HD21 ' A' ' 59' ' ' LEU . 18.6 m0 -113.32 144.86 42.03 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.409 0.684 . . . . 0.0 110.061 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.649 ' HB2' ' HB2' ' A' ' 33' ' ' GLN . 39.7 mt-10 -91.71 122.03 33.89 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.786 0.834 . . . . 0.0 109.841 -175.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.25 169.62 20.51 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.039 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.436 ' HB2' HD11 ' A' ' 32' ' ' LEU . 35.5 tt0 -124.09 154.22 40.29 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.972 0.909 . . . . 0.0 108.886 177.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.634 ' HE3' ' HA ' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -129.84 172.83 11.25 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 122.967 0.507 . . . . 0.0 109.958 173.819 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.478 ' HG2' ' HE2' ' A' ' 44' ' ' LYS . 6.3 mm-40 -67.09 -10.57 51.45 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.466 1.106 . . . . 0.0 111.46 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -55.29 -25.6 35.08 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.865 1.266 . . . . 0.0 111.541 168.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.32 -24.15 32.78 Favored Glycine 0 C--N 1.354 1.552 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 177.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.58 173.99 7.76 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.725 0.81 . . . . 0.0 110.602 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 38.2 mtm-85 -123.54 157.59 33.28 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.122 0.969 . . . . 0.0 108.645 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.99 154.2 25.32 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.586 ' HB3' ' HG2' ' A' ' 41' ' ' GLU . 4.8 p-90 -111.34 126.8 55.3 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -138.25 148.24 58.89 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.879 0.872 . . . . 0.0 109.319 -172.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.582 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 57.1 Cg_endo -69.68 142.87 49.45 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.302 2.001 . . . . 0.0 111.24 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.95 -23.06 66.14 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.925 0.89 . . . . 0.0 110.758 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.5 m -64.71 -40.03 94.66 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.267 1.027 . . . . 0.0 111.622 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.582 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 17.3 t80 -74.01 -32.89 63.57 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 121.316 0.579 . . . . 0.0 110.996 -173.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.6 m -104.54 -169.14 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.345 1.058 . . . . 0.0 108.899 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -141.18 130.94 24.21 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.729 0.412 . . . . 0.0 110.263 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.569 HD21 ' HZ3' ' A' ' 40' ' ' TRP . 94.8 mt -71.57 141.75 50.04 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.662 0.785 . . . . 0.0 111.552 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.7 mt . . . . . 0 C--O 1.244 0.806 0 C-N-CA 124.14 0.976 . . . . 0.0 109.848 -179.956 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.0 m -66.99 137.91 56.86 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.434 0.693 . . . . 0.0 110.569 174.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -143.27 -117.57 1.24 Allowed Glycine 0 C--N 1.34 0.787 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 177.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.79 137.49 47.67 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.37 0.668 . . . . 0.0 109.541 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -161.13 172.8 16.13 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.39 0.615 . . . . 0.0 111.501 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.641 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 20.6 p -141.41 171.82 13.54 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.315 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.461 ' HB2' HD21 ' A' ' 60' ' ' LEU . 28.2 tpt85 -117.51 128.64 55.18 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.742 1.217 . . . . 0.0 109.272 -172.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.0 p -80.15 112.68 17.7 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.366 0.666 . . . . 0.0 109.326 173.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.94 -58.98 3.21 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.348 0.659 . . . . 0.0 110.762 -175.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -137.36 156.64 75.07 Favored Pre-proline 0 N--CA 1.488 1.434 0 C-N-CA 123.617 0.767 . . . . 0.0 109.69 -175.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . 44.9 Cg_endo -66.22 125.31 13.83 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.532 2.155 . . . . 0.0 112.381 175.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -92.86 121.33 34.11 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.127 0.971 . . . . 0.0 108.599 176.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.7 t -124.76 -161.99 1.06 Allowed 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 175.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 161.52 -35.61 0.39 Allowed Glycine 0 C--N 1.339 0.74 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 66.67 2.98 2.76 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.4 1.08 . . . . 0.0 112.877 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -82.11 -41.74 20.1 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.217 1.007 . . . . 0.0 109.261 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 20.8 m80 -84.91 119.16 25.04 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.168 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.38 -52.32 36.47 Favored Glycine 0 C--N 1.346 1.088 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 171.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -122.59 144.02 49.37 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.571 1.149 . . . . 0.0 109.438 173.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.19 159.56 10.11 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.54 HD11 ' HD3' ' A' ' 44' ' ' LYS . 16.9 tp -88.25 132.71 34.27 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 117.971 0.886 . . . . 0.0 108.773 -177.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -123.47 169.21 11.62 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.389 1.076 . . . . 0.0 109.031 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -123.54 113.34 18.58 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.612 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . . . -95.73 160.45 14.48 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 173.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.83 128.07 34.59 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.312 0.645 . . . . 0.0 111.121 -170.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.16 -30.81 6.33 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-O 119.305 -0.719 . . . . 0.0 113.927 176.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -61.57 130.84 47.89 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 117.665 0.733 . . . . 0.0 112.039 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 61.3 mt -99.25 103.32 15.17 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 175.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.641 ' HB ' ' SG ' ' A' ' 6' ' ' CYS . 21.9 mm -88.07 109.2 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -169.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.2 m -74.38 109.54 7.95 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.481 0.488 . . . . 0.0 110.622 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.8 mt -69.81 104.34 2.43 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.849 -0.796 . . . . 0.0 108.849 175.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 70.5 mt -74.16 -30.63 62.34 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.658 0.783 . . . . 0.0 110.032 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -127.11 136.34 51.99 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.223 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.1 m -129.75 90.39 43.47 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.768 1.227 . . . . 0.0 108.576 175.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.62 -155.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.691 2.261 . . . . 0.0 110.926 177.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -63.21 -31.98 73.26 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.031 0.532 . . . . 0.0 111.171 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.34 -163.59 29.91 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 116.417 -0.356 . . . . 0.0 112.218 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.58 -76.49 2.1 Favored Glycine 0 C--N 1.345 1.04 0 C-N-CA 123.458 0.551 . . . . 0.0 112.11 177.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -114.41 132.52 56.21 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.304 0.642 . . . . 0.0 109.475 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -117.67 153.39 33.41 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.435 0.694 . . . . 0.0 109.432 173.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -91.69 120.4 32.41 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 173.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -123.03 135.47 10.04 Favored Glycine 0 C--N 1.342 0.874 0 O-C-N 123.379 0.425 . . . . 0.0 112.71 -175.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.573 ' HA ' ' HG2' ' A' ' 49' ' ' ARG . 10.6 tp10 -105.04 140.96 37.45 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.371 1.069 . . . . 0.0 110.228 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.615 ' HG2' HD12 ' A' ' 29' ' ' ILE . 22.3 mtpt -124.53 157.53 35.11 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.797 0.839 . . . . 0.0 110.27 176.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.81 0.68 26.07 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.42 0.688 . . . . 0.0 111.326 174.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.56 -27.66 68.6 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.423 1.089 . . . . 0.0 110.159 168.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.66 -17.21 57.85 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.011 -176.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -98.66 154.84 17.65 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.857 0.863 . . . . 0.0 110.119 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.573 ' HG2' ' HA ' ' A' ' 43' ' ' GLU . 72.1 mtm180 -124.62 169.04 12.33 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.488 1.115 . . . . 0.0 109.499 170.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.91 173.15 39.09 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.55 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -111.71 125.26 53.78 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -151.57 147.12 19.64 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 124.23 1.012 . . . . 0.0 109.492 -175.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -83.31 178.75 5.53 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.255 2.637 . . . . 0.0 111.539 172.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.02 -14.09 61.06 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.008 0.923 . . . . 0.0 112.046 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -59.68 -19.62 50.81 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.565 1.146 . . . . 0.0 113.155 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -113.05 -16.05 12.71 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.657 0.783 . . . . 0.0 111.868 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.15 136.22 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 122.973 0.509 . . . . 0.0 111.324 -172.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -91.87 112.79 24.85 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.765 0.826 . . . . 0.0 109.782 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.59 123.37 18.64 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.056 0.542 . . . . 0.0 110.764 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.461 HD21 ' HB2' ' A' ' 7' ' ' ARG . 86.7 mt . . . . . 0 CA--C 1.55 0.952 0 C-N-CA 123.747 0.819 . . . . 0.0 110.745 -177.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.7 t -138.82 155.34 48.23 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.803 0.841 . . . . 0.0 110.078 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.69 91.18 0.77 Allowed Glycine 0 C--N 1.354 1.57 0 O-C-N 123.958 0.786 . . . . 0.0 112.317 -178.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.89 132.54 54.26 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.549 1.14 . . . . 0.0 110.721 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -142.46 153.43 43.67 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.478 0.711 . . . . 0.0 110.959 -172.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.462 ' SG ' HD11 ' A' ' 31' ' ' LEU . 81.2 m -139.15 148.89 43.82 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.875 1.27 . . . . 0.0 108.967 175.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -108.14 152.35 24.67 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.454 0.702 . . . . 0.0 109.778 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.491 HG21 ' HB2' ' A' ' 23' ' ' PHE . 24.5 p -87.89 130.19 34.99 Favored 'General case' 0 C--O 1.242 0.711 0 C-N-CA 123.47 0.708 . . . . 0.0 110.464 173.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.5 mt -79.35 -53.5 6.87 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.249 1.019 . . . . 0.0 110.012 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -134.89 155.12 79.53 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 123.599 0.76 . . . . 0.0 109.574 -173.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.516 ' HD3' ' HB2' ' A' ' 25' ' ' ALA . 64.6 Cg_endo -78.71 85.37 1.86 Allowed 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 121.874 1.716 . . . . 0.0 110.646 170.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -92.7 101.18 13.58 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.092 -175.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.9 m -153.9 63.29 0.72 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.816 1.246 . . . . 0.0 107.905 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.26 -33.25 86.73 Favored Glycine 0 C--N 1.357 1.732 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.4 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -127.39 138.27 52.96 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.55 1.14 . . . . 0.0 108.555 170.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -66.55 -51.93 51.2 Favored 'General case' 0 CA--C 1.55 0.973 0 O-C-N 123.784 0.678 . . . . 0.0 109.615 176.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.4 t60 64.55 -77.52 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.423 1.489 . . . . 0.0 111.791 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 145.17 -66.46 0.43 Allowed Glycine 0 C--N 1.34 0.782 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -76.84 103.95 7.07 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.243 0.617 . . . . 0.0 109.823 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.74 -162.59 34.13 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.442 HD22 ' HA3' ' A' ' 50' ' ' GLY . 20.7 tp -143.24 120.04 11.22 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 176.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -77.46 120.94 23.15 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.491 ' HB2' HG21 ' A' ' 8' ' ' THR . 33.1 p90 -120.75 130.02 53.86 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.179 0.991 . . . . 0.0 110.104 -178.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -104.31 153.98 20.37 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.056 0.943 . . . . 0.0 110.488 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.516 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . . . -58.5 121.56 11.21 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.969 0.908 . . . . 0.0 111.99 -178.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.56 -23.96 16.56 Favored Glycine 0 C--N 1.347 1.164 0 C-N-CA 123.337 0.494 . . . . 0.0 113.661 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -60.9 128.48 36.69 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.552 0.741 . . . . 0.0 111.526 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.2 mt -96.24 125.13 40.54 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.8 mp -104.86 116.39 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 175.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.8 m -87.0 111.5 20.92 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.462 HD11 ' SG ' ' A' ' 6' ' ' CYS . 7.0 mp -65.69 115.96 6.4 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.044 0.938 . . . . 0.0 110.698 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.421 HD11 ' HB2' ' A' ' 43' ' ' GLU . 58.6 mt -84.72 -36.25 21.95 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.151 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -116.51 135.64 53.65 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.054 0.942 . . . . 0.0 109.309 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.5 m -143.71 66.41 15.22 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 124.046 0.938 . . . . 0.0 110.434 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.402 ' HD2' ' HD1' ' A' ' 40' ' ' TRP . 7.6 Cg_exo -77.03 -173.12 1.64 Allowed 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 123.211 2.607 . . . . 0.0 112.73 174.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -77.37 101.18 6.22 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.566 0.747 . . . . 0.0 110.548 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.72 -154.94 26.08 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 116.371 -0.377 . . . . 0.0 112.647 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.9 -28.67 4.1 Favored Glycine 0 C--N 1.346 1.129 0 N-CA-C 112.236 -0.346 . . . . 0.0 112.236 176.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -81.06 110.62 16.76 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.593 0.757 . . . . 0.0 109.512 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.402 ' HD1' ' HD2' ' A' ' 35' ' ' PRO . 7.0 m0 -125.36 138.75 54.05 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.741 0.817 . . . . 0.0 109.726 178.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.577 ' HG2' ' HB3' ' A' ' 51' ' ' TRP . 28.2 mt-10 -94.87 138.32 32.8 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.687 0.395 . . . . 0.0 110.496 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.13 171.01 27.16 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.412 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.421 ' HB2' HD11 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -127.83 148.22 50.45 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.124 0.57 . . . . 0.0 110.17 -169.759 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.467 ' HE3' ' HB3' ' A' ' 46' ' ' ASP . 39.7 mtmt -88.3 -173.22 4.11 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.605 1.562 . . . . 0.0 110.24 176.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -86.6 62.1 7.21 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 165.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.467 ' HB3' ' HE3' ' A' ' 44' ' ' LYS . 38.0 t70 -148.56 -47.75 0.15 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -168.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.64 -9.76 28.05 Favored Glycine 0 N--CA 1.473 1.136 0 CA-C-O 119.848 -0.418 . . . . 0.0 113.683 -174.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.58 130.99 45.86 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 117.544 0.672 . . . . 0.0 110.1 172.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -103.14 143.07 33.09 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.778 0.831 . . . . 0.0 109.446 -175.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.442 ' HA3' HD22 ' A' ' 21' ' ' LEU . . . -134.34 155.15 21.74 Favored Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 177.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.577 ' HB3' ' HG2' ' A' ' 41' ' ' GLU . 1.1 p-90 -99.66 132.19 45.17 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.995 0.918 . . . . 0.0 109.88 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -133.26 129.39 20.78 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 123.657 0.783 . . . . 0.0 109.446 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.65 151.98 83.05 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.3 2.0 . . . . 0.0 111.15 162.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.572 ' HB1' HD11 ' A' ' 59' ' ' LEU . . . -60.0 -26.47 66.08 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.473 1.109 . . . . 0.0 112.178 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.1 m -73.14 -16.79 61.44 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.829 0.852 . . . . 0.0 113.118 -177.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -96.8 -24.71 15.78 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.002 0.521 . . . . 0.0 111.992 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.2 m -116.89 151.73 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.113 0.565 . . . . 0.0 110.963 -173.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -81.17 103.85 11.25 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.78 0.832 . . . . 0.0 109.288 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.572 HD11 ' HB1' ' A' ' 54' ' ' ALA . 43.8 mt -67.77 115.1 6.94 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.1 mt . . . . . 0 C--O 1.25 1.104 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -177.546 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtm . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 72.7 p -85.09 141.91 29.9 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.521 0.728 . . . . 0.0 111.094 -176.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -118.26 120.48 4.73 Favored Glycine 0 C--N 1.346 1.106 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.533 ' HB3' ' HB2' ' A' ' 31' ' ' LEU . . . -77.08 106.8 9.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.453 0.701 . . . . 0.0 109.651 -177.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -78.64 142.24 37.37 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.751 0.42 . . . . 0.0 110.359 -176.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 76.7 m -138.75 159.56 41.81 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.985 0.914 . . . . 0.0 109.229 174.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.568 ' HB2' ' HB3' ' A' ' 58' ' ' GLN . 19.9 mmt180 -106.69 147.72 29.24 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.643 1.177 . . . . 0.0 108.688 176.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.543 HG21 ' HB2' ' A' ' 23' ' ' PHE . 21.8 p -94.68 118.16 31.28 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.098 175.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.476 HD21 ' HB2' ' A' ' 58' ' ' GLN . 86.0 mt -69.47 -50.62 43.68 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.945 0.498 . . . . 0.0 110.885 -177.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -135.2 148.29 65.87 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 123.569 0.748 . . . . 0.0 109.731 -178.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . 2.8 Cg_exo -74.9 121.68 6.77 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.792 2.328 . . . . 0.0 111.232 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -128.34 102.3 6.6 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.163 0.506 . . . . 0.0 109.89 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.1 m -153.22 30.61 0.48 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.874 1.27 . . . . 0.0 109.528 174.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.03 88.46 0.01 OUTLIER Glycine 0 C--N 1.356 1.644 0 O-C-N 124.44 1.088 . . . . 0.0 113.611 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 57.62 48.79 13.59 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.167 1.387 . . . . 0.0 110.347 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -98.9 80.11 2.46 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.055 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -90.99 -18.96 23.77 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.795 0.838 . . . . 0.0 111.106 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.56 -165.39 24.86 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.932 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -73.84 85.79 1.72 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.76 0.791 . . . . 0.0 110.627 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -164.64 143.4 8.49 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.721 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.595 HD11 ' HB3' ' A' ' 44' ' ' LYS . 27.0 tp -90.18 142.44 27.71 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.919 0.488 . . . . 0.0 110.822 -171.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -99.89 138.92 36.3 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.23 1.012 . . . . 0.0 110.655 -175.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.543 ' HB2' HG21 ' A' ' 8' ' ' THR . 28.1 p90 -154.16 121.98 5.93 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.592 0.757 . . . . 0.0 110.45 -174.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . . . -92.08 152.51 19.91 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.61 1.164 . . . . 0.0 109.654 171.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.409 ' H ' ' HG3' ' A' ' 11' ' ' PRO . . . -61.99 125.02 22.38 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.719 0.808 . . . . 0.0 111.922 -175.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.87 -20.65 17.1 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 123.643 0.589 . . . . 0.0 113.343 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -72.23 142.91 48.97 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 121.329 0.585 . . . . 0.0 112.219 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.61 111.12 19.25 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.303 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.4 mm -91.36 120.76 40.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 123.471 0.708 . . . . 0.0 109.636 174.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.6 m -85.74 103.85 14.9 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 91.2 mt -71.86 107.45 4.64 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 67.2 mt -75.39 -48.46 22.81 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.591 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -126.45 136.94 53.28 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.067 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.3 m -115.22 91.45 27.88 Favored Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 124.259 1.024 . . . . 0.0 108.929 176.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.62 -49.65 15.23 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 123.298 2.665 . . . . 0.0 112.889 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -164.09 -79.29 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.693 0.797 . . . . 0.0 109.5 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -161.4 149.47 18.26 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 -174.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.37 -61.49 2.86 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 116.577 0.189 . . . . 0.0 112.761 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 40.9 m95 -121.3 99.73 6.65 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.927 0.491 . . . . 0.0 109.786 -172.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -112.12 146.22 38.4 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -90.12 117.2 28.72 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.13 148.58 18.24 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.678 177.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -103.36 160.49 14.65 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.561 0.696 . . . . 0.0 109.816 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.595 ' HB3' HD11 ' A' ' 21' ' ' LEU . 2.0 tmtp? -132.73 155.94 47.93 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 170.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.44 ' H ' ' HD3' ' A' ' 44' ' ' LYS . 9.6 pt-20 -66.52 6.33 0.47 Allowed 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -67.78 -15.66 63.74 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.332 0.653 . . . . 0.0 111.49 168.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.49 -15.24 61.36 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 112.37 -0.292 . . . . 0.0 112.37 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.443 ' HB2' HD13 ' A' ' 21' ' ' LEU . 89.0 mt -96.63 163.03 13.19 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.629 0.772 . . . . 0.0 110.099 176.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 35.9 ttp-105 -119.98 155.75 32.22 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 169.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -150.52 161.47 28.98 Favored Glycine 0 C--N 1.336 0.577 0 N-CA-C 112.343 -0.303 . . . . 0.0 112.343 177.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -88.76 129.87 35.46 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 171.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 59.2 m-85 -108.35 137.22 19.87 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 123.324 0.65 . . . . 0.0 111.035 -173.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 52' ' ' PHE . 6.4 Cg_exo -73.66 124.04 9.0 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 123.086 2.524 . . . . 0.0 111.199 177.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.83 -45.08 86.72 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.744 1.218 . . . . 0.0 113.098 -171.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.3 t -75.98 -25.48 55.86 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.189 0.596 . . . . 0.0 111.12 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -85.77 -18.24 33.54 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.416 0.686 . . . . 0.0 111.167 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.3 m -108.99 147.31 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.094 0.558 . . . . 0.0 109.553 173.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.568 ' HB3' ' HB2' ' A' ' 7' ' ' ARG . 34.1 tt0 -87.64 115.01 24.78 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 174.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.2 mt -76.95 128.66 34.94 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.771 0.429 . . . . 0.0 110.155 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.2 mt . . . . . 0 C--O 1.249 1.066 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 176.475 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 ttm . . . . . 0 CA--C 1.542 0.666 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.6 t -167.91 164.3 13.91 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.92 0.888 . . . . 0.0 109.838 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 72.29 24.81 75.77 Favored Glycine 0 C--N 1.35 1.35 0 CA-C-N 115.843 -0.617 . . . . 0.0 113.104 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 31' ' ' LEU . . . -75.91 86.97 2.87 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.871 0.868 . . . . 0.0 111.072 -173.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.419 ' HB2' ' HB2' ' A' ' 60' ' ' LEU . 93.6 mtt180 -110.28 151.78 26.96 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.352 1.061 . . . . 0.0 109.579 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.417 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 28.3 p -158.91 140.62 13.48 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.448 0.699 . . . . 0.0 109.154 171.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.524 ' HB2' HD11 ' A' ' 60' ' ' LEU . 40.2 ttp180 -112.68 130.4 56.06 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.287 0.635 . . . . 0.0 109.45 177.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 45.1 p -66.51 139.21 57.93 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 122.974 0.51 . . . . 0.0 111.468 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.41 HD21 ' HB2' ' A' ' 58' ' ' GLN . 86.0 mt -97.93 -22.53 16.27 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.328 1.051 . . . . 0.0 110.286 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -131.89 151.72 79.01 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 124.02 0.928 . . . . 0.0 109.574 -177.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.86 164.37 33.64 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.304 2.002 . . . . 0.0 111.366 169.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -93.65 102.79 14.98 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.3 p -69.56 120.18 14.95 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 123.222 0.609 . . . . 0.0 109.399 174.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.35 -179.01 48.16 Favored Glycine 0 C--N 1.342 0.894 0 O-C-N 123.595 0.559 . . . . 0.0 112.535 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -83.63 169.15 15.65 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.127 0.571 . . . . 0.0 109.482 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 55.9 mtp85 -56.63 -56.25 23.75 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.503 0.721 . . . . 0.0 111.143 178.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 69.3 t60 66.97 171.14 0.25 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.809 1.243 . . . . 0.0 112.526 169.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.72 -68.86 1.52 Allowed Glycine 0 C--N 1.351 1.391 0 CA-C-N 116.487 -0.324 . . . . 0.0 112.874 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -153.74 148.23 26.13 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.2 0.6 . . . . 0.0 111.278 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 168.81 -175.3 43.34 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.8 tp -90.21 114.13 26.07 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 121.572 0.701 . . . . 0.0 109.614 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -122.58 151.84 41.02 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 125.033 1.333 . . . . 0.0 107.768 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -156.18 152.42 27.83 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.184 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.473 ' O ' ' HG2' ' A' ' 27' ' ' GLU . . . -96.48 169.46 9.89 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.828 1.251 . . . . 0.0 109.027 165.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.09 111.63 3.48 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 122.12 -0.363 . . . . 0.0 110.064 171.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.26 19.8 6.15 Favored Glycine 0 C--N 1.351 1.375 0 N-CA-C 114.388 0.515 . . . . 0.0 114.388 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 24' ' ' ALA . 10.9 mm-40 -92.0 136.69 32.97 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 117.772 0.786 . . . . 0.0 111.138 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.8 mt -84.16 103.06 13.05 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.523 0.729 . . . . 0.0 109.902 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.417 ' HB ' ' SG ' ' A' ' 6' ' ' CYS . 47.5 mm -92.1 124.11 44.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.586 1.154 . . . . 0.0 109.491 176.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.0 m -88.46 107.29 18.79 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.167 0.987 . . . . 0.0 109.112 174.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.465 ' HB2' ' HB1' ' A' ' 4' ' ' ALA . 96.2 mt -70.98 111.98 6.78 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.409 ' H ' ' HA2' ' A' ' 42' ' ' GLY . 82.3 mt -80.46 -53.95 6.13 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 123.151 0.58 . . . . 0.0 109.488 -178.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.606 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 47.2 mt-30 -109.0 135.63 49.87 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.0 m -135.09 84.23 37.31 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 123.413 0.685 . . . . 0.0 110.205 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.12 161.72 37.97 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.583 2.189 . . . . 0.0 111.374 169.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -73.12 100.07 2.96 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.142 0.577 . . . . 0.0 110.11 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.18 -154.42 20.42 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.26 -16.21 23.55 Favored Glycine 0 N--CA 1.47 0.92 0 N-CA-C 112.101 -0.4 . . . . 0.0 112.101 172.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 53.9 m95 -92.14 119.22 31.59 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.272 1.029 . . . . 0.0 109.346 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.4 ' CZ3' HD21 ' A' ' 59' ' ' LEU . 5.2 m-90 -131.39 153.18 49.94 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.674 0.79 . . . . 0.0 109.781 178.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.606 ' HB3' ' HB2' ' A' ' 33' ' ' GLN . 3.1 tm-20 -102.79 132.33 49.03 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.409 ' HA2' ' H ' ' A' ' 32' ' ' LEU . . . -152.76 152.17 23.88 Favored Glycine 0 CA--C 1.508 -0.388 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.088 -177.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 49' ' ' ARG . 9.8 pt-20 -103.67 152.5 21.72 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.113 0.565 . . . . 0.0 110.125 173.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -78.68 154.42 30.17 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 157.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -73.6 16.51 0.2 Allowed 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -170.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -97.24 -1.11 45.53 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.671 1.188 . . . . 0.0 111.282 169.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.81 3.4 68.41 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-O 120.115 -0.269 . . . . 0.0 113.737 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.6 mt -91.25 114.98 27.64 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.541 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 12.6 ptt180 -116.97 165.73 13.01 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.864 0.466 . . . . 0.0 111.863 -173.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 177.7 171.47 41.18 Favored Glycine 0 C--N 1.348 1.239 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.797 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -94.98 128.19 41.6 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.45 0.7 . . . . 0.0 110.315 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -147.7 145.24 20.73 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 124.161 0.985 . . . . 0.0 109.766 175.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -78.4 176.6 9.73 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.685 2.257 . . . . 0.0 111.518 173.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.27 -21.46 61.93 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.038 175.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.9 m -53.22 -33.66 53.79 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.273 1.429 . . . . 0.0 113.471 -176.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -96.2 -18.0 20.39 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.104 0.562 . . . . 0.0 112.431 -176.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 35.8 m -120.03 174.39 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-O 121.411 0.624 . . . . 0.0 112.0 -171.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.41 ' HB2' HD21 ' A' ' 9' ' ' LEU . 22.5 tp60 -130.79 115.49 16.69 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.177 1.391 . . . . 0.0 107.819 174.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.4 HD21 ' CZ3' ' A' ' 40' ' ' TRP . 78.3 mt -63.03 126.37 27.11 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.929 0.768 . . . . 0.0 110.442 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 7' ' ' ARG . 80.2 mt . . . . . 0 C--O 1.252 1.194 0 C-N-CA 124.15 0.98 . . . . 0.0 108.791 -176.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.0 tmm? . . . . . 0 N--CA 1.485 1.277 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.4 p -135.53 -164.8 1.59 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.148 0.979 . . . . 0.0 110.066 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 92.18 -59.72 2.69 Favored Glycine 0 C--N 1.353 1.495 0 N-CA-C 111.984 -0.447 . . . . 0.0 111.984 176.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 31' ' ' LEU . . . -75.38 90.48 2.67 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.193 0.597 . . . . 0.0 110.406 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -81.39 123.46 28.58 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.171 0.988 . . . . 0.0 109.372 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 59' ' ' LEU . 48.6 t -124.14 155.7 37.97 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.223 0.535 . . . . 0.0 110.929 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -116.04 131.96 56.79 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.627 1.171 . . . . 0.0 109.175 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.54 ' HA ' HG12 ' A' ' 57' ' ' VAL . 16.5 p -77.37 121.29 23.56 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.488 0.715 . . . . 0.0 109.813 170.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.42 HD11 ' HG3' ' A' ' 58' ' ' GLN . 81.4 mt -73.06 -51.51 17.82 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.29 0.636 . . . . 0.0 109.676 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -137.8 152.85 73.22 Favored Pre-proline 0 N--CA 1.483 1.183 0 C-N-CA 123.662 0.785 . . . . 0.0 110.467 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.41 129.51 12.97 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.354 2.036 . . . . 0.0 111.72 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -117.22 101.6 8.58 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.4 t -92.75 -47.28 7.15 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.448 -171.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.79 -117.55 0.43 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -178.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 60.93 -74.34 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.621 1.568 . . . . 0.0 111.703 -177.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.481 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -79.91 -11.72 59.78 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.532 0.733 . . . . 0.0 111.942 -178.137 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -140.64 172.21 13.02 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.31 0.644 . . . . 0.0 110.476 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.72 -23.18 0.38 Allowed Glycine 0 C--N 1.346 1.123 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.081 175.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -125.28 21.94 7.89 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.769 0.827 . . . . 0.0 111.347 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.08 176.9 54.51 Favored Glycine 0 C--N 1.351 1.39 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 172.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.424 HD21 ' HG2' ' A' ' 44' ' ' LYS . 44.8 tp -89.87 124.79 35.0 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -79.49 136.96 37.05 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.549 0.74 . . . . 0.0 110.479 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -149.04 128.6 13.13 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.067 0.947 . . . . 0.0 109.245 177.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.8 150.82 20.28 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.3 1.04 . . . . 0.0 110.017 177.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.11 133.4 54.38 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.622 0.769 . . . . 0.0 111.716 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.56 -23.38 28.38 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 119.605 -0.553 . . . . 0.0 113.179 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -65.0 136.17 56.48 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-N 117.201 0.5 . . . . 0.0 111.69 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 73.9 mt -85.67 101.43 12.74 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.3 mm -88.62 111.18 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.929 0.891 . . . . 0.0 108.644 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.2 p -77.32 105.42 8.42 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.553 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 39.8 mt -67.56 142.19 56.59 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 173.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.8 mt -74.34 -43.04 58.32 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.968 0.507 . . . . 0.0 110.57 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -157.14 157.17 33.97 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.112 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.5 m -109.66 94.36 16.51 Favored Pre-proline 0 CA--C 1.557 1.24 0 C-N-CA 123.38 0.672 . . . . 0.0 110.944 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.42 ' HD2' ' CD1' ' A' ' 40' ' ' TRP . 79.3 Cg_endo -81.86 170.57 13.88 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.578 2.185 . . . . 0.0 111.174 167.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.4 143.84 54.94 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.108 0.48 . . . . 0.0 111.369 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.47 166.99 33.81 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.356 -177.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.0 55.26 4.98 Favored Glycine 0 C--N 1.348 1.199 0 C-N-CA 123.211 0.434 . . . . 0.0 112.584 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.401 ' HZ3' ' HG3' ' A' ' 53' ' ' PRO . 75.6 t-105 -143.79 114.76 7.81 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.437 1.095 . . . . 0.0 108.484 -177.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.42 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 12.9 m-90 -136.28 144.19 44.62 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.938 0.895 . . . . 0.0 109.712 -177.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -95.74 116.28 28.66 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 169.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 31' ' ' LEU . . . -108.76 143.76 16.28 Favored Glycine 0 C--N 1.337 0.635 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 49' ' ' ARG . 31.8 tt0 -115.52 136.9 52.61 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.007 0.523 . . . . 0.0 109.837 -178.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.424 ' HG2' HD21 ' A' ' 21' ' ' LEU . 30.2 mmmt -71.62 163.43 27.77 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.696 1.198 . . . . 0.0 109.787 170.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -64.71 -11.66 38.47 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.963 0.905 . . . . 0.0 112.685 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -89.22 -8.12 54.18 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.334 1.054 . . . . 0.0 112.49 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.43 -1.27 66.53 Favored Glycine 0 C--N 1.345 1.078 0 O-C-N 123.147 0.279 . . . . 0.0 112.842 -173.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.8 mt -83.05 104.99 13.67 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.665 0.786 . . . . 0.0 109.73 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 28.0 ptt180 -102.64 154.33 19.25 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -159.18 -178.28 33.04 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.908 -0.587 . . . . 0.0 113.062 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -77.05 129.58 36.26 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.24 1.016 . . . . 0.0 110.47 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -135.39 94.28 15.67 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 123.914 0.886 . . . . 0.0 109.617 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HG3' ' HZ3' ' A' ' 39' ' ' TRP . 11.8 Cg_exo -71.45 148.32 54.08 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.915 2.41 . . . . 0.0 110.37 168.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.41 ' HB2' ' HZ3' ' A' ' 40' ' ' TRP . . . -63.31 -19.54 64.69 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.21 0.604 . . . . 0.0 112.396 -178.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.5 m -62.32 -31.05 71.61 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.756 0.822 . . . . 0.0 111.631 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -98.71 -27.65 13.87 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.4 0.68 . . . . 0.0 111.586 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.581 ' HB ' ' SG ' ' A' ' 6' ' ' CYS . 26.1 m -138.79 139.34 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 122.94 0.496 . . . . 0.0 111.321 -174.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.42 ' HG3' HD11 ' A' ' 9' ' ' LEU . 53.1 mt-30 -128.82 133.16 47.92 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.546 0.738 . . . . 0.0 109.482 174.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.736 ' HA ' ' HA ' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -82.56 140.5 33.23 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.997 0.519 . . . . 0.0 112.312 -172.303 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 C--O 1.251 1.164 0 C-N-CA 124.772 1.229 . . . . 0.0 109.447 -178.114 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.3 m -73.88 145.88 44.49 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 171.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.12 76.81 1.4 Allowed Glycine 0 C--N 1.346 1.106 0 O-C-N 123.658 0.599 . . . . 0.0 111.641 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.89 76.31 1.16 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.849 0.86 . . . . 0.0 109.157 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.48 164.33 21.91 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.183 -173.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.447 ' SG ' HD23 ' A' ' 59' ' ' LEU . 78.2 m -145.12 166.86 24.18 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.981 0.913 . . . . 0.0 109.682 178.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.527 ' HG3' HD11 ' A' ' 60' ' ' LEU . 59.0 mtm180 -119.19 133.58 55.69 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.142 0.577 . . . . 0.0 109.98 175.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.603 HG23 HD11 ' A' ' 29' ' ' ILE . 8.9 p -73.45 121.65 20.87 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.428 0.455 . . . . 0.0 111.647 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.63 -15.98 27.73 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.788 0.835 . . . . 0.0 110.233 169.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -107.18 122.26 42.01 Favored Pre-proline 0 N--CA 1.48 1.073 0 C-N-CA 123.674 0.789 . . . . 0.0 110.58 171.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.408 ' HB3' ' N ' ' A' ' 25' ' ' ALA . 96.3 Cg_endo -83.44 49.93 3.1 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.928 2.418 . . . . 0.0 111.449 164.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -91.24 109.97 21.25 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -173.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.7 t -70.6 -21.37 62.67 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.524 1.13 . . . . 0.0 111.784 -177.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.35 -84.1 1.08 Allowed Glycine 0 C--N 1.347 1.185 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -171.86 161.33 5.8 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 124.999 1.32 . . . . 0.0 108.904 175.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -91.79 131.74 36.93 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 168.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -140.33 -64.22 0.47 Allowed 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.404 0.682 . . . . 0.0 109.495 -176.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.67 75.26 0.17 Allowed Glycine 0 C--N 1.346 1.106 0 CA-C-O 120.05 -0.305 . . . . 0.0 112.439 -175.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 66.29 21.71 10.97 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.549 1.14 . . . . 0.0 112.314 173.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.2 166.1 25.57 Favored Glycine 0 C--N 1.348 1.229 0 O-C-N 123.588 0.555 . . . . 0.0 113.591 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.46 HD11 ' HB2' ' A' ' 44' ' ' LYS . 27.5 tp -89.82 129.79 36.15 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.453 0.701 . . . . 0.0 109.492 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.25 161.14 19.44 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.964 1.306 . . . . 0.0 108.725 177.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -136.9 141.87 42.73 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.944 0.498 . . . . 0.0 111.741 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.62 169.96 10.1 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.777 1.231 . . . . 0.0 109.198 164.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.408 ' N ' ' HB3' ' A' ' 11' ' ' PRO . . . -72.72 115.92 12.58 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.94 19.9 8.77 Favored Glycine 0 N--CA 1.477 1.39 0 O-C-N 123.028 0.205 . . . . 0.0 113.483 177.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -72.85 149.99 43.06 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.917 0.487 . . . . 0.0 111.641 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.7 mt -106.37 108.1 19.44 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.603 HD11 HG23 ' A' ' 8' ' ' THR . 3.3 mp -103.21 107.79 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -175.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.0 m -75.8 108.06 8.4 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 173.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.24 123.51 19.73 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 123.704 0.628 . . . . 0.0 110.092 178.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.2 mt -73.84 -43.54 58.39 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.97 0.908 . . . . 0.0 109.12 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -126.45 155.46 42.19 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 124.912 1.285 . . . . 0.0 108.457 171.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.2 m -125.93 74.76 71.39 Favored Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 123.755 0.822 . . . . 0.0 110.939 176.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.39 164.38 35.38 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.427 2.084 . . . . 0.0 111.735 170.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -76.52 92.72 3.46 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.968 0.907 . . . . 0.0 109.85 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.93 -166.42 54.0 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-N 115.472 -0.785 . . . . 0.0 113.297 175.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.36 -104.24 1.02 Allowed Glycine 0 C--N 1.346 1.135 0 C-N-CA 123.74 0.685 . . . . 0.0 114.123 173.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -122.33 143.21 49.78 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.343 1.057 . . . . 0.0 109.901 -172.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.3 m-90 -124.57 145.31 49.66 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.169 0.988 . . . . 0.0 109.423 174.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -90.35 126.0 35.72 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 164.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.99 172.43 22.89 Favored Glycine 0 N--CA 1.467 0.766 0 O-C-N 123.621 0.575 . . . . 0.0 112.037 -176.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -131.87 145.13 51.35 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.228 0.537 . . . . 0.0 110.081 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.509 ' HG2' ' H ' ' A' ' 46' ' ' ASP . 64.9 tttp -71.75 154.8 41.08 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 164.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -64.41 -20.44 66.15 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.048 0.539 . . . . 0.0 111.856 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.509 ' H ' ' HG2' ' A' ' 44' ' ' LYS . 37.8 t70 -65.71 -20.36 66.25 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.166 0.987 . . . . 0.0 111.793 172.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.01 -16.13 30.58 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.196 176.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.3 mt -66.1 134.22 52.36 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 117.263 0.531 . . . . 0.0 110.501 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.9 mtt85 -113.38 142.54 45.75 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.287 1.035 . . . . 0.0 111.062 -174.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.17 154.91 25.94 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.646 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -96.05 127.57 42.18 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -146.76 148.77 34.31 Favored Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 124.18 0.992 . . . . 0.0 110.439 -173.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -84.82 -176.82 2.6 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.129 2.552 . . . . 0.0 111.911 174.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.39 -15.11 62.81 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.741 0.816 . . . . 0.0 111.926 176.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.5 m -55.45 -40.0 71.03 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.069 1.348 . . . . 0.0 113.335 -175.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -90.89 -29.05 17.72 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.999 0.52 . . . . 0.0 111.589 -175.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.55 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 35.3 m -105.39 -179.8 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.369 0.668 . . . . 0.0 110.52 -173.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -134.59 124.06 24.83 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.688 0.795 . . . . 0.0 109.128 175.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.447 HD23 ' SG ' ' A' ' 6' ' ' CYS . 74.0 mt -69.95 117.28 11.33 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.527 HD11 ' HG3' ' A' ' 7' ' ' ARG . 64.4 mt . . . . . 0 CA--C 1.548 0.879 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptp . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.7 t 60.18 82.32 0.16 Allowed 'General case' 0 CA--C 1.548 0.875 0 O-C-N 124.662 1.226 . . . . 0.0 111.09 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.13 84.72 1.24 Allowed Glycine 0 C--N 1.345 1.054 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.805 -174.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.7 97.22 1.04 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 171.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.427 ' HB2' HD12 ' A' ' 60' ' ' LEU . 99.3 mtt180 -94.93 149.62 21.05 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.57 0.748 . . . . 0.0 110.57 -177.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.592 ' SG ' HD23 ' A' ' 59' ' ' LEU . 49.3 m -128.89 143.8 51.0 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 173.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -105.89 127.68 53.28 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 74.4 p -68.71 127.25 32.4 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 123.924 0.765 . . . . 0.0 109.558 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 58' ' ' GLN . 95.7 mt -70.1 -75.93 0.11 Allowed 'General case' 0 CA--C 1.537 0.468 0 O-C-N 123.459 0.474 . . . . 0.0 109.978 -177.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -151.37 137.92 11.59 Favored Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 123.634 0.774 . . . . 0.0 109.03 -177.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.37 95.53 0.61 Allowed 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.215 1.943 . . . . 0.0 111.756 175.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.52 ' HB2' ' HE1' ' A' ' 56' ' ' TYR . 52.9 m-85 -91.58 102.99 15.64 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 175.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.8 p -100.53 100.99 11.81 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.655 0.782 . . . . 0.0 109.073 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -155.84 18.36 0.49 Allowed Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.396 177.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -116.43 163.53 15.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.027 0.931 . . . . 0.0 109.813 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -70.35 161.51 30.31 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.737 0.415 . . . . 0.0 110.063 176.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 30.9 p80 -71.66 178.83 3.35 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.382 0.673 . . . . 0.0 111.285 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.11 89.94 2.09 Favored Glycine 0 C--N 1.343 0.923 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -174.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.8 58.89 2.25 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.871 1.268 . . . . 0.0 108.828 -176.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.45 99.92 1.83 Allowed Glycine 0 C--N 1.343 0.968 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 176.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.5 tp -88.53 127.73 35.54 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -177.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 49.3 ttt-85 -78.88 122.98 26.78 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -129.18 114.18 15.99 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.059 0.943 . . . . 0.0 109.208 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.56 143.74 51.49 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.49 0.716 . . . . 0.0 109.913 175.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.99 111.21 1.58 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.655 0.782 . . . . 0.0 111.572 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.22 3.64 24.29 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-O 119.096 -0.836 . . . . 0.0 114.794 173.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.63 127.3 32.47 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 118.232 1.016 . . . . 0.0 111.782 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.699 HD22 HD11 ' A' ' 60' ' ' LEU . 54.2 mt -85.37 102.15 13.18 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 175.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.595 HG21 ' HE1' ' A' ' 51' ' ' TRP . 34.8 mm -107.68 125.81 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.812 0.845 . . . . 0.0 109.448 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.1 m -81.77 136.95 35.4 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.542 0.737 . . . . 0.0 110.461 178.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.7 mt -76.71 129.4 36.28 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.846 0.858 . . . . 0.0 109.674 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.717 HD11 ' HG3' ' A' ' 43' ' ' GLU . 96.0 mt -77.02 -28.47 54.93 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.811 0.445 . . . . 0.0 110.631 174.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -155.01 147.7 24.34 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.823 0.849 . . . . 0.0 109.456 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.6 m -112.97 92.21 20.42 Favored Pre-proline 0 CA--C 1.559 1.299 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 166.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -68.58 -27.85 32.27 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.618 2.212 . . . . 0.0 111.908 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -175.85 -51.61 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.856 1.262 . . . . 0.0 109.169 175.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.93 176.84 28.53 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.851 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.25 -79.71 0.4 Allowed Glycine 0 C--N 1.347 1.153 0 N-CA-C 111.907 -0.477 . . . . 0.0 111.907 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -84.64 108.94 17.64 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.335 0.654 . . . . 0.0 109.565 171.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -113.16 178.18 4.37 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.059 0.944 . . . . 0.0 109.092 171.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 51' ' ' TRP . 0.9 OUTLIER -137.49 145.31 42.89 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.543 0.737 . . . . 0.0 109.36 173.272 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.514 ' HA2' ' HG ' ' A' ' 32' ' ' LEU . . . -154.48 178.57 31.2 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.794 -178.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.717 ' HG3' HD11 ' A' ' 32' ' ' LEU . 45.6 mt-10 -103.25 148.49 25.76 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.077 0.551 . . . . 0.0 109.799 176.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -112.83 145.09 41.24 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.693 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -69.29 -7.23 35.13 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.259 0.624 . . . . 0.0 112.432 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.69 -7.44 53.3 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.526 1.13 . . . . 0.0 111.878 172.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.76 -19.39 51.69 Favored Glycine 0 C--N 1.348 1.24 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 -177.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 65.0 mt -82.24 158.53 23.49 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.59 1.156 . . . . 0.0 110.25 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -120.53 177.76 4.93 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.898 0.879 . . . . 0.0 109.485 174.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.46 158.36 13.84 Favored Glycine 0 N--CA 1.467 0.714 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 -174.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.595 ' HE1' HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -156.06 173.24 17.1 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.494 0.664 . . . . 0.0 111.833 -171.829 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -125.54 167.16 17.32 Favored Pre-proline 0 N--CA 1.48 1.056 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.798 -173.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.36 170.52 9.31 Favored 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 122.213 1.942 . . . . 0.0 112.87 174.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.23 -15.23 56.4 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.494 1.118 . . . . 0.0 113.416 -175.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.3 p -62.51 -30.17 71.09 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.325 1.05 . . . . 0.0 113.062 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.52 ' HE1' ' HB2' ' A' ' 12' ' ' PHE . 85.1 m-85 -94.99 -6.56 42.06 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -176.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.6 m -135.39 -179.85 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 123.768 0.827 . . . . 0.0 110.397 -177.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.401 ' HB2' HD21 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -152.4 131.76 12.88 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 173.739 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.592 HD23 ' SG ' ' A' ' 6' ' ' CYS . 85.8 mt -65.32 133.98 52.58 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.764 0.826 . . . . 0.0 111.025 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.699 HD11 HD22 ' A' ' 28' ' ' LEU . 69.3 mt . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.896 -0.574 . . . . 0.0 109.572 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.512 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.404 ' HB3' HD11 ' A' ' 31' ' ' LEU . . . -76.98 127.26 32.38 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 122.969 0.507 . . . . 0.0 110.451 -177.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.645 ' HG3' ' HB2' ' A' ' 60' ' ' LEU . 35.2 ptt180 -86.68 157.38 19.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.87 0.868 . . . . 0.0 110.149 175.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 28.5 p -152.18 146.84 25.78 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.218 1.007 . . . . 0.0 108.921 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.414 ' HB2' HD11 ' A' ' 60' ' ' LEU . 61.9 ttt180 -106.07 125.57 51.16 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.524 HG22 HG12 ' A' ' 57' ' ' VAL . 49.6 p -72.27 140.01 48.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.49 0.716 . . . . 0.0 109.337 177.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mp -85.16 -74.46 0.4 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -144.89 100.39 4.61 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -69.8 101.34 0.9 Allowed 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 123.322 2.681 . . . . 0.0 112.103 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -92.88 161.65 14.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.314 0.646 . . . . 0.0 110.017 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.0 p -152.1 176.96 11.0 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.552 0.741 . . . . 0.0 110.555 -173.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -171.51 -50.94 0.04 OUTLIER Glycine 0 C--N 1.34 0.774 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -85.67 86.23 7.37 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 173.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -100.56 100.09 10.76 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -142.91 123.36 13.94 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.8 -145.95 33.23 Favored Glycine 0 C--N 1.345 1.06 0 O-C-N 123.571 0.545 . . . . 0.0 112.022 -174.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -94.77 60.57 2.51 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.745 0.818 . . . . 0.0 111.297 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.53 136.65 44.7 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-O 119.393 -0.671 . . . . 0.0 111.589 174.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.446 ' HB3' ' HE2' ' A' ' 52' ' ' PHE . 47.4 tp -85.98 114.03 22.55 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 117.363 0.581 . . . . 0.0 109.769 -169.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -99.83 116.73 32.58 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.341 0.657 . . . . 0.0 109.841 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -86.43 157.15 19.89 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.274 0.63 . . . . 0.0 109.387 172.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.75 154.48 19.88 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 169.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.26 133.9 46.43 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.02 0.528 . . . . 0.0 110.538 173.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.92 5.82 88.76 Favored Glycine 0 N--CA 1.475 1.27 0 O-C-N 123.305 0.378 . . . . 0.0 113.474 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -77.13 140.73 40.31 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.028 0.931 . . . . 0.0 111.268 -173.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.1 mt -91.06 104.48 17.06 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.514 0.725 . . . . 0.0 109.2 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.5 mm -117.82 130.62 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.006 1.323 . . . . 0.0 109.666 -176.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 87.7 m -90.45 138.52 31.49 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 171.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.404 HD11 ' HB3' ' A' ' 4' ' ' ALA . 1.4 pp -75.77 151.27 37.6 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.606 0.362 . . . . 0.0 110.692 174.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 93.6 mt -109.15 -2.41 18.06 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.016 0.926 . . . . 0.0 110.939 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.407 ' HG2' ' HD3' ' A' ' 35' ' ' PRO . 15.2 tt0 -143.48 152.54 41.61 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.51 56.15 21.29 Favored Pre-proline 0 CA--C 1.57 1.724 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.459 ' HD2' ' CD1' ' A' ' 40' ' ' TRP . 91.0 Cg_endo -77.16 126.29 8.46 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 121.727 1.618 . . . . 0.0 110.085 170.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -62.91 102.69 0.38 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.477 0.711 . . . . 0.0 109.699 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.9 54.22 7.37 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.237 -175.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -142.97 -172.55 14.07 Favored Glycine 0 C--N 1.343 0.951 0 C-N-CA 122.807 0.241 . . . . 0.0 112.68 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 25.0 m95 -81.38 140.74 34.55 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.459 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 12.5 m0 -117.64 136.63 53.19 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 2.2 mp0 -87.36 123.96 32.88 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 175.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.48 143.05 19.88 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -102.89 143.72 32.13 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 173.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -129.49 152.42 49.04 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.336 0.654 . . . . 0.0 110.296 173.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -67.26 -21.9 65.7 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.821 0.849 . . . . 0.0 109.997 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -51.35 -37.74 49.49 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.192 1.397 . . . . 0.0 111.15 169.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.02 -5.09 32.02 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-O 119.295 -0.725 . . . . 0.0 113.828 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 65.6 mt -92.23 172.6 8.31 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.076 0.938 . . . . 0.0 111.604 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -145.13 148.0 33.13 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.439 1.495 . . . . 0.0 109.05 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.435 ' N ' HD22 ' A' ' 21' ' ' LEU . . . -174.72 152.23 13.7 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 175.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.444 ' HB3' ' HG3' ' A' ' 41' ' ' GLU . 39.9 p-90 -97.23 129.98 44.5 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.862 0.865 . . . . 0.0 109.869 -174.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.446 ' HE2' ' HB3' ' A' ' 21' ' ' LEU . 78.8 m-85 -138.19 153.71 73.38 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 124.949 1.3 . . . . 0.0 109.041 -178.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -74.13 168.24 25.27 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.584 2.189 . . . . 0.0 112.457 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.47 -15.19 63.53 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.277 1.031 . . . . 0.0 111.787 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.8 m -55.64 -34.85 65.31 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.691 1.196 . . . . 0.0 112.658 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -97.03 -10.94 25.15 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.524 HG12 HG22 ' A' ' 8' ' ' THR . 34.5 m -122.53 161.1 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.44 0.696 . . . . 0.0 110.854 -177.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -131.18 115.58 16.56 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.346 1.058 . . . . 0.0 108.723 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.3 mt -58.49 132.42 53.69 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.335 0.654 . . . . 0.0 111.074 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.645 ' HB2' ' HG3' ' A' ' 5' ' ' ARG . 90.2 mt . . . . . 0 C--O 1.251 1.135 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.673 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.44 134.79 54.44 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.936 0.894 . . . . 0.0 109.833 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -154.68 177.18 11.52 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.105 0.962 . . . . 0.0 109.572 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.7 m -123.94 -176.45 3.48 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -142.83 128.51 19.22 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.1 p -66.99 147.54 53.1 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.73 0.812 . . . . 0.0 112.344 -176.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.7 mt -84.2 -52.62 6.11 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.271 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -139.11 166.69 22.95 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 124.151 0.98 . . . . 0.0 109.149 -176.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.69 95.58 0.34 Allowed 'Trans proline' 0 C--N 1.388 2.629 0 C-N-CA 121.801 1.667 . . . . 0.0 110.515 175.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -96.85 154.99 16.97 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.32 0.648 . . . . 0.0 111.285 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.7 m -122.47 -10.69 8.39 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.286 1.034 . . . . 0.0 111.059 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.76 -46.62 1.91 Allowed Glycine 0 C--N 1.349 1.269 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -172.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 63.64 16.84 10.0 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.897 1.279 . . . . 0.0 112.254 178.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -121.62 154.61 36.55 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 124.424 1.089 . . . . 0.0 108.663 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -70.43 154.23 42.12 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.216 0.607 . . . . 0.0 110.889 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.43 -116.34 4.88 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -92.29 76.63 5.24 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-O 121.695 0.759 . . . . 0.0 109.151 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.94 93.08 1.82 Allowed Glycine 0 C--N 1.338 0.65 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.7 174.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.565 HD21 ' HB2' ' A' ' 44' ' ' LYS . 36.4 tp -98.66 130.3 45.17 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.231 0.612 . . . . 0.0 109.508 177.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.92 158.32 30.78 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 168.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -158.41 150.5 21.65 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 174.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.01 142.75 38.05 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.815 0.846 . . . . 0.0 110.72 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.54 145.4 50.84 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.464 0.705 . . . . 0.0 111.35 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.46 19.79 79.74 Favored Glycine 0 C--N 1.345 1.053 0 O-C-N 123.808 0.693 . . . . 0.0 113.196 173.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -109.16 156.28 20.03 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.35 0.66 . . . . 0.0 110.776 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.7 mt -79.89 124.38 28.61 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.929 -171.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.593 HG13 HG11 ' A' ' 57' ' ' VAL . 47.6 mm -88.66 106.58 16.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 172.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.9 p -73.5 108.3 6.28 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.5 mt -66.76 93.35 0.25 Allowed 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.163 0.914 . . . . 0.0 109.148 -175.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.587 HD11 ' HB2' ' A' ' 43' ' ' GLU . 83.3 mt -75.16 -51.89 12.31 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.965 0.906 . . . . 0.0 109.638 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -101.9 136.07 42.37 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.16 86.56 41.7 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.287 1.035 . . . . 0.0 109.216 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.57 -174.41 2.26 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.868 2.378 . . . . 0.0 112.082 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -73.46 -23.27 60.06 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.281 0.632 . . . . 0.0 110.343 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 179.19 174.85 45.68 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 109.74 -101.57 1.47 Allowed Glycine 0 C--N 1.341 0.819 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 14.5 p-90 -137.83 165.1 27.29 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.59 0.756 . . . . 0.0 109.755 -177.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -122.32 149.27 43.98 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.587 0.755 . . . . 0.0 109.183 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.44 ' HG2' HD12 ' A' ' 32' ' ' LEU . 43.2 tt0 -91.15 138.43 31.6 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.4 ' H ' ' HD2' ' A' ' 52' ' ' PHE . . . -121.89 158.61 16.59 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 177.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.587 ' HB2' HD11 ' A' ' 32' ' ' LEU . 28.8 tt0 -110.1 119.36 39.05 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.063 0.545 . . . . 0.0 110.032 -176.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.565 ' HB2' HD21 ' A' ' 21' ' ' LEU . 56.5 tttm -78.76 155.12 29.47 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.439 0.696 . . . . 0.0 109.262 171.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -66.75 -7.02 18.2 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -173.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -78.24 -8.53 58.46 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.517 0.727 . . . . 0.0 111.236 172.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.96 -5.36 84.6 Favored Glycine 0 C--N 1.347 1.193 0 C-N-CA 123.298 0.475 . . . . 0.0 112.403 -171.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.1 mt -78.78 140.59 38.22 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 123.861 0.864 . . . . 0.0 110.584 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.581 HH11 HD13 ' A' ' 32' ' ' LEU . 58.8 mtt-85 -107.07 149.88 27.13 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.562 1.145 . . . . 0.0 108.139 177.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -156.25 -176.3 28.2 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 121.282 -0.485 . . . . 0.0 113.753 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -73.38 126.64 30.63 Favored 'General case' 0 C--N 1.346 0.438 0 C-N-CA 123.235 0.614 . . . . 0.0 110.418 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.4 ' HD2' ' H ' ' A' ' 42' ' ' GLY . 75.3 m-85 -139.27 85.26 15.66 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 123.661 0.784 . . . . 0.0 110.149 174.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.3 151.42 82.51 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.032 2.488 . . . . 0.0 112.023 170.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.24 -15.76 60.7 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.965 0.906 . . . . 0.0 110.79 171.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.3 m -67.75 -38.12 83.05 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 124.32 1.048 . . . . 0.0 111.117 173.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -80.94 -13.0 59.29 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.361 1.064 . . . . 0.0 112.205 -173.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.593 HG11 HG13 ' A' ' 29' ' ' ILE . 29.8 m -132.78 146.2 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.462 0.705 . . . . 0.0 111.091 -171.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.2 127.56 41.34 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 169.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.0 mt -69.06 123.6 21.51 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.928 0.891 . . . . 0.0 110.291 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 72.0 mt . . . . . 0 C--O 1.248 1.008 0 C-N-CA 122.727 0.411 . . . . 0.0 109.95 178.857 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.894 0 CA-C-O 119.79 -0.45 . . . . 0.0 113.79 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.27 103.84 0.21 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.507 0.723 . . . . 0.0 111.494 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.463 ' HG2' ' HA ' ' A' ' 30' ' ' THR . 61.2 mtt180 -143.02 170.4 15.77 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.847 0.859 . . . . 0.0 111.004 -177.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.608 ' SG ' HD23 ' A' ' 59' ' ' LEU . 81.9 m -133.93 172.13 13.23 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 113.882 -1.508 . . . . 0.0 108.352 172.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.6 ' HB2' HD21 ' A' ' 60' ' ' LEU . 36.1 ttm180 -124.61 140.36 53.01 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 172.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.8 p -82.0 136.19 35.28 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.501 0.72 . . . . 0.0 110.262 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.403 HD21 ' HG3' ' A' ' 58' ' ' GLN . 75.3 mt -74.89 -67.1 0.67 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.497 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -141.73 157.66 64.4 Favored Pre-proline 0 N--CA 1.48 1.026 0 C-N-CA 124.718 1.207 . . . . 0.0 108.366 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 25' ' ' ALA . 56.5 Cg_endo -66.38 88.53 0.26 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.263 1.976 . . . . 0.0 111.533 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -91.83 146.87 23.41 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.449 0.7 . . . . 0.0 110.498 -177.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.0 p -153.51 161.26 42.41 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.578 1.151 . . . . 0.0 108.276 173.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.5 -84.23 0.13 Allowed Glycine 0 C--N 1.348 1.236 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -144.5 160.35 41.25 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.829 1.252 . . . . 0.0 108.811 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -74.93 82.55 2.19 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 122.74 0.416 . . . . 0.0 110.736 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.6 t60 171.82 -50.17 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.265 1.826 . . . . 0.0 107.17 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.24 149.74 51.26 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 114.915 -1.039 . . . . 0.0 113.776 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -81.31 163.64 22.76 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.905 0.882 . . . . 0.0 112.106 -175.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.08 160.89 11.69 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.261 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.419 HD21 ' HB2' ' A' ' 44' ' ' LYS . 33.9 tp -89.53 115.99 27.35 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.627 ' HD2' ' H ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -85.74 154.8 21.37 Favored 'General case' 0 C--O 1.247 0.944 0 C-N-CA 123.648 0.779 . . . . 0.0 111.063 -176.474 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.462 ' HZ ' ' HE1' ' A' ' 56' ' ' TYR . 21.4 p90 -156.42 149.57 24.24 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.192 -171.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.87 148.58 22.01 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.936 0.895 . . . . 0.0 109.657 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.539 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . . . -61.35 114.55 3.25 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.414 0.686 . . . . 0.0 111.606 -178.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.09 -13.16 24.1 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-O 119.248 -0.751 . . . . 0.0 114.209 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -70.91 163.0 28.33 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 118.056 0.928 . . . . 0.0 111.03 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 mp -99.03 126.15 44.68 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.53 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.3 mm -92.89 108.66 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 169.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.463 ' HA ' ' HG2' ' A' ' 5' ' ' ARG . 54.5 m -77.8 107.93 10.66 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.467 HD21 ' SG ' ' A' ' 6' ' ' CYS . 42.6 mt -69.3 115.07 8.15 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.525 ' HB2' ' HG3' ' A' ' 41' ' ' GLU . 46.7 mt -74.72 -50.55 17.05 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.412 0.685 . . . . 0.0 110.091 -173.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.467 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 52.3 tt0 -147.22 166.38 27.18 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.074 0.949 . . . . 0.0 108.624 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.5 m -101.96 84.4 0.57 Allowed Pre-proline 0 CA--C 1.566 1.588 0 C-N-CA 124.347 1.059 . . . . 0.0 109.713 173.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 33' ' ' GLN . 4.8 Cg_exo -74.42 -36.88 2.76 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 122.888 2.392 . . . . 0.0 111.663 -174.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -109.15 -67.61 0.97 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.241 1.016 . . . . 0.0 109.15 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.36 -35.47 1.88 Allowed Glycine 0 C--N 1.35 1.324 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -100.83 -42.52 2.44 Favored Glycine 0 C--N 1.345 1.078 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 171.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -86.8 137.47 32.39 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 168.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -128.02 177.5 6.84 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.727 0.811 . . . . 0.0 109.747 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.525 ' HG3' ' HB2' ' A' ' 32' ' ' LEU . 15.8 pt-20 -118.66 149.64 41.06 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.166 0.986 . . . . 0.0 108.384 174.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.41 125.68 1.87 Allowed Glycine 0 C--N 1.335 0.491 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.454 ' HB2' HD11 ' A' ' 32' ' ' LEU . 35.5 tt0 -101.16 123.55 45.48 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.419 ' HB2' HD21 ' A' ' 21' ' ' LEU . 17.9 tptm -77.04 167.24 22.15 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.915 0.886 . . . . 0.0 110.072 175.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -52.21 -35.4 49.18 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.407 1.483 . . . . 0.0 113.505 -175.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -78.26 -16.38 57.85 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.145 0.578 . . . . 0.0 111.662 -175.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.56 -7.55 30.1 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-O 119.702 -0.499 . . . . 0.0 113.446 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.01 125.1 25.6 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 117.619 0.709 . . . . 0.0 110.295 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.2 mtp85 -105.26 128.67 53.55 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -135.38 155.3 22.08 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 29.3 p-90 -80.88 138.98 36.17 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.149 0.579 . . . . 0.0 109.695 174.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -140.58 104.96 6.41 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 123.925 0.89 . . . . 0.0 108.881 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.468 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 94.5 Cg_endo -80.31 165.04 21.38 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.975 2.45 . . . . 0.0 112.219 172.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.01 -30.0 71.1 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.772 0.829 . . . . 0.0 111.013 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.0 p -75.39 7.48 3.53 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.136 0.974 . . . . 0.0 112.541 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.468 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 2.6 t80 -124.9 -45.14 1.9 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.6 m -130.51 141.1 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.223 1.009 . . . . 0.0 109.643 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.403 ' HG3' HD21 ' A' ' 9' ' ' LEU . 42.8 mt-30 -89.39 132.97 34.73 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 122.952 0.501 . . . . 0.0 111.326 -175.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.608 HD23 ' SG ' ' A' ' 6' ' ' CYS . 93.2 mt -62.32 145.3 54.17 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.225 1.01 . . . . 0.0 111.9 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.6 HD21 ' HB2' ' A' ' 7' ' ' ARG . 95.0 mt . . . . . 0 C--O 1.245 0.84 0 C-N-CA 123.617 0.767 . . . . 0.0 109.832 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.459 0.209 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.534 ' HB3' ' HB2' ' A' ' 31' ' ' LEU . . . -134.88 149.64 50.33 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.755 0.822 . . . . 0.0 109.375 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.401 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 4.4 mmt85 -128.04 155.0 45.03 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.89 0.876 . . . . 0.0 110.717 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.449 ' SG ' HD11 ' A' ' 31' ' ' LEU . 72.4 m -143.62 173.13 11.93 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.229 1.412 . . . . 0.0 108.795 175.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.9 ttt180 -142.84 131.09 22.05 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.623 HG21 ' HB3' ' A' ' 23' ' ' PHE . 35.2 p -68.12 125.91 27.84 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 124.018 0.927 . . . . 0.0 111.24 -176.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.539 HD21 ' HB2' ' A' ' 58' ' ' GLN . 93.1 mt -67.21 -59.99 2.98 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 123.708 0.63 . . . . 0.0 109.505 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -139.83 153.84 70.22 Favored Pre-proline 0 N--CA 1.476 0.853 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.14 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.42 ' HD3' ' HB2' ' A' ' 25' ' ' ALA . 48.2 Cg_endo -83.63 29.8 0.54 Allowed 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.621 2.214 . . . . 0.0 113.73 -172.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -90.88 101.0 13.76 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.564 ' HB2' ' HA ' ' A' ' 22' ' ' ARG . 25.2 m -148.04 134.39 19.56 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -178.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.21 53.08 4.01 Favored Glycine 0 C--N 1.341 0.824 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -171.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -59.88 104.16 0.27 Allowed 'General case' 0 C--O 1.245 0.841 0 C-N-CA 124.26 1.024 . . . . 0.0 111.414 -177.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 61.8 18.03 9.34 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.651 1.18 . . . . 0.0 112.34 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -156.28 117.9 3.91 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.874 0.869 . . . . 0.0 108.825 -171.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.02 -162.99 16.84 Favored Glycine 0 CA--C 1.533 1.167 0 O-C-N 123.21 0.319 . . . . 0.0 112.539 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 71.53 -2.92 2.28 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.009 1.323 . . . . 0.0 113.304 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.4 178.61 35.62 Favored Glycine 0 C--N 1.348 1.201 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 44' ' ' LYS . 43.7 tp -90.36 112.93 24.7 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.564 ' HA ' ' HB2' ' A' ' 13' ' ' SER . 64.7 mtt180 -82.42 139.05 34.23 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.852 0.72 . . . . 0.0 109.374 174.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.623 ' HB3' HG21 ' A' ' 8' ' ' THR . 97.1 m-85 -113.11 135.4 53.85 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.371 0.668 . . . . 0.0 109.604 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.12 138.42 33.04 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 171.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.42 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . . . -64.29 135.59 56.36 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.546 0.738 . . . . 0.0 111.657 -176.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.4 -13.09 67.41 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-O 119.552 -0.582 . . . . 0.0 114.021 177.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -64.96 129.92 41.49 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.183 0.593 . . . . 0.0 111.919 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.9 mt -80.44 100.35 8.45 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.9 mm -95.62 115.2 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.468 0.707 . . . . 0.0 109.502 -175.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.0 m -74.65 125.24 28.25 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 122.943 0.497 . . . . 0.0 109.755 175.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.534 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 82.4 mt -76.88 126.09 30.4 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 170.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.52 -51.31 15.09 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.529 0.68 . . . . 0.0 110.342 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -153.27 162.42 41.32 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.469 -173.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.9 m -100.82 89.13 1.16 Allowed Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 124.032 0.933 . . . . 0.0 109.569 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -79.76 -4.22 13.31 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.288 2.659 . . . . 0.0 113.518 -171.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -162.6 -69.86 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.808 0.843 . . . . 0.0 109.645 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.24 -52.85 0.55 Allowed Glycine 0 C--N 1.341 0.831 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -174.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -72.31 -46.44 33.98 Favored Glycine 0 C--N 1.344 0.984 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 173.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -93.71 135.46 34.98 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.882 0.873 . . . . 0.0 109.21 174.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 14.5 m0 -133.17 150.39 52.01 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.071 0.949 . . . . 0.0 110.388 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 42.2 mt-10 -91.54 145.85 24.27 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.875 0.87 . . . . 0.0 110.689 -173.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -147.57 170.31 28.34 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.241 0.925 . . . . 0.0 110.99 177.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -126.05 167.23 15.63 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.528 0.731 . . . . 0.0 112.423 -177.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.652 ' HB2' HD11 ' A' ' 21' ' ' LEU . 3.3 tmtp? -126.4 146.64 49.99 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 164.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.433 ' H ' ' HD3' ' A' ' 44' ' ' LYS . 1.7 mp0 -66.45 -9.71 36.87 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.081 0.952 . . . . 0.0 111.647 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.415 ' H ' ' HD2' ' A' ' 44' ' ' LYS . 30.6 t70 -77.76 -8.65 58.29 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 124.858 1.263 . . . . 0.0 111.537 178.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.87 -13.42 57.67 Favored Glycine 0 C--N 1.355 1.61 0 C-N-CA 123.159 0.409 . . . . 0.0 112.916 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.16 133.66 34.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.311 0.644 . . . . 0.0 109.841 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -111.62 173.81 6.17 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.134 0.974 . . . . 0.0 109.689 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -167.88 153.49 22.8 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.56 174.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -121.61 125.75 47.46 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -144.02 156.14 58.56 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 124.217 1.007 . . . . 0.0 109.718 -168.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -68.57 153.85 72.76 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 122.725 2.284 . . . . 0.0 112.719 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.66 -14.51 63.0 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.6 1.16 . . . . 0.0 112.288 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.7 t -55.94 -23.58 32.88 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.508 1.123 . . . . 0.0 112.969 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -106.72 -7.07 17.43 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.2 0.6 . . . . 0.0 112.392 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' A' ' 6' ' ' CYS . 12.9 m -135.9 124.76 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.688 0.795 . . . . 0.0 110.206 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.539 ' HB2' HD21 ' A' ' 9' ' ' LEU . 63.2 tt0 -80.81 127.09 32.12 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 37.9 mt -73.59 133.89 43.61 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.761 0.824 . . . . 0.0 110.871 -173.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 5' ' ' ARG . 74.0 mt . . . . . 0 C--O 1.251 1.151 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.777 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 31' ' ' LEU . . . -68.55 140.69 55.62 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 81.9 mtm-85 -126.55 138.61 53.49 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.082 0.553 . . . . 0.0 110.137 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.676 ' SG ' HD23 ' A' ' 59' ' ' LEU . 77.3 m -128.49 170.47 13.13 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.475 1.11 . . . . 0.0 109.709 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -140.71 138.18 34.03 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.607 0.763 . . . . 0.0 109.153 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.645 HG23 HD11 ' A' ' 29' ' ' ILE . 1.6 p -66.91 128.81 37.73 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.579 0.751 . . . . 0.0 110.839 176.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.462 ' H ' HD12 ' A' ' 9' ' ' LEU . 3.5 mp -74.38 -38.17 63.24 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -129.78 152.63 80.16 Favored Pre-proline 0 C--O 1.245 0.867 0 C-N-CA 125.405 1.482 . . . . 0.0 108.03 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.48 145.29 76.39 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.065 1.843 . . . . 0.0 111.843 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -89.92 106.64 18.61 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 173.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.8 m -59.34 138.69 57.54 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 124.323 1.014 . . . . 0.0 111.164 -176.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.78 72.04 1.83 Allowed Glycine 0 C--N 1.349 1.257 0 O-C-N 123.92 0.763 . . . . 0.0 111.439 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -70.56 96.99 1.25 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.287 1.035 . . . . 0.0 109.856 -176.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -77.45 75.78 4.0 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.92 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -169.1 95.85 0.34 Allowed 'General case' 0 C--O 1.241 0.641 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.78 -131.19 10.6 Favored Glycine 0 N--CA 1.469 0.844 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -174.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -155.0 142.22 19.42 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.217 0.607 . . . . 0.0 109.994 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.23 157.55 29.69 Favored Glycine 0 C--N 1.344 1.001 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.8 tp -90.15 126.0 35.65 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -88.96 134.22 34.05 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.1 0.96 . . . . 0.0 111.615 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -145.07 111.53 5.71 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 163.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.71 157.74 28.48 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.54 0.736 . . . . 0.0 109.939 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.98 119.52 7.39 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.309 0.643 . . . . 0.0 111.326 -174.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.93 -22.03 12.96 Favored Glycine 0 C--N 1.347 1.184 0 O-C-N 123.654 0.596 . . . . 0.0 113.148 -176.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -72.2 143.11 48.98 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.179 0.514 . . . . 0.0 111.427 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.29 117.3 30.05 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.317 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.645 HD11 HG23 ' A' ' 8' ' ' THR . 3.3 mp -85.4 108.27 17.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.4 m -85.06 102.35 13.16 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.54 HD11 ' SG ' ' A' ' 6' ' ' CYS . 90.2 mt -76.23 104.52 6.79 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.243 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.563 HD11 ' HB2' ' A' ' 43' ' ' GLU . 58.9 mt -77.95 -42.91 31.41 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.537 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 32.6 mm-40 -121.33 136.99 54.89 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.384 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.7 m -137.38 72.06 52.09 Favored Pre-proline 0 CA--C 1.557 1.217 0 C-N-CA 124.301 1.04 . . . . 0.0 109.643 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.42 169.54 20.59 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.52 2.147 . . . . 0.0 112.269 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.46 92.17 0.43 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.618 0.767 . . . . 0.0 110.196 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 166.68 -164.84 38.02 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.563 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.08 -29.52 9.62 Favored Glycine 0 N--CA 1.473 1.115 0 N-CA-C 113.403 0.121 . . . . 0.0 113.403 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -94.19 100.21 12.33 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.526 0.73 . . . . 0.0 110.159 -168.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -111.19 150.98 28.75 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.304 1.042 . . . . 0.0 109.248 -175.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 33' ' ' GLN . 35.5 tt0 -89.39 125.91 35.33 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -176.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -123.17 140.6 13.17 Favored Glycine 0 C--N 1.34 0.752 0 O-C-N 124.689 1.243 . . . . 0.0 110.1 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.563 ' HB2' HD11 ' A' ' 32' ' ' LEU . 37.8 tt0 -106.37 140.67 38.93 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.123 0.487 . . . . 0.0 110.717 -177.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -97.05 151.85 19.33 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.013 1.325 . . . . 0.0 108.085 172.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -68.2 -14.2 62.81 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.934 0.493 . . . . 0.0 111.93 -173.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -69.12 -20.71 64.05 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.52 0.728 . . . . 0.0 111.644 174.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.07 -9.4 36.59 Favored Glycine 0 C--N 1.344 1.008 0 C-N-CA 123.413 0.53 . . . . 0.0 112.406 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.1 mp -75.72 121.33 22.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.576 0.75 . . . . 0.0 109.795 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -104.59 158.37 16.54 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.858 0.863 . . . . 0.0 108.978 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -172.13 163.1 35.33 Favored Glycine 0 CA--C 1.507 -0.461 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.879 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 3.6 p-90 -86.06 138.35 32.01 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.591 0.757 . . . . 0.0 109.062 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -132.26 140.13 37.03 Favored Pre-proline 0 C--O 1.242 0.677 0 C-N-CA 124.105 0.962 . . . . 0.0 108.429 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.518 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 39.7 Cg_endo -69.45 134.5 28.81 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 121.843 1.695 . . . . 0.0 109.98 173.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.62 -24.9 65.87 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.371 1.068 . . . . 0.0 111.29 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.0 m -64.82 -35.82 82.33 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.263 1.025 . . . . 0.0 111.32 176.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.518 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 35.5 t80 -81.69 -19.69 41.05 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.377 0.671 . . . . 0.0 111.581 -173.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 6' ' ' CYS . 35.4 m -115.41 149.71 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.237 0.615 . . . . 0.0 110.691 -176.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -110.64 117.58 33.87 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.79 0.836 . . . . 0.0 110.168 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.676 HD23 ' SG ' ' A' ' 6' ' ' CYS . 64.2 mt -66.46 123.23 19.44 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 171.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.2 mp . . . . . 0 C--O 1.248 1.021 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.162 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.774 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 31' ' ' LEU . . . -73.51 164.68 26.33 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.889 0.476 . . . . 0.0 109.95 173.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.475 ' HG3' ' HB2' ' A' ' 60' ' ' LEU . 15.6 ptt180 -141.89 149.55 40.36 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.445 0.698 . . . . 0.0 109.908 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.652 ' SG ' ' HA ' ' A' ' 59' ' ' LEU . 57.0 m -145.11 145.31 31.36 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.571 0.749 . . . . 0.0 109.503 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.54 ' HB2' HD11 ' A' ' 60' ' ' LEU . 6.7 tmm_? -106.77 136.56 46.38 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.416 ' HA ' HG12 ' A' ' 57' ' ' VAL . 52.5 p -75.59 127.46 33.12 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.779 1.232 . . . . 0.0 111.891 -174.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.427 HD21 ' HG2' ' A' ' 58' ' ' GLN . 96.1 mt -67.87 -56.47 8.98 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.443 0.697 . . . . 0.0 110.38 177.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -129.22 154.46 80.56 Favored Pre-proline 0 N--CA 1.478 0.949 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.249 -175.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.27 138.52 51.51 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.899 2.4 . . . . 0.0 111.983 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.424 ' HD2' ' HA ' ' A' ' 22' ' ' ARG . 50.4 t80 -111.38 101.24 9.71 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 172.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.0 m -138.27 70.16 1.39 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 169.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -106.27 -46.37 1.16 Allowed Glycine 0 C--N 1.34 0.786 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.977 176.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 56.74 31.81 20.06 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.337 1.055 . . . . 0.0 111.667 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -63.28 -36.41 83.58 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.73 0.812 . . . . 0.0 110.581 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -123.62 152.92 41.42 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.631 1.172 . . . . 0.0 109.36 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.62 -39.7 93.89 Favored Glycine 0 C--N 1.343 0.965 0 O-C-N 123.964 0.79 . . . . 0.0 112.234 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -82.15 89.3 6.47 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.37 136.24 2.89 Favored Glycine 0 C--N 1.345 1.082 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.0 tp -91.01 119.58 31.3 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.549 0.74 . . . . 0.0 109.685 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.424 ' HA ' ' HD2' ' A' ' 12' ' ' PHE . 15.3 ptm180 -92.23 146.68 23.52 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -158.96 174.59 14.72 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.073 0.949 . . . . 0.0 110.765 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.03 168.09 9.28 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.183 0.993 . . . . 0.0 108.855 170.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.79 146.65 49.62 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 172.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.86 -9.82 76.68 Favored Glycine 0 N--CA 1.468 0.799 0 CA-C-N 116.07 -0.514 . . . . 0.0 113.888 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -76.44 135.12 39.4 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.24 0.616 . . . . 0.0 111.019 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.426 HD23 ' HD2' ' A' ' 5' ' ' ARG . 6.9 mp -98.44 114.73 27.21 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.621 HG13 ' HD3' ' A' ' 44' ' ' LYS . 2.6 mp -102.24 125.34 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 174.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 87.0 m -76.3 126.88 31.79 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.77 0.828 . . . . 0.0 110.507 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.614 HD11 ' SG ' ' A' ' 6' ' ' CYS . 5.6 mp -76.2 140.56 41.73 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.907 174.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.3 mt -82.77 -47.24 12.15 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.593 177.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -146.83 156.67 43.3 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.126 0.97 . . . . 0.0 109.358 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.4 m -114.01 87.5 12.96 Favored Pre-proline 0 CA--C 1.561 1.377 0 C-N-CA 123.73 0.812 . . . . 0.0 109.968 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 40' ' ' TRP . 72.6 Cg_endo -73.57 82.89 1.6 Allowed 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.515 2.143 . . . . 0.0 111.584 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 59.03 -86.88 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.146 1.379 . . . . 0.0 111.553 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.55 -168.91 29.44 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-N 116.388 -0.369 . . . . 0.0 112.628 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.46 -71.86 2.61 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -124.0 136.91 54.6 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.076 0.95 . . . . 0.0 108.724 172.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . 11.4 m-90 -124.22 160.46 27.88 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 173.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -110.92 148.58 32.17 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.069 0.461 . . . . 0.0 110.635 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.82 175.31 31.41 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.531 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -139.4 144.73 38.26 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.621 ' HD3' HG13 ' A' ' 29' ' ' ILE . 27.6 tptp -101.99 156.36 17.58 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.724 -178.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -52.88 -25.76 12.68 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 125.535 1.534 . . . . 0.0 113.01 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.81 -16.07 63.46 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.36 1.064 . . . . 0.0 112.551 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.47 -0.96 75.3 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 -171.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.6 mt -85.5 124.21 31.82 Favored 'General case' 0 C--N 1.346 0.433 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 45.0 ttp85 -104.74 138.72 40.61 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 149.71 154.5 6.43 Favored Glycine 0 C--O 1.243 0.695 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.439 ' HZ2' ' HB2' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -154.73 172.47 17.88 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.518 0.675 . . . . 0.0 111.192 -174.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -138.87 153.09 71.61 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 124.591 1.157 . . . . 0.0 109.616 -168.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.99 172.98 3.41 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.564 2.176 . . . . 0.0 113.268 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.38 -15.4 10.47 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.728 1.211 . . . . 0.0 113.24 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.8 t -61.16 -34.06 74.42 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.688 0.795 . . . . 0.0 112.083 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -92.2 -33.06 14.85 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.277 0.631 . . . . 0.0 111.432 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 8' ' ' THR . 11.4 m -138.46 138.76 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.358 0.663 . . . . 0.0 111.069 -166.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.427 ' HG2' HD21 ' A' ' 9' ' ' LEU . 13.6 mm100 -97.4 128.9 44.59 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.205 0.602 . . . . 0.0 110.466 174.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.652 ' HA ' ' SG ' ' A' ' 6' ' ' CYS . 5.0 mp -79.58 118.75 21.71 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.367 -173.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 7' ' ' ARG . 85.9 mt . . . . . 0 C--O 1.249 1.079 0 C-N-CA 123.909 0.883 . . . . 0.0 109.863 -177.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.805 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.64 106.67 3.13 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.15 0.58 . . . . 0.0 110.2 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -136.52 139.4 42.23 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.577 ' SG ' HD23 ' A' ' 59' ' ' LEU . 54.4 m -129.71 154.44 47.17 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.959 0.904 . . . . 0.0 109.058 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.423 HH21 ' HA ' ' A' ' 9' ' ' LEU . 6.4 ttp180 -105.87 128.61 53.87 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 40.3 p -69.45 140.79 54.09 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.701 0.8 . . . . 0.0 110.976 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.543 HD21 ' HB2' ' A' ' 58' ' ' GLN . 91.0 mt -73.9 -68.03 0.55 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.024 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -144.7 157.76 54.56 Favored Pre-proline 0 N--CA 1.482 1.152 0 C-N-CA 124.131 0.972 . . . . 0.0 109.169 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.603 ' HD3' ' HB2' ' A' ' 25' ' ' ALA . 10.9 Cg_exo -70.99 162.02 44.13 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 122.643 2.229 . . . . 0.0 110.919 173.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -91.93 155.44 18.15 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.979 0.511 . . . . 0.0 110.377 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.7 m -60.43 -31.11 70.09 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.201 0.601 . . . . 0.0 111.976 -175.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.2 -37.48 3.32 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-O 119.92 -0.378 . . . . 0.0 112.406 175.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -65.78 96.2 0.28 Allowed 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.111 0.565 . . . . 0.0 110.445 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.425 ' HD2' ' HA ' ' A' ' 16' ' ' ARG . 18.2 tpt180 -161.07 117.45 2.24 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.575 173.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -74.23 86.58 1.93 Allowed 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 121.894 0.854 . . . . 0.0 110.0 175.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.21 156.4 9.44 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.187 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.78 130.75 35.59 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -145.82 172.85 26.38 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 112.259 -0.336 . . . . 0.0 112.259 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.5 tp -90.91 136.56 32.99 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.445 0.698 . . . . 0.0 109.829 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -88.31 136.39 33.01 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 123.903 0.752 . . . . 0.0 110.272 174.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -160.18 176.11 12.14 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.174 0.989 . . . . 0.0 110.31 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.422 ' HA ' ' HG3' ' A' ' 11' ' ' PRO . . . -123.96 167.37 14.24 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.329 1.052 . . . . 0.0 109.874 176.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.603 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . . . -67.19 128.44 36.4 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.375 0.67 . . . . 0.0 110.686 175.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.22 1.46 59.41 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-O 119.738 -0.479 . . . . 0.0 113.671 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -78.93 116.69 19.41 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.967 0.507 . . . . 0.0 110.971 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 mp -76.63 100.61 5.41 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 172.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.5 mm -94.05 121.31 44.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 123.975 0.91 . . . . 0.0 109.274 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 31.6 m -74.95 125.38 28.76 Favored 'General case' 0 C--O 1.241 0.658 0 C-N-CA 123.158 0.583 . . . . 0.0 109.88 175.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.1 mt -73.48 128.68 36.16 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.586 HD13 HH11 ' A' ' 49' ' ' ARG . 74.2 mt -73.57 -52.2 14.31 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.871 0.868 . . . . 0.0 110.037 -174.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -139.0 144.57 38.96 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 173.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.5 m -110.01 108.89 59.19 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.661 0.784 . . . . 0.0 110.095 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -72.34 171.67 16.5 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.964 2.442 . . . . 0.0 111.549 171.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -81.47 -6.49 59.0 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.041 177.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.25 -176.81 39.05 Favored Glycine 0 C--N 1.351 1.397 0 O-C-N 123.18 0.3 . . . . 0.0 112.743 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -100.47 36.42 4.16 Favored Glycine 0 C--N 1.348 1.22 0 C-N-CA 123.395 0.522 . . . . 0.0 112.547 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -126.9 108.03 10.62 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 175.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 25.0 m0 -111.74 145.68 38.9 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.764 0.426 . . . . 0.0 110.459 -172.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.71 ' HG2' ' HB3' ' A' ' 51' ' ' TRP . 38.8 mt-10 -106.13 123.86 48.68 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.925 0.89 . . . . 0.0 109.602 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -118.6 -179.72 16.95 Favored Glycine 0 C--N 1.34 0.75 0 O-C-N 123.766 0.667 . . . . 0.0 112.468 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.405 ' HB2' HD21 ' A' ' 32' ' ' LEU . 28.2 tt0 -145.86 159.61 42.96 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.069 0.947 . . . . 0.0 109.903 -176.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.464 ' HE3' ' HG2' ' A' ' 45' ' ' GLU . 20.8 mmmt -121.02 170.4 9.55 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.908 0.883 . . . . 0.0 111.284 175.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.464 ' HG2' ' HE3' ' A' ' 44' ' ' LYS . 10.4 pt-20 -54.49 -28.67 46.41 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.614 1.566 . . . . 0.0 112.65 174.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -63.09 -34.17 77.03 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.844 1.257 . . . . 0.0 111.318 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.17 -22.61 24.8 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -173.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 51.7 tp -63.17 140.76 58.91 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 123.117 0.567 . . . . 0.0 109.877 175.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.586 HH11 HD13 ' A' ' 32' ' ' LEU . 49.9 mtt-85 -116.71 173.29 6.71 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.436 1.095 . . . . 0.0 108.491 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.65 175.66 45.9 Favored Glycine 0 CA--C 1.505 -0.537 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.71 ' HB3' ' HG2' ' A' ' 41' ' ' GLU . 33.0 p-90 -141.85 136.0 30.13 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.48 0.712 . . . . 0.0 109.765 -176.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -139.77 161.0 58.71 Favored Pre-proline 0 C--O 1.247 0.925 0 C-N-CA 124.603 1.161 . . . . 0.0 108.748 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.06 144.94 35.46 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.017 2.478 . . . . 0.0 113.095 171.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.22 -27.05 68.79 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.094 0.958 . . . . 0.0 111.404 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.1 m -68.62 -25.35 64.81 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.79 0.836 . . . . 0.0 111.468 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -77.37 -19.81 55.69 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.147 0.579 . . . . 0.0 111.276 -174.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.8 m -117.24 168.23 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.85 0.86 . . . . 0.0 109.837 175.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.543 ' HB2' HD21 ' A' ' 9' ' ' LEU . 24.6 tt0 -119.71 135.06 54.99 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.828 0.851 . . . . 0.0 108.796 177.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.577 HD23 ' SG ' ' A' ' 6' ' ' CYS . 96.6 mt -65.72 145.31 56.17 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.773 0.429 . . . . 0.0 110.206 172.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--O 1.251 1.18 0 C-N-CA 122.908 0.483 . . . . 0.0 109.992 177.941 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.374 0 N-CA-C 112.55 -0.22 . . . . 0.0 112.55 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.651 ' HB3' HD21 ' A' ' 31' ' ' LEU . . . -83.37 136.92 34.17 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.711 ' HB2' ' HB2' ' A' ' 60' ' ' LEU . 46.7 mtt-85 -120.97 169.52 10.4 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.682 0.753 . . . . 0.0 110.036 -167.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.1 m -135.32 148.29 49.42 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 169.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.411 ' HD2' HD21 ' A' ' 60' ' ' LEU . 17.5 ptm180 -123.53 128.92 50.44 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 175.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.2 p -79.73 125.88 30.23 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.528 -176.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.6 mt -72.47 -52.17 16.99 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.228 -174.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.446 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 71.3 m-85 -139.79 159.81 63.45 Favored Pre-proline 0 N--CA 1.483 1.207 0 C-N-CA 123.828 0.851 . . . . 0.0 109.656 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.41 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . 1.8 Cg_endo -79.17 99.95 1.3 Allowed 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 122.197 1.931 . . . . 0.0 109.886 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -99.72 140.49 33.84 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.314 0.646 . . . . 0.0 109.837 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.2 m -144.35 95.33 2.7 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.934 0.894 . . . . 0.0 108.819 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.34 -170.09 44.58 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.535 173.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -129.42 132.08 46.92 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.952 0.406 . . . . 0.0 110.65 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.8 mtt-85 -145.19 141.69 28.92 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.049 1.34 . . . . 0.0 108.895 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -68.95 99.56 1.08 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 171.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.8 -120.3 1.45 Allowed Glycine 0 C--N 1.341 0.849 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -176.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.467 HE21 ' HA ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -162.12 123.09 2.62 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.308 0.643 . . . . 0.0 110.054 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.27 163.69 21.09 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 169.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.6 tp -92.98 126.27 37.98 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 117.484 0.642 . . . . 0.0 109.499 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -77.76 150.19 34.4 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.218 1.007 . . . . 0.0 111.596 -171.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -152.35 148.46 27.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.584 0.753 . . . . 0.0 110.162 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . . . -110.06 167.09 10.43 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.648 1.179 . . . . 0.0 108.513 173.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . . . -75.98 142.74 41.85 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.636 0.375 . . . . 0.0 111.447 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.44 -21.49 45.27 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.753 170.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.77 162.4 22.93 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 121.267 0.556 . . . . 0.0 110.29 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 mp -108.16 119.81 40.55 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.427 -174.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.2 mm -85.84 114.86 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 174.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.5 m -89.42 131.07 35.65 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.391 0.676 . . . . 0.0 109.449 177.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.651 HD21 ' HB3' ' A' ' 4' ' ' ALA . 2.7 pp -76.15 148.85 37.51 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.29 0.567 . . . . 0.0 111.422 177.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.58 HD11 ' HB2' ' A' ' 43' ' ' GLU . 48.5 mt -99.66 -19.21 16.92 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.198 0.999 . . . . 0.0 109.664 176.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -153.53 150.54 28.81 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.642 0.777 . . . . 0.0 109.89 -173.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.8 m -119.62 86.57 35.08 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.088 0.955 . . . . 0.0 109.273 170.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -85.39 -168.35 0.49 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.693 2.262 . . . . 0.0 110.679 171.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -84.72 140.75 31.06 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 172.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.17 161.3 37.33 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 123.764 0.665 . . . . 0.0 111.788 -175.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.53 58.21 4.68 Favored Glycine 0 C--N 1.348 1.197 0 C-N-CA 123.134 0.397 . . . . 0.0 112.557 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -130.91 99.38 4.89 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 36.5 m0 -113.13 145.5 40.82 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.427 0.691 . . . . 0.0 109.432 -177.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.75 117.41 28.59 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -176.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.9 168.87 26.44 Favored Glycine 0 C--O 1.239 0.46 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 170.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.58 ' HB2' HD11 ' A' ' 32' ' ' LEU . 41.6 tt0 -149.79 146.71 27.32 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.889 0.476 . . . . 0.0 110.207 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -104.59 -177.5 3.38 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.625 0.726 . . . . 0.0 112.34 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.77 -33.54 73.11 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.337 1.455 . . . . 0.0 109.683 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -58.85 -25.76 63.57 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.181 1.392 . . . . 0.0 112.051 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.21 -11.72 71.25 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.889 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.1 mt -72.54 131.23 42.23 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 123.742 0.817 . . . . 0.0 109.202 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -117.53 160.94 20.41 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.958 0.903 . . . . 0.0 110.156 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -173.56 155.7 22.7 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.646 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 46.1 p-90 -70.68 152.35 43.95 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.321 0.648 . . . . 0.0 110.958 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -134.08 138.01 29.57 Favored Pre-proline 0 C--O 1.243 0.745 0 C-N-CA 123.979 0.912 . . . . 0.0 109.101 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.473 ' HB2' ' HB2' ' A' ' 56' ' ' TYR . 9.1 Cg_exo -71.49 113.07 3.51 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.768 2.312 . . . . 0.0 110.378 172.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.99 -32.5 73.77 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.56 0.744 . . . . 0.0 112.11 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.3 t -73.45 -17.64 61.22 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.846 0.458 . . . . 0.0 111.576 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.473 ' HB2' ' HB2' ' A' ' 53' ' ' PRO . 35.1 t80 -75.67 -35.48 60.36 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.712 0.805 . . . . 0.0 110.383 -177.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.9 m -111.81 166.5 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.9 0.88 . . . . 0.0 110.765 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -83.24 125.4 31.53 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 63.9 mt -84.51 141.82 30.48 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.655 0.382 . . . . 0.0 110.529 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.711 ' HB2' ' HB2' ' A' ' 5' ' ' ARG . 96.5 mt . . . . . 0 C--O 1.253 1.255 0 C-N-CA 123.955 0.902 . . . . 0.0 108.877 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.364 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.02 99.5 0.87 Allowed 'General case' 0 C--N 1.35 0.621 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -117.55 156.08 28.69 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.418 0.687 . . . . 0.0 110.068 -176.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.9 m -139.44 156.2 47.11 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.609 1.164 . . . . 0.0 108.659 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -107.39 148.78 28.66 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.661 0.784 . . . . 0.0 109.222 176.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.0 p -91.26 130.17 37.16 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 122.82 0.448 . . . . 0.0 110.557 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.2 mt -63.09 -64.03 1.03 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.299 1.04 . . . . 0.0 111.02 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -129.29 158.41 73.16 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 123.988 0.915 . . . . 0.0 108.949 -177.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.653 ' HD3' ' HB2' ' A' ' 25' ' ' ALA . 72.7 Cg_endo -73.68 98.07 1.02 Allowed 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.067 1.845 . . . . 0.0 110.987 176.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -90.8 100.23 13.12 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.7 m -96.98 75.82 2.67 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.911 0.885 . . . . 0.0 109.788 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -134.51 153.67 21.13 Favored Glycine 0 C--O 1.244 0.757 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.611 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 56.64 73.5 0.45 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.268 1.027 . . . . 0.0 110.217 -175.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -85.81 32.35 0.6 Allowed 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.439 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -169.06 159.76 9.42 Favored 'General case' 0 C--O 1.247 0.936 0 C-N-CA 124.984 1.313 . . . . 0.0 108.84 -170.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.61 -123.31 19.32 Favored Glycine 0 C--N 1.344 0.993 0 O-C-N 123.388 0.43 . . . . 0.0 113.685 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -94.48 5.56 51.45 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.859 0.864 . . . . 0.0 112.267 -174.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.1 126.4 8.28 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.271 0.357 . . . . 0.0 112.877 -177.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.0 tp -105.23 117.75 34.81 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 173.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -87.39 149.42 24.48 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.124 0.97 . . . . 0.0 110.239 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -158.44 153.13 24.72 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.718 0.807 . . . . 0.0 110.814 -177.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.14 169.22 11.03 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.484 1.114 . . . . 0.0 110.667 172.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.653 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . . . -61.06 125.71 24.7 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.279 0.631 . . . . 0.0 111.191 175.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.03 -4.71 65.54 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-O 119.203 -0.776 . . . . 0.0 114.116 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -52.39 120.0 5.07 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.037 0.935 . . . . 0.0 111.702 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.4 mt -82.52 99.62 9.6 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 48.9 mm -88.43 111.04 21.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 124.454 1.102 . . . . 0.0 108.079 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.5 m -87.51 107.48 18.59 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.553 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.51 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 41.4 mt -65.01 134.87 54.83 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.635 0.774 . . . . 0.0 109.624 175.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.2 mt -75.34 -47.77 26.19 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.276 0.631 . . . . 0.0 109.736 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -141.19 159.43 42.23 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.528 1.131 . . . . 0.0 108.396 174.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.0 m -119.59 84.81 31.09 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 171.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -72.07 169.27 21.81 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.761 2.307 . . . . 0.0 111.254 175.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -70.55 96.99 1.24 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.385 0.674 . . . . 0.0 110.019 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.95 173.56 23.15 Favored Glycine 0 C--N 1.344 0.985 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.808 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -91.99 28.6 8.46 Favored Glycine 0 C--N 1.345 1.052 0 C-N-CA 122.853 0.263 . . . . 0.0 113.12 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -127.16 116.71 21.06 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.571 1.148 . . . . 0.0 108.052 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 8.7 m0 -128.89 139.32 52.19 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -91.53 119.27 31.32 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' A' ' 31' ' ' LEU . . . -110.44 136.34 13.52 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.236 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -104.11 141.17 36.7 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.181 0.593 . . . . 0.0 109.971 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.433 ' HG2' ' H ' ' A' ' 46' ' ' ASP . 88.7 tttt -93.97 160.3 14.78 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.712 1.205 . . . . 0.0 109.565 177.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.88 -24.55 52.66 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.449 1.1 . . . . 0.0 111.977 175.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.433 ' H ' ' HG2' ' A' ' 44' ' ' LYS . 15.1 t70 -60.35 -36.11 77.24 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.105 1.362 . . . . 0.0 111.95 175.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.78 -20.19 22.59 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 116.252 -0.431 . . . . 0.0 112.458 -177.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -76.63 134.17 39.4 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -119.27 139.83 51.26 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.34 1.056 . . . . 0.0 109.459 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -133.18 150.63 19.86 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 178.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 48.7 m95 -82.8 130.2 35.1 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.105 0.962 . . . . 0.0 108.999 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -140.07 151.71 65.67 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 122.973 0.509 . . . . 0.0 111.289 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -65.88 158.89 51.57 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.982 2.455 . . . . 0.0 112.043 168.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.96 -36.76 82.93 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.0 0.92 . . . . 0.0 111.861 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.7 t -79.66 -14.63 58.65 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.894 0.878 . . . . 0.0 111.71 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -71.93 -29.22 64.07 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.386 0.674 . . . . 0.0 110.519 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.1 m -111.72 172.67 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.253 1.021 . . . . 0.0 109.857 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -113.93 126.22 54.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.02 0.928 . . . . 0.0 109.478 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 75.0 mt -69.73 140.7 53.52 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.295 0.638 . . . . 0.0 109.925 176.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 CA--C 1.556 1.188 0 C-N-CA 123.243 0.617 . . . . 0.0 110.751 -179.369 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.926 0 CA-C-O 121.112 0.284 . . . . 0.0 112.743 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.65 ' HB1' ' HB2' ' A' ' 31' ' ' LEU . . . -78.43 83.35 4.65 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.492 0.717 . . . . 0.0 111.175 -175.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -127.99 134.45 49.26 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.143 0.977 . . . . 0.0 110.098 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.701 ' SG ' HD11 ' A' ' 31' ' ' LEU . 89.4 m -139.73 146.33 39.43 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.996 0.918 . . . . 0.0 108.65 165.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -105.43 137.97 42.38 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.1 p -70.59 119.21 14.41 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.169 0.988 . . . . 0.0 110.27 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.8 -56.8 7.81 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.484 0.713 . . . . 0.0 110.61 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -134.66 155.02 79.85 Favored Pre-proline 0 N--CA 1.482 1.14 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.487 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . 72.0 Cg_endo -73.04 88.07 0.97 Allowed 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.059 1.84 . . . . 0.0 111.993 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -91.83 100.15 12.89 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.9 t -160.63 84.81 0.7 Allowed 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.46 -3.15 88.72 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.846 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.35 105.42 8.52 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.45 1.1 . . . . 0.0 109.218 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -69.92 84.22 0.49 Allowed 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.859 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 78.8 m80 63.9 14.24 8.22 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.117 1.367 . . . . 0.0 112.721 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.77 66.98 1.89 Allowed Glycine 0 C--N 1.35 1.329 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 61.4 79.94 0.24 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.372 1.069 . . . . 0.0 110.551 -175.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.02 -176.69 39.99 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.807 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' A' ' 44' ' ' LYS . 32.4 tp -107.37 123.35 48.24 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.228 0.611 . . . . 0.0 109.737 -176.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -94.84 118.19 31.37 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -154.23 173.05 16.65 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.198 0.599 . . . . 0.0 111.301 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.487 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . . . -128.3 157.27 41.42 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.597 1.159 . . . . 0.0 109.376 175.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.14 134.59 55.15 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.511 0.724 . . . . 0.0 111.621 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.63 -14.31 29.81 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 123.334 0.396 . . . . 0.0 113.365 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -81.88 142.38 32.55 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.125 0.57 . . . . 0.0 111.819 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.466 HD12 HD11 ' A' ' 60' ' ' LEU . 1.9 mm? -95.37 105.18 17.11 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.299 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.6 mm -85.02 116.42 28.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.5 m -77.34 111.58 13.16 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.219 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.701 HD11 ' SG ' ' A' ' 6' ' ' CYS . 34.4 mt -70.46 139.46 51.73 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 123.867 0.729 . . . . 0.0 111.716 -171.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.524 ' HB2' ' HG3' ' A' ' 41' ' ' GLU . 70.3 mt -101.17 -30.99 11.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.632 0.773 . . . . 0.0 109.458 174.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.542 ' HG3' ' HG2' ' A' ' 41' ' ' GLU . 70.9 mt-30 -97.12 149.71 21.67 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.344 0.657 . . . . 0.0 110.854 172.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.6 m -142.93 54.64 3.43 Favored Pre-proline 0 CA--C 1.578 2.046 0 C-N-CA 124.81 1.244 . . . . 0.0 110.292 173.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 33' ' ' GLN . 63.7 Cg_endo -81.58 -170.24 0.94 Allowed 'Trans proline' 0 C--N 1.391 2.77 0 C-N-CA 122.754 2.302 . . . . 0.0 112.297 -175.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -74.6 77.76 1.99 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.922 0.889 . . . . 0.0 109.645 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.78 -128.16 45.95 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.198 -174.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.21 -87.1 0.19 Allowed Glycine 0 C--N 1.349 1.279 0 C-N-CA 123.109 0.385 . . . . 0.0 112.947 175.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.8 OUTLIER -149.69 165.97 30.75 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.424 0.69 . . . . 0.0 110.482 -174.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -140.77 134.21 29.9 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.643 0.777 . . . . 0.0 109.147 173.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.542 ' HG2' ' HG3' ' A' ' 33' ' ' GLN . 10.6 pt-20 -91.34 160.53 15.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 163.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.55 178.33 41.57 Favored Glycine 0 C--O 1.243 0.673 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.646 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -104.79 139.96 38.79 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.787 0.835 . . . . 0.0 110.613 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.615 ' HB2' HD11 ' A' ' 21' ' ' LEU . 10.1 tmtt? -95.64 156.98 16.1 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.159 1.384 . . . . 0.0 107.61 176.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.553 ' H ' ' HD3' ' A' ' 44' ' ' LYS . 38.6 mm-40 -55.44 -33.98 64.06 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -177.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.85 -14.24 62.65 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.05 0.54 . . . . 0.0 112.367 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.08 -9.27 59.63 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.881 -174.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.3 tp -65.24 127.75 32.99 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 123.812 0.845 . . . . 0.0 109.538 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -104.81 131.88 51.74 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.662 0.785 . . . . 0.0 109.059 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.503 ' HA3' ' HB2' ' A' ' 21' ' ' LEU . . . -149.29 173.96 28.99 Favored Glycine 0 C--N 1.336 0.577 0 O-C-N 123.35 0.406 . . . . 0.0 112.343 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 41' ' ' GLU . 51.3 p-90 -141.79 142.24 33.2 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.916 0.887 . . . . 0.0 109.79 -173.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -157.01 149.94 18.43 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 123.905 0.882 . . . . 0.0 110.205 175.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 39' ' ' TRP . 82.7 Cg_exo -51.26 165.98 0.5 Allowed 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.462 2.775 . . . . 0.0 114.652 167.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.4 -15.55 49.72 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.416 1.086 . . . . 0.0 112.832 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.3 m -69.17 -21.79 63.96 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.006 0.923 . . . . 0.0 112.2 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -98.72 -47.75 5.21 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.515 0.726 . . . . 0.0 109.702 -175.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.7 m -112.09 130.11 66.35 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.696 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -123.57 126.7 47.12 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.779 0.832 . . . . 0.0 110.577 -171.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.538 HD23 ' SG ' ' A' ' 6' ' ' CYS . 90.3 mt -52.71 133.24 36.85 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.2 1.0 . . . . 0.0 111.862 177.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.466 HD11 HD12 ' A' ' 28' ' ' LEU . 7.1 mp . . . . . 0 C--O 1.252 1.214 0 C-N-CA 123.203 0.601 . . . . 0.0 110.987 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.611 0 N-CA-C 112.104 -0.398 . . . . 0.0 112.104 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.401 ' HB3' ' HB2' ' A' ' 31' ' ' LEU . . . -72.68 87.39 1.25 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 171.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -80.17 142.01 35.14 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.168 -176.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.573 ' HB3' ' HB ' ' A' ' 57' ' ' VAL . 71.6 m -133.08 141.27 48.11 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 172.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -106.63 127.39 53.31 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.466 HG21 ' HB2' ' A' ' 23' ' ' PHE . 37.6 p -68.81 130.39 42.68 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.933 0.893 . . . . 0.0 111.158 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.56 HD21 ' HB2' ' A' ' 58' ' ' GLN . 79.7 mt -86.28 -34.93 20.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.56 1.144 . . . . 0.0 110.474 -177.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -135.73 145.27 52.37 Favored Pre-proline 0 N--CA 1.487 1.389 0 C-N-CA 123.383 0.673 . . . . 0.0 110.453 -175.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . 63.4 Cg_endo -73.05 126.97 11.64 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.385 2.057 . . . . 0.0 110.71 166.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -150.34 133.52 16.25 Favored 'General case' 0 C--O 1.244 0.816 0 C-N-CA 122.947 0.499 . . . . 0.0 109.932 -174.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.3 m 65.81 117.79 0.03 OUTLIER 'General case' 0 C--N 1.36 1.055 0 C-N-CA 125.522 1.529 . . . . 0.0 112.151 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.85 29.91 1.68 Allowed Glycine 0 C--N 1.342 0.863 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 173.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -96.63 160.94 14.11 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.696 0.798 . . . . 0.0 110.559 -171.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -94.79 62.25 2.67 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.034 0.934 . . . . 0.0 109.674 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -79.35 -23.11 43.61 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.334 173.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 122.67 -118.86 3.74 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -77.09 134.36 38.77 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.985 0.514 . . . . 0.0 110.452 177.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.66 165.78 18.14 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.679 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.3 tp -105.81 121.58 44.33 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.272 0.558 . . . . 0.0 109.563 176.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -104.98 154.98 19.38 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.084 1.354 . . . . 0.0 107.945 177.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.466 ' HB2' HG21 ' A' ' 8' ' ' THR . 48.0 p90 -155.51 159.57 39.86 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -175.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . . . -135.36 143.24 45.97 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.556 1.543 . . . . 0.0 108.55 176.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.01 118.03 3.95 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 124.122 0.889 . . . . 0.0 111.748 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.03 7.0 22.08 Favored Glycine 0 CA--C 1.536 1.403 0 O-C-N 123.746 0.654 . . . . 0.0 113.267 -176.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -95.81 145.66 25.17 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.471 0.708 . . . . 0.0 110.529 171.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.504 HD22 HD11 ' A' ' 60' ' ' LEU . 48.0 mt -109.3 104.93 14.14 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.073 0.949 . . . . 0.0 109.381 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.9 mp -90.78 131.73 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.0 m -85.5 109.07 18.23 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.542 0.737 . . . . 0.0 109.428 177.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.486 HD11 ' SG ' ' A' ' 6' ' ' CYS . 84.6 mt -66.15 115.81 6.55 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.419 HD11 ' HB3' ' A' ' 43' ' ' GLU . 84.7 mt -76.55 -31.19 57.43 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.331 0.652 . . . . 0.0 111.533 -177.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.573 ' HG2' ' HD3' ' A' ' 35' ' ' PRO . 9.4 tt0 -137.58 136.34 37.48 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -177.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.441 ' HA ' ' HD1' ' A' ' 40' ' ' TRP . 6.1 m -133.33 69.44 77.54 Favored Pre-proline 0 CA--C 1.559 1.324 0 C-N-CA 124.731 1.213 . . . . 0.0 109.503 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.573 ' HD3' ' HG2' ' A' ' 33' ' ' GLN . 65.7 Cg_endo -81.15 -22.27 6.05 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.981 2.454 . . . . 0.0 112.881 -171.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -161.55 145.37 12.76 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.161 1.385 . . . . 0.0 107.949 -171.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -81.57 59.75 4.8 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 123.6 0.562 . . . . 0.0 113.384 -177.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.28 -89.84 1.0 Allowed Glycine 0 C--N 1.352 1.431 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 1.9 p-90 -132.11 148.18 52.47 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.441 ' HD1' ' HA ' ' A' ' 34' ' ' VAL . 6.5 m-90 -131.83 160.08 36.67 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.129 0.49 . . . . 0.0 110.952 -167.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -93.65 151.68 19.5 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.028 172.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.16 -179.43 27.77 Favored Glycine 0 C--O 1.242 0.635 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.158 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB3' HD11 ' A' ' 32' ' ' LEU . 5.8 pt-20 -140.86 167.67 21.62 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.999 0.904 . . . . 0.0 112.292 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.585 ' HD3' ' N ' ' A' ' 45' ' ' GLU . 11.2 tmtt? -114.87 156.81 24.26 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 113.459 -1.701 . . . . 0.0 106.996 166.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.585 ' N ' ' HD3' ' A' ' 44' ' ' LYS . 35.8 mt-10 -46.81 -31.14 2.84 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 125.675 1.59 . . . . 0.0 113.638 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.92 1.42 12.83 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.203 1.001 . . . . 0.0 112.983 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.48 -1.62 85.97 Favored Glycine 0 C--N 1.352 1.423 0 C-N-CA 122.688 0.185 . . . . 0.0 112.789 -177.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.2 119.94 12.35 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.561 0.744 . . . . 0.0 110.379 -177.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -104.48 141.32 36.58 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.456 0.703 . . . . 0.0 109.282 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.07 152.15 22.15 Favored Glycine 0 C--N 1.341 0.854 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 174.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -119.22 128.28 54.06 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.464 1.106 . . . . 0.0 108.126 -178.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -133.72 137.81 29.56 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 123.27 0.628 . . . . 0.0 110.675 -172.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -56.03 152.27 37.81 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.3 2.667 . . . . 0.0 112.513 165.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.87 -15.5 62.0 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.328 1.051 . . . . 0.0 112.404 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.8 t -67.21 -26.59 66.68 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.266 0.626 . . . . 0.0 111.68 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -82.98 -30.56 28.11 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.974 0.51 . . . . 0.0 111.266 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 6' ' ' CYS . 15.6 m -134.45 124.86 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 123.254 0.622 . . . . 0.0 111.43 -168.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.56 ' HB2' HD21 ' A' ' 9' ' ' LEU . 6.6 tp-100 -80.75 130.86 35.31 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.337 0.655 . . . . 0.0 110.345 176.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.434 HD21 ' CZ3' ' A' ' 40' ' ' TRP . 81.9 mt -74.13 108.44 6.93 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.299 1.039 . . . . 0.0 111.252 -175.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.504 HD11 HD22 ' A' ' 28' ' ' LEU . 76.8 mt . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.626 -0.702 . . . . 0.0 109.816 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.155 0 CA-C-O 120.049 -0.306 . . . . 0.0 112.661 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.12 105.44 0.7 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.163 0.585 . . . . 0.0 110.269 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -109.02 172.57 6.77 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.465 ' SG ' ' HZ2' ' A' ' 51' ' ' TRP . 59.6 m -149.23 153.55 37.77 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.582 0.753 . . . . 0.0 110.409 -173.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.428 ' HG3' HD21 ' A' ' 60' ' ' LEU . 18.1 mtp180 -130.94 133.08 45.51 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.922 0.889 . . . . 0.0 109.262 175.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.5 p -78.84 122.13 25.69 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 173.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.557 HD21 ' HB2' ' A' ' 58' ' ' GLN . 87.9 mt -68.63 -47.04 67.66 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.016 0.527 . . . . 0.0 111.039 -174.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -144.53 155.24 57.06 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 124.863 1.265 . . . . 0.0 109.25 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.592 ' HD3' ' HB2' ' A' ' 25' ' ' ALA . 59.3 Cg_endo -83.06 167.57 14.07 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.545 2.163 . . . . 0.0 112.63 -174.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -120.02 100.09 7.01 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 173.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.4 m -98.47 84.06 3.13 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.116 0.566 . . . . 0.0 109.891 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.92 -164.53 36.6 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.74 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -82.15 118.0 22.73 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.406 1.082 . . . . 0.0 110.46 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -106.21 30.43 5.93 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.789 0.836 . . . . 0.0 109.973 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.5 m80 67.87 -76.06 0.06 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.883 1.673 . . . . 0.0 111.27 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.58 -86.17 0.05 OUTLIER Glycine 0 C--N 1.346 1.122 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -63.0 117.81 6.95 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.262 0.625 . . . . 0.0 110.756 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.89 -164.12 35.41 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.442 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.0 tp -137.51 142.51 41.46 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.008 0.923 . . . . 0.0 108.556 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -91.92 131.22 37.4 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 170.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -151.71 143.69 23.83 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.186 0.595 . . . . 0.0 112.001 -171.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.491 ' O ' ' HG2' ' A' ' 27' ' ' GLU . . . -87.88 170.95 10.72 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.915 1.286 . . . . 0.0 109.898 167.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.592 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . . . -71.44 112.4 7.53 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.959 -0.463 . . . . 0.0 110.474 172.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.09 17.46 7.78 Favored Glycine 0 N--CA 1.475 1.255 0 C-N-CA 123.139 0.399 . . . . 0.0 113.721 174.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 24' ' ' ALA . 10.2 mm-40 -69.75 125.32 26.39 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 122.678 0.391 . . . . 0.0 110.958 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.7 mt -85.42 101.95 13.04 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.838 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.6 mm -105.59 140.41 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.5 m -113.5 118.94 35.88 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.546 0.612 . . . . 0.0 109.73 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.419 ' HG ' ' SG ' ' A' ' 6' ' ' CYS . 68.8 mt -58.99 121.43 11.2 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 123.695 0.622 . . . . 0.0 110.784 177.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.479 HD11 ' HB2' ' A' ' 43' ' ' GLU . 80.9 mt -75.15 -46.61 33.14 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.017 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -155.23 166.02 34.85 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.936 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.3 m -120.63 81.56 32.64 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 124.084 0.954 . . . . 0.0 109.052 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -83.31 -21.5 4.43 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.53 2.154 . . . . 0.0 114.076 -172.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -155.43 142.99 19.63 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.337 0.655 . . . . 0.0 110.632 -168.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.85 61.02 4.12 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.532 0.52 . . . . 0.0 112.622 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.34 -53.33 0.04 OUTLIER Glycine 0 C--N 1.342 0.869 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 49.2 m95 -118.94 128.0 54.01 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 170.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.452 ' HE3' ' HZ3' ' A' ' 51' ' ' TRP . 15.5 m-90 -119.09 170.57 8.94 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -132.48 133.0 43.28 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.133 0.492 . . . . 0.0 111.147 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.8 168.4 19.81 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 114.612 -1.177 . . . . 0.0 110.821 173.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.479 ' HB2' HD11 ' A' ' 32' ' ' LEU . 29.2 tt0 -125.7 151.28 46.82 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.184 0.593 . . . . 0.0 109.801 -178.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.451 ' HE3' ' HB3' ' A' ' 27' ' ' GLU . 1.3 mmtp -89.95 163.12 15.09 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.392 1.077 . . . . 0.0 110.244 176.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -63.84 -24.53 67.79 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.71 0.804 . . . . 0.0 111.243 170.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.84 -23.31 65.01 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.366 1.066 . . . . 0.0 111.685 174.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.32 -21.29 37.77 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.095 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.5 133.59 35.85 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.213 0.605 . . . . 0.0 109.606 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 28.5 ptt85 -105.78 147.18 28.91 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.363 0.601 . . . . 0.0 110.175 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 173.44 150.32 7.43 Favored Glycine 0 C--O 1.243 0.703 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 174.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.465 ' HZ2' ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -156.31 171.67 19.82 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.707 0.765 . . . . 0.0 110.888 -173.314 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -147.15 150.37 38.02 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 125.27 1.428 . . . . 0.0 107.841 -173.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -42.28 147.85 0.47 Allowed 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 123.773 2.982 . . . . 0.0 113.681 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.448 ' H ' ' HZ3' ' A' ' 40' ' ' TRP . . . -57.19 -22.02 37.57 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.812 0.845 . . . . 0.0 112.974 -171.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.1 m -58.44 -28.39 65.24 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.34 1.056 . . . . 0.0 112.791 177.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -79.88 -29.61 40.01 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.7 0.8 . . . . 0.0 111.776 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.411 HG21 ' CZ2' ' A' ' 51' ' ' TRP . 23.7 m -123.86 -171.8 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 123.247 0.619 . . . . 0.0 112.078 -166.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.557 ' HB2' HD21 ' A' ' 9' ' ' LEU . 7.7 tp60 -120.61 139.75 52.53 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.0 1.32 . . . . 0.0 108.594 174.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.413 HD21 ' HH2' ' A' ' 51' ' ' TRP . 96.7 mt -104.35 119.71 39.57 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.439 0.696 . . . . 0.0 109.648 176.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.428 HD21 ' HG3' ' A' ' 7' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--O 1.253 1.241 0 C-N-CA 124.107 0.963 . . . . 0.0 108.789 175.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.582 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.16 114.35 13.76 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.495 1.118 . . . . 0.0 109.034 -174.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -129.22 154.62 46.61 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.324 1.05 . . . . 0.0 109.341 176.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.579 ' SG ' HD11 ' A' ' 31' ' ' LEU . 84.0 m -122.97 175.89 6.33 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.854 -1.067 . . . . 0.0 108.773 173.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -156.32 129.01 7.76 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.58 HG23 HD11 ' A' ' 29' ' ' ILE . 34.3 p -66.77 147.73 52.86 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.064 0.946 . . . . 0.0 111.393 -175.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.5 mt -80.23 -62.57 1.64 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.815 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -141.51 164.56 34.2 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 123.991 0.917 . . . . 0.0 109.706 -172.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.548 ' HG3' ' HB2' ' A' ' 25' ' ' ALA . 26.5 Cg_exo -62.4 121.45 9.44 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 122.727 2.284 . . . . 0.0 112.37 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -91.43 142.99 27.07 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.6 m -125.77 -72.33 0.66 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.981 0.513 . . . . 0.0 109.886 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.15 153.2 19.67 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -170.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -74.79 -32.71 62.09 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.484 0.713 . . . . 0.0 111.141 -176.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -163.04 131.06 3.74 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.802 0.841 . . . . 0.0 109.205 -177.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -163.56 115.05 1.42 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.189 0.996 . . . . 0.0 109.604 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.68 -47.97 88.52 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.246 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -155.49 148.31 24.31 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.537 0.735 . . . . 0.0 110.063 175.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -152.94 -164.83 12.81 Favored Glycine 0 C--O 1.241 0.57 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 171.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.6 tp -99.9 125.02 45.82 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 175.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.56 133.62 37.32 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.881 0.872 . . . . 0.0 110.986 -174.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -134.0 147.8 51.04 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.031 0.933 . . . . 0.0 108.568 170.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.64 166.57 12.74 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.633 0.773 . . . . 0.0 109.274 169.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.548 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -66.2 120.8 13.87 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.222 0.609 . . . . 0.0 110.169 176.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.75 17.08 80.21 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 123.287 0.367 . . . . 0.0 113.237 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.76 143.51 26.65 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.165 0.586 . . . . 0.0 109.466 179.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 mp -74.7 164.63 26.36 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.362 1.065 . . . . 0.0 111.499 -175.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.58 HD11 HG23 ' A' ' 8' ' ' THR . 4.1 mp -131.8 123.39 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 174.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.1 m -85.6 106.19 16.72 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.579 HD11 ' SG ' ' A' ' 6' ' ' CYS . 88.5 mt -77.42 106.13 8.99 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.982 0.513 . . . . 0.0 109.906 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.436 HD11 ' HB2' ' A' ' 43' ' ' GLU . 86.0 mt -83.37 -51.59 7.27 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.805 0.842 . . . . 0.0 109.776 -178.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.649 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 1.4 mp0 -106.48 146.62 30.34 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.692 0.797 . . . . 0.0 108.856 172.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.4 m -128.0 69.71 77.37 Favored Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 123.644 0.778 . . . . 0.0 110.232 172.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 40' ' ' TRP . 64.2 Cg_endo -71.25 132.2 20.53 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 122.392 2.061 . . . . 0.0 111.845 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.5 t70 60.91 -88.04 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.967 1.307 . . . . 0.0 112.074 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 161.11 40.55 0.02 OUTLIER Glycine 0 C--N 1.344 0.978 0 O-C-N 122.912 0.133 . . . . 0.0 112.838 -173.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.24 -86.64 0.07 OUTLIER Glycine 0 C--N 1.348 1.225 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 18.1 m95 -82.88 114.53 21.25 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.569 ' HZ3' HD21 ' A' ' 59' ' ' LEU . 18.6 m0 -113.32 144.86 42.03 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.409 0.684 . . . . 0.0 110.061 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.649 ' HB2' ' HB2' ' A' ' 33' ' ' GLN . 39.7 mt-10 -91.71 122.03 33.89 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.786 0.834 . . . . 0.0 109.841 -175.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.25 169.62 20.51 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.039 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.436 ' HB2' HD11 ' A' ' 32' ' ' LEU . 35.5 tt0 -124.09 154.22 40.29 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.972 0.909 . . . . 0.0 108.886 177.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.634 ' HE3' ' HA ' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -129.84 172.83 11.25 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 122.967 0.507 . . . . 0.0 109.958 173.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.478 ' HG2' ' HE2' ' A' ' 44' ' ' LYS . 6.3 mm-40 -67.09 -10.57 51.45 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.466 1.106 . . . . 0.0 111.46 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -55.29 -25.6 35.08 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.865 1.266 . . . . 0.0 111.541 168.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.32 -24.15 32.78 Favored Glycine 0 C--N 1.354 1.552 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 177.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.58 173.99 7.76 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.725 0.81 . . . . 0.0 110.602 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 38.2 mtm-85 -123.54 157.59 33.28 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.122 0.969 . . . . 0.0 108.645 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.99 154.2 25.32 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.586 ' HB3' ' HG2' ' A' ' 41' ' ' GLU . 4.8 p-90 -111.34 126.8 55.3 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -138.25 148.24 58.89 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.879 0.872 . . . . 0.0 109.319 -172.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.582 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 57.1 Cg_endo -69.68 142.87 49.45 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.302 2.001 . . . . 0.0 111.24 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.95 -23.06 66.14 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.925 0.89 . . . . 0.0 110.758 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.5 m -64.71 -40.03 94.66 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.267 1.027 . . . . 0.0 111.622 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.582 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 17.3 t80 -74.01 -32.89 63.57 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 121.316 0.579 . . . . 0.0 110.996 -173.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.6 m -104.54 -169.14 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.345 1.058 . . . . 0.0 108.899 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -141.18 130.94 24.21 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.729 0.412 . . . . 0.0 110.263 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.569 HD21 ' HZ3' ' A' ' 40' ' ' TRP . 94.8 mt -71.57 141.75 50.04 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.662 0.785 . . . . 0.0 111.552 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.7 mt . . . . . 0 C--O 1.244 0.806 0 C-N-CA 124.14 0.976 . . . . 0.0 109.848 -179.956 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.539 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.79 137.49 47.67 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.37 0.668 . . . . 0.0 109.541 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -161.13 172.8 16.13 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.39 0.615 . . . . 0.0 111.501 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.641 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 20.6 p -141.41 171.82 13.54 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.315 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.461 ' HB2' HD21 ' A' ' 60' ' ' LEU . 28.2 tpt85 -117.51 128.64 55.18 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.742 1.217 . . . . 0.0 109.272 -172.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.0 p -80.15 112.68 17.7 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.366 0.666 . . . . 0.0 109.326 173.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.94 -58.98 3.21 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.348 0.659 . . . . 0.0 110.762 -175.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -137.36 156.64 75.07 Favored Pre-proline 0 N--CA 1.488 1.434 0 C-N-CA 123.617 0.767 . . . . 0.0 109.69 -175.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . 44.9 Cg_endo -66.22 125.31 13.83 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.532 2.155 . . . . 0.0 112.381 175.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -92.86 121.33 34.11 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.127 0.971 . . . . 0.0 108.599 176.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.7 t -124.76 -161.99 1.06 Allowed 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 175.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 161.52 -35.61 0.39 Allowed Glycine 0 C--N 1.339 0.74 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 66.67 2.98 2.76 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.4 1.08 . . . . 0.0 112.877 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -82.11 -41.74 20.1 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.217 1.007 . . . . 0.0 109.261 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 20.8 m80 -84.91 119.16 25.04 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.168 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.38 -52.32 36.47 Favored Glycine 0 C--N 1.346 1.088 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 171.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -122.59 144.02 49.37 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.571 1.149 . . . . 0.0 109.438 173.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.19 159.56 10.11 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.54 HD11 ' HD3' ' A' ' 44' ' ' LYS . 16.9 tp -88.25 132.71 34.27 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 117.971 0.886 . . . . 0.0 108.773 -177.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -123.47 169.21 11.62 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.389 1.076 . . . . 0.0 109.031 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -123.54 113.34 18.58 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.612 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . . . -95.73 160.45 14.48 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 173.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.83 128.07 34.59 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.312 0.645 . . . . 0.0 111.121 -170.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.16 -30.81 6.33 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-O 119.305 -0.719 . . . . 0.0 113.927 176.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -61.57 130.84 47.89 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 117.665 0.733 . . . . 0.0 112.039 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 61.3 mt -99.25 103.32 15.17 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 175.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.641 ' HB ' ' SG ' ' A' ' 6' ' ' CYS . 21.9 mm -88.07 109.2 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -169.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.2 m -74.38 109.54 7.95 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.481 0.488 . . . . 0.0 110.622 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.8 mt -69.81 104.34 2.43 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.849 -0.796 . . . . 0.0 108.849 175.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 70.5 mt -74.16 -30.63 62.34 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.658 0.783 . . . . 0.0 110.032 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -127.11 136.34 51.99 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.223 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.1 m -129.75 90.39 43.47 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.768 1.227 . . . . 0.0 108.576 175.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.62 -155.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.691 2.261 . . . . 0.0 110.926 177.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -63.21 -31.98 73.26 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.031 0.532 . . . . 0.0 111.171 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.34 -163.59 29.91 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 116.417 -0.356 . . . . 0.0 112.218 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.58 -76.49 2.1 Favored Glycine 0 C--N 1.345 1.04 0 C-N-CA 123.458 0.551 . . . . 0.0 112.11 177.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -114.41 132.52 56.21 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.304 0.642 . . . . 0.0 109.475 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -117.67 153.39 33.41 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.435 0.694 . . . . 0.0 109.432 173.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -91.69 120.4 32.41 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 173.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -123.03 135.47 10.04 Favored Glycine 0 C--N 1.342 0.874 0 O-C-N 123.379 0.425 . . . . 0.0 112.71 -175.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.573 ' HA ' ' HG2' ' A' ' 49' ' ' ARG . 10.6 tp10 -105.04 140.96 37.45 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.371 1.069 . . . . 0.0 110.228 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.615 ' HG2' HD12 ' A' ' 29' ' ' ILE . 22.3 mtpt -124.53 157.53 35.11 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.797 0.839 . . . . 0.0 110.27 176.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.81 0.68 26.07 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.42 0.688 . . . . 0.0 111.326 174.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.56 -27.66 68.6 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.423 1.089 . . . . 0.0 110.159 168.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.66 -17.21 57.85 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.011 -176.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -98.66 154.84 17.65 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.857 0.863 . . . . 0.0 110.119 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.573 ' HG2' ' HA ' ' A' ' 43' ' ' GLU . 72.1 mtm180 -124.62 169.04 12.33 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.488 1.115 . . . . 0.0 109.499 170.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.91 173.15 39.09 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.55 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -111.71 125.26 53.78 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -151.57 147.12 19.64 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 124.23 1.012 . . . . 0.0 109.492 -175.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -83.31 178.75 5.53 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.255 2.637 . . . . 0.0 111.539 172.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.02 -14.09 61.06 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.008 0.923 . . . . 0.0 112.046 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -59.68 -19.62 50.81 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.565 1.146 . . . . 0.0 113.155 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -113.05 -16.05 12.71 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.657 0.783 . . . . 0.0 111.868 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.15 136.22 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 122.973 0.509 . . . . 0.0 111.324 -172.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -91.87 112.79 24.85 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.765 0.826 . . . . 0.0 109.782 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.59 123.37 18.64 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.056 0.542 . . . . 0.0 110.764 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.461 HD21 ' HB2' ' A' ' 7' ' ' ARG . 86.7 mt . . . . . 0 CA--C 1.55 0.952 0 C-N-CA 123.747 0.819 . . . . 0.0 110.745 -177.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.833 0 CA-C-O 119.84 -0.422 . . . . 0.0 112.317 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.89 132.54 54.26 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.549 1.14 . . . . 0.0 110.721 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -142.46 153.43 43.67 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.478 0.711 . . . . 0.0 110.959 -172.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.462 ' SG ' HD11 ' A' ' 31' ' ' LEU . 81.2 m -139.15 148.89 43.82 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.875 1.27 . . . . 0.0 108.967 175.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -108.14 152.35 24.67 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.454 0.702 . . . . 0.0 109.778 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.491 HG21 ' HB2' ' A' ' 23' ' ' PHE . 24.5 p -87.89 130.19 34.99 Favored 'General case' 0 C--O 1.242 0.711 0 C-N-CA 123.47 0.708 . . . . 0.0 110.464 173.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.5 mt -79.35 -53.5 6.87 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.249 1.019 . . . . 0.0 110.012 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -134.89 155.12 79.53 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 123.599 0.76 . . . . 0.0 109.574 -173.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.516 ' HD3' ' HB2' ' A' ' 25' ' ' ALA . 64.6 Cg_endo -78.71 85.37 1.86 Allowed 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 121.874 1.716 . . . . 0.0 110.646 170.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -92.7 101.18 13.58 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.092 -175.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.9 m -153.9 63.29 0.72 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.816 1.246 . . . . 0.0 107.905 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.26 -33.25 86.73 Favored Glycine 0 C--N 1.357 1.732 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.4 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -127.39 138.27 52.96 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.55 1.14 . . . . 0.0 108.555 170.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -66.55 -51.93 51.2 Favored 'General case' 0 CA--C 1.55 0.973 0 O-C-N 123.784 0.678 . . . . 0.0 109.615 176.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.4 t60 64.55 -77.52 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.423 1.489 . . . . 0.0 111.791 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 145.17 -66.46 0.43 Allowed Glycine 0 C--N 1.34 0.782 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -76.84 103.95 7.07 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.243 0.617 . . . . 0.0 109.823 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.74 -162.59 34.13 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.442 HD22 ' HA3' ' A' ' 50' ' ' GLY . 20.7 tp -143.24 120.04 11.22 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 176.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -77.46 120.94 23.15 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.491 ' HB2' HG21 ' A' ' 8' ' ' THR . 33.1 p90 -120.75 130.02 53.86 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.179 0.991 . . . . 0.0 110.104 -178.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -104.31 153.98 20.37 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.056 0.943 . . . . 0.0 110.488 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.516 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . . . -58.5 121.56 11.21 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.969 0.908 . . . . 0.0 111.99 -178.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.56 -23.96 16.56 Favored Glycine 0 C--N 1.347 1.164 0 C-N-CA 123.337 0.494 . . . . 0.0 113.661 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -60.9 128.48 36.69 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.552 0.741 . . . . 0.0 111.526 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.2 mt -96.24 125.13 40.54 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.8 mp -104.86 116.39 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 175.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.8 m -87.0 111.5 20.92 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.462 HD11 ' SG ' ' A' ' 6' ' ' CYS . 7.0 mp -65.69 115.96 6.4 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.044 0.938 . . . . 0.0 110.698 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.421 HD11 ' HB2' ' A' ' 43' ' ' GLU . 58.6 mt -84.72 -36.25 21.95 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.151 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -116.51 135.64 53.65 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.054 0.942 . . . . 0.0 109.309 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.5 m -143.71 66.41 15.22 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 124.046 0.938 . . . . 0.0 110.434 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.402 ' HD2' ' HD1' ' A' ' 40' ' ' TRP . 7.6 Cg_exo -77.03 -173.12 1.64 Allowed 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 123.211 2.607 . . . . 0.0 112.73 174.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -77.37 101.18 6.22 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.566 0.747 . . . . 0.0 110.548 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.72 -154.94 26.08 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 116.371 -0.377 . . . . 0.0 112.647 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.9 -28.67 4.1 Favored Glycine 0 C--N 1.346 1.129 0 N-CA-C 112.236 -0.346 . . . . 0.0 112.236 176.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -81.06 110.62 16.76 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.593 0.757 . . . . 0.0 109.512 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.402 ' HD1' ' HD2' ' A' ' 35' ' ' PRO . 7.0 m0 -125.36 138.75 54.05 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.741 0.817 . . . . 0.0 109.726 178.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.577 ' HG2' ' HB3' ' A' ' 51' ' ' TRP . 28.2 mt-10 -94.87 138.32 32.8 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.687 0.395 . . . . 0.0 110.496 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.13 171.01 27.16 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.412 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.421 ' HB2' HD11 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -127.83 148.22 50.45 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.124 0.57 . . . . 0.0 110.17 -169.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.467 ' HE3' ' HB3' ' A' ' 46' ' ' ASP . 39.7 mtmt -88.3 -173.22 4.11 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.605 1.562 . . . . 0.0 110.24 176.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -86.6 62.1 7.21 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 165.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.467 ' HB3' ' HE3' ' A' ' 44' ' ' LYS . 38.0 t70 -148.56 -47.75 0.15 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -168.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.64 -9.76 28.05 Favored Glycine 0 N--CA 1.473 1.136 0 CA-C-O 119.848 -0.418 . . . . 0.0 113.683 -174.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.58 130.99 45.86 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 117.544 0.672 . . . . 0.0 110.1 172.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -103.14 143.07 33.09 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.778 0.831 . . . . 0.0 109.446 -175.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.442 ' HA3' HD22 ' A' ' 21' ' ' LEU . . . -134.34 155.15 21.74 Favored Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 177.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.577 ' HB3' ' HG2' ' A' ' 41' ' ' GLU . 1.1 p-90 -99.66 132.19 45.17 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.995 0.918 . . . . 0.0 109.88 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -133.26 129.39 20.78 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 123.657 0.783 . . . . 0.0 109.446 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.65 151.98 83.05 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.3 2.0 . . . . 0.0 111.15 162.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.572 ' HB1' HD11 ' A' ' 59' ' ' LEU . . . -60.0 -26.47 66.08 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.473 1.109 . . . . 0.0 112.178 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.1 m -73.14 -16.79 61.44 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.829 0.852 . . . . 0.0 113.118 -177.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -96.8 -24.71 15.78 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.002 0.521 . . . . 0.0 111.992 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.2 m -116.89 151.73 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.113 0.565 . . . . 0.0 110.963 -173.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -81.17 103.85 11.25 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.78 0.832 . . . . 0.0 109.288 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.572 HD11 ' HB1' ' A' ' 54' ' ' ALA . 43.8 mt -67.77 115.1 6.94 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.1 mt . . . . . 0 C--O 1.25 1.104 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -177.546 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.77 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.533 ' HB3' ' HB2' ' A' ' 31' ' ' LEU . . . -77.08 106.8 9.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.453 0.701 . . . . 0.0 109.651 -177.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -78.64 142.24 37.37 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.751 0.42 . . . . 0.0 110.359 -176.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 76.7 m -138.75 159.56 41.81 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.985 0.914 . . . . 0.0 109.229 174.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.568 ' HB2' ' HB3' ' A' ' 58' ' ' GLN . 19.9 mmt180 -106.69 147.72 29.24 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.643 1.177 . . . . 0.0 108.688 176.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.543 HG21 ' HB2' ' A' ' 23' ' ' PHE . 21.8 p -94.68 118.16 31.28 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.098 175.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.476 HD21 ' HB2' ' A' ' 58' ' ' GLN . 86.0 mt -69.47 -50.62 43.68 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.945 0.498 . . . . 0.0 110.885 -177.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -135.2 148.29 65.87 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 123.569 0.748 . . . . 0.0 109.731 -178.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . 2.8 Cg_exo -74.9 121.68 6.77 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.792 2.328 . . . . 0.0 111.232 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -128.34 102.3 6.6 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.163 0.506 . . . . 0.0 109.89 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.1 m -153.22 30.61 0.48 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.874 1.27 . . . . 0.0 109.528 174.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.03 88.46 0.01 OUTLIER Glycine 0 C--N 1.356 1.644 0 O-C-N 124.44 1.088 . . . . 0.0 113.611 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 57.62 48.79 13.59 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.167 1.387 . . . . 0.0 110.347 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -98.9 80.11 2.46 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.055 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -90.99 -18.96 23.77 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.795 0.838 . . . . 0.0 111.106 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.56 -165.39 24.86 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.932 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -73.84 85.79 1.72 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.76 0.791 . . . . 0.0 110.627 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -164.64 143.4 8.49 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.721 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.595 HD11 ' HB3' ' A' ' 44' ' ' LYS . 27.0 tp -90.18 142.44 27.71 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.919 0.488 . . . . 0.0 110.822 -171.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -99.89 138.92 36.3 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.23 1.012 . . . . 0.0 110.655 -175.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.543 ' HB2' HG21 ' A' ' 8' ' ' THR . 28.1 p90 -154.16 121.98 5.93 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.592 0.757 . . . . 0.0 110.45 -174.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . . . -92.08 152.51 19.91 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.61 1.164 . . . . 0.0 109.654 171.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.409 ' H ' ' HG3' ' A' ' 11' ' ' PRO . . . -61.99 125.02 22.38 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.719 0.808 . . . . 0.0 111.922 -175.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.87 -20.65 17.1 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 123.643 0.589 . . . . 0.0 113.343 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -72.23 142.91 48.97 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 121.329 0.585 . . . . 0.0 112.219 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.61 111.12 19.25 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.303 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.4 mm -91.36 120.76 40.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 123.471 0.708 . . . . 0.0 109.636 174.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.6 m -85.74 103.85 14.9 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 91.2 mt -71.86 107.45 4.64 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 67.2 mt -75.39 -48.46 22.81 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.591 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -126.45 136.94 53.28 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.067 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.3 m -115.22 91.45 27.88 Favored Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 124.259 1.024 . . . . 0.0 108.929 176.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.62 -49.65 15.23 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 123.298 2.665 . . . . 0.0 112.889 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -164.09 -79.29 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.693 0.797 . . . . 0.0 109.5 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -161.4 149.47 18.26 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 -174.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.37 -61.49 2.86 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 116.577 0.189 . . . . 0.0 112.761 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 40.9 m95 -121.3 99.73 6.65 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.927 0.491 . . . . 0.0 109.786 -172.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -112.12 146.22 38.4 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -90.12 117.2 28.72 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.13 148.58 18.24 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.678 177.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -103.36 160.49 14.65 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.561 0.696 . . . . 0.0 109.816 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.595 ' HB3' HD11 ' A' ' 21' ' ' LEU . 2.0 tmtp? -132.73 155.94 47.93 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 170.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.44 ' H ' ' HD3' ' A' ' 44' ' ' LYS . 9.6 pt-20 -66.52 6.33 0.47 Allowed 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -67.78 -15.66 63.74 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.332 0.653 . . . . 0.0 111.49 168.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.49 -15.24 61.36 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 112.37 -0.292 . . . . 0.0 112.37 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.443 ' HB2' HD13 ' A' ' 21' ' ' LEU . 89.0 mt -96.63 163.03 13.19 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.629 0.772 . . . . 0.0 110.099 176.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 35.9 ttp-105 -119.98 155.75 32.22 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 169.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -150.52 161.47 28.98 Favored Glycine 0 C--N 1.336 0.577 0 N-CA-C 112.343 -0.303 . . . . 0.0 112.343 177.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -88.76 129.87 35.46 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 171.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 59.2 m-85 -108.35 137.22 19.87 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 123.324 0.65 . . . . 0.0 111.035 -173.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 52' ' ' PHE . 6.4 Cg_exo -73.66 124.04 9.0 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 123.086 2.524 . . . . 0.0 111.199 177.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.83 -45.08 86.72 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.744 1.218 . . . . 0.0 113.098 -171.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.3 t -75.98 -25.48 55.86 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.189 0.596 . . . . 0.0 111.12 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -85.77 -18.24 33.54 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.416 0.686 . . . . 0.0 111.167 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.3 m -108.99 147.31 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.094 0.558 . . . . 0.0 109.553 173.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.568 ' HB3' ' HB2' ' A' ' 7' ' ' ARG . 34.1 tt0 -87.64 115.01 24.78 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 174.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.2 mt -76.95 128.66 34.94 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.771 0.429 . . . . 0.0 110.155 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.2 mt . . . . . 0 C--O 1.249 1.066 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 176.475 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.11 0 CA-C-O 120.312 -0.16 . . . . 0.0 113.104 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 31' ' ' LEU . . . -75.91 86.97 2.87 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.871 0.868 . . . . 0.0 111.072 -173.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.419 ' HB2' ' HB2' ' A' ' 60' ' ' LEU . 93.6 mtt180 -110.28 151.78 26.96 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.352 1.061 . . . . 0.0 109.579 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.417 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 28.3 p -158.91 140.62 13.48 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.448 0.699 . . . . 0.0 109.154 171.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.524 ' HB2' HD11 ' A' ' 60' ' ' LEU . 40.2 ttp180 -112.68 130.4 56.06 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.287 0.635 . . . . 0.0 109.45 177.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 45.1 p -66.51 139.21 57.93 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 122.974 0.51 . . . . 0.0 111.468 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.41 HD21 ' HB2' ' A' ' 58' ' ' GLN . 86.0 mt -97.93 -22.53 16.27 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.328 1.051 . . . . 0.0 110.286 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -131.89 151.72 79.01 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 124.02 0.928 . . . . 0.0 109.574 -177.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.86 164.37 33.64 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.304 2.002 . . . . 0.0 111.366 169.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -93.65 102.79 14.98 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.3 p -69.56 120.18 14.95 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 123.222 0.609 . . . . 0.0 109.399 174.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.35 -179.01 48.16 Favored Glycine 0 C--N 1.342 0.894 0 O-C-N 123.595 0.559 . . . . 0.0 112.535 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -83.63 169.15 15.65 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.127 0.571 . . . . 0.0 109.482 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 55.9 mtp85 -56.63 -56.25 23.75 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.503 0.721 . . . . 0.0 111.143 178.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 69.3 t60 66.97 171.14 0.25 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.809 1.243 . . . . 0.0 112.526 169.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.72 -68.86 1.52 Allowed Glycine 0 C--N 1.351 1.391 0 CA-C-N 116.487 -0.324 . . . . 0.0 112.874 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -153.74 148.23 26.13 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.2 0.6 . . . . 0.0 111.278 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 168.81 -175.3 43.34 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.8 tp -90.21 114.13 26.07 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 121.572 0.701 . . . . 0.0 109.614 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -122.58 151.84 41.02 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 125.033 1.333 . . . . 0.0 107.768 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -156.18 152.42 27.83 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.184 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.473 ' O ' ' HG2' ' A' ' 27' ' ' GLU . . . -96.48 169.46 9.89 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.828 1.251 . . . . 0.0 109.027 165.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.09 111.63 3.48 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 122.12 -0.363 . . . . 0.0 110.064 171.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.26 19.8 6.15 Favored Glycine 0 C--N 1.351 1.375 0 N-CA-C 114.388 0.515 . . . . 0.0 114.388 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 24' ' ' ALA . 10.9 mm-40 -92.0 136.69 32.97 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 117.772 0.786 . . . . 0.0 111.138 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.8 mt -84.16 103.06 13.05 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.523 0.729 . . . . 0.0 109.902 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.417 ' HB ' ' SG ' ' A' ' 6' ' ' CYS . 47.5 mm -92.1 124.11 44.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.586 1.154 . . . . 0.0 109.491 176.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.0 m -88.46 107.29 18.79 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.167 0.987 . . . . 0.0 109.112 174.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.465 ' HB2' ' HB1' ' A' ' 4' ' ' ALA . 96.2 mt -70.98 111.98 6.78 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.409 ' H ' ' HA2' ' A' ' 42' ' ' GLY . 82.3 mt -80.46 -53.95 6.13 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 123.151 0.58 . . . . 0.0 109.488 -178.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.606 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 47.2 mt-30 -109.0 135.63 49.87 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.0 m -135.09 84.23 37.31 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 123.413 0.685 . . . . 0.0 110.205 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.12 161.72 37.97 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.583 2.189 . . . . 0.0 111.374 169.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -73.12 100.07 2.96 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.142 0.577 . . . . 0.0 110.11 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.18 -154.42 20.42 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.26 -16.21 23.55 Favored Glycine 0 N--CA 1.47 0.92 0 N-CA-C 112.101 -0.4 . . . . 0.0 112.101 172.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 53.9 m95 -92.14 119.22 31.59 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.272 1.029 . . . . 0.0 109.346 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.4 ' CZ3' HD21 ' A' ' 59' ' ' LEU . 5.2 m-90 -131.39 153.18 49.94 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.674 0.79 . . . . 0.0 109.781 178.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.606 ' HB3' ' HB2' ' A' ' 33' ' ' GLN . 3.1 tm-20 -102.79 132.33 49.03 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.409 ' HA2' ' H ' ' A' ' 32' ' ' LEU . . . -152.76 152.17 23.88 Favored Glycine 0 CA--C 1.508 -0.388 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.088 -177.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 49' ' ' ARG . 9.8 pt-20 -103.67 152.5 21.72 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.113 0.565 . . . . 0.0 110.125 173.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -78.68 154.42 30.17 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 157.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -73.6 16.51 0.2 Allowed 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -170.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -97.24 -1.11 45.53 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.671 1.188 . . . . 0.0 111.282 169.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.81 3.4 68.41 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-O 120.115 -0.269 . . . . 0.0 113.737 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.6 mt -91.25 114.98 27.64 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.541 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 12.6 ptt180 -116.97 165.73 13.01 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.864 0.466 . . . . 0.0 111.863 -173.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 177.7 171.47 41.18 Favored Glycine 0 C--N 1.348 1.239 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.797 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -94.98 128.19 41.6 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.45 0.7 . . . . 0.0 110.315 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -147.7 145.24 20.73 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 124.161 0.985 . . . . 0.0 109.766 175.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -78.4 176.6 9.73 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.685 2.257 . . . . 0.0 111.518 173.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.27 -21.46 61.93 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.038 175.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.9 m -53.22 -33.66 53.79 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.273 1.429 . . . . 0.0 113.471 -176.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -96.2 -18.0 20.39 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.104 0.562 . . . . 0.0 112.431 -176.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 35.8 m -120.03 174.39 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-O 121.411 0.624 . . . . 0.0 112.0 -171.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.41 ' HB2' HD21 ' A' ' 9' ' ' LEU . 22.5 tp60 -130.79 115.49 16.69 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.177 1.391 . . . . 0.0 107.819 174.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.4 HD21 ' CZ3' ' A' ' 40' ' ' TRP . 78.3 mt -63.03 126.37 27.11 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.929 0.768 . . . . 0.0 110.442 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 7' ' ' ARG . 80.2 mt . . . . . 0 C--O 1.252 1.194 0 C-N-CA 124.15 0.98 . . . . 0.0 108.791 -176.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.611 0 N-CA-C 111.984 -0.447 . . . . 0.0 111.984 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 31' ' ' LEU . . . -75.38 90.48 2.67 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.193 0.597 . . . . 0.0 110.406 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -81.39 123.46 28.58 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.171 0.988 . . . . 0.0 109.372 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 59' ' ' LEU . 48.6 t -124.14 155.7 37.97 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.223 0.535 . . . . 0.0 110.929 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -116.04 131.96 56.79 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.627 1.171 . . . . 0.0 109.175 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.54 ' HA ' HG12 ' A' ' 57' ' ' VAL . 16.5 p -77.37 121.29 23.56 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.488 0.715 . . . . 0.0 109.813 170.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.42 HD11 ' HG3' ' A' ' 58' ' ' GLN . 81.4 mt -73.06 -51.51 17.82 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.29 0.636 . . . . 0.0 109.676 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -137.8 152.85 73.22 Favored Pre-proline 0 N--CA 1.483 1.183 0 C-N-CA 123.662 0.785 . . . . 0.0 110.467 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.41 129.51 12.97 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.354 2.036 . . . . 0.0 111.72 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -117.22 101.6 8.58 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.4 t -92.75 -47.28 7.15 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.448 -171.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.79 -117.55 0.43 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -178.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 60.93 -74.34 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.621 1.568 . . . . 0.0 111.703 -177.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.481 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -79.91 -11.72 59.78 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.532 0.733 . . . . 0.0 111.942 -178.137 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -140.64 172.21 13.02 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.31 0.644 . . . . 0.0 110.476 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.72 -23.18 0.38 Allowed Glycine 0 C--N 1.346 1.123 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.081 175.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -125.28 21.94 7.89 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.769 0.827 . . . . 0.0 111.347 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.08 176.9 54.51 Favored Glycine 0 C--N 1.351 1.39 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 172.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.424 HD21 ' HG2' ' A' ' 44' ' ' LYS . 44.8 tp -89.87 124.79 35.0 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -79.49 136.96 37.05 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.549 0.74 . . . . 0.0 110.479 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -149.04 128.6 13.13 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.067 0.947 . . . . 0.0 109.245 177.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.8 150.82 20.28 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.3 1.04 . . . . 0.0 110.017 177.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.11 133.4 54.38 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.622 0.769 . . . . 0.0 111.716 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.56 -23.38 28.38 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 119.605 -0.553 . . . . 0.0 113.179 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -65.0 136.17 56.48 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-N 117.201 0.5 . . . . 0.0 111.69 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 73.9 mt -85.67 101.43 12.74 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.3 mm -88.62 111.18 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.929 0.891 . . . . 0.0 108.644 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.2 p -77.32 105.42 8.42 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.553 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 39.8 mt -67.56 142.19 56.59 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 173.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.8 mt -74.34 -43.04 58.32 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.968 0.507 . . . . 0.0 110.57 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -157.14 157.17 33.97 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.112 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.5 m -109.66 94.36 16.51 Favored Pre-proline 0 CA--C 1.557 1.24 0 C-N-CA 123.38 0.672 . . . . 0.0 110.944 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.42 ' HD2' ' CD1' ' A' ' 40' ' ' TRP . 79.3 Cg_endo -81.86 170.57 13.88 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.578 2.185 . . . . 0.0 111.174 167.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.4 143.84 54.94 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.108 0.48 . . . . 0.0 111.369 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.47 166.99 33.81 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.356 -177.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.0 55.26 4.98 Favored Glycine 0 C--N 1.348 1.199 0 C-N-CA 123.211 0.434 . . . . 0.0 112.584 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.401 ' HZ3' ' HG3' ' A' ' 53' ' ' PRO . 75.6 t-105 -143.79 114.76 7.81 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.437 1.095 . . . . 0.0 108.484 -177.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.42 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 12.9 m-90 -136.28 144.19 44.62 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.938 0.895 . . . . 0.0 109.712 -177.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -95.74 116.28 28.66 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 169.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 31' ' ' LEU . . . -108.76 143.76 16.28 Favored Glycine 0 C--N 1.337 0.635 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 49' ' ' ARG . 31.8 tt0 -115.52 136.9 52.61 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.007 0.523 . . . . 0.0 109.837 -178.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.424 ' HG2' HD21 ' A' ' 21' ' ' LEU . 30.2 mmmt -71.62 163.43 27.77 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.696 1.198 . . . . 0.0 109.787 170.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -64.71 -11.66 38.47 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.963 0.905 . . . . 0.0 112.685 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -89.22 -8.12 54.18 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.334 1.054 . . . . 0.0 112.49 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.43 -1.27 66.53 Favored Glycine 0 C--N 1.345 1.078 0 O-C-N 123.147 0.279 . . . . 0.0 112.842 -173.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.8 mt -83.05 104.99 13.67 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.665 0.786 . . . . 0.0 109.73 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 28.0 ptt180 -102.64 154.33 19.25 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -159.18 -178.28 33.04 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.908 -0.587 . . . . 0.0 113.062 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -77.05 129.58 36.26 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.24 1.016 . . . . 0.0 110.47 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -135.39 94.28 15.67 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 123.914 0.886 . . . . 0.0 109.617 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HG3' ' HZ3' ' A' ' 39' ' ' TRP . 11.8 Cg_exo -71.45 148.32 54.08 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.915 2.41 . . . . 0.0 110.37 168.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.41 ' HB2' ' HZ3' ' A' ' 40' ' ' TRP . . . -63.31 -19.54 64.69 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.21 0.604 . . . . 0.0 112.396 -178.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.5 m -62.32 -31.05 71.61 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.756 0.822 . . . . 0.0 111.631 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -98.71 -27.65 13.87 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.4 0.68 . . . . 0.0 111.586 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.581 ' HB ' ' SG ' ' A' ' 6' ' ' CYS . 26.1 m -138.79 139.34 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 122.94 0.496 . . . . 0.0 111.321 -174.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.42 ' HG3' HD11 ' A' ' 9' ' ' LEU . 53.1 mt-30 -128.82 133.16 47.92 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.546 0.738 . . . . 0.0 109.482 174.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.736 ' HA ' ' HA ' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -82.56 140.5 33.23 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.997 0.519 . . . . 0.0 112.312 -172.303 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 C--O 1.251 1.164 0 C-N-CA 124.772 1.229 . . . . 0.0 109.447 -178.114 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.703 0 N-CA-C 111.641 -0.583 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.89 76.31 1.16 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.849 0.86 . . . . 0.0 109.157 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.48 164.33 21.91 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.183 -173.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.447 ' SG ' HD23 ' A' ' 59' ' ' LEU . 78.2 m -145.12 166.86 24.18 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.981 0.913 . . . . 0.0 109.682 178.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.527 ' HG3' HD11 ' A' ' 60' ' ' LEU . 59.0 mtm180 -119.19 133.58 55.69 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.142 0.577 . . . . 0.0 109.98 175.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.603 HG23 HD11 ' A' ' 29' ' ' ILE . 8.9 p -73.45 121.65 20.87 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.428 0.455 . . . . 0.0 111.647 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.63 -15.98 27.73 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.788 0.835 . . . . 0.0 110.233 169.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -107.18 122.26 42.01 Favored Pre-proline 0 N--CA 1.48 1.073 0 C-N-CA 123.674 0.789 . . . . 0.0 110.58 171.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.408 ' HB3' ' N ' ' A' ' 25' ' ' ALA . 96.3 Cg_endo -83.44 49.93 3.1 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.928 2.418 . . . . 0.0 111.449 164.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -91.24 109.97 21.25 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -173.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.7 t -70.6 -21.37 62.67 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.524 1.13 . . . . 0.0 111.784 -177.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.35 -84.1 1.08 Allowed Glycine 0 C--N 1.347 1.185 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -171.86 161.33 5.8 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 124.999 1.32 . . . . 0.0 108.904 175.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -91.79 131.74 36.93 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 168.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -140.33 -64.22 0.47 Allowed 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.404 0.682 . . . . 0.0 109.495 -176.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.67 75.26 0.17 Allowed Glycine 0 C--N 1.346 1.106 0 CA-C-O 120.05 -0.305 . . . . 0.0 112.439 -175.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 66.29 21.71 10.97 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.549 1.14 . . . . 0.0 112.314 173.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.2 166.1 25.57 Favored Glycine 0 C--N 1.348 1.229 0 O-C-N 123.588 0.555 . . . . 0.0 113.591 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.46 HD11 ' HB2' ' A' ' 44' ' ' LYS . 27.5 tp -89.82 129.79 36.15 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.453 0.701 . . . . 0.0 109.492 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.25 161.14 19.44 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.964 1.306 . . . . 0.0 108.725 177.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -136.9 141.87 42.73 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.944 0.498 . . . . 0.0 111.741 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.62 169.96 10.1 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.777 1.231 . . . . 0.0 109.198 164.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.408 ' N ' ' HB3' ' A' ' 11' ' ' PRO . . . -72.72 115.92 12.58 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.94 19.9 8.77 Favored Glycine 0 N--CA 1.477 1.39 0 O-C-N 123.028 0.205 . . . . 0.0 113.483 177.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -72.85 149.99 43.06 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.917 0.487 . . . . 0.0 111.641 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.7 mt -106.37 108.1 19.44 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.603 HD11 HG23 ' A' ' 8' ' ' THR . 3.3 mp -103.21 107.79 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -175.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.0 m -75.8 108.06 8.4 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 173.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.24 123.51 19.73 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 123.704 0.628 . . . . 0.0 110.092 178.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.2 mt -73.84 -43.54 58.39 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.97 0.908 . . . . 0.0 109.12 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -126.45 155.46 42.19 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 124.912 1.285 . . . . 0.0 108.457 171.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.2 m -125.93 74.76 71.39 Favored Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 123.755 0.822 . . . . 0.0 110.939 176.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.39 164.38 35.38 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.427 2.084 . . . . 0.0 111.735 170.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -76.52 92.72 3.46 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.968 0.907 . . . . 0.0 109.85 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.93 -166.42 54.0 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-N 115.472 -0.785 . . . . 0.0 113.297 175.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.36 -104.24 1.02 Allowed Glycine 0 C--N 1.346 1.135 0 C-N-CA 123.74 0.685 . . . . 0.0 114.123 173.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -122.33 143.21 49.78 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.343 1.057 . . . . 0.0 109.901 -172.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.3 m-90 -124.57 145.31 49.66 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.169 0.988 . . . . 0.0 109.423 174.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -90.35 126.0 35.72 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 164.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.99 172.43 22.89 Favored Glycine 0 N--CA 1.467 0.766 0 O-C-N 123.621 0.575 . . . . 0.0 112.037 -176.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -131.87 145.13 51.35 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.228 0.537 . . . . 0.0 110.081 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.509 ' HG2' ' H ' ' A' ' 46' ' ' ASP . 64.9 tttp -71.75 154.8 41.08 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 164.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -64.41 -20.44 66.15 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.048 0.539 . . . . 0.0 111.856 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.509 ' H ' ' HG2' ' A' ' 44' ' ' LYS . 37.8 t70 -65.71 -20.36 66.25 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.166 0.987 . . . . 0.0 111.793 172.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.01 -16.13 30.58 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.196 176.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.3 mt -66.1 134.22 52.36 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 117.263 0.531 . . . . 0.0 110.501 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.9 mtt85 -113.38 142.54 45.75 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.287 1.035 . . . . 0.0 111.062 -174.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.17 154.91 25.94 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.646 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -96.05 127.57 42.18 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -146.76 148.77 34.31 Favored Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 124.18 0.992 . . . . 0.0 110.439 -173.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -84.82 -176.82 2.6 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.129 2.552 . . . . 0.0 111.911 174.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.39 -15.11 62.81 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.741 0.816 . . . . 0.0 111.926 176.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.5 m -55.45 -40.0 71.03 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.069 1.348 . . . . 0.0 113.335 -175.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -90.89 -29.05 17.72 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.999 0.52 . . . . 0.0 111.589 -175.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.55 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 35.3 m -105.39 -179.8 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.369 0.668 . . . . 0.0 110.52 -173.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -134.59 124.06 24.83 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.688 0.795 . . . . 0.0 109.128 175.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.447 HD23 ' SG ' ' A' ' 6' ' ' CYS . 74.0 mt -69.95 117.28 11.33 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.527 HD11 ' HG3' ' A' ' 7' ' ' ARG . 64.4 mt . . . . . 0 CA--C 1.548 0.879 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.516 0 CA-C-O 120.179 -0.234 . . . . 0.0 112.805 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.7 97.22 1.04 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 171.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.427 ' HB2' HD12 ' A' ' 60' ' ' LEU . 99.3 mtt180 -94.93 149.62 21.05 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.57 0.748 . . . . 0.0 110.57 -177.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.592 ' SG ' HD23 ' A' ' 59' ' ' LEU . 49.3 m -128.89 143.8 51.0 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 173.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -105.89 127.68 53.28 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 74.4 p -68.71 127.25 32.4 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 123.924 0.765 . . . . 0.0 109.558 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 58' ' ' GLN . 95.7 mt -70.1 -75.93 0.11 Allowed 'General case' 0 CA--C 1.537 0.468 0 O-C-N 123.459 0.474 . . . . 0.0 109.978 -177.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -151.37 137.92 11.59 Favored Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 123.634 0.774 . . . . 0.0 109.03 -177.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.37 95.53 0.61 Allowed 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.215 1.943 . . . . 0.0 111.756 175.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.52 ' HB2' ' HE1' ' A' ' 56' ' ' TYR . 52.9 m-85 -91.58 102.99 15.64 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 175.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.8 p -100.53 100.99 11.81 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.655 0.782 . . . . 0.0 109.073 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -155.84 18.36 0.49 Allowed Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.396 177.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -116.43 163.53 15.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.027 0.931 . . . . 0.0 109.813 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -70.35 161.51 30.31 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.737 0.415 . . . . 0.0 110.063 176.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 30.9 p80 -71.66 178.83 3.35 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.382 0.673 . . . . 0.0 111.285 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.11 89.94 2.09 Favored Glycine 0 C--N 1.343 0.923 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -174.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.8 58.89 2.25 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.871 1.268 . . . . 0.0 108.828 -176.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.45 99.92 1.83 Allowed Glycine 0 C--N 1.343 0.968 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 176.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.5 tp -88.53 127.73 35.54 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -177.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 49.3 ttt-85 -78.88 122.98 26.78 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -129.18 114.18 15.99 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.059 0.943 . . . . 0.0 109.208 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.56 143.74 51.49 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.49 0.716 . . . . 0.0 109.913 175.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.99 111.21 1.58 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.655 0.782 . . . . 0.0 111.572 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.22 3.64 24.29 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-O 119.096 -0.836 . . . . 0.0 114.794 173.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.63 127.3 32.47 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 118.232 1.016 . . . . 0.0 111.782 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.699 HD22 HD11 ' A' ' 60' ' ' LEU . 54.2 mt -85.37 102.15 13.18 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 175.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.595 HG21 ' HE1' ' A' ' 51' ' ' TRP . 34.8 mm -107.68 125.81 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.812 0.845 . . . . 0.0 109.448 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.1 m -81.77 136.95 35.4 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.542 0.737 . . . . 0.0 110.461 178.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.7 mt -76.71 129.4 36.28 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.846 0.858 . . . . 0.0 109.674 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.717 HD11 ' HG3' ' A' ' 43' ' ' GLU . 96.0 mt -77.02 -28.47 54.93 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.811 0.445 . . . . 0.0 110.631 174.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -155.01 147.7 24.34 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.823 0.849 . . . . 0.0 109.456 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.6 m -112.97 92.21 20.42 Favored Pre-proline 0 CA--C 1.559 1.299 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 166.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -68.58 -27.85 32.27 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.618 2.212 . . . . 0.0 111.908 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -175.85 -51.61 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.856 1.262 . . . . 0.0 109.169 175.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.93 176.84 28.53 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.851 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.25 -79.71 0.4 Allowed Glycine 0 C--N 1.347 1.153 0 N-CA-C 111.907 -0.477 . . . . 0.0 111.907 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -84.64 108.94 17.64 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.335 0.654 . . . . 0.0 109.565 171.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -113.16 178.18 4.37 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.059 0.944 . . . . 0.0 109.092 171.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 51' ' ' TRP . 0.9 OUTLIER -137.49 145.31 42.89 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.543 0.737 . . . . 0.0 109.36 173.272 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.514 ' HA2' ' HG ' ' A' ' 32' ' ' LEU . . . -154.48 178.57 31.2 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.794 -178.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.717 ' HG3' HD11 ' A' ' 32' ' ' LEU . 45.6 mt-10 -103.25 148.49 25.76 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.077 0.551 . . . . 0.0 109.799 176.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -112.83 145.09 41.24 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.693 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -69.29 -7.23 35.13 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.259 0.624 . . . . 0.0 112.432 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.69 -7.44 53.3 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.526 1.13 . . . . 0.0 111.878 172.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.76 -19.39 51.69 Favored Glycine 0 C--N 1.348 1.24 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 -177.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 65.0 mt -82.24 158.53 23.49 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.59 1.156 . . . . 0.0 110.25 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -120.53 177.76 4.93 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.898 0.879 . . . . 0.0 109.485 174.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.46 158.36 13.84 Favored Glycine 0 N--CA 1.467 0.714 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 -174.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.595 ' HE1' HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -156.06 173.24 17.1 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.494 0.664 . . . . 0.0 111.833 -171.829 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -125.54 167.16 17.32 Favored Pre-proline 0 N--CA 1.48 1.056 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.798 -173.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.36 170.52 9.31 Favored 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 122.213 1.942 . . . . 0.0 112.87 174.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.23 -15.23 56.4 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.494 1.118 . . . . 0.0 113.416 -175.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.3 p -62.51 -30.17 71.09 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.325 1.05 . . . . 0.0 113.062 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.52 ' HE1' ' HB2' ' A' ' 12' ' ' PHE . 85.1 m-85 -94.99 -6.56 42.06 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -176.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.6 m -135.39 -179.85 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 123.768 0.827 . . . . 0.0 110.397 -177.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.401 ' HB2' HD21 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -152.4 131.76 12.88 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 173.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.592 HD23 ' SG ' ' A' ' 6' ' ' CYS . 85.8 mt -65.32 133.98 52.58 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.764 0.826 . . . . 0.0 111.025 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.699 HD11 HD22 ' A' ' 28' ' ' LEU . 69.3 mt . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.896 -0.574 . . . . 0.0 109.572 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.5 ttm . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 m -75.35 -40.27 58.39 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.4 0.68 . . . . 0.0 110.36 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -130.69 164.69 23.04 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.062 176.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.404 ' HB3' HD11 ' A' ' 31' ' ' LEU . . . -76.98 127.26 32.38 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 122.969 0.507 . . . . 0.0 110.451 -177.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.645 ' HG3' ' HB2' ' A' ' 60' ' ' LEU . 35.2 ptt180 -86.68 157.38 19.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.87 0.868 . . . . 0.0 110.149 175.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 28.5 p -152.18 146.84 25.78 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.218 1.007 . . . . 0.0 108.921 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.414 ' HB2' HD11 ' A' ' 60' ' ' LEU . 61.9 ttt180 -106.07 125.57 51.16 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.524 HG22 HG12 ' A' ' 57' ' ' VAL . 49.6 p -72.27 140.01 48.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.49 0.716 . . . . 0.0 109.337 177.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mp -85.16 -74.46 0.4 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -144.89 100.39 4.61 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -69.8 101.34 0.9 Allowed 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 123.322 2.681 . . . . 0.0 112.103 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -92.88 161.65 14.41 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.314 0.646 . . . . 0.0 110.017 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.0 p -152.1 176.96 11.0 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.552 0.741 . . . . 0.0 110.555 -173.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -171.51 -50.94 0.04 OUTLIER Glycine 0 C--N 1.34 0.774 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -85.67 86.23 7.37 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 173.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -100.56 100.09 10.76 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -142.91 123.36 13.94 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.8 -145.95 33.23 Favored Glycine 0 C--N 1.345 1.06 0 O-C-N 123.571 0.545 . . . . 0.0 112.022 -174.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -94.77 60.57 2.51 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.745 0.818 . . . . 0.0 111.297 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.53 136.65 44.7 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-O 119.393 -0.671 . . . . 0.0 111.589 174.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.446 ' HB3' ' HE2' ' A' ' 52' ' ' PHE . 47.4 tp -85.98 114.03 22.55 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 117.363 0.581 . . . . 0.0 109.769 -169.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -99.83 116.73 32.58 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.341 0.657 . . . . 0.0 109.841 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -86.43 157.15 19.89 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.274 0.63 . . . . 0.0 109.387 172.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.75 154.48 19.88 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 169.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.26 133.9 46.43 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.02 0.528 . . . . 0.0 110.538 173.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.92 5.82 88.76 Favored Glycine 0 N--CA 1.475 1.27 0 O-C-N 123.305 0.378 . . . . 0.0 113.474 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -77.13 140.73 40.31 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.028 0.931 . . . . 0.0 111.268 -173.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.1 mt -91.06 104.48 17.06 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.514 0.725 . . . . 0.0 109.2 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.5 mm -117.82 130.62 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.006 1.323 . . . . 0.0 109.666 -176.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 87.7 m -90.45 138.52 31.49 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 171.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.404 HD11 ' HB3' ' A' ' 4' ' ' ALA . 1.4 pp -75.77 151.27 37.6 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.606 0.362 . . . . 0.0 110.692 174.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 93.6 mt -109.15 -2.41 18.06 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.016 0.926 . . . . 0.0 110.939 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.407 ' HG2' ' HD3' ' A' ' 35' ' ' PRO . 15.2 tt0 -143.48 152.54 41.61 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.51 56.15 21.29 Favored Pre-proline 0 CA--C 1.57 1.724 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.459 ' HD2' ' CD1' ' A' ' 40' ' ' TRP . 91.0 Cg_endo -77.16 126.29 8.46 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 121.727 1.618 . . . . 0.0 110.085 170.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -62.91 102.69 0.38 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.477 0.711 . . . . 0.0 109.699 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.9 54.22 7.37 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.237 -175.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -142.97 -172.55 14.07 Favored Glycine 0 C--N 1.343 0.951 0 C-N-CA 122.807 0.241 . . . . 0.0 112.68 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 25.0 m95 -81.38 140.74 34.55 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.459 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 12.5 m0 -117.64 136.63 53.19 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 2.2 mp0 -87.36 123.96 32.88 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 175.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.48 143.05 19.88 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -102.89 143.72 32.13 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 173.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -129.49 152.42 49.04 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.336 0.654 . . . . 0.0 110.296 173.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -67.26 -21.9 65.7 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.821 0.849 . . . . 0.0 109.997 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -51.35 -37.74 49.49 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.192 1.397 . . . . 0.0 111.15 169.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.02 -5.09 32.02 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-O 119.295 -0.725 . . . . 0.0 113.828 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 65.6 mt -92.23 172.6 8.31 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.076 0.938 . . . . 0.0 111.604 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -145.13 148.0 33.13 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.439 1.495 . . . . 0.0 109.05 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.435 ' N ' HD22 ' A' ' 21' ' ' LEU . . . -174.72 152.23 13.7 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 175.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.444 ' HB3' ' HG3' ' A' ' 41' ' ' GLU . 39.9 p-90 -97.23 129.98 44.5 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.862 0.865 . . . . 0.0 109.869 -174.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.446 ' HE2' ' HB3' ' A' ' 21' ' ' LEU . 78.8 m-85 -138.19 153.71 73.38 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 124.949 1.3 . . . . 0.0 109.041 -178.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -74.13 168.24 25.27 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.584 2.189 . . . . 0.0 112.457 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.47 -15.19 63.53 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.277 1.031 . . . . 0.0 111.787 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.8 m -55.64 -34.85 65.31 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.691 1.196 . . . . 0.0 112.658 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -97.03 -10.94 25.15 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.524 HG12 HG22 ' A' ' 8' ' ' THR . 34.5 m -122.53 161.1 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.44 0.696 . . . . 0.0 110.854 -177.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -131.18 115.58 16.56 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.346 1.058 . . . . 0.0 108.723 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.3 mt -58.49 132.42 53.69 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.335 0.654 . . . . 0.0 111.074 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.645 ' HB2' ' HG3' ' A' ' 5' ' ' ARG . 90.2 mt . . . . . 0 C--O 1.251 1.135 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tmm? . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.4 t -89.54 131.94 35.31 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 175.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -170.73 167.25 40.42 Favored Glycine 0 C--N 1.346 1.115 0 O-C-N 123.298 0.374 . . . . 0.0 112.48 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.44 134.79 54.44 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.936 0.894 . . . . 0.0 109.833 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -154.68 177.18 11.52 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.105 0.962 . . . . 0.0 109.572 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.7 m -123.94 -176.45 3.48 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -142.83 128.51 19.22 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.1 p -66.99 147.54 53.1 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.73 0.812 . . . . 0.0 112.344 -176.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.7 mt -84.2 -52.62 6.11 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.271 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -139.11 166.69 22.95 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 124.151 0.98 . . . . 0.0 109.149 -176.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.69 95.58 0.34 Allowed 'Trans proline' 0 C--N 1.388 2.629 0 C-N-CA 121.801 1.667 . . . . 0.0 110.515 175.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -96.85 154.99 16.97 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.32 0.648 . . . . 0.0 111.285 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.7 m -122.47 -10.69 8.39 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.286 1.034 . . . . 0.0 111.059 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.76 -46.62 1.91 Allowed Glycine 0 C--N 1.349 1.269 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -172.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 63.64 16.84 10.0 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.897 1.279 . . . . 0.0 112.254 178.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -121.62 154.61 36.55 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 124.424 1.089 . . . . 0.0 108.663 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -70.43 154.23 42.12 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.216 0.607 . . . . 0.0 110.889 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.43 -116.34 4.88 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -92.29 76.63 5.24 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-O 121.695 0.759 . . . . 0.0 109.151 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.94 93.08 1.82 Allowed Glycine 0 C--N 1.338 0.65 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.7 174.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.565 HD21 ' HB2' ' A' ' 44' ' ' LYS . 36.4 tp -98.66 130.3 45.17 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.231 0.612 . . . . 0.0 109.508 177.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.92 158.32 30.78 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 168.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -158.41 150.5 21.65 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 174.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.01 142.75 38.05 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.815 0.846 . . . . 0.0 110.72 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.54 145.4 50.84 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.464 0.705 . . . . 0.0 111.35 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.46 19.79 79.74 Favored Glycine 0 C--N 1.345 1.053 0 O-C-N 123.808 0.693 . . . . 0.0 113.196 173.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -109.16 156.28 20.03 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.35 0.66 . . . . 0.0 110.776 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.7 mt -79.89 124.38 28.61 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.929 -171.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.593 HG13 HG11 ' A' ' 57' ' ' VAL . 47.6 mm -88.66 106.58 16.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 172.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.9 p -73.5 108.3 6.28 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.5 mt -66.76 93.35 0.25 Allowed 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.163 0.914 . . . . 0.0 109.148 -175.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.587 HD11 ' HB2' ' A' ' 43' ' ' GLU . 83.3 mt -75.16 -51.89 12.31 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.965 0.906 . . . . 0.0 109.638 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -101.9 136.07 42.37 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.16 86.56 41.7 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.287 1.035 . . . . 0.0 109.216 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.57 -174.41 2.26 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.868 2.378 . . . . 0.0 112.082 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -73.46 -23.27 60.06 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.281 0.632 . . . . 0.0 110.343 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 179.19 174.85 45.68 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 109.74 -101.57 1.47 Allowed Glycine 0 C--N 1.341 0.819 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 14.5 p-90 -137.83 165.1 27.29 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.59 0.756 . . . . 0.0 109.755 -177.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -122.32 149.27 43.98 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.587 0.755 . . . . 0.0 109.183 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.44 ' HG2' HD12 ' A' ' 32' ' ' LEU . 43.2 tt0 -91.15 138.43 31.6 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.4 ' H ' ' HD2' ' A' ' 52' ' ' PHE . . . -121.89 158.61 16.59 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 177.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.587 ' HB2' HD11 ' A' ' 32' ' ' LEU . 28.8 tt0 -110.1 119.36 39.05 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.063 0.545 . . . . 0.0 110.032 -176.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.565 ' HB2' HD21 ' A' ' 21' ' ' LEU . 56.5 tttm -78.76 155.12 29.47 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.439 0.696 . . . . 0.0 109.262 171.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -66.75 -7.02 18.2 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -173.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -78.24 -8.53 58.46 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.517 0.727 . . . . 0.0 111.236 172.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.96 -5.36 84.6 Favored Glycine 0 C--N 1.347 1.193 0 C-N-CA 123.298 0.475 . . . . 0.0 112.403 -171.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.1 mt -78.78 140.59 38.22 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 123.861 0.864 . . . . 0.0 110.584 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.581 HH11 HD13 ' A' ' 32' ' ' LEU . 58.8 mtt-85 -107.07 149.88 27.13 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.562 1.145 . . . . 0.0 108.139 177.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -156.25 -176.3 28.2 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 121.282 -0.485 . . . . 0.0 113.753 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -73.38 126.64 30.63 Favored 'General case' 0 C--N 1.346 0.438 0 C-N-CA 123.235 0.614 . . . . 0.0 110.418 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.4 ' HD2' ' H ' ' A' ' 42' ' ' GLY . 75.3 m-85 -139.27 85.26 15.66 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 123.661 0.784 . . . . 0.0 110.149 174.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.3 151.42 82.51 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.032 2.488 . . . . 0.0 112.023 170.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.24 -15.76 60.7 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.965 0.906 . . . . 0.0 110.79 171.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.3 m -67.75 -38.12 83.05 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 124.32 1.048 . . . . 0.0 111.117 173.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -80.94 -13.0 59.29 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.361 1.064 . . . . 0.0 112.205 -173.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.593 HG11 HG13 ' A' ' 29' ' ' ILE . 29.8 m -132.78 146.2 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.462 0.705 . . . . 0.0 111.091 -171.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.2 127.56 41.34 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 169.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.0 mt -69.06 123.6 21.51 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.928 0.891 . . . . 0.0 110.291 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 72.0 mt . . . . . 0 C--O 1.248 1.008 0 C-N-CA 122.727 0.411 . . . . 0.0 109.95 178.857 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.8 mtp . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.5 t -67.75 94.71 0.46 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.12 0.968 . . . . 0.0 111.399 -175.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.54 -38.48 2.91 Favored Glycine 0 C--N 1.351 1.362 0 CA-C-N 116.067 -0.515 . . . . 0.0 113.79 174.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.27 103.84 0.21 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.507 0.723 . . . . 0.0 111.494 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.463 ' HG2' ' HA ' ' A' ' 30' ' ' THR . 61.2 mtt180 -143.02 170.4 15.77 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.847 0.859 . . . . 0.0 111.004 -177.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.608 ' SG ' HD23 ' A' ' 59' ' ' LEU . 81.9 m -133.93 172.13 13.23 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 113.882 -1.508 . . . . 0.0 108.352 172.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.6 ' HB2' HD21 ' A' ' 60' ' ' LEU . 36.1 ttm180 -124.61 140.36 53.01 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 172.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.8 p -82.0 136.19 35.28 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.501 0.72 . . . . 0.0 110.262 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.403 HD21 ' HG3' ' A' ' 58' ' ' GLN . 75.3 mt -74.89 -67.1 0.67 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.497 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -141.73 157.66 64.4 Favored Pre-proline 0 N--CA 1.48 1.026 0 C-N-CA 124.718 1.207 . . . . 0.0 108.366 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 25' ' ' ALA . 56.5 Cg_endo -66.38 88.53 0.26 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.263 1.976 . . . . 0.0 111.533 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -91.83 146.87 23.41 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.449 0.7 . . . . 0.0 110.498 -177.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.0 p -153.51 161.26 42.41 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.578 1.151 . . . . 0.0 108.276 173.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.5 -84.23 0.13 Allowed Glycine 0 C--N 1.348 1.236 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -144.5 160.35 41.25 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.829 1.252 . . . . 0.0 108.811 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -74.93 82.55 2.19 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 122.74 0.416 . . . . 0.0 110.736 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.6 t60 171.82 -50.17 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.265 1.826 . . . . 0.0 107.17 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.24 149.74 51.26 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 114.915 -1.039 . . . . 0.0 113.776 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -81.31 163.64 22.76 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.905 0.882 . . . . 0.0 112.106 -175.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.08 160.89 11.69 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.261 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.419 HD21 ' HB2' ' A' ' 44' ' ' LYS . 33.9 tp -89.53 115.99 27.35 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.627 ' HD2' ' H ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -85.74 154.8 21.37 Favored 'General case' 0 C--O 1.247 0.944 0 C-N-CA 123.648 0.779 . . . . 0.0 111.063 -176.474 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.462 ' HZ ' ' HE1' ' A' ' 56' ' ' TYR . 21.4 p90 -156.42 149.57 24.24 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.192 -171.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.87 148.58 22.01 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.936 0.895 . . . . 0.0 109.657 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.539 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . . . -61.35 114.55 3.25 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.414 0.686 . . . . 0.0 111.606 -178.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.09 -13.16 24.1 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-O 119.248 -0.751 . . . . 0.0 114.209 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -70.91 163.0 28.33 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 118.056 0.928 . . . . 0.0 111.03 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 mp -99.03 126.15 44.68 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.53 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.3 mm -92.89 108.66 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 169.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.463 ' HA ' ' HG2' ' A' ' 5' ' ' ARG . 54.5 m -77.8 107.93 10.66 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.467 HD21 ' SG ' ' A' ' 6' ' ' CYS . 42.6 mt -69.3 115.07 8.15 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.525 ' HB2' ' HG3' ' A' ' 41' ' ' GLU . 46.7 mt -74.72 -50.55 17.05 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.412 0.685 . . . . 0.0 110.091 -173.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.467 ' O ' ' HD3' ' A' ' 35' ' ' PRO . 52.3 tt0 -147.22 166.38 27.18 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.074 0.949 . . . . 0.0 108.624 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.5 m -101.96 84.4 0.57 Allowed Pre-proline 0 CA--C 1.566 1.588 0 C-N-CA 124.347 1.059 . . . . 0.0 109.713 173.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 33' ' ' GLN . 4.8 Cg_exo -74.42 -36.88 2.76 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 122.888 2.392 . . . . 0.0 111.663 -174.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -109.15 -67.61 0.97 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.241 1.016 . . . . 0.0 109.15 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.36 -35.47 1.88 Allowed Glycine 0 C--N 1.35 1.324 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -100.83 -42.52 2.44 Favored Glycine 0 C--N 1.345 1.078 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 171.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -86.8 137.47 32.39 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 168.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -128.02 177.5 6.84 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.727 0.811 . . . . 0.0 109.747 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.525 ' HG3' ' HB2' ' A' ' 32' ' ' LEU . 15.8 pt-20 -118.66 149.64 41.06 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.166 0.986 . . . . 0.0 108.384 174.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.41 125.68 1.87 Allowed Glycine 0 C--N 1.335 0.491 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.454 ' HB2' HD11 ' A' ' 32' ' ' LEU . 35.5 tt0 -101.16 123.55 45.48 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.419 ' HB2' HD21 ' A' ' 21' ' ' LEU . 17.9 tptm -77.04 167.24 22.15 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.915 0.886 . . . . 0.0 110.072 175.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -52.21 -35.4 49.18 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.407 1.483 . . . . 0.0 113.505 -175.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -78.26 -16.38 57.85 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.145 0.578 . . . . 0.0 111.662 -175.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.56 -7.55 30.1 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-O 119.702 -0.499 . . . . 0.0 113.446 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.01 125.1 25.6 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 117.619 0.709 . . . . 0.0 110.295 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.2 mtp85 -105.26 128.67 53.55 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -135.38 155.3 22.08 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 29.3 p-90 -80.88 138.98 36.17 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.149 0.579 . . . . 0.0 109.695 174.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -140.58 104.96 6.41 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 123.925 0.89 . . . . 0.0 108.881 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.468 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 94.5 Cg_endo -80.31 165.04 21.38 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.975 2.45 . . . . 0.0 112.219 172.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.01 -30.0 71.1 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.772 0.829 . . . . 0.0 111.013 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.0 p -75.39 7.48 3.53 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.136 0.974 . . . . 0.0 112.541 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.468 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 2.6 t80 -124.9 -45.14 1.9 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.6 m -130.51 141.1 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.223 1.009 . . . . 0.0 109.643 -177.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.403 ' HG3' HD21 ' A' ' 9' ' ' LEU . 42.8 mt-30 -89.39 132.97 34.73 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 122.952 0.501 . . . . 0.0 111.326 -175.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.608 HD23 ' SG ' ' A' ' 6' ' ' CYS . 93.2 mt -62.32 145.3 54.17 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.225 1.01 . . . . 0.0 111.9 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.6 HD21 ' HB2' ' A' ' 7' ' ' ARG . 95.0 mt . . . . . 0 C--O 1.245 0.84 0 C-N-CA 123.617 0.767 . . . . 0.0 109.832 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.701 0.286 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.5 t -94.88 82.91 3.9 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.742 0.817 . . . . 0.0 110.005 -169.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -172.28 -121.11 0.58 Allowed Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.472 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.534 ' HB3' ' HB2' ' A' ' 31' ' ' LEU . . . -134.88 149.64 50.33 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.755 0.822 . . . . 0.0 109.375 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.401 ' HB3' ' HB2' ' A' ' 60' ' ' LEU . 4.4 mmt85 -128.04 155.0 45.03 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.89 0.876 . . . . 0.0 110.717 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.449 ' SG ' HD11 ' A' ' 31' ' ' LEU . 72.4 m -143.62 173.13 11.93 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.229 1.412 . . . . 0.0 108.795 175.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.9 ttt180 -142.84 131.09 22.05 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.623 HG21 ' HB3' ' A' ' 23' ' ' PHE . 35.2 p -68.12 125.91 27.84 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 124.018 0.927 . . . . 0.0 111.24 -176.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.539 HD21 ' HB2' ' A' ' 58' ' ' GLN . 93.1 mt -67.21 -59.99 2.98 Favored 'General case' 0 C--N 1.351 0.651 0 O-C-N 123.708 0.63 . . . . 0.0 109.505 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -139.83 153.84 70.22 Favored Pre-proline 0 N--CA 1.476 0.853 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.14 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.42 ' HD3' ' HB2' ' A' ' 25' ' ' ALA . 48.2 Cg_endo -83.63 29.8 0.54 Allowed 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.621 2.214 . . . . 0.0 113.73 -172.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -90.88 101.0 13.76 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.564 ' HB2' ' HA ' ' A' ' 22' ' ' ARG . 25.2 m -148.04 134.39 19.56 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -178.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.21 53.08 4.01 Favored Glycine 0 C--N 1.341 0.824 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -171.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -59.88 104.16 0.27 Allowed 'General case' 0 C--O 1.245 0.841 0 C-N-CA 124.26 1.024 . . . . 0.0 111.414 -177.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 61.8 18.03 9.34 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.651 1.18 . . . . 0.0 112.34 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -156.28 117.9 3.91 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.874 0.869 . . . . 0.0 108.825 -171.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.02 -162.99 16.84 Favored Glycine 0 CA--C 1.533 1.167 0 O-C-N 123.21 0.319 . . . . 0.0 112.539 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 71.53 -2.92 2.28 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.009 1.323 . . . . 0.0 113.304 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.4 178.61 35.62 Favored Glycine 0 C--N 1.348 1.201 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 44' ' ' LYS . 43.7 tp -90.36 112.93 24.7 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.564 ' HA ' ' HB2' ' A' ' 13' ' ' SER . 64.7 mtt180 -82.42 139.05 34.23 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.852 0.72 . . . . 0.0 109.374 174.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.623 ' HB3' HG21 ' A' ' 8' ' ' THR . 97.1 m-85 -113.11 135.4 53.85 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.371 0.668 . . . . 0.0 109.604 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.12 138.42 33.04 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 171.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.42 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . . . -64.29 135.59 56.36 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.546 0.738 . . . . 0.0 111.657 -176.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.4 -13.09 67.41 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-O 119.552 -0.582 . . . . 0.0 114.021 177.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -64.96 129.92 41.49 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.183 0.593 . . . . 0.0 111.919 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.9 mt -80.44 100.35 8.45 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.9 mm -95.62 115.2 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.468 0.707 . . . . 0.0 109.502 -175.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.0 m -74.65 125.24 28.25 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 122.943 0.497 . . . . 0.0 109.755 175.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.534 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 82.4 mt -76.88 126.09 30.4 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 170.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.52 -51.31 15.09 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.529 0.68 . . . . 0.0 110.342 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -153.27 162.42 41.32 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.469 -173.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.9 m -100.82 89.13 1.16 Allowed Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 124.032 0.933 . . . . 0.0 109.569 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -79.76 -4.22 13.31 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.288 2.659 . . . . 0.0 113.518 -171.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -162.6 -69.86 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.808 0.843 . . . . 0.0 109.645 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.24 -52.85 0.55 Allowed Glycine 0 C--N 1.341 0.831 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -174.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -72.31 -46.44 33.98 Favored Glycine 0 C--N 1.344 0.984 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 173.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -93.71 135.46 34.98 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.882 0.873 . . . . 0.0 109.21 174.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 14.5 m0 -133.17 150.39 52.01 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.071 0.949 . . . . 0.0 110.388 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 42.2 mt-10 -91.54 145.85 24.27 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.875 0.87 . . . . 0.0 110.689 -173.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -147.57 170.31 28.34 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.241 0.925 . . . . 0.0 110.99 177.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -126.05 167.23 15.63 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.528 0.731 . . . . 0.0 112.423 -177.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.652 ' HB2' HD11 ' A' ' 21' ' ' LEU . 3.3 tmtp? -126.4 146.64 49.99 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 164.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.433 ' H ' ' HD3' ' A' ' 44' ' ' LYS . 1.7 mp0 -66.45 -9.71 36.87 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.081 0.952 . . . . 0.0 111.647 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.415 ' H ' ' HD2' ' A' ' 44' ' ' LYS . 30.6 t70 -77.76 -8.65 58.29 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 124.858 1.263 . . . . 0.0 111.537 178.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.87 -13.42 57.67 Favored Glycine 0 C--N 1.355 1.61 0 C-N-CA 123.159 0.409 . . . . 0.0 112.916 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.16 133.66 34.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.311 0.644 . . . . 0.0 109.841 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -111.62 173.81 6.17 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.134 0.974 . . . . 0.0 109.689 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -167.88 153.49 22.8 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.56 174.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -121.61 125.75 47.46 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -144.02 156.14 58.56 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 124.217 1.007 . . . . 0.0 109.718 -168.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -68.57 153.85 72.76 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 122.725 2.284 . . . . 0.0 112.719 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.66 -14.51 63.0 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.6 1.16 . . . . 0.0 112.288 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.7 t -55.94 -23.58 32.88 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.508 1.123 . . . . 0.0 112.969 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -106.72 -7.07 17.43 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.2 0.6 . . . . 0.0 112.392 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' A' ' 6' ' ' CYS . 12.9 m -135.9 124.76 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.688 0.795 . . . . 0.0 110.206 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.539 ' HB2' HD21 ' A' ' 9' ' ' LEU . 63.2 tt0 -80.81 127.09 32.12 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 37.9 mt -73.59 133.89 43.61 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.761 0.824 . . . . 0.0 110.871 -173.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 5' ' ' ARG . 74.0 mt . . . . . 0 C--O 1.251 1.151 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.9 m -72.79 104.95 4.15 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 170.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -145.72 163.67 28.23 Favored Glycine 0 C--N 1.343 0.946 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 31' ' ' LEU . . . -68.55 140.69 55.62 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 81.9 mtm-85 -126.55 138.61 53.49 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.082 0.553 . . . . 0.0 110.137 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.676 ' SG ' HD23 ' A' ' 59' ' ' LEU . 77.3 m -128.49 170.47 13.13 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.475 1.11 . . . . 0.0 109.709 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -140.71 138.18 34.03 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.607 0.763 . . . . 0.0 109.153 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.645 HG23 HD11 ' A' ' 29' ' ' ILE . 1.6 p -66.91 128.81 37.73 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.579 0.751 . . . . 0.0 110.839 176.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.462 ' H ' HD12 ' A' ' 9' ' ' LEU . 3.5 mp -74.38 -38.17 63.24 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -129.78 152.63 80.16 Favored Pre-proline 0 C--O 1.245 0.867 0 C-N-CA 125.405 1.482 . . . . 0.0 108.03 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.48 145.29 76.39 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.065 1.843 . . . . 0.0 111.843 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -89.92 106.64 18.61 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 173.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.8 m -59.34 138.69 57.54 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 124.323 1.014 . . . . 0.0 111.164 -176.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.78 72.04 1.83 Allowed Glycine 0 C--N 1.349 1.257 0 O-C-N 123.92 0.763 . . . . 0.0 111.439 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -70.56 96.99 1.25 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.287 1.035 . . . . 0.0 109.856 -176.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -77.45 75.78 4.0 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.92 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -169.1 95.85 0.34 Allowed 'General case' 0 C--O 1.241 0.641 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.78 -131.19 10.6 Favored Glycine 0 N--CA 1.469 0.844 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -174.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -155.0 142.22 19.42 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.217 0.607 . . . . 0.0 109.994 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.23 157.55 29.69 Favored Glycine 0 C--N 1.344 1.001 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.8 tp -90.15 126.0 35.65 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -88.96 134.22 34.05 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.1 0.96 . . . . 0.0 111.615 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -145.07 111.53 5.71 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 163.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.71 157.74 28.48 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.54 0.736 . . . . 0.0 109.939 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.98 119.52 7.39 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.309 0.643 . . . . 0.0 111.326 -174.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.93 -22.03 12.96 Favored Glycine 0 C--N 1.347 1.184 0 O-C-N 123.654 0.596 . . . . 0.0 113.148 -176.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -72.2 143.11 48.98 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.179 0.514 . . . . 0.0 111.427 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.29 117.3 30.05 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.317 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.645 HD11 HG23 ' A' ' 8' ' ' THR . 3.3 mp -85.4 108.27 17.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.4 m -85.06 102.35 13.16 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.54 HD11 ' SG ' ' A' ' 6' ' ' CYS . 90.2 mt -76.23 104.52 6.79 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.243 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.563 HD11 ' HB2' ' A' ' 43' ' ' GLU . 58.9 mt -77.95 -42.91 31.41 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.537 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 32.6 mm-40 -121.33 136.99 54.89 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.384 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.7 m -137.38 72.06 52.09 Favored Pre-proline 0 CA--C 1.557 1.217 0 C-N-CA 124.301 1.04 . . . . 0.0 109.643 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.42 169.54 20.59 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.52 2.147 . . . . 0.0 112.269 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.46 92.17 0.43 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.618 0.767 . . . . 0.0 110.196 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 166.68 -164.84 38.02 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.563 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.08 -29.52 9.62 Favored Glycine 0 N--CA 1.473 1.115 0 N-CA-C 113.403 0.121 . . . . 0.0 113.403 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -94.19 100.21 12.33 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.526 0.73 . . . . 0.0 110.159 -168.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -111.19 150.98 28.75 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.304 1.042 . . . . 0.0 109.248 -175.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 33' ' ' GLN . 35.5 tt0 -89.39 125.91 35.33 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -176.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -123.17 140.6 13.17 Favored Glycine 0 C--N 1.34 0.752 0 O-C-N 124.689 1.243 . . . . 0.0 110.1 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.563 ' HB2' HD11 ' A' ' 32' ' ' LEU . 37.8 tt0 -106.37 140.67 38.93 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.123 0.487 . . . . 0.0 110.717 -177.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -97.05 151.85 19.33 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.013 1.325 . . . . 0.0 108.085 172.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -68.2 -14.2 62.81 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.934 0.493 . . . . 0.0 111.93 -173.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -69.12 -20.71 64.05 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.52 0.728 . . . . 0.0 111.644 174.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.07 -9.4 36.59 Favored Glycine 0 C--N 1.344 1.008 0 C-N-CA 123.413 0.53 . . . . 0.0 112.406 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.1 mp -75.72 121.33 22.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.576 0.75 . . . . 0.0 109.795 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.6 mtm180 -104.59 158.37 16.54 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.858 0.863 . . . . 0.0 108.978 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -172.13 163.1 35.33 Favored Glycine 0 CA--C 1.507 -0.461 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.879 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 3.6 p-90 -86.06 138.35 32.01 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.591 0.757 . . . . 0.0 109.062 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -132.26 140.13 37.03 Favored Pre-proline 0 C--O 1.242 0.677 0 C-N-CA 124.105 0.962 . . . . 0.0 108.429 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.518 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 39.7 Cg_endo -69.45 134.5 28.81 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 121.843 1.695 . . . . 0.0 109.98 173.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.62 -24.9 65.87 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.371 1.068 . . . . 0.0 111.29 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.0 m -64.82 -35.82 82.33 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.263 1.025 . . . . 0.0 111.32 176.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.518 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 35.5 t80 -81.69 -19.69 41.05 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.377 0.671 . . . . 0.0 111.581 -173.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 6' ' ' CYS . 35.4 m -115.41 149.71 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.237 0.615 . . . . 0.0 110.691 -176.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -110.64 117.58 33.87 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.79 0.836 . . . . 0.0 110.168 -175.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.676 HD23 ' SG ' ' A' ' 6' ' ' CYS . 64.2 mt -66.46 123.23 19.44 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 171.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.2 mp . . . . . 0 C--O 1.248 1.021 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.162 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.0 mtt . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.9 p -77.95 -57.4 3.82 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.799 0.839 . . . . 0.0 109.945 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -110.65 -163.52 18.63 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.986 172.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 31' ' ' LEU . . . -73.51 164.68 26.33 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.889 0.476 . . . . 0.0 109.95 173.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.475 ' HG3' ' HB2' ' A' ' 60' ' ' LEU . 15.6 ptt180 -141.89 149.55 40.36 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.445 0.698 . . . . 0.0 109.908 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.652 ' SG ' ' HA ' ' A' ' 59' ' ' LEU . 57.0 m -145.11 145.31 31.36 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.571 0.749 . . . . 0.0 109.503 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.54 ' HB2' HD11 ' A' ' 60' ' ' LEU . 6.7 tmm_? -106.77 136.56 46.38 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.416 ' HA ' HG12 ' A' ' 57' ' ' VAL . 52.5 p -75.59 127.46 33.12 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.779 1.232 . . . . 0.0 111.891 -174.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.427 HD21 ' HG2' ' A' ' 58' ' ' GLN . 96.1 mt -67.87 -56.47 8.98 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.443 0.697 . . . . 0.0 110.38 177.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -129.22 154.46 80.56 Favored Pre-proline 0 N--CA 1.478 0.949 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.249 -175.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.27 138.52 51.51 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.899 2.4 . . . . 0.0 111.983 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.424 ' HD2' ' HA ' ' A' ' 22' ' ' ARG . 50.4 t80 -111.38 101.24 9.71 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 172.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.0 m -138.27 70.16 1.39 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 169.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -106.27 -46.37 1.16 Allowed Glycine 0 C--N 1.34 0.786 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.977 176.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 56.74 31.81 20.06 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.337 1.055 . . . . 0.0 111.667 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -63.28 -36.41 83.58 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.73 0.812 . . . . 0.0 110.581 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -123.62 152.92 41.42 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.631 1.172 . . . . 0.0 109.36 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.62 -39.7 93.89 Favored Glycine 0 C--N 1.343 0.965 0 O-C-N 123.964 0.79 . . . . 0.0 112.234 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -82.15 89.3 6.47 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.37 136.24 2.89 Favored Glycine 0 C--N 1.345 1.082 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.0 tp -91.01 119.58 31.3 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.549 0.74 . . . . 0.0 109.685 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.424 ' HA ' ' HD2' ' A' ' 12' ' ' PHE . 15.3 ptm180 -92.23 146.68 23.52 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -158.96 174.59 14.72 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.073 0.949 . . . . 0.0 110.765 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.03 168.09 9.28 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.183 0.993 . . . . 0.0 108.855 170.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.79 146.65 49.62 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 172.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 90.86 -9.82 76.68 Favored Glycine 0 N--CA 1.468 0.799 0 CA-C-N 116.07 -0.514 . . . . 0.0 113.888 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -76.44 135.12 39.4 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.24 0.616 . . . . 0.0 111.019 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.426 HD23 ' HD2' ' A' ' 5' ' ' ARG . 6.9 mp -98.44 114.73 27.21 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.621 HG13 ' HD3' ' A' ' 44' ' ' LYS . 2.6 mp -102.24 125.34 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 174.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 87.0 m -76.3 126.88 31.79 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.77 0.828 . . . . 0.0 110.507 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.614 HD11 ' SG ' ' A' ' 6' ' ' CYS . 5.6 mp -76.2 140.56 41.73 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.907 174.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.3 mt -82.77 -47.24 12.15 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.593 177.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -146.83 156.67 43.3 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.126 0.97 . . . . 0.0 109.358 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.4 m -114.01 87.5 12.96 Favored Pre-proline 0 CA--C 1.561 1.377 0 C-N-CA 123.73 0.812 . . . . 0.0 109.968 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 40' ' ' TRP . 72.6 Cg_endo -73.57 82.89 1.6 Allowed 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.515 2.143 . . . . 0.0 111.584 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 59.03 -86.88 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 125.146 1.379 . . . . 0.0 111.553 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.55 -168.91 29.44 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-N 116.388 -0.369 . . . . 0.0 112.628 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.46 -71.86 2.61 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -124.0 136.91 54.6 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.076 0.95 . . . . 0.0 108.724 172.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 35' ' ' PRO . 11.4 m-90 -124.22 160.46 27.88 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 173.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -110.92 148.58 32.17 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.069 0.461 . . . . 0.0 110.635 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.82 175.31 31.41 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.531 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -139.4 144.73 38.26 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.621 ' HD3' HG13 ' A' ' 29' ' ' ILE . 27.6 tptp -101.99 156.36 17.58 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.724 -178.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -52.88 -25.76 12.68 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 125.535 1.534 . . . . 0.0 113.01 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.81 -16.07 63.46 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.36 1.064 . . . . 0.0 112.551 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.47 -0.96 75.3 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 -171.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.6 mt -85.5 124.21 31.82 Favored 'General case' 0 C--N 1.346 0.433 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 45.0 ttp85 -104.74 138.72 40.61 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 149.71 154.5 6.43 Favored Glycine 0 C--O 1.243 0.695 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.439 ' HZ2' ' HB2' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -154.73 172.47 17.88 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.518 0.675 . . . . 0.0 111.192 -174.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -138.87 153.09 71.61 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 124.591 1.157 . . . . 0.0 109.616 -168.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.99 172.98 3.41 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.564 2.176 . . . . 0.0 113.268 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.38 -15.4 10.47 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.728 1.211 . . . . 0.0 113.24 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.8 t -61.16 -34.06 74.42 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.688 0.795 . . . . 0.0 112.083 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -92.2 -33.06 14.85 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.277 0.631 . . . . 0.0 111.432 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 8' ' ' THR . 11.4 m -138.46 138.76 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.358 0.663 . . . . 0.0 111.069 -166.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.427 ' HG2' HD21 ' A' ' 9' ' ' LEU . 13.6 mm100 -97.4 128.9 44.59 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.205 0.602 . . . . 0.0 110.466 174.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.652 ' HA ' ' SG ' ' A' ' 6' ' ' CYS . 5.0 mp -79.58 118.75 21.71 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.367 -173.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 7' ' ' ARG . 85.9 mt . . . . . 0 C--O 1.249 1.079 0 C-N-CA 123.909 0.883 . . . . 0.0 109.863 -177.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.5 t 68.3 168.71 0.27 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.125 1.37 . . . . 0.0 112.228 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 112.01 -145.57 17.91 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.64 106.67 3.13 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.15 0.58 . . . . 0.0 110.2 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -136.52 139.4 42.23 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.577 ' SG ' HD23 ' A' ' 59' ' ' LEU . 54.4 m -129.71 154.44 47.17 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.959 0.904 . . . . 0.0 109.058 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.423 HH21 ' HA ' ' A' ' 9' ' ' LEU . 6.4 ttp180 -105.87 128.61 53.87 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 40.3 p -69.45 140.79 54.09 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.701 0.8 . . . . 0.0 110.976 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.543 HD21 ' HB2' ' A' ' 58' ' ' GLN . 91.0 mt -73.9 -68.03 0.55 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.024 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -144.7 157.76 54.56 Favored Pre-proline 0 N--CA 1.482 1.152 0 C-N-CA 124.131 0.972 . . . . 0.0 109.169 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.603 ' HD3' ' HB2' ' A' ' 25' ' ' ALA . 10.9 Cg_exo -70.99 162.02 44.13 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 122.643 2.229 . . . . 0.0 110.919 173.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -91.93 155.44 18.15 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.979 0.511 . . . . 0.0 110.377 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.7 m -60.43 -31.11 70.09 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.201 0.601 . . . . 0.0 111.976 -175.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.2 -37.48 3.32 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-O 119.92 -0.378 . . . . 0.0 112.406 175.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -65.78 96.2 0.28 Allowed 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.111 0.565 . . . . 0.0 110.445 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.425 ' HD2' ' HA ' ' A' ' 16' ' ' ARG . 18.2 tpt180 -161.07 117.45 2.24 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.575 173.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -74.23 86.58 1.93 Allowed 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 121.894 0.854 . . . . 0.0 110.0 175.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.21 156.4 9.44 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.187 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.78 130.75 35.59 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -145.82 172.85 26.38 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 112.259 -0.336 . . . . 0.0 112.259 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.5 tp -90.91 136.56 32.99 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.445 0.698 . . . . 0.0 109.829 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -88.31 136.39 33.01 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 123.903 0.752 . . . . 0.0 110.272 174.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -160.18 176.11 12.14 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.174 0.989 . . . . 0.0 110.31 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.422 ' HA ' ' HG3' ' A' ' 11' ' ' PRO . . . -123.96 167.37 14.24 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.329 1.052 . . . . 0.0 109.874 176.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.603 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . . . -67.19 128.44 36.4 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.375 0.67 . . . . 0.0 110.686 175.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.22 1.46 59.41 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-O 119.738 -0.479 . . . . 0.0 113.671 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -78.93 116.69 19.41 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.967 0.507 . . . . 0.0 110.971 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 mp -76.63 100.61 5.41 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 172.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.5 mm -94.05 121.31 44.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 123.975 0.91 . . . . 0.0 109.274 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 31.6 m -74.95 125.38 28.76 Favored 'General case' 0 C--O 1.241 0.658 0 C-N-CA 123.158 0.583 . . . . 0.0 109.88 175.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.1 mt -73.48 128.68 36.16 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.586 HD13 HH11 ' A' ' 49' ' ' ARG . 74.2 mt -73.57 -52.2 14.31 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.871 0.868 . . . . 0.0 110.037 -174.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -139.0 144.57 38.96 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 173.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.5 m -110.01 108.89 59.19 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.661 0.784 . . . . 0.0 110.095 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -72.34 171.67 16.5 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.964 2.442 . . . . 0.0 111.549 171.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -81.47 -6.49 59.0 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.041 177.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -94.25 -176.81 39.05 Favored Glycine 0 C--N 1.351 1.397 0 O-C-N 123.18 0.3 . . . . 0.0 112.743 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -100.47 36.42 4.16 Favored Glycine 0 C--N 1.348 1.22 0 C-N-CA 123.395 0.522 . . . . 0.0 112.547 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -126.9 108.03 10.62 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 175.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 25.0 m0 -111.74 145.68 38.9 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.764 0.426 . . . . 0.0 110.459 -172.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.71 ' HG2' ' HB3' ' A' ' 51' ' ' TRP . 38.8 mt-10 -106.13 123.86 48.68 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.925 0.89 . . . . 0.0 109.602 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -118.6 -179.72 16.95 Favored Glycine 0 C--N 1.34 0.75 0 O-C-N 123.766 0.667 . . . . 0.0 112.468 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.405 ' HB2' HD21 ' A' ' 32' ' ' LEU . 28.2 tt0 -145.86 159.61 42.96 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.069 0.947 . . . . 0.0 109.903 -176.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.464 ' HE3' ' HG2' ' A' ' 45' ' ' GLU . 20.8 mmmt -121.02 170.4 9.55 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.908 0.883 . . . . 0.0 111.284 175.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.464 ' HG2' ' HE3' ' A' ' 44' ' ' LYS . 10.4 pt-20 -54.49 -28.67 46.41 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.614 1.566 . . . . 0.0 112.65 174.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -63.09 -34.17 77.03 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.844 1.257 . . . . 0.0 111.318 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.17 -22.61 24.8 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 -173.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 51.7 tp -63.17 140.76 58.91 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 123.117 0.567 . . . . 0.0 109.877 175.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.586 HH11 HD13 ' A' ' 32' ' ' LEU . 49.9 mtt-85 -116.71 173.29 6.71 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.436 1.095 . . . . 0.0 108.491 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.65 175.66 45.9 Favored Glycine 0 CA--C 1.505 -0.537 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.71 ' HB3' ' HG2' ' A' ' 41' ' ' GLU . 33.0 p-90 -141.85 136.0 30.13 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.48 0.712 . . . . 0.0 109.765 -176.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -139.77 161.0 58.71 Favored Pre-proline 0 C--O 1.247 0.925 0 C-N-CA 124.603 1.161 . . . . 0.0 108.748 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -52.06 144.94 35.46 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.017 2.478 . . . . 0.0 113.095 171.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.22 -27.05 68.79 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.094 0.958 . . . . 0.0 111.404 177.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.1 m -68.62 -25.35 64.81 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.79 0.836 . . . . 0.0 111.468 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -77.37 -19.81 55.69 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.147 0.579 . . . . 0.0 111.276 -174.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.8 m -117.24 168.23 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.85 0.86 . . . . 0.0 109.837 175.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.543 ' HB2' HD21 ' A' ' 9' ' ' LEU . 24.6 tt0 -119.71 135.06 54.99 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.828 0.851 . . . . 0.0 108.796 177.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.577 HD23 ' SG ' ' A' ' 6' ' ' CYS . 96.6 mt -65.72 145.31 56.17 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.773 0.429 . . . . 0.0 110.206 172.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--O 1.251 1.18 0 C-N-CA 122.908 0.483 . . . . 0.0 109.992 177.941 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.4 t -72.27 117.79 14.35 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.35 75.75 1.35 Allowed Glycine 0 C--N 1.346 1.12 0 O-C-N 123.83 0.706 . . . . 0.0 112.55 -176.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.651 ' HB3' HD21 ' A' ' 31' ' ' LEU . . . -83.37 136.92 34.17 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.711 ' HB2' ' HB2' ' A' ' 60' ' ' LEU . 46.7 mtt-85 -120.97 169.52 10.4 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.682 0.753 . . . . 0.0 110.036 -167.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.1 m -135.32 148.29 49.42 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 169.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.411 ' HD2' HD21 ' A' ' 60' ' ' LEU . 17.5 ptm180 -123.53 128.92 50.44 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 175.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.2 p -79.73 125.88 30.23 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.528 -176.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.6 mt -72.47 -52.17 16.99 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.228 -174.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.446 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 71.3 m-85 -139.79 159.81 63.45 Favored Pre-proline 0 N--CA 1.483 1.207 0 C-N-CA 123.828 0.851 . . . . 0.0 109.656 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.41 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . 1.8 Cg_endo -79.17 99.95 1.3 Allowed 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 122.197 1.931 . . . . 0.0 109.886 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -99.72 140.49 33.84 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.314 0.646 . . . . 0.0 109.837 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.2 m -144.35 95.33 2.7 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.934 0.894 . . . . 0.0 108.819 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.34 -170.09 44.58 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.535 173.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -129.42 132.08 46.92 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.952 0.406 . . . . 0.0 110.65 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.8 mtt-85 -145.19 141.69 28.92 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.049 1.34 . . . . 0.0 108.895 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -68.95 99.56 1.08 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 171.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.8 -120.3 1.45 Allowed Glycine 0 C--N 1.341 0.849 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -176.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.467 HE21 ' HA ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -162.12 123.09 2.62 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.308 0.643 . . . . 0.0 110.054 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.27 163.69 21.09 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 169.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.6 tp -92.98 126.27 37.98 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 117.484 0.642 . . . . 0.0 109.499 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -77.76 150.19 34.4 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.218 1.007 . . . . 0.0 111.596 -171.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -152.35 148.46 27.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.584 0.753 . . . . 0.0 110.162 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . . . -110.06 167.09 10.43 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.648 1.179 . . . . 0.0 108.513 173.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . . . -75.98 142.74 41.85 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.636 0.375 . . . . 0.0 111.447 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.44 -21.49 45.27 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.753 170.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.77 162.4 22.93 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-O 121.267 0.556 . . . . 0.0 110.29 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 mp -108.16 119.81 40.55 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.427 -174.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.2 mm -85.84 114.86 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 174.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.5 m -89.42 131.07 35.65 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.391 0.676 . . . . 0.0 109.449 177.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.651 HD21 ' HB3' ' A' ' 4' ' ' ALA . 2.7 pp -76.15 148.85 37.51 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.29 0.567 . . . . 0.0 111.422 177.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.58 HD11 ' HB2' ' A' ' 43' ' ' GLU . 48.5 mt -99.66 -19.21 16.92 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.198 0.999 . . . . 0.0 109.664 176.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -153.53 150.54 28.81 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.642 0.777 . . . . 0.0 109.89 -173.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.8 m -119.62 86.57 35.08 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.088 0.955 . . . . 0.0 109.273 170.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -85.39 -168.35 0.49 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.693 2.262 . . . . 0.0 110.679 171.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -84.72 140.75 31.06 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 172.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.17 161.3 37.33 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 123.764 0.665 . . . . 0.0 111.788 -175.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.53 58.21 4.68 Favored Glycine 0 C--N 1.348 1.197 0 C-N-CA 123.134 0.397 . . . . 0.0 112.557 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -130.91 99.38 4.89 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 36.5 m0 -113.13 145.5 40.82 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.427 0.691 . . . . 0.0 109.432 -177.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.75 117.41 28.59 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -176.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.9 168.87 26.44 Favored Glycine 0 C--O 1.239 0.46 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 170.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.58 ' HB2' HD11 ' A' ' 32' ' ' LEU . 41.6 tt0 -149.79 146.71 27.32 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.889 0.476 . . . . 0.0 110.207 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -104.59 -177.5 3.38 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.625 0.726 . . . . 0.0 112.34 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.77 -33.54 73.11 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.337 1.455 . . . . 0.0 109.683 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -58.85 -25.76 63.57 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.181 1.392 . . . . 0.0 112.051 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.21 -11.72 71.25 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.889 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.1 mt -72.54 131.23 42.23 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 123.742 0.817 . . . . 0.0 109.202 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -117.53 160.94 20.41 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.958 0.903 . . . . 0.0 110.156 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -173.56 155.7 22.7 Favored Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.646 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 46.1 p-90 -70.68 152.35 43.95 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.321 0.648 . . . . 0.0 110.958 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -134.08 138.01 29.57 Favored Pre-proline 0 C--O 1.243 0.745 0 C-N-CA 123.979 0.912 . . . . 0.0 109.101 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.473 ' HB2' ' HB2' ' A' ' 56' ' ' TYR . 9.1 Cg_exo -71.49 113.07 3.51 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.768 2.312 . . . . 0.0 110.378 172.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.99 -32.5 73.77 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.56 0.744 . . . . 0.0 112.11 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.3 t -73.45 -17.64 61.22 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.846 0.458 . . . . 0.0 111.576 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.473 ' HB2' ' HB2' ' A' ' 53' ' ' PRO . 35.1 t80 -75.67 -35.48 60.36 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.712 0.805 . . . . 0.0 110.383 -177.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.9 m -111.81 166.5 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.9 0.88 . . . . 0.0 110.765 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -83.24 125.4 31.53 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 63.9 mt -84.51 141.82 30.48 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.655 0.382 . . . . 0.0 110.529 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.711 ' HB2' ' HB2' ' A' ' 5' ' ' ARG . 96.5 mt . . . . . 0 C--O 1.253 1.255 0 C-N-CA 123.955 0.902 . . . . 0.0 108.877 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.6 ttp . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.5 p -64.36 -44.11 92.43 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.399 0.68 . . . . 0.0 110.229 175.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 144.95 95.33 0.19 Allowed Glycine 0 C--N 1.342 0.88 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.265 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.02 99.5 0.87 Allowed 'General case' 0 C--N 1.35 0.621 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -117.55 156.08 28.69 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.418 0.687 . . . . 0.0 110.068 -176.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.9 m -139.44 156.2 47.11 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.609 1.164 . . . . 0.0 108.659 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -107.39 148.78 28.66 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.661 0.784 . . . . 0.0 109.222 176.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.0 p -91.26 130.17 37.16 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 122.82 0.448 . . . . 0.0 110.557 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.2 mt -63.09 -64.03 1.03 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.299 1.04 . . . . 0.0 111.02 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -129.29 158.41 73.16 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 123.988 0.915 . . . . 0.0 108.949 -177.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.653 ' HD3' ' HB2' ' A' ' 25' ' ' ALA . 72.7 Cg_endo -73.68 98.07 1.02 Allowed 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.067 1.845 . . . . 0.0 110.987 176.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -90.8 100.23 13.12 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.7 m -96.98 75.82 2.67 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.911 0.885 . . . . 0.0 109.788 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -134.51 153.67 21.13 Favored Glycine 0 C--O 1.244 0.757 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.611 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 56.64 73.5 0.45 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.268 1.027 . . . . 0.0 110.217 -175.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -85.81 32.35 0.6 Allowed 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.439 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -169.06 159.76 9.42 Favored 'General case' 0 C--O 1.247 0.936 0 C-N-CA 124.984 1.313 . . . . 0.0 108.84 -170.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.61 -123.31 19.32 Favored Glycine 0 C--N 1.344 0.993 0 O-C-N 123.388 0.43 . . . . 0.0 113.685 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -94.48 5.56 51.45 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.859 0.864 . . . . 0.0 112.267 -174.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.1 126.4 8.28 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.271 0.357 . . . . 0.0 112.877 -177.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.0 tp -105.23 117.75 34.81 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 173.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -87.39 149.42 24.48 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.124 0.97 . . . . 0.0 110.239 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -158.44 153.13 24.72 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.718 0.807 . . . . 0.0 110.814 -177.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.14 169.22 11.03 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.484 1.114 . . . . 0.0 110.667 172.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.653 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . . . -61.06 125.71 24.7 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.279 0.631 . . . . 0.0 111.191 175.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.03 -4.71 65.54 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-O 119.203 -0.776 . . . . 0.0 114.116 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -52.39 120.0 5.07 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.037 0.935 . . . . 0.0 111.702 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.4 mt -82.52 99.62 9.6 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 48.9 mm -88.43 111.04 21.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 124.454 1.102 . . . . 0.0 108.079 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.5 m -87.51 107.48 18.59 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.553 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.51 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 41.4 mt -65.01 134.87 54.83 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.635 0.774 . . . . 0.0 109.624 175.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.2 mt -75.34 -47.77 26.19 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.276 0.631 . . . . 0.0 109.736 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -141.19 159.43 42.23 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.528 1.131 . . . . 0.0 108.396 174.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.0 m -119.59 84.81 31.09 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 171.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -72.07 169.27 21.81 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.761 2.307 . . . . 0.0 111.254 175.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -70.55 96.99 1.24 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.385 0.674 . . . . 0.0 110.019 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.95 173.56 23.15 Favored Glycine 0 C--N 1.344 0.985 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.808 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -91.99 28.6 8.46 Favored Glycine 0 C--N 1.345 1.052 0 C-N-CA 122.853 0.263 . . . . 0.0 113.12 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -127.16 116.71 21.06 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.571 1.148 . . . . 0.0 108.052 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 8.7 m0 -128.89 139.32 52.19 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -91.53 119.27 31.32 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' A' ' 31' ' ' LEU . . . -110.44 136.34 13.52 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.236 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -104.11 141.17 36.7 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.181 0.593 . . . . 0.0 109.971 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.433 ' HG2' ' H ' ' A' ' 46' ' ' ASP . 88.7 tttt -93.97 160.3 14.78 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.712 1.205 . . . . 0.0 109.565 177.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -56.88 -24.55 52.66 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.449 1.1 . . . . 0.0 111.977 175.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.433 ' H ' ' HG2' ' A' ' 44' ' ' LYS . 15.1 t70 -60.35 -36.11 77.24 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.105 1.362 . . . . 0.0 111.95 175.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.78 -20.19 22.59 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 116.252 -0.431 . . . . 0.0 112.458 -177.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -76.63 134.17 39.4 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -119.27 139.83 51.26 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.34 1.056 . . . . 0.0 109.459 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -133.18 150.63 19.86 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 178.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 48.7 m95 -82.8 130.2 35.1 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.105 0.962 . . . . 0.0 108.999 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -140.07 151.71 65.67 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 122.973 0.509 . . . . 0.0 111.289 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -65.88 158.89 51.57 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.982 2.455 . . . . 0.0 112.043 168.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.96 -36.76 82.93 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.0 0.92 . . . . 0.0 111.861 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.7 t -79.66 -14.63 58.65 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.894 0.878 . . . . 0.0 111.71 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -71.93 -29.22 64.07 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.386 0.674 . . . . 0.0 110.519 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.1 m -111.72 172.67 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.253 1.021 . . . . 0.0 109.857 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -113.93 126.22 54.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.02 0.928 . . . . 0.0 109.478 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 75.0 mt -69.73 140.7 53.52 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.295 0.638 . . . . 0.0 109.925 176.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 CA--C 1.556 1.188 0 C-N-CA 123.243 0.617 . . . . 0.0 110.751 -179.369 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 120.597 0.237 . . . . 0.0 110.453 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.8 p -109.01 177.96 4.61 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.668 0.787 . . . . 0.0 111.305 -175.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 89.74 -65.68 2.96 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.743 174.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.65 ' HB1' ' HB2' ' A' ' 31' ' ' LEU . . . -78.43 83.35 4.65 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.492 0.717 . . . . 0.0 111.175 -175.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -127.99 134.45 49.26 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.143 0.977 . . . . 0.0 110.098 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.701 ' SG ' HD11 ' A' ' 31' ' ' LEU . 89.4 m -139.73 146.33 39.43 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.996 0.918 . . . . 0.0 108.65 165.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -105.43 137.97 42.38 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.1 p -70.59 119.21 14.41 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.169 0.988 . . . . 0.0 110.27 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.8 -56.8 7.81 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.484 0.713 . . . . 0.0 110.61 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -134.66 155.02 79.85 Favored Pre-proline 0 N--CA 1.482 1.14 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.487 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . 72.0 Cg_endo -73.04 88.07 0.97 Allowed 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.059 1.84 . . . . 0.0 111.993 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -91.83 100.15 12.89 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.9 t -160.63 84.81 0.7 Allowed 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.46 -3.15 88.72 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.846 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.35 105.42 8.52 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.45 1.1 . . . . 0.0 109.218 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -69.92 84.22 0.49 Allowed 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.859 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 78.8 m80 63.9 14.24 8.22 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.117 1.367 . . . . 0.0 112.721 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.77 66.98 1.89 Allowed Glycine 0 C--N 1.35 1.329 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 61.4 79.94 0.24 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.372 1.069 . . . . 0.0 110.551 -175.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.02 -176.69 39.99 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.807 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' A' ' 44' ' ' LYS . 32.4 tp -107.37 123.35 48.24 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.228 0.611 . . . . 0.0 109.737 -176.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -94.84 118.19 31.37 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -154.23 173.05 16.65 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.198 0.599 . . . . 0.0 111.301 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.487 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . . . -128.3 157.27 41.42 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.597 1.159 . . . . 0.0 109.376 175.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.14 134.59 55.15 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.511 0.724 . . . . 0.0 111.621 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.63 -14.31 29.81 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 123.334 0.396 . . . . 0.0 113.365 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -81.88 142.38 32.55 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.125 0.57 . . . . 0.0 111.819 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.466 HD12 HD11 ' A' ' 60' ' ' LEU . 1.9 mm? -95.37 105.18 17.11 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.299 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.6 mm -85.02 116.42 28.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 177.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.5 m -77.34 111.58 13.16 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.219 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.701 HD11 ' SG ' ' A' ' 6' ' ' CYS . 34.4 mt -70.46 139.46 51.73 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 123.867 0.729 . . . . 0.0 111.716 -171.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.524 ' HB2' ' HG3' ' A' ' 41' ' ' GLU . 70.3 mt -101.17 -30.99 11.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.632 0.773 . . . . 0.0 109.458 174.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.542 ' HG3' ' HG2' ' A' ' 41' ' ' GLU . 70.9 mt-30 -97.12 149.71 21.67 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.344 0.657 . . . . 0.0 110.854 172.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.6 m -142.93 54.64 3.43 Favored Pre-proline 0 CA--C 1.578 2.046 0 C-N-CA 124.81 1.244 . . . . 0.0 110.292 173.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 33' ' ' GLN . 63.7 Cg_endo -81.58 -170.24 0.94 Allowed 'Trans proline' 0 C--N 1.391 2.77 0 C-N-CA 122.754 2.302 . . . . 0.0 112.297 -175.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -74.6 77.76 1.99 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.922 0.889 . . . . 0.0 109.645 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.78 -128.16 45.95 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.198 -174.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.21 -87.1 0.19 Allowed Glycine 0 C--N 1.349 1.279 0 C-N-CA 123.109 0.385 . . . . 0.0 112.947 175.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 0.8 OUTLIER -149.69 165.97 30.75 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.424 0.69 . . . . 0.0 110.482 -174.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -140.77 134.21 29.9 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.643 0.777 . . . . 0.0 109.147 173.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.542 ' HG2' ' HG3' ' A' ' 33' ' ' GLN . 10.6 pt-20 -91.34 160.53 15.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 163.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.55 178.33 41.57 Favored Glycine 0 C--O 1.243 0.673 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.646 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -104.79 139.96 38.79 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.787 0.835 . . . . 0.0 110.613 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.615 ' HB2' HD11 ' A' ' 21' ' ' LEU . 10.1 tmtt? -95.64 156.98 16.1 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.159 1.384 . . . . 0.0 107.61 176.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.553 ' H ' ' HD3' ' A' ' 44' ' ' LYS . 38.6 mm-40 -55.44 -33.98 64.06 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -177.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.85 -14.24 62.65 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.05 0.54 . . . . 0.0 112.367 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.08 -9.27 59.63 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.881 -174.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.3 tp -65.24 127.75 32.99 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 123.812 0.845 . . . . 0.0 109.538 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -104.81 131.88 51.74 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.662 0.785 . . . . 0.0 109.059 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.503 ' HA3' ' HB2' ' A' ' 21' ' ' LEU . . . -149.29 173.96 28.99 Favored Glycine 0 C--N 1.336 0.577 0 O-C-N 123.35 0.406 . . . . 0.0 112.343 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 41' ' ' GLU . 51.3 p-90 -141.79 142.24 33.2 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.916 0.887 . . . . 0.0 109.79 -173.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -157.01 149.94 18.43 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 123.905 0.882 . . . . 0.0 110.205 175.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 39' ' ' TRP . 82.7 Cg_exo -51.26 165.98 0.5 Allowed 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.462 2.775 . . . . 0.0 114.652 167.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.4 -15.55 49.72 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.416 1.086 . . . . 0.0 112.832 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.3 m -69.17 -21.79 63.96 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.006 0.923 . . . . 0.0 112.2 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -98.72 -47.75 5.21 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.515 0.726 . . . . 0.0 109.702 -175.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.7 m -112.09 130.11 66.35 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.696 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -123.57 126.7 47.12 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.779 0.832 . . . . 0.0 110.577 -171.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.538 HD23 ' SG ' ' A' ' 6' ' ' CYS . 90.3 mt -52.71 133.24 36.85 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.2 1.0 . . . . 0.0 111.862 177.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.466 HD11 HD12 ' A' ' 28' ' ' LEU . 7.1 mp . . . . . 0 C--O 1.252 1.214 0 C-N-CA 123.203 0.601 . . . . 0.0 110.987 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.3 m -63.09 104.91 0.62 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.938 0.895 . . . . 0.0 110.962 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -105.86 147.62 16.29 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.104 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.401 ' HB3' ' HB2' ' A' ' 31' ' ' LEU . . . -72.68 87.39 1.25 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 171.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -80.17 142.01 35.14 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.168 -176.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.573 ' HB3' ' HB ' ' A' ' 57' ' ' VAL . 71.6 m -133.08 141.27 48.11 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 172.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -106.63 127.39 53.31 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.466 HG21 ' HB2' ' A' ' 23' ' ' PHE . 37.6 p -68.81 130.39 42.68 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.933 0.893 . . . . 0.0 111.158 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.56 HD21 ' HB2' ' A' ' 58' ' ' GLN . 79.7 mt -86.28 -34.93 20.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.56 1.144 . . . . 0.0 110.474 -177.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -135.73 145.27 52.37 Favored Pre-proline 0 N--CA 1.487 1.389 0 C-N-CA 123.383 0.673 . . . . 0.0 110.453 -175.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . 63.4 Cg_endo -73.05 126.97 11.64 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.385 2.057 . . . . 0.0 110.71 166.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -150.34 133.52 16.25 Favored 'General case' 0 C--O 1.244 0.816 0 C-N-CA 122.947 0.499 . . . . 0.0 109.932 -174.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.3 m 65.81 117.79 0.03 OUTLIER 'General case' 0 C--N 1.36 1.055 0 C-N-CA 125.522 1.529 . . . . 0.0 112.151 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.85 29.91 1.68 Allowed Glycine 0 C--N 1.342 0.863 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 173.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -96.63 160.94 14.11 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.696 0.798 . . . . 0.0 110.559 -171.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -94.79 62.25 2.67 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.034 0.934 . . . . 0.0 109.674 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -79.35 -23.11 43.61 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.334 173.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 122.67 -118.86 3.74 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -77.09 134.36 38.77 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.985 0.514 . . . . 0.0 110.452 177.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.66 165.78 18.14 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.679 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.3 tp -105.81 121.58 44.33 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.272 0.558 . . . . 0.0 109.563 176.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -104.98 154.98 19.38 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.084 1.354 . . . . 0.0 107.945 177.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.466 ' HB2' HG21 ' A' ' 8' ' ' THR . 48.0 p90 -155.51 159.57 39.86 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -175.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . . . -135.36 143.24 45.97 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.556 1.543 . . . . 0.0 108.55 176.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.01 118.03 3.95 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 124.122 0.889 . . . . 0.0 111.748 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.03 7.0 22.08 Favored Glycine 0 CA--C 1.536 1.403 0 O-C-N 123.746 0.654 . . . . 0.0 113.267 -176.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -95.81 145.66 25.17 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.471 0.708 . . . . 0.0 110.529 171.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.504 HD22 HD11 ' A' ' 60' ' ' LEU . 48.0 mt -109.3 104.93 14.14 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.073 0.949 . . . . 0.0 109.381 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.9 mp -90.78 131.73 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.0 m -85.5 109.07 18.23 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.542 0.737 . . . . 0.0 109.428 177.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.486 HD11 ' SG ' ' A' ' 6' ' ' CYS . 84.6 mt -66.15 115.81 6.55 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.419 HD11 ' HB3' ' A' ' 43' ' ' GLU . 84.7 mt -76.55 -31.19 57.43 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.331 0.652 . . . . 0.0 111.533 -177.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.573 ' HG2' ' HD3' ' A' ' 35' ' ' PRO . 9.4 tt0 -137.58 136.34 37.48 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -177.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.441 ' HA ' ' HD1' ' A' ' 40' ' ' TRP . 6.1 m -133.33 69.44 77.54 Favored Pre-proline 0 CA--C 1.559 1.324 0 C-N-CA 124.731 1.213 . . . . 0.0 109.503 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.573 ' HD3' ' HG2' ' A' ' 33' ' ' GLN . 65.7 Cg_endo -81.15 -22.27 6.05 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.981 2.454 . . . . 0.0 112.881 -171.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -161.55 145.37 12.76 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.161 1.385 . . . . 0.0 107.949 -171.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -81.57 59.75 4.8 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 123.6 0.562 . . . . 0.0 113.384 -177.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.28 -89.84 1.0 Allowed Glycine 0 C--N 1.352 1.431 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 1.9 p-90 -132.11 148.18 52.47 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.441 ' HD1' ' HA ' ' A' ' 34' ' ' VAL . 6.5 m-90 -131.83 160.08 36.67 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.129 0.49 . . . . 0.0 110.952 -167.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -93.65 151.68 19.5 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.028 172.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.16 -179.43 27.77 Favored Glycine 0 C--O 1.242 0.635 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.158 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB3' HD11 ' A' ' 32' ' ' LEU . 5.8 pt-20 -140.86 167.67 21.62 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.999 0.904 . . . . 0.0 112.292 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.585 ' HD3' ' N ' ' A' ' 45' ' ' GLU . 11.2 tmtt? -114.87 156.81 24.26 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 113.459 -1.701 . . . . 0.0 106.996 166.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.585 ' N ' ' HD3' ' A' ' 44' ' ' LYS . 35.8 mt-10 -46.81 -31.14 2.84 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 125.675 1.59 . . . . 0.0 113.638 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.92 1.42 12.83 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.203 1.001 . . . . 0.0 112.983 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.48 -1.62 85.97 Favored Glycine 0 C--N 1.352 1.423 0 C-N-CA 122.688 0.185 . . . . 0.0 112.789 -177.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.2 119.94 12.35 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.561 0.744 . . . . 0.0 110.379 -177.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -104.48 141.32 36.58 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.456 0.703 . . . . 0.0 109.282 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.07 152.15 22.15 Favored Glycine 0 C--N 1.341 0.854 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 174.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -119.22 128.28 54.06 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.464 1.106 . . . . 0.0 108.126 -178.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -133.72 137.81 29.56 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 123.27 0.628 . . . . 0.0 110.675 -172.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -56.03 152.27 37.81 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.3 2.667 . . . . 0.0 112.513 165.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.87 -15.5 62.0 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.328 1.051 . . . . 0.0 112.404 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.8 t -67.21 -26.59 66.68 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.266 0.626 . . . . 0.0 111.68 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -82.98 -30.56 28.11 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.974 0.51 . . . . 0.0 111.266 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 6' ' ' CYS . 15.6 m -134.45 124.86 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 123.254 0.622 . . . . 0.0 111.43 -168.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.56 ' HB2' HD21 ' A' ' 9' ' ' LEU . 6.6 tp-100 -80.75 130.86 35.31 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.337 0.655 . . . . 0.0 110.345 176.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.434 HD21 ' CZ3' ' A' ' 40' ' ' TRP . 81.9 mt -74.13 108.44 6.93 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.299 1.039 . . . . 0.0 111.252 -175.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.504 HD11 HD22 ' A' ' 28' ' ' LEU . 76.8 mt . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.626 -0.702 . . . . 0.0 109.816 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tpt . . . . . 0 N--CA 1.484 1.267 0 CA-C-O 120.615 0.245 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -106.8 123.87 48.79 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.289 0.635 . . . . 0.0 110.084 -176.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.29 174.75 33.85 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 123.589 0.556 . . . . 0.0 112.661 176.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.12 105.44 0.7 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.163 0.585 . . . . 0.0 110.269 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -109.02 172.57 6.77 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.465 ' SG ' ' HZ2' ' A' ' 51' ' ' TRP . 59.6 m -149.23 153.55 37.77 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.582 0.753 . . . . 0.0 110.409 -173.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.428 ' HG3' HD21 ' A' ' 60' ' ' LEU . 18.1 mtp180 -130.94 133.08 45.51 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.922 0.889 . . . . 0.0 109.262 175.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.5 p -78.84 122.13 25.69 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 173.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.557 HD21 ' HB2' ' A' ' 58' ' ' GLN . 87.9 mt -68.63 -47.04 67.66 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.016 0.527 . . . . 0.0 111.039 -174.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -144.53 155.24 57.06 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 124.863 1.265 . . . . 0.0 109.25 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.592 ' HD3' ' HB2' ' A' ' 25' ' ' ALA . 59.3 Cg_endo -83.06 167.57 14.07 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.545 2.163 . . . . 0.0 112.63 -174.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -120.02 100.09 7.01 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 173.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.4 m -98.47 84.06 3.13 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.116 0.566 . . . . 0.0 109.891 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.92 -164.53 36.6 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.74 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -82.15 118.0 22.73 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.406 1.082 . . . . 0.0 110.46 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -106.21 30.43 5.93 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.789 0.836 . . . . 0.0 109.973 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.5 m80 67.87 -76.06 0.06 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.883 1.673 . . . . 0.0 111.27 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.58 -86.17 0.05 OUTLIER Glycine 0 C--N 1.346 1.122 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -63.0 117.81 6.95 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.262 0.625 . . . . 0.0 110.756 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.89 -164.12 35.41 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.442 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 63.0 tp -137.51 142.51 41.46 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.008 0.923 . . . . 0.0 108.556 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -91.92 131.22 37.4 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 170.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -151.71 143.69 23.83 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.186 0.595 . . . . 0.0 112.001 -171.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.491 ' O ' ' HG2' ' A' ' 27' ' ' GLU . . . -87.88 170.95 10.72 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.915 1.286 . . . . 0.0 109.898 167.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.592 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . . . -71.44 112.4 7.53 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.959 -0.463 . . . . 0.0 110.474 172.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.09 17.46 7.78 Favored Glycine 0 N--CA 1.475 1.255 0 C-N-CA 123.139 0.399 . . . . 0.0 113.721 174.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 24' ' ' ALA . 10.2 mm-40 -69.75 125.32 26.39 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 122.678 0.391 . . . . 0.0 110.958 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.7 mt -85.42 101.95 13.04 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.838 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.6 mm -105.59 140.41 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.5 m -113.5 118.94 35.88 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.546 0.612 . . . . 0.0 109.73 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.419 ' HG ' ' SG ' ' A' ' 6' ' ' CYS . 68.8 mt -58.99 121.43 11.2 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 123.695 0.622 . . . . 0.0 110.784 177.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.479 HD11 ' HB2' ' A' ' 43' ' ' GLU . 80.9 mt -75.15 -46.61 33.14 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.017 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -155.23 166.02 34.85 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.936 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.3 m -120.63 81.56 32.64 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 124.084 0.954 . . . . 0.0 109.052 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -83.31 -21.5 4.43 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.53 2.154 . . . . 0.0 114.076 -172.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -155.43 142.99 19.63 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.337 0.655 . . . . 0.0 110.632 -168.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.85 61.02 4.12 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.532 0.52 . . . . 0.0 112.622 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.34 -53.33 0.04 OUTLIER Glycine 0 C--N 1.342 0.869 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 49.2 m95 -118.94 128.0 54.01 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 170.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.452 ' HE3' ' HZ3' ' A' ' 51' ' ' TRP . 15.5 m-90 -119.09 170.57 8.94 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 171.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -132.48 133.0 43.28 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.133 0.492 . . . . 0.0 111.147 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.8 168.4 19.81 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 114.612 -1.177 . . . . 0.0 110.821 173.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.479 ' HB2' HD11 ' A' ' 32' ' ' LEU . 29.2 tt0 -125.7 151.28 46.82 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.184 0.593 . . . . 0.0 109.801 -178.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.451 ' HE3' ' HB3' ' A' ' 27' ' ' GLU . 1.3 mmtp -89.95 163.12 15.09 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.392 1.077 . . . . 0.0 110.244 176.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -63.84 -24.53 67.79 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.71 0.804 . . . . 0.0 111.243 170.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.84 -23.31 65.01 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.366 1.066 . . . . 0.0 111.685 174.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.32 -21.29 37.77 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.095 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.5 133.59 35.85 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.213 0.605 . . . . 0.0 109.606 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 28.5 ptt85 -105.78 147.18 28.91 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.363 0.601 . . . . 0.0 110.175 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 173.44 150.32 7.43 Favored Glycine 0 C--O 1.243 0.703 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 174.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.465 ' HZ2' ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -156.31 171.67 19.82 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.707 0.765 . . . . 0.0 110.888 -173.314 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -147.15 150.37 38.02 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 125.27 1.428 . . . . 0.0 107.841 -173.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -42.28 147.85 0.47 Allowed 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 123.773 2.982 . . . . 0.0 113.681 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.448 ' H ' ' HZ3' ' A' ' 40' ' ' TRP . . . -57.19 -22.02 37.57 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.812 0.845 . . . . 0.0 112.974 -171.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.1 m -58.44 -28.39 65.24 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.34 1.056 . . . . 0.0 112.791 177.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -79.88 -29.61 40.01 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.7 0.8 . . . . 0.0 111.776 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.411 HG21 ' CZ2' ' A' ' 51' ' ' TRP . 23.7 m -123.86 -171.8 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 123.247 0.619 . . . . 0.0 112.078 -166.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.557 ' HB2' HD21 ' A' ' 9' ' ' LEU . 7.7 tp60 -120.61 139.75 52.53 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.0 1.32 . . . . 0.0 108.594 174.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.413 HD21 ' HH2' ' A' ' 51' ' ' TRP . 96.7 mt -104.35 119.71 39.57 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.439 0.696 . . . . 0.0 109.648 176.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.428 HD21 ' HG3' ' A' ' 7' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--O 1.253 1.241 0 C-N-CA 124.107 0.963 . . . . 0.0 108.789 175.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtm . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.9 t -144.41 87.17 1.86 Allowed 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.3 59.9 4.89 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 173.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.16 114.35 13.76 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.495 1.118 . . . . 0.0 109.034 -174.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -129.22 154.62 46.61 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.324 1.05 . . . . 0.0 109.341 176.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.579 ' SG ' HD11 ' A' ' 31' ' ' LEU . 84.0 m -122.97 175.89 6.33 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.854 -1.067 . . . . 0.0 108.773 173.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -156.32 129.01 7.76 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.58 HG23 HD11 ' A' ' 29' ' ' ILE . 34.3 p -66.77 147.73 52.86 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.064 0.946 . . . . 0.0 111.393 -175.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.5 mt -80.23 -62.57 1.64 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.815 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -141.51 164.56 34.2 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 123.991 0.917 . . . . 0.0 109.706 -172.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.548 ' HG3' ' HB2' ' A' ' 25' ' ' ALA . 26.5 Cg_exo -62.4 121.45 9.44 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 122.727 2.284 . . . . 0.0 112.37 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -91.43 142.99 27.07 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.6 m -125.77 -72.33 0.66 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.981 0.513 . . . . 0.0 109.886 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.15 153.2 19.67 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -170.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -74.79 -32.71 62.09 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.484 0.713 . . . . 0.0 111.141 -176.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -163.04 131.06 3.74 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.802 0.841 . . . . 0.0 109.205 -177.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -163.56 115.05 1.42 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.189 0.996 . . . . 0.0 109.604 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.68 -47.97 88.52 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.246 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -155.49 148.31 24.31 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.537 0.735 . . . . 0.0 110.063 175.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -152.94 -164.83 12.81 Favored Glycine 0 C--O 1.241 0.57 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 171.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.6 tp -99.9 125.02 45.82 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 175.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.56 133.62 37.32 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.881 0.872 . . . . 0.0 110.986 -174.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -134.0 147.8 51.04 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.031 0.933 . . . . 0.0 108.568 170.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.64 166.57 12.74 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.633 0.773 . . . . 0.0 109.274 169.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.548 ' HB2' ' HG3' ' A' ' 11' ' ' PRO . . . -66.2 120.8 13.87 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.222 0.609 . . . . 0.0 110.169 176.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.75 17.08 80.21 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 123.287 0.367 . . . . 0.0 113.237 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.76 143.51 26.65 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.165 0.586 . . . . 0.0 109.466 179.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 mp -74.7 164.63 26.36 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.362 1.065 . . . . 0.0 111.499 -175.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.58 HD11 HG23 ' A' ' 8' ' ' THR . 4.1 mp -131.8 123.39 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 174.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.1 m -85.6 106.19 16.72 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.579 HD11 ' SG ' ' A' ' 6' ' ' CYS . 88.5 mt -77.42 106.13 8.99 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.982 0.513 . . . . 0.0 109.906 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.436 HD11 ' HB2' ' A' ' 43' ' ' GLU . 86.0 mt -83.37 -51.59 7.27 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.805 0.842 . . . . 0.0 109.776 -178.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.649 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 1.4 mp0 -106.48 146.62 30.34 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.692 0.797 . . . . 0.0 108.856 172.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.4 m -128.0 69.71 77.37 Favored Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 123.644 0.778 . . . . 0.0 110.232 172.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 40' ' ' TRP . 64.2 Cg_endo -71.25 132.2 20.53 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 122.392 2.061 . . . . 0.0 111.845 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.5 t70 60.91 -88.04 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.967 1.307 . . . . 0.0 112.074 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 161.11 40.55 0.02 OUTLIER Glycine 0 C--N 1.344 0.978 0 O-C-N 122.912 0.133 . . . . 0.0 112.838 -173.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.24 -86.64 0.07 OUTLIER Glycine 0 C--N 1.348 1.225 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 18.1 m95 -82.88 114.53 21.25 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.569 ' HZ3' HD21 ' A' ' 59' ' ' LEU . 18.6 m0 -113.32 144.86 42.03 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.409 0.684 . . . . 0.0 110.061 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.649 ' HB2' ' HB2' ' A' ' 33' ' ' GLN . 39.7 mt-10 -91.71 122.03 33.89 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.786 0.834 . . . . 0.0 109.841 -175.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.25 169.62 20.51 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.039 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.436 ' HB2' HD11 ' A' ' 32' ' ' LEU . 35.5 tt0 -124.09 154.22 40.29 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.972 0.909 . . . . 0.0 108.886 177.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.634 ' HE3' ' HA ' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -129.84 172.83 11.25 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 122.967 0.507 . . . . 0.0 109.958 173.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.478 ' HG2' ' HE2' ' A' ' 44' ' ' LYS . 6.3 mm-40 -67.09 -10.57 51.45 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.466 1.106 . . . . 0.0 111.46 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -55.29 -25.6 35.08 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.865 1.266 . . . . 0.0 111.541 168.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.32 -24.15 32.78 Favored Glycine 0 C--N 1.354 1.552 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 177.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.58 173.99 7.76 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.725 0.81 . . . . 0.0 110.602 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 38.2 mtm-85 -123.54 157.59 33.28 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.122 0.969 . . . . 0.0 108.645 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.99 154.2 25.32 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.586 ' HB3' ' HG2' ' A' ' 41' ' ' GLU . 4.8 p-90 -111.34 126.8 55.3 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -138.25 148.24 58.89 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.879 0.872 . . . . 0.0 109.319 -172.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.582 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 57.1 Cg_endo -69.68 142.87 49.45 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.302 2.001 . . . . 0.0 111.24 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.95 -23.06 66.14 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.925 0.89 . . . . 0.0 110.758 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.5 m -64.71 -40.03 94.66 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.267 1.027 . . . . 0.0 111.622 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.582 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 17.3 t80 -74.01 -32.89 63.57 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 121.316 0.579 . . . . 0.0 110.996 -173.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.6 m -104.54 -169.14 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.345 1.058 . . . . 0.0 108.899 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -141.18 130.94 24.21 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.729 0.412 . . . . 0.0 110.263 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.569 HD21 ' HZ3' ' A' ' 40' ' ' TRP . 94.8 mt -71.57 141.75 50.04 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.662 0.785 . . . . 0.0 111.552 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.7 mt . . . . . 0 C--O 1.244 0.806 0 C-N-CA 124.14 0.976 . . . . 0.0 109.848 -179.956 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.0 m -66.99 137.91 56.86 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.434 0.693 . . . . 0.0 110.569 174.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -143.27 -117.57 1.24 Allowed Glycine 0 C--N 1.34 0.787 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 177.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.79 137.49 47.67 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.37 0.668 . . . . 0.0 109.541 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -161.13 172.8 16.13 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.39 0.615 . . . . 0.0 111.501 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.641 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 20.6 p -141.41 171.82 13.54 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.315 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.461 ' HB2' HD21 ' A' ' 60' ' ' LEU . 28.2 tpt85 -117.51 128.64 55.18 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.742 1.217 . . . . 0.0 109.272 -172.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.0 p -80.15 112.68 17.7 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.366 0.666 . . . . 0.0 109.326 173.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.94 -58.98 3.21 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.348 0.659 . . . . 0.0 110.762 -175.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -137.36 156.64 75.07 Favored Pre-proline 0 N--CA 1.488 1.434 0 C-N-CA 123.617 0.767 . . . . 0.0 109.69 -175.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . 44.9 Cg_endo -66.22 125.31 13.83 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.532 2.155 . . . . 0.0 112.381 175.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -92.86 121.33 34.11 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.127 0.971 . . . . 0.0 108.599 176.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.7 t -124.76 -161.99 1.06 Allowed 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 175.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 161.52 -35.61 0.39 Allowed Glycine 0 C--N 1.339 0.74 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 66.67 2.98 2.76 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.4 1.08 . . . . 0.0 112.877 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -82.11 -41.74 20.1 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.217 1.007 . . . . 0.0 109.261 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 20.8 m80 -84.91 119.16 25.04 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.168 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.38 -52.32 36.47 Favored Glycine 0 C--N 1.346 1.088 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 171.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -122.59 144.02 49.37 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.571 1.149 . . . . 0.0 109.438 173.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.19 159.56 10.11 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.54 HD11 ' HD3' ' A' ' 44' ' ' LYS . 16.9 tp -88.25 132.71 34.27 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 117.971 0.886 . . . . 0.0 108.773 -177.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -123.47 169.21 11.62 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.389 1.076 . . . . 0.0 109.031 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -123.54 113.34 18.58 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.612 ' HA ' ' HA ' ' A' ' 11' ' ' PRO . . . -95.73 160.45 14.48 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 173.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.83 128.07 34.59 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.312 0.645 . . . . 0.0 111.121 -170.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.16 -30.81 6.33 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-O 119.305 -0.719 . . . . 0.0 113.927 176.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -61.57 130.84 47.89 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 117.665 0.733 . . . . 0.0 112.039 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 61.3 mt -99.25 103.32 15.17 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 175.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.641 ' HB ' ' SG ' ' A' ' 6' ' ' CYS . 21.9 mm -88.07 109.2 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -169.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.2 m -74.38 109.54 7.95 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.481 0.488 . . . . 0.0 110.622 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.8 mt -69.81 104.34 2.43 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.849 -0.796 . . . . 0.0 108.849 175.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 70.5 mt -74.16 -30.63 62.34 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.658 0.783 . . . . 0.0 110.032 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -127.11 136.34 51.99 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.223 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.1 m -129.75 90.39 43.47 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.768 1.227 . . . . 0.0 108.576 175.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.62 -155.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.691 2.261 . . . . 0.0 110.926 177.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -63.21 -31.98 73.26 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.031 0.532 . . . . 0.0 111.171 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.34 -163.59 29.91 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 116.417 -0.356 . . . . 0.0 112.218 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.58 -76.49 2.1 Favored Glycine 0 C--N 1.345 1.04 0 C-N-CA 123.458 0.551 . . . . 0.0 112.11 177.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -114.41 132.52 56.21 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.304 0.642 . . . . 0.0 109.475 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -117.67 153.39 33.41 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.435 0.694 . . . . 0.0 109.432 173.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -91.69 120.4 32.41 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 173.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -123.03 135.47 10.04 Favored Glycine 0 C--N 1.342 0.874 0 O-C-N 123.379 0.425 . . . . 0.0 112.71 -175.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.573 ' HA ' ' HG2' ' A' ' 49' ' ' ARG . 10.6 tp10 -105.04 140.96 37.45 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.371 1.069 . . . . 0.0 110.228 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.615 ' HG2' HD12 ' A' ' 29' ' ' ILE . 22.3 mtpt -124.53 157.53 35.11 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.797 0.839 . . . . 0.0 110.27 176.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.81 0.68 26.07 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.42 0.688 . . . . 0.0 111.326 174.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.56 -27.66 68.6 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.423 1.089 . . . . 0.0 110.159 168.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.66 -17.21 57.85 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.011 -176.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -98.66 154.84 17.65 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.857 0.863 . . . . 0.0 110.119 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.573 ' HG2' ' HA ' ' A' ' 43' ' ' GLU . 72.1 mtm180 -124.62 169.04 12.33 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.488 1.115 . . . . 0.0 109.499 170.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.91 173.15 39.09 Favored Glycine 0 C--N 1.339 0.715 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.55 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -111.71 125.26 53.78 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -151.57 147.12 19.64 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 124.23 1.012 . . . . 0.0 109.492 -175.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -83.31 178.75 5.53 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.255 2.637 . . . . 0.0 111.539 172.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.02 -14.09 61.06 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.008 0.923 . . . . 0.0 112.046 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -59.68 -19.62 50.81 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.565 1.146 . . . . 0.0 113.155 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -113.05 -16.05 12.71 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.657 0.783 . . . . 0.0 111.868 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.15 136.22 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 122.973 0.509 . . . . 0.0 111.324 -172.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -91.87 112.79 24.85 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.765 0.826 . . . . 0.0 109.782 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.59 123.37 18.64 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.056 0.542 . . . . 0.0 110.764 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.461 HD21 ' HB2' ' A' ' 7' ' ' ARG . 86.7 mt . . . . . 0 CA--C 1.55 0.952 0 C-N-CA 123.747 0.819 . . . . 0.0 110.745 -177.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.7 t -138.82 155.34 48.23 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.803 0.841 . . . . 0.0 110.078 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.69 91.18 0.77 Allowed Glycine 0 C--N 1.354 1.57 0 O-C-N 123.958 0.786 . . . . 0.0 112.317 -178.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.89 132.54 54.26 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.549 1.14 . . . . 0.0 110.721 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -142.46 153.43 43.67 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.478 0.711 . . . . 0.0 110.959 -172.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.462 ' SG ' HD11 ' A' ' 31' ' ' LEU . 81.2 m -139.15 148.89 43.82 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.875 1.27 . . . . 0.0 108.967 175.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -108.14 152.35 24.67 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.454 0.702 . . . . 0.0 109.778 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.491 HG21 ' HB2' ' A' ' 23' ' ' PHE . 24.5 p -87.89 130.19 34.99 Favored 'General case' 0 C--O 1.242 0.711 0 C-N-CA 123.47 0.708 . . . . 0.0 110.464 173.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.5 mt -79.35 -53.5 6.87 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.249 1.019 . . . . 0.0 110.012 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -134.89 155.12 79.53 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 123.599 0.76 . . . . 0.0 109.574 -173.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.516 ' HD3' ' HB2' ' A' ' 25' ' ' ALA . 64.6 Cg_endo -78.71 85.37 1.86 Allowed 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 121.874 1.716 . . . . 0.0 110.646 170.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -92.7 101.18 13.58 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.092 -175.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.9 m -153.9 63.29 0.72 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.816 1.246 . . . . 0.0 107.905 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.26 -33.25 86.73 Favored Glycine 0 C--N 1.357 1.732 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.4 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -127.39 138.27 52.96 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.55 1.14 . . . . 0.0 108.555 170.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -66.55 -51.93 51.2 Favored 'General case' 0 CA--C 1.55 0.973 0 O-C-N 123.784 0.678 . . . . 0.0 109.615 176.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.4 t60 64.55 -77.52 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.423 1.489 . . . . 0.0 111.791 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 145.17 -66.46 0.43 Allowed Glycine 0 C--N 1.34 0.782 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -76.84 103.95 7.07 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.243 0.617 . . . . 0.0 109.823 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.74 -162.59 34.13 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.442 HD22 ' HA3' ' A' ' 50' ' ' GLY . 20.7 tp -143.24 120.04 11.22 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 176.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -77.46 120.94 23.15 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.491 ' HB2' HG21 ' A' ' 8' ' ' THR . 33.1 p90 -120.75 130.02 53.86 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.179 0.991 . . . . 0.0 110.104 -178.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -104.31 153.98 20.37 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.056 0.943 . . . . 0.0 110.488 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.516 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . . . -58.5 121.56 11.21 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.969 0.908 . . . . 0.0 111.99 -178.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.56 -23.96 16.56 Favored Glycine 0 C--N 1.347 1.164 0 C-N-CA 123.337 0.494 . . . . 0.0 113.661 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -60.9 128.48 36.69 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.552 0.741 . . . . 0.0 111.526 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 90.2 mt -96.24 125.13 40.54 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.8 mp -104.86 116.39 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 175.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.8 m -87.0 111.5 20.92 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.462 HD11 ' SG ' ' A' ' 6' ' ' CYS . 7.0 mp -65.69 115.96 6.4 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.044 0.938 . . . . 0.0 110.698 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.421 HD11 ' HB2' ' A' ' 43' ' ' GLU . 58.6 mt -84.72 -36.25 21.95 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.151 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -116.51 135.64 53.65 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.054 0.942 . . . . 0.0 109.309 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.5 m -143.71 66.41 15.22 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 124.046 0.938 . . . . 0.0 110.434 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.402 ' HD2' ' HD1' ' A' ' 40' ' ' TRP . 7.6 Cg_exo -77.03 -173.12 1.64 Allowed 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 123.211 2.607 . . . . 0.0 112.73 174.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -77.37 101.18 6.22 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.566 0.747 . . . . 0.0 110.548 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.72 -154.94 26.08 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 116.371 -0.377 . . . . 0.0 112.647 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.9 -28.67 4.1 Favored Glycine 0 C--N 1.346 1.129 0 N-CA-C 112.236 -0.346 . . . . 0.0 112.236 176.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -81.06 110.62 16.76 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.593 0.757 . . . . 0.0 109.512 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.402 ' HD1' ' HD2' ' A' ' 35' ' ' PRO . 7.0 m0 -125.36 138.75 54.05 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.741 0.817 . . . . 0.0 109.726 178.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.577 ' HG2' ' HB3' ' A' ' 51' ' ' TRP . 28.2 mt-10 -94.87 138.32 32.8 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.687 0.395 . . . . 0.0 110.496 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.13 171.01 27.16 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.412 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.421 ' HB2' HD11 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -127.83 148.22 50.45 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.124 0.57 . . . . 0.0 110.17 -169.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.467 ' HE3' ' HB3' ' A' ' 46' ' ' ASP . 39.7 mtmt -88.3 -173.22 4.11 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.605 1.562 . . . . 0.0 110.24 176.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -86.6 62.1 7.21 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 165.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.467 ' HB3' ' HE3' ' A' ' 44' ' ' LYS . 38.0 t70 -148.56 -47.75 0.15 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -168.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.64 -9.76 28.05 Favored Glycine 0 N--CA 1.473 1.136 0 CA-C-O 119.848 -0.418 . . . . 0.0 113.683 -174.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.58 130.99 45.86 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 117.544 0.672 . . . . 0.0 110.1 172.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -103.14 143.07 33.09 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.778 0.831 . . . . 0.0 109.446 -175.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.442 ' HA3' HD22 ' A' ' 21' ' ' LEU . . . -134.34 155.15 21.74 Favored Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 177.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.577 ' HB3' ' HG2' ' A' ' 41' ' ' GLU . 1.1 p-90 -99.66 132.19 45.17 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.995 0.918 . . . . 0.0 109.88 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -133.26 129.39 20.78 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 123.657 0.783 . . . . 0.0 109.446 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.65 151.98 83.05 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.3 2.0 . . . . 0.0 111.15 162.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.572 ' HB1' HD11 ' A' ' 59' ' ' LEU . . . -60.0 -26.47 66.08 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.473 1.109 . . . . 0.0 112.178 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.1 m -73.14 -16.79 61.44 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.829 0.852 . . . . 0.0 113.118 -177.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -96.8 -24.71 15.78 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.002 0.521 . . . . 0.0 111.992 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.2 m -116.89 151.73 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 123.113 0.565 . . . . 0.0 110.963 -173.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -81.17 103.85 11.25 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.78 0.832 . . . . 0.0 109.288 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.572 HD11 ' HB1' ' A' ' 54' ' ' ALA . 43.8 mt -67.77 115.1 6.94 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.1 mt . . . . . 0 C--O 1.25 1.104 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -177.546 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtm . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 72.7 p -85.09 141.91 29.9 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.521 0.728 . . . . 0.0 111.094 -176.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -118.26 120.48 4.73 Favored Glycine 0 C--N 1.346 1.106 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.533 ' HB3' ' HB2' ' A' ' 31' ' ' LEU . . . -77.08 106.8 9.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.453 0.701 . . . . 0.0 109.651 -177.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -78.64 142.24 37.37 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.751 0.42 . . . . 0.0 110.359 -176.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 76.7 m -138.75 159.56 41.81 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.985 0.914 . . . . 0.0 109.229 174.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.568 ' HB2' ' HB3' ' A' ' 58' ' ' GLN . 19.9 mmt180 -106.69 147.72 29.24 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.643 1.177 . . . . 0.0 108.688 176.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.543 HG21 ' HB2' ' A' ' 23' ' ' PHE . 21.8 p -94.68 118.16 31.28 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.098 175.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.476 HD21 ' HB2' ' A' ' 58' ' ' GLN . 86.0 mt -69.47 -50.62 43.68 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.945 0.498 . . . . 0.0 110.885 -177.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -135.2 148.29 65.87 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 123.569 0.748 . . . . 0.0 109.731 -178.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . 2.8 Cg_exo -74.9 121.68 6.77 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.792 2.328 . . . . 0.0 111.232 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -128.34 102.3 6.6 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.163 0.506 . . . . 0.0 109.89 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.1 m -153.22 30.61 0.48 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.874 1.27 . . . . 0.0 109.528 174.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.03 88.46 0.01 OUTLIER Glycine 0 C--N 1.356 1.644 0 O-C-N 124.44 1.088 . . . . 0.0 113.611 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 57.62 48.79 13.59 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.167 1.387 . . . . 0.0 110.347 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -98.9 80.11 2.46 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.055 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -90.99 -18.96 23.77 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.795 0.838 . . . . 0.0 111.106 177.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.56 -165.39 24.86 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.932 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -73.84 85.79 1.72 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.76 0.791 . . . . 0.0 110.627 -178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -164.64 143.4 8.49 Favored Glycine 0 C--N 1.339 0.726 0 CA-C-N 114.17 -1.377 . . . . 0.0 109.721 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.595 HD11 ' HB3' ' A' ' 44' ' ' LYS . 27.0 tp -90.18 142.44 27.71 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.919 0.488 . . . . 0.0 110.822 -171.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -99.89 138.92 36.3 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.23 1.012 . . . . 0.0 110.655 -175.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.543 ' HB2' HG21 ' A' ' 8' ' ' THR . 28.1 p90 -154.16 121.98 5.93 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.592 0.757 . . . . 0.0 110.45 -174.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . . . -92.08 152.51 19.91 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.61 1.164 . . . . 0.0 109.654 171.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.409 ' H ' ' HG3' ' A' ' 11' ' ' PRO . . . -61.99 125.02 22.38 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.719 0.808 . . . . 0.0 111.922 -175.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.87 -20.65 17.1 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 123.643 0.589 . . . . 0.0 113.343 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -72.23 142.91 48.97 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 121.329 0.585 . . . . 0.0 112.219 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.61 111.12 19.25 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.303 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.4 mm -91.36 120.76 40.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 123.471 0.708 . . . . 0.0 109.636 174.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.6 m -85.74 103.85 14.9 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 91.2 mt -71.86 107.45 4.64 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 67.2 mt -75.39 -48.46 22.81 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.591 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -126.45 136.94 53.28 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.067 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.3 m -115.22 91.45 27.88 Favored Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 124.259 1.024 . . . . 0.0 108.929 176.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.62 -49.65 15.23 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 123.298 2.665 . . . . 0.0 112.889 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -164.09 -79.29 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.693 0.797 . . . . 0.0 109.5 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -161.4 149.47 18.26 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 -174.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.37 -61.49 2.86 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 116.577 0.189 . . . . 0.0 112.761 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 40.9 m95 -121.3 99.73 6.65 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.927 0.491 . . . . 0.0 109.786 -172.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -112.12 146.22 38.4 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -90.12 117.2 28.72 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.13 148.58 18.24 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.678 177.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -103.36 160.49 14.65 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.561 0.696 . . . . 0.0 109.816 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.595 ' HB3' HD11 ' A' ' 21' ' ' LEU . 2.0 tmtp? -132.73 155.94 47.93 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 170.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.44 ' H ' ' HD3' ' A' ' 44' ' ' LYS . 9.6 pt-20 -66.52 6.33 0.47 Allowed 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -67.78 -15.66 63.74 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.332 0.653 . . . . 0.0 111.49 168.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.49 -15.24 61.36 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 112.37 -0.292 . . . . 0.0 112.37 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.443 ' HB2' HD13 ' A' ' 21' ' ' LEU . 89.0 mt -96.63 163.03 13.19 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.629 0.772 . . . . 0.0 110.099 176.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 35.9 ttp-105 -119.98 155.75 32.22 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 169.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -150.52 161.47 28.98 Favored Glycine 0 C--N 1.336 0.577 0 N-CA-C 112.343 -0.303 . . . . 0.0 112.343 177.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -88.76 129.87 35.46 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 171.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 59.2 m-85 -108.35 137.22 19.87 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 123.324 0.65 . . . . 0.0 111.035 -173.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 52' ' ' PHE . 6.4 Cg_exo -73.66 124.04 9.0 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 123.086 2.524 . . . . 0.0 111.199 177.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.83 -45.08 86.72 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.744 1.218 . . . . 0.0 113.098 -171.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.3 t -75.98 -25.48 55.86 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.189 0.596 . . . . 0.0 111.12 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -85.77 -18.24 33.54 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.416 0.686 . . . . 0.0 111.167 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.3 m -108.99 147.31 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.094 0.558 . . . . 0.0 109.553 173.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.568 ' HB3' ' HB2' ' A' ' 7' ' ' ARG . 34.1 tt0 -87.64 115.01 24.78 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 174.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.2 mt -76.95 128.66 34.94 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.771 0.429 . . . . 0.0 110.155 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.2 mt . . . . . 0 C--O 1.249 1.066 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 176.475 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 ttm . . . . . 0 CA--C 1.542 0.666 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.6 t -167.91 164.3 13.91 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.92 0.888 . . . . 0.0 109.838 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 72.29 24.81 75.77 Favored Glycine 0 C--N 1.35 1.35 0 CA-C-N 115.843 -0.617 . . . . 0.0 113.104 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 31' ' ' LEU . . . -75.91 86.97 2.87 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.871 0.868 . . . . 0.0 111.072 -173.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.419 ' HB2' ' HB2' ' A' ' 60' ' ' LEU . 93.6 mtt180 -110.28 151.78 26.96 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.352 1.061 . . . . 0.0 109.579 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.417 ' SG ' ' HB ' ' A' ' 29' ' ' ILE . 28.3 p -158.91 140.62 13.48 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.448 0.699 . . . . 0.0 109.154 171.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.524 ' HB2' HD11 ' A' ' 60' ' ' LEU . 40.2 ttp180 -112.68 130.4 56.06 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.287 0.635 . . . . 0.0 109.45 177.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 45.1 p -66.51 139.21 57.93 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 122.974 0.51 . . . . 0.0 111.468 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.41 HD21 ' HB2' ' A' ' 58' ' ' GLN . 86.0 mt -97.93 -22.53 16.27 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.328 1.051 . . . . 0.0 110.286 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -131.89 151.72 79.01 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 124.02 0.928 . . . . 0.0 109.574 -177.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.86 164.37 33.64 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.304 2.002 . . . . 0.0 111.366 169.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -93.65 102.79 14.98 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.3 p -69.56 120.18 14.95 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 123.222 0.609 . . . . 0.0 109.399 174.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.35 -179.01 48.16 Favored Glycine 0 C--N 1.342 0.894 0 O-C-N 123.595 0.559 . . . . 0.0 112.535 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -83.63 169.15 15.65 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.127 0.571 . . . . 0.0 109.482 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 55.9 mtp85 -56.63 -56.25 23.75 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.503 0.721 . . . . 0.0 111.143 178.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 69.3 t60 66.97 171.14 0.25 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.809 1.243 . . . . 0.0 112.526 169.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.72 -68.86 1.52 Allowed Glycine 0 C--N 1.351 1.391 0 CA-C-N 116.487 -0.324 . . . . 0.0 112.874 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -153.74 148.23 26.13 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.2 0.6 . . . . 0.0 111.278 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 168.81 -175.3 43.34 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 31.8 tp -90.21 114.13 26.07 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 121.572 0.701 . . . . 0.0 109.614 174.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -122.58 151.84 41.02 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 125.033 1.333 . . . . 0.0 107.768 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -156.18 152.42 27.83 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.184 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.473 ' O ' ' HG2' ' A' ' 27' ' ' GLU . . . -96.48 169.46 9.89 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.828 1.251 . . . . 0.0 109.027 165.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.09 111.63 3.48 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 122.12 -0.363 . . . . 0.0 110.064 171.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.26 19.8 6.15 Favored Glycine 0 C--N 1.351 1.375 0 N-CA-C 114.388 0.515 . . . . 0.0 114.388 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 24' ' ' ALA . 10.9 mm-40 -92.0 136.69 32.97 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 117.772 0.786 . . . . 0.0 111.138 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.8 mt -84.16 103.06 13.05 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.523 0.729 . . . . 0.0 109.902 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.417 ' HB ' ' SG ' ' A' ' 6' ' ' CYS . 47.5 mm -92.1 124.11 44.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.586 1.154 . . . . 0.0 109.491 176.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.0 m -88.46 107.29 18.79 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.167 0.987 . . . . 0.0 109.112 174.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.465 ' HB2' ' HB1' ' A' ' 4' ' ' ALA . 96.2 mt -70.98 111.98 6.78 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.409 ' H ' ' HA2' ' A' ' 42' ' ' GLY . 82.3 mt -80.46 -53.95 6.13 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 123.151 0.58 . . . . 0.0 109.488 -178.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.606 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 47.2 mt-30 -109.0 135.63 49.87 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.0 m -135.09 84.23 37.31 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 123.413 0.685 . . . . 0.0 110.205 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.12 161.72 37.97 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.583 2.189 . . . . 0.0 111.374 169.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -73.12 100.07 2.96 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.142 0.577 . . . . 0.0 110.11 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.18 -154.42 20.42 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -102.26 -16.21 23.55 Favored Glycine 0 N--CA 1.47 0.92 0 N-CA-C 112.101 -0.4 . . . . 0.0 112.101 172.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 53.9 m95 -92.14 119.22 31.59 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.272 1.029 . . . . 0.0 109.346 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.4 ' CZ3' HD21 ' A' ' 59' ' ' LEU . 5.2 m-90 -131.39 153.18 49.94 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.674 0.79 . . . . 0.0 109.781 178.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.606 ' HB3' ' HB2' ' A' ' 33' ' ' GLN . 3.1 tm-20 -102.79 132.33 49.03 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.409 ' HA2' ' H ' ' A' ' 32' ' ' LEU . . . -152.76 152.17 23.88 Favored Glycine 0 CA--C 1.508 -0.388 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.088 -177.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 49' ' ' ARG . 9.8 pt-20 -103.67 152.5 21.72 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.113 0.565 . . . . 0.0 110.125 173.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -78.68 154.42 30.17 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 157.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -73.6 16.51 0.2 Allowed 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -170.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -97.24 -1.11 45.53 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.671 1.188 . . . . 0.0 111.282 169.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.81 3.4 68.41 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-O 120.115 -0.269 . . . . 0.0 113.737 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.6 mt -91.25 114.98 27.64 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.541 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 12.6 ptt180 -116.97 165.73 13.01 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.864 0.466 . . . . 0.0 111.863 -173.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 177.7 171.47 41.18 Favored Glycine 0 C--N 1.348 1.239 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.797 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -94.98 128.19 41.6 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.45 0.7 . . . . 0.0 110.315 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -147.7 145.24 20.73 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 124.161 0.985 . . . . 0.0 109.766 175.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -78.4 176.6 9.73 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.685 2.257 . . . . 0.0 111.518 173.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.27 -21.46 61.93 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.038 175.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.9 m -53.22 -33.66 53.79 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.273 1.429 . . . . 0.0 113.471 -176.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -96.2 -18.0 20.39 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.104 0.562 . . . . 0.0 112.431 -176.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 35.8 m -120.03 174.39 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-O 121.411 0.624 . . . . 0.0 112.0 -171.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.41 ' HB2' HD21 ' A' ' 9' ' ' LEU . 22.5 tp60 -130.79 115.49 16.69 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.177 1.391 . . . . 0.0 107.819 174.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.4 HD21 ' CZ3' ' A' ' 40' ' ' TRP . 78.3 mt -63.03 126.37 27.11 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.929 0.768 . . . . 0.0 110.442 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 7' ' ' ARG . 80.2 mt . . . . . 0 C--O 1.252 1.194 0 C-N-CA 124.15 0.98 . . . . 0.0 108.791 -176.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.0 tmm? . . . . . 0 N--CA 1.485 1.277 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.4 p -135.53 -164.8 1.59 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.148 0.979 . . . . 0.0 110.066 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 92.18 -59.72 2.69 Favored Glycine 0 C--N 1.353 1.495 0 N-CA-C 111.984 -0.447 . . . . 0.0 111.984 176.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 31' ' ' LEU . . . -75.38 90.48 2.67 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.193 0.597 . . . . 0.0 110.406 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -81.39 123.46 28.58 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.171 0.988 . . . . 0.0 109.372 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.736 ' HA ' ' HA ' ' A' ' 59' ' ' LEU . 48.6 t -124.14 155.7 37.97 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.223 0.535 . . . . 0.0 110.929 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -116.04 131.96 56.79 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.627 1.171 . . . . 0.0 109.175 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.54 ' HA ' HG12 ' A' ' 57' ' ' VAL . 16.5 p -77.37 121.29 23.56 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.488 0.715 . . . . 0.0 109.813 170.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.42 HD11 ' HG3' ' A' ' 58' ' ' GLN . 81.4 mt -73.06 -51.51 17.82 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.29 0.636 . . . . 0.0 109.676 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -137.8 152.85 73.22 Favored Pre-proline 0 N--CA 1.483 1.183 0 C-N-CA 123.662 0.785 . . . . 0.0 110.467 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.41 129.51 12.97 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.354 2.036 . . . . 0.0 111.72 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -117.22 101.6 8.58 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.4 t -92.75 -47.28 7.15 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.448 -171.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -170.79 -117.55 0.43 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -178.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 60.93 -74.34 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.621 1.568 . . . . 0.0 111.703 -177.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.481 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -79.91 -11.72 59.78 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.532 0.733 . . . . 0.0 111.942 -178.137 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -140.64 172.21 13.02 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.31 0.644 . . . . 0.0 110.476 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -138.72 -23.18 0.38 Allowed Glycine 0 C--N 1.346 1.123 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.081 175.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -125.28 21.94 7.89 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.769 0.827 . . . . 0.0 111.347 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.08 176.9 54.51 Favored Glycine 0 C--N 1.351 1.39 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 172.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.424 HD21 ' HG2' ' A' ' 44' ' ' LYS . 44.8 tp -89.87 124.79 35.0 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -79.49 136.96 37.05 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.549 0.74 . . . . 0.0 110.479 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -149.04 128.6 13.13 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.067 0.947 . . . . 0.0 109.245 177.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.8 150.82 20.28 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.3 1.04 . . . . 0.0 110.017 177.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.11 133.4 54.38 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.622 0.769 . . . . 0.0 111.716 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.56 -23.38 28.38 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 119.605 -0.553 . . . . 0.0 113.179 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -65.0 136.17 56.48 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-N 117.201 0.5 . . . . 0.0 111.69 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 73.9 mt -85.67 101.43 12.74 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.3 mm -88.62 111.18 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.929 0.891 . . . . 0.0 108.644 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.2 p -77.32 105.42 8.42 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 174.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.553 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 39.8 mt -67.56 142.19 56.59 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 173.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.8 mt -74.34 -43.04 58.32 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.968 0.507 . . . . 0.0 110.57 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -157.14 157.17 33.97 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.112 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.5 m -109.66 94.36 16.51 Favored Pre-proline 0 CA--C 1.557 1.24 0 C-N-CA 123.38 0.672 . . . . 0.0 110.944 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.42 ' HD2' ' CD1' ' A' ' 40' ' ' TRP . 79.3 Cg_endo -81.86 170.57 13.88 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.578 2.185 . . . . 0.0 111.174 167.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.4 143.84 54.94 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.108 0.48 . . . . 0.0 111.369 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.47 166.99 33.81 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.356 -177.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.0 55.26 4.98 Favored Glycine 0 C--N 1.348 1.199 0 C-N-CA 123.211 0.434 . . . . 0.0 112.584 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.401 ' HZ3' ' HG3' ' A' ' 53' ' ' PRO . 75.6 t-105 -143.79 114.76 7.81 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.437 1.095 . . . . 0.0 108.484 -177.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.42 ' CD1' ' HD2' ' A' ' 35' ' ' PRO . 12.9 m-90 -136.28 144.19 44.62 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.938 0.895 . . . . 0.0 109.712 -177.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -95.74 116.28 28.66 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 169.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.553 ' HA2' ' HA ' ' A' ' 31' ' ' LEU . . . -108.76 143.76 16.28 Favored Glycine 0 C--N 1.337 0.635 0 N-CA-C 110.556 -1.017 . . . . 0.0 110.556 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 49' ' ' ARG . 31.8 tt0 -115.52 136.9 52.61 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.007 0.523 . . . . 0.0 109.837 -178.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.424 ' HG2' HD21 ' A' ' 21' ' ' LEU . 30.2 mmmt -71.62 163.43 27.77 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.696 1.198 . . . . 0.0 109.787 170.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -64.71 -11.66 38.47 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.963 0.905 . . . . 0.0 112.685 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -89.22 -8.12 54.18 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.334 1.054 . . . . 0.0 112.49 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.43 -1.27 66.53 Favored Glycine 0 C--N 1.345 1.078 0 O-C-N 123.147 0.279 . . . . 0.0 112.842 -173.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.8 mt -83.05 104.99 13.67 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.665 0.786 . . . . 0.0 109.73 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 28.0 ptt180 -102.64 154.33 19.25 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -159.18 -178.28 33.04 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.908 -0.587 . . . . 0.0 113.062 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 49.8 p-90 -77.05 129.58 36.26 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.24 1.016 . . . . 0.0 110.47 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -135.39 94.28 15.67 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 123.914 0.886 . . . . 0.0 109.617 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HG3' ' HZ3' ' A' ' 39' ' ' TRP . 11.8 Cg_exo -71.45 148.32 54.08 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.915 2.41 . . . . 0.0 110.37 168.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.41 ' HB2' ' HZ3' ' A' ' 40' ' ' TRP . . . -63.31 -19.54 64.69 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.21 0.604 . . . . 0.0 112.396 -178.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.5 m -62.32 -31.05 71.61 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.756 0.822 . . . . 0.0 111.631 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -98.71 -27.65 13.87 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.4 0.68 . . . . 0.0 111.586 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.581 ' HB ' ' SG ' ' A' ' 6' ' ' CYS . 26.1 m -138.79 139.34 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 122.94 0.496 . . . . 0.0 111.321 -174.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.42 ' HG3' HD11 ' A' ' 9' ' ' LEU . 53.1 mt-30 -128.82 133.16 47.92 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.546 0.738 . . . . 0.0 109.482 174.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.736 ' HA ' ' HA ' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -82.56 140.5 33.23 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.997 0.519 . . . . 0.0 112.312 -172.303 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 C--O 1.251 1.164 0 C-N-CA 124.772 1.229 . . . . 0.0 109.447 -178.114 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.3 m -73.88 145.88 44.49 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 171.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.12 76.81 1.4 Allowed Glycine 0 C--N 1.346 1.106 0 O-C-N 123.658 0.599 . . . . 0.0 111.641 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.89 76.31 1.16 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.849 0.86 . . . . 0.0 109.157 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -164.48 164.33 21.91 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.183 -173.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.447 ' SG ' HD23 ' A' ' 59' ' ' LEU . 78.2 m -145.12 166.86 24.18 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.981 0.913 . . . . 0.0 109.682 178.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.527 ' HG3' HD11 ' A' ' 60' ' ' LEU . 59.0 mtm180 -119.19 133.58 55.69 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.142 0.577 . . . . 0.0 109.98 175.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.603 HG23 HD11 ' A' ' 29' ' ' ILE . 8.9 p -73.45 121.65 20.87 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.428 0.455 . . . . 0.0 111.647 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.63 -15.98 27.73 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.788 0.835 . . . . 0.0 110.233 169.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -107.18 122.26 42.01 Favored Pre-proline 0 N--CA 1.48 1.073 0 C-N-CA 123.674 0.789 . . . . 0.0 110.58 171.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.408 ' HB3' ' N ' ' A' ' 25' ' ' ALA . 96.3 Cg_endo -83.44 49.93 3.1 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.928 2.418 . . . . 0.0 111.449 164.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -91.24 109.97 21.25 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -173.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.7 t -70.6 -21.37 62.67 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.524 1.13 . . . . 0.0 111.784 -177.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.35 -84.1 1.08 Allowed Glycine 0 C--N 1.347 1.185 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -171.86 161.33 5.8 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 124.999 1.32 . . . . 0.0 108.904 175.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -91.79 131.74 36.93 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 168.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -140.33 -64.22 0.47 Allowed 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.404 0.682 . . . . 0.0 109.495 -176.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.67 75.26 0.17 Allowed Glycine 0 C--N 1.346 1.106 0 CA-C-O 120.05 -0.305 . . . . 0.0 112.439 -175.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 66.29 21.71 10.97 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.549 1.14 . . . . 0.0 112.314 173.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.2 166.1 25.57 Favored Glycine 0 C--N 1.348 1.229 0 O-C-N 123.588 0.555 . . . . 0.0 113.591 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.46 HD11 ' HB2' ' A' ' 44' ' ' LYS . 27.5 tp -89.82 129.79 36.15 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.453 0.701 . . . . 0.0 109.492 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.25 161.14 19.44 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.964 1.306 . . . . 0.0 108.725 177.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -136.9 141.87 42.73 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.944 0.498 . . . . 0.0 111.741 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.62 169.96 10.1 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.777 1.231 . . . . 0.0 109.198 164.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.408 ' N ' ' HB3' ' A' ' 11' ' ' PRO . . . -72.72 115.92 12.58 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.94 19.9 8.77 Favored Glycine 0 N--CA 1.477 1.39 0 O-C-N 123.028 0.205 . . . . 0.0 113.483 177.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -72.85 149.99 43.06 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.917 0.487 . . . . 0.0 111.641 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.7 mt -106.37 108.1 19.44 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.603 HD11 HG23 ' A' ' 8' ' ' THR . 3.3 mp -103.21 107.79 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -175.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.0 m -75.8 108.06 8.4 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 173.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.24 123.51 19.73 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 123.704 0.628 . . . . 0.0 110.092 178.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.2 mt -73.84 -43.54 58.39 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.97 0.908 . . . . 0.0 109.12 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -126.45 155.46 42.19 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 124.912 1.285 . . . . 0.0 108.457 171.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.2 m -125.93 74.76 71.39 Favored Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 123.755 0.822 . . . . 0.0 110.939 176.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.39 164.38 35.38 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.427 2.084 . . . . 0.0 111.735 170.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -76.52 92.72 3.46 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.968 0.907 . . . . 0.0 109.85 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.93 -166.42 54.0 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-N 115.472 -0.785 . . . . 0.0 113.297 175.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.36 -104.24 1.02 Allowed Glycine 0 C--N 1.346 1.135 0 C-N-CA 123.74 0.685 . . . . 0.0 114.123 173.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -122.33 143.21 49.78 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.343 1.057 . . . . 0.0 109.901 -172.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.3 m-90 -124.57 145.31 49.66 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.169 0.988 . . . . 0.0 109.423 174.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -90.35 126.0 35.72 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 164.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.99 172.43 22.89 Favored Glycine 0 N--CA 1.467 0.766 0 O-C-N 123.621 0.575 . . . . 0.0 112.037 -176.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -131.87 145.13 51.35 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.228 0.537 . . . . 0.0 110.081 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.509 ' HG2' ' H ' ' A' ' 46' ' ' ASP . 64.9 tttp -71.75 154.8 41.08 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 164.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -64.41 -20.44 66.15 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.048 0.539 . . . . 0.0 111.856 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.509 ' H ' ' HG2' ' A' ' 44' ' ' LYS . 37.8 t70 -65.71 -20.36 66.25 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.166 0.987 . . . . 0.0 111.793 172.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.01 -16.13 30.58 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.196 176.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.3 mt -66.1 134.22 52.36 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 117.263 0.531 . . . . 0.0 110.501 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.9 mtt85 -113.38 142.54 45.75 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.287 1.035 . . . . 0.0 111.062 -174.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.17 154.91 25.94 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.646 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -96.05 127.57 42.18 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -146.76 148.77 34.31 Favored Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 124.18 0.992 . . . . 0.0 110.439 -173.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -84.82 -176.82 2.6 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.129 2.552 . . . . 0.0 111.911 174.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.39 -15.11 62.81 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.741 0.816 . . . . 0.0 111.926 176.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.5 m -55.45 -40.0 71.03 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.069 1.348 . . . . 0.0 113.335 -175.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -90.89 -29.05 17.72 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.999 0.52 . . . . 0.0 111.589 -175.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.55 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 35.3 m -105.39 -179.8 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.369 0.668 . . . . 0.0 110.52 -173.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -134.59 124.06 24.83 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.688 0.795 . . . . 0.0 109.128 175.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.447 HD23 ' SG ' ' A' ' 6' ' ' CYS . 74.0 mt -69.95 117.28 11.33 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.527 HD11 ' HG3' ' A' ' 7' ' ' ARG . 64.4 mt . . . . . 0 CA--C 1.548 0.879 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptp . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.7 t 60.18 82.32 0.16 Allowed 'General case' 0 CA--C 1.548 0.875 0 O-C-N 124.662 1.226 . . . . 0.0 111.09 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.13 84.72 1.24 Allowed Glycine 0 C--N 1.345 1.054 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.805 -174.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.7 97.22 1.04 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 171.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.427 ' HB2' HD12 ' A' ' 60' ' ' LEU . 99.3 mtt180 -94.93 149.62 21.05 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.57 0.748 . . . . 0.0 110.57 -177.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.592 ' SG ' HD23 ' A' ' 59' ' ' LEU . 49.3 m -128.89 143.8 51.0 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 173.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 49.3 ttt180 -105.89 127.68 53.28 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 74.4 p -68.71 127.25 32.4 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 123.924 0.765 . . . . 0.0 109.558 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 58' ' ' GLN . 95.7 mt -70.1 -75.93 0.11 Allowed 'General case' 0 CA--C 1.537 0.468 0 O-C-N 123.459 0.474 . . . . 0.0 109.978 -177.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -151.37 137.92 11.59 Favored Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 123.634 0.774 . . . . 0.0 109.03 -177.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.37 95.53 0.61 Allowed 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.215 1.943 . . . . 0.0 111.756 175.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.52 ' HB2' ' HE1' ' A' ' 56' ' ' TYR . 52.9 m-85 -91.58 102.99 15.64 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 175.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.8 p -100.53 100.99 11.81 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.655 0.782 . . . . 0.0 109.073 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -155.84 18.36 0.49 Allowed Glycine 0 C--N 1.34 0.771 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.396 177.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -116.43 163.53 15.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.027 0.931 . . . . 0.0 109.813 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -70.35 161.51 30.31 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.737 0.415 . . . . 0.0 110.063 176.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 30.9 p80 -71.66 178.83 3.35 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.382 0.673 . . . . 0.0 111.285 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.11 89.94 2.09 Favored Glycine 0 C--N 1.343 0.923 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -174.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.8 58.89 2.25 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.871 1.268 . . . . 0.0 108.828 -176.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.45 99.92 1.83 Allowed Glycine 0 C--N 1.343 0.968 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 176.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.5 tp -88.53 127.73 35.54 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -177.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 49.3 ttt-85 -78.88 122.98 26.78 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 177.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -129.18 114.18 15.99 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.059 0.943 . . . . 0.0 109.208 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.56 143.74 51.49 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.49 0.716 . . . . 0.0 109.913 175.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.99 111.21 1.58 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.655 0.782 . . . . 0.0 111.572 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.22 3.64 24.29 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-O 119.096 -0.836 . . . . 0.0 114.794 173.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -69.63 127.3 32.47 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 118.232 1.016 . . . . 0.0 111.782 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.699 HD22 HD11 ' A' ' 60' ' ' LEU . 54.2 mt -85.37 102.15 13.18 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 175.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.595 HG21 ' HE1' ' A' ' 51' ' ' TRP . 34.8 mm -107.68 125.81 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.812 0.845 . . . . 0.0 109.448 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.1 m -81.77 136.95 35.4 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.542 0.737 . . . . 0.0 110.461 178.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.7 mt -76.71 129.4 36.28 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.846 0.858 . . . . 0.0 109.674 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.717 HD11 ' HG3' ' A' ' 43' ' ' GLU . 96.0 mt -77.02 -28.47 54.93 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.811 0.445 . . . . 0.0 110.631 174.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -155.01 147.7 24.34 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.823 0.849 . . . . 0.0 109.456 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.6 m -112.97 92.21 20.42 Favored Pre-proline 0 CA--C 1.559 1.299 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 166.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -68.58 -27.85 32.27 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.618 2.212 . . . . 0.0 111.908 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -175.85 -51.61 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.856 1.262 . . . . 0.0 109.169 175.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.93 176.84 28.53 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.851 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.25 -79.71 0.4 Allowed Glycine 0 C--N 1.347 1.153 0 N-CA-C 111.907 -0.477 . . . . 0.0 111.907 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -84.64 108.94 17.64 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.335 0.654 . . . . 0.0 109.565 171.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -113.16 178.18 4.37 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.059 0.944 . . . . 0.0 109.092 171.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 51' ' ' TRP . 0.9 OUTLIER -137.49 145.31 42.89 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.543 0.737 . . . . 0.0 109.36 173.272 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.514 ' HA2' ' HG ' ' A' ' 32' ' ' LEU . . . -154.48 178.57 31.2 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.794 -178.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.717 ' HG3' HD11 ' A' ' 32' ' ' LEU . 45.6 mt-10 -103.25 148.49 25.76 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.077 0.551 . . . . 0.0 109.799 176.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -112.83 145.09 41.24 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.693 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -69.29 -7.23 35.13 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.259 0.624 . . . . 0.0 112.432 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.69 -7.44 53.3 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.526 1.13 . . . . 0.0 111.878 172.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.76 -19.39 51.69 Favored Glycine 0 C--N 1.348 1.24 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 -177.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 65.0 mt -82.24 158.53 23.49 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.59 1.156 . . . . 0.0 110.25 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -120.53 177.76 4.93 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.898 0.879 . . . . 0.0 109.485 174.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.46 158.36 13.84 Favored Glycine 0 N--CA 1.467 0.714 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 -174.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.595 ' HE1' HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -156.06 173.24 17.1 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.494 0.664 . . . . 0.0 111.833 -171.829 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -125.54 167.16 17.32 Favored Pre-proline 0 N--CA 1.48 1.056 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.798 -173.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.36 170.52 9.31 Favored 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 122.213 1.942 . . . . 0.0 112.87 174.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.23 -15.23 56.4 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.494 1.118 . . . . 0.0 113.416 -175.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.3 p -62.51 -30.17 71.09 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.325 1.05 . . . . 0.0 113.062 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.52 ' HE1' ' HB2' ' A' ' 12' ' ' PHE . 85.1 m-85 -94.99 -6.56 42.06 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -176.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.6 m -135.39 -179.85 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 123.768 0.827 . . . . 0.0 110.397 -177.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.401 ' HB2' HD21 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -152.4 131.76 12.88 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 173.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.592 HD23 ' SG ' ' A' ' 6' ' ' CYS . 85.8 mt -65.32 133.98 52.58 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.764 0.826 . . . . 0.0 111.025 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.699 HD11 HD22 ' A' ' 28' ' ' LEU . 69.3 mt . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.896 -0.574 . . . . 0.0 109.572 177.222 . . . . . . . . 1 1 . 1 stop_ save_